data_5lg9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5lg9 _Structure_validation_residue.Date_analyzed 2016-12-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.084 0.469 . . . . 2.08 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.29 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 1.0 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.739 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.9 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 1.07 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 1.06 110.604 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 1.15 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.61 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.91 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.31 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.77 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.81 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.41 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 1.09 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' A' ' 66' ' ' PHE . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 1.3 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.21 109.436 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 1.12 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.739 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 1.09 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.37 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.86 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 2.46 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.8 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.95 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.78 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 m120 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.62 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 1.04 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 1.2 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.568 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 1.04 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.27 110.709 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.586 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 1.01 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.9 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.35 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 1.36 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.69 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.42 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 1.4 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.77 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.28 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 4.03 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 2.46 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.52 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 2.29 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.51 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.63 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.48 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.9 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.57 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 1.22 111.567 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HD22 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 1.07 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.61 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.2 t-20 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 2.15 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 1.04 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.84 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 2.01 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.92 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 2.22 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.73 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 1.11 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.3 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.79 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.18 112.088 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 1.06 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.89 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 2.0 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.28 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 1.04 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 2.43 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.687 ' O ' HG21 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.63 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 80' ' ' ILE . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 1.08 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 2.44 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.687 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 1.13 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 2.06 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.33 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.65 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 1.05 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 1.04 110.372 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 2.15 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 1.08 110.047 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 2.26 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.549 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 2.44 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 . . . . . 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 4.92 111.714 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.543 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.971 -0.752 . . . . 3.65 108.971 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.84 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 1.13 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.91 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 1.06 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.11 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 86' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 1.1 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 1.04 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.48 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 1.06 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.76 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.47 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.49 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.85 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 1.44 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 2.42 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.35 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.07 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 2.28 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 1.18 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.93 110.09 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 1.09 110.578 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.47 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 1.36 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 1.07 110.624 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.97 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.35 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.585 HG23 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 1.1 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 1.06 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.483 ' HG3' HG23 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.21 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.48 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 67' ' ' TYR . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 1.09 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.513 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 1.21 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.76 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.7 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.45 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.6 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.87 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.898 HD21 ' SD ' ' A' ' 140' ' ' MET . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 1.04 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 2.25 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 1.18 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.45 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 1.14 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 1.15 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 1.14 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.84 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 1.16 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.38 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 1.37 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.6 ' O ' HG22 ' A' ' 151' ' ' THR . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 3.01 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.423 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.7 111.294 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 1.11 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.31 109.305 168.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.28 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 1.01 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.96 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 1.08 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.771 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.95 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 2.2 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.705 0.288 . . . . 2.08 110.511 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.704 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.29 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 1.0 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.722 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.9 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.468 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 1.07 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 1.06 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.558 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 1.15 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.61 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.91 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.31 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.77 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.81 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.41 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 1.09 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 66' ' ' PHE . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 1.3 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.21 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 1.12 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.722 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 1.09 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.595 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.37 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.704 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.86 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 2.46 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.8 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.95 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.63 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.78 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.62 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 1.2 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 1.04 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.27 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 1.01 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.9 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.35 112.106 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 1.36 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.69 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.42 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.568 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 1.4 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.77 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.28 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.491 ' HA ' HG11 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 4.03 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 2.46 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.52 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 2.29 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.51 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.63 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.48 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.9 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.9 t-20 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.57 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 1.22 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 1.07 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.61 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 2.15 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 1.04 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.84 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 2.01 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.92 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.559 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 2.22 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.73 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' ILE . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.3 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.526 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 1.0 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.79 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.18 110.77 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 1.06 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.89 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 2.0 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.28 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.772 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 1.04 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 2.43 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.63 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.72 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 2.44 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 1.13 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 2.06 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.33 113.355 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.65 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 1.05 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 2.15 109.121 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 1.08 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 2.26 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 2.44 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 4.92 110.637 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.5 -0.555 . . . . 3.65 109.5 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.84 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.559 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 1.13 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.553 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.91 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 1.06 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.11 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 1.1 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 1.04 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.48 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.634 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 1.06 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.76 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.47 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.49 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.85 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 1.44 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 2.42 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.35 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 1.07 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 2.28 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 1.18 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.93 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 1.09 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.47 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 1.36 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' CB ' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 1.07 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.97 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.35 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.522 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 1.1 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.507 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 1.06 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.853 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.432 ' N ' ' HG3' ' A' ' 125' ' ' MET . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.48 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 1.09 109.726 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.489 HD13 ' HG3' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 1.21 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.435 ' HB3' ' HH ' ' A' ' 67' ' ' TYR . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.76 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.7 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.526 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.45 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.6 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.87 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.686 HD21 ' SD ' ' A' ' 140' ' ' MET . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 1.04 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 2.25 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.636 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 1.18 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.591 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.45 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 1.14 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.686 ' SD ' HD21 ' A' ' 135' ' ' LEU . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 1.15 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 1.14 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.84 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 1.16 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.634 ' CD2' HD21 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.38 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.764 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 1.03 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 1.37 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 3.01 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17 112.243 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.7 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 1.11 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.489 ' HG3' HD13 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.31 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.28 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 1.01 113.269 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.764 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.96 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.657 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 1.08 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.645 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.95 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.72 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 2.2 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.058 0.456 . . . . 2.08 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.29 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 1.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.658 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.9 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 1.07 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 1.06 110.513 -175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.475 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 1.15 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.61 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.91 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.31 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.77 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.81 111.41 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.41 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 1.09 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' PHE . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 1.3 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.21 109.579 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 1.12 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 1.09 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.37 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.86 110.823 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 2.46 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.8 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.95 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.62 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 1.04 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.724 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 1.2 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 1.04 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.27 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 1.01 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.9 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.35 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 1.36 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.69 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.42 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 1.4 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.77 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.28 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 4.03 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 2.46 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.52 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 2.29 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.51 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.63 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.48 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.9 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.57 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 1.22 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 65' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 1.07 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.61 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 2.15 109.842 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 1.04 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.84 111.117 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 2.01 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.92 111.203 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 2.22 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.443 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.11 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.514 ' O ' HG13 ' A' ' 70' ' ' ILE . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.3 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 1.0 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.79 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.18 111.34 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.708 HG21 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 1.06 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.89 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 2.0 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.568 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 1.04 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 2.43 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.63 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 1.08 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.666 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 2.44 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 1.13 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 2.06 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.33 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.65 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 HD13 ' HE2' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 1.05 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.435 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.04 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 2.15 108.986 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 2.26 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 2.44 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.724 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 4.92 111.369 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.698 -0.482 . . . . 3.65 109.698 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.84 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 1.13 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.634 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.91 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 1.06 111.584 -169.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.11 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 1.1 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 1.04 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.404 ' HB2' ' HZ1' ' A' ' 104' ' ' LYS . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.48 109.957 173.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.635 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 1.06 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HE3' HG21 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.76 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.47 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.476 ' O ' HG21 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.49 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.85 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 1.44 110.619 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 2.42 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.35 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 1.07 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 2.28 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 1.18 111.732 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.93 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 1.09 109.824 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.47 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 1.36 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG12 ' CB ' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 1.07 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.432 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.97 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.35 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.482 HG21 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 1.1 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 1.06 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.469 ' HG3' HG23 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.21 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.437 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.48 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 1.09 110.409 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.545 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 1.21 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.76 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.7 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.468 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.45 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.6 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.87 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 140' ' ' MET . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 1.04 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 2.25 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.672 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 1.18 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.45 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 1.14 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.672 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 1.15 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 1.14 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.522 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.84 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 1.16 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD22 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.38 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 1.03 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 1.37 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HB2' HD23 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 3.01 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.451 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.7 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 1.11 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.545 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.31 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.28 115.217 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 1.01 113.355 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.96 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 1.08 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.95 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.666 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 2.2 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.059 -0.348 . . . . 2.08 110.059 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.559 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.29 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 1.0 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.773 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.9 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 1.07 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 1.06 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 1.15 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.61 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.91 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.31 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.77 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.81 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.587 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.41 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 1.09 110.251 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 9' ' ' LEU . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 1.3 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.21 109.572 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 1.12 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.704 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 1.09 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.86 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 2.46 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.8 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.95 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.773 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.78 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.62 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 1.04 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 1.2 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.663 ' SD ' HG22 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 1.04 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.27 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 1.01 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.9 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.35 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 1.36 109.289 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.69 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.42 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 1.4 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.77 113.028 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.28 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.584 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 4.03 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 2.46 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.52 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 2.29 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.51 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.63 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.48 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.9 111.388 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.458 HD21 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.57 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' HD21 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 1.22 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HD22 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 1.07 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.61 112.035 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 2.15 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 HG22 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 1.04 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.84 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 2.01 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.92 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' CE ' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 2.22 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.73 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 1.11 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.3 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.578 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 1.0 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.79 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.18 110.794 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 1.06 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.89 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 2.0 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.747 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 1.04 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 2.43 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.63 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 1.08 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 2.44 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 1.13 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 2.06 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.33 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.65 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 1.05 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 2.15 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 1.08 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 2.26 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 2.44 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 4.92 111.24 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.594 -0.521 . . . . 3.65 109.594 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.84 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.499 HG12 ' CE ' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 1.13 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.91 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 1.06 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.11 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 1.1 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.48 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 145' ' ' PHE . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 1.06 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.76 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.47 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.49 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.85 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 1.44 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 2.42 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.35 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 1.07 109.98 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 2.28 109.548 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 1.18 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.93 110.592 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 1.09 110.85 172.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.47 110.097 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 1.36 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 1.07 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.97 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.35 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.464 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 1.1 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 1.06 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.21 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.48 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.45 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 1.09 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 132' ' ' SER . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 1.21 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.76 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.7 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.45 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.6 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.87 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 145' ' ' PHE . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 1.04 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.505 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 2.25 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.707 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 1.18 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.45 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 1.14 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.707 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 1.15 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 1.14 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.84 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.425 ' HB3' ' HE2' ' A' ' 140' ' ' MET . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 1.16 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.38 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 1.03 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 1.37 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB2' HD23 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 3.01 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.7 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 1.11 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.484 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.31 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.28 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 1.01 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.96 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 1.08 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.95 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 2.2 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.913 -0.403 . . . . 2.08 109.913 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.29 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 1.0 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.745 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.9 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 1.07 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 1.06 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 1.15 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.61 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.91 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.31 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.77 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.81 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.625 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.41 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 1.09 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' CD1' ' A' ' 66' ' ' PHE . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 1.3 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.21 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 1.12 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.727 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 1.09 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.697 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.86 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 2.46 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.8 109.458 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.95 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.745 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.78 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.62 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 1.04 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 1.2 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.613 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 1.04 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.411 ' O ' HD23 ' A' ' 84' ' ' LEU . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.27 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 1.01 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.9 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.35 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 1.36 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.69 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.42 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 1.4 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.457 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.77 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.28 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG11 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 4.03 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 2.46 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.52 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 2.29 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.51 110.995 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.63 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.48 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.9 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.57 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 1.22 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 65' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 1.07 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.61 112.316 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 2.15 111.066 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 1.04 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.84 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 2.01 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.92 111.07 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 2.22 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.73 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 1.11 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 70' ' ' ILE . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.3 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 1.0 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.412 ' O ' ' SG ' ' A' ' 71' ' ' CYS . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.79 110.914 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.18 111.192 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.642 ' O ' HG12 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 1.06 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 68' ' ' SER . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.89 109.894 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.7 mm100 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 2.0 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.28 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 1.04 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 2.43 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.63 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 1.08 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.699 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 2.44 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 1.13 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 2.06 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.33 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.65 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 1.05 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.489 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 1.04 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 1.08 110.277 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 8.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 2.26 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 2.44 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 4.92 111.754 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.702 -0.481 . . . . 3.65 109.702 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.84 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.489 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 1.13 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.91 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 1.06 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.11 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 1.1 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.437 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 1.04 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.872 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.48 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 1.06 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.76 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.47 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.49 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.85 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 1.44 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 2.42 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.35 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 1.07 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 14.0 m120 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 2.28 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 1.18 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.489 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 1.09 111.135 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.47 109.537 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 1.36 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 1.07 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.97 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.35 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.634 HG21 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 1.1 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 1.06 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.872 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.21 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.403 ' N ' ' HG3' ' A' ' 125' ' ' MET . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.48 110.051 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 1.09 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 131' ' ' GLY . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.76 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.7 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.413 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.45 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.6 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.87 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 145' ' ' PHE . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 1.04 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 138' ' ' LYS . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 1.18 110.153 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' N ' HG21 ' A' ' 137' ' ' VAL . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.45 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 1.14 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.539 ' HE1' ' SD ' ' A' ' 144' ' ' MET . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 1.15 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 1.14 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' O ' HG13 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.84 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.539 ' SD ' ' HE1' ' A' ' 140' ' ' MET . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 1.16 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.535 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.653 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 1.03 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 1.37 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 3.01 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.7 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 1.11 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.519 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.31 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.28 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 1.01 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.96 110.742 166.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 1.08 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.95 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.699 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 2.2 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.227 0.537 . . . . 2.08 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.29 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 1.0 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.776 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.9 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 1.07 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 1.06 110.645 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.616 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 1.15 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.61 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.91 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.31 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.77 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.81 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.616 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.41 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 1.09 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 66' ' ' PHE . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 1.3 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.21 109.491 -173.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 1.12 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.776 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 1.09 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.37 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HE3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.86 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 2.46 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.8 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.95 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.78 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.62 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 1.04 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 1.2 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.591 ' SD ' HG22 ' A' ' 70' ' ' ILE . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 1.04 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.27 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.602 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 1.01 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.9 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.495 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.35 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 1.36 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.69 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.42 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 1.4 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 41' ' ' VAL . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.77 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.28 111.146 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.534 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 4.03 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 2.46 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93 110.605 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.52 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.483 ' N ' HG13 ' A' ' 47' ' ' VAL . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 2.29 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.51 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.63 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.48 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.9 111.464 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.57 110.47 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 1.22 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HD23 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 1.07 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.61 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 2.15 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 1.04 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.84 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 2.01 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.92 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 2.22 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.73 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 1.11 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.546 ' O ' HG13 ' A' ' 70' ' ' ILE . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.3 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.79 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.18 111.485 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 74' ' ' VAL . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 1.06 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.89 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 mm100 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 2.0 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.602 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.28 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.761 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 1.04 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 2.43 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 80' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.63 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 1.08 111.789 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 2.44 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 1.13 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 2.06 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.33 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.65 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 1.05 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 1.04 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD13 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 2.15 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 1.08 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 2.26 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 2.44 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.594 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 4.92 110.466 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.503 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.308 -0.627 . . . . 3.65 109.308 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.84 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 1.13 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.91 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 1.06 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.11 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 1.1 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 1.04 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.87 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 1.06 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.76 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.47 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.49 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.85 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.629 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 1.44 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 2.42 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.35 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 1.07 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 2.28 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 1.18 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.93 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 1.09 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.47 109.958 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 1.36 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 1.07 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.97 112.984 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.35 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 1.1 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.427 ' HB2' HD11 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 1.06 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.87 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.21 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.48 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 1.09 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 1.21 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.76 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.7 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.418 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.45 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.6 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.87 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 140' ' ' MET . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 1.04 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 2.25 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.726 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 1.18 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.45 111.254 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 1.14 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 135' ' ' LEU . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 1.15 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 1.14 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.84 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.16 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.38 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.654 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 1.03 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 1.37 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.545 ' O ' HG21 ' A' ' 151' ' ' THR . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 3.01 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.7 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 1.11 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.31 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.28 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 1.01 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 1.08 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.654 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.95 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 2.2 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.227 0.537 . . . . 2.08 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.29 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HB1' ' CZ3' ' A' ' 23' ' ' TRP . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 1.0 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.644 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.9 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.545 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 1.07 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 1.06 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 1.15 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.61 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.91 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.31 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.77 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.81 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.41 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 1.09 110.23 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 66' ' ' PHE . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 1.3 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.21 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 1.12 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.644 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 1.09 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.583 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.37 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.553 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.86 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 2.46 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.8 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.95 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.78 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.62 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 1.04 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 1.2 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG21 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 1.04 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.27 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.601 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 1.01 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.9 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.35 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 1.36 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.69 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.42 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 1.4 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.77 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.28 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' HG13 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 4.03 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 2.46 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.52 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 2.29 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.51 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.63 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.48 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.9 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.57 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 1.22 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 1.07 109.971 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.61 111.555 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 2.15 110.748 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 1.04 111.464 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.84 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 2.01 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.92 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 2.22 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.73 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 1.11 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.3 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.79 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.18 111.582 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.675 HG21 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 1.06 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.89 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 2.0 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.601 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.28 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 1.04 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 2.43 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG21 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.63 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 1.08 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.701 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 2.44 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 1.13 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 2.06 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.33 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.65 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 1.05 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 1.04 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 2.15 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 1.08 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 2.26 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 2.44 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 4.92 111.159 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.915 -0.772 . . . . 3.65 108.915 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.84 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 1.13 110.531 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.604 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.91 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 1.06 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.11 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 1.1 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 1.04 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.48 110.26 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 1.06 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.76 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.47 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.49 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.85 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 1.44 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 2.42 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.35 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 1.07 109.636 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 2.28 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 1.18 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.93 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 1.09 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.47 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 1.36 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 1.07 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.516 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.97 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.35 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 1.1 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 1.06 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.21 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.48 111.15 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.464 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 1.09 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 1.21 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.76 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.7 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.45 111.548 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.6 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.87 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' SD ' ' A' ' 140' ' ' MET . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 1.04 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 2.25 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.659 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 1.18 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.45 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 1.14 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.659 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 1.15 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 1.14 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.535 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.84 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 1.16 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.38 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 1.03 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 1.37 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HB2' HD23 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 3.01 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17 112.027 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 3.5 t-20 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.7 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 1.11 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.31 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.28 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.639 ' HB2' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 1.01 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.96 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 1.08 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.95 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.701 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 2.2 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 2.08 111.208 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.665 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.29 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 1.0 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.715 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.9 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 1.07 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 1.06 111.052 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 1.15 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.61 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.91 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.31 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.77 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.81 111.577 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.41 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 1.09 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HB2' HG22 ' A' ' 56' ' ' ILE . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 1.3 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.21 110.26 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 1.12 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.715 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 1.09 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.495 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.37 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.86 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 2.46 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.8 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.95 111.614 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.679 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.78 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.62 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 1.04 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.638 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 1.2 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 1.04 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.27 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 1.01 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.9 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.35 112.904 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.471 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 1.36 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.69 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.42 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 1.4 111.175 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.77 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.28 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.499 ' HA ' HG13 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 4.03 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 2.46 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.52 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 2.29 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.51 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.63 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.48 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.9 111.968 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.468 ' HB3' HG22 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.57 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.22 112.102 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 1.07 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.61 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 2.15 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 1.04 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.84 111.568 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 2.01 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.92 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.564 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 2.22 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.73 111.657 -173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 1.11 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.3 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.452 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 1.0 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.79 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.18 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 1.06 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.89 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 2.0 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.28 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 1.04 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 2.43 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.63 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 1.08 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 2.44 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 1.13 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 2.06 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.33 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.65 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD13 ' HE1' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 1.05 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 1.04 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 2.15 109.381 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 1.08 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 2.26 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 2.44 107.832 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.638 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 4.92 111.443 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.98 -0.378 . . . . 3.65 109.98 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.84 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.564 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 1.13 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' CB ' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.91 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.403 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.11 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 1.1 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 1.04 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.48 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 1.06 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HE2' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.76 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.47 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.49 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.85 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 1.44 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 2.42 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.35 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 1.07 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 2.28 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 1.18 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.93 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 1.09 110.624 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.47 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 1.36 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.07 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.97 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.35 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.1 109.721 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.433 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 1.06 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.479 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.21 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.48 110.923 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.09 110.387 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.472 HD23 HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 1.21 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 98' ' ' VAL . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.76 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.7 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.45 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.87 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.706 HD23 ' SD ' ' A' ' 140' ' ' MET . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 1.04 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 2.25 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.678 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 1.18 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.45 111.171 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 1.14 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.706 ' SD ' HD23 ' A' ' 135' ' ' LEU . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 1.15 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 1.14 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 1.16 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.38 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.705 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 1.03 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 1.37 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 3.01 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.7 111.612 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 1.11 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.31 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.28 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 1.01 113.401 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.96 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 1.08 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.705 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.95 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 2.2 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.958 0.408 . . . . 2.08 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.29 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 1.0 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.784 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.9 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 1.07 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 1.06 110.878 -174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 1.15 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.61 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.91 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.31 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.77 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.81 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.41 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 1.09 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 9' ' ' LEU . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 1.3 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.21 109.811 -174.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 HD12 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 1.12 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.715 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 1.09 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.37 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.86 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 2.46 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.8 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.95 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.784 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.78 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.62 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 1.04 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 1.2 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.654 ' SD ' HG21 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 1.04 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.27 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 1.01 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.9 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.35 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 1.36 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.69 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.42 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 1.4 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.77 112.886 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.28 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HA ' HG11 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 4.03 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 2.46 110.792 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 2.29 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.63 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.48 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.9 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.57 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 1.22 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 65' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 1.07 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.61 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 2.15 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 1.04 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.84 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 2.01 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.92 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 2.22 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.73 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 1.11 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.3 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 1.0 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.79 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.18 111.508 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.654 HG21 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 1.06 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.89 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 2.0 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.28 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 1.04 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 2.43 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.63 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 1.08 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 2.44 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 1.13 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 2.06 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.33 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.65 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 1.05 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 1.04 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 2.15 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 1.08 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 2.26 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 2.44 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 . . . . . 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 4.92 111.986 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.009 0.433 . . . . 3.65 111.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.84 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.473 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 1.13 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.91 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 1.06 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.11 110.156 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.584 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 1.1 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 1.04 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.48 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.664 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 1.06 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HE3' HG23 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.76 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.47 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.49 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.85 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 1.44 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 2.42 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.35 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 2.28 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 1.18 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.93 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' CA ' ' HG1' ' A' ' 85' ' ' THR . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 1.09 110.362 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.47 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 1.36 112.324 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 122' ' ' ILE . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 1.07 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.97 112.155 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.35 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 119' ' ' VAL . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 1.1 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.497 ' HB2' HD13 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 1.06 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.439 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.21 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.48 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 1.09 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 134' ' ' SER . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 1.21 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 131' ' ' GLY . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.76 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.7 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.45 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.87 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 145' ' ' PHE . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 1.04 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 2.25 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.663 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 1.18 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.45 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 1.14 111.224 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.663 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 1.15 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 1.14 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.84 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 1.16 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.664 ' CD2' HD21 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.757 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 1.03 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 1.37 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HB2' HD22 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 3.01 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.7 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 1.11 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.31 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.28 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 1.01 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.757 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.96 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.613 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 1.08 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.95 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 2.2 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.687 0.28 . . . . 2.08 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.29 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HB1' ' CZ3' ' A' ' 23' ' ' TRP . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 1.0 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.74 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.9 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 1.07 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 1.06 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 1.15 108.336 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.61 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.91 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.31 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.77 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.456 HD21 ' NE2' ' A' ' 60' ' ' GLN . 93.0 m-20 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.81 111.394 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.41 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 1.09 110.208 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 66' ' ' PHE . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 1.3 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.21 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 1.12 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.74 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 1.09 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.544 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.37 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.86 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 2.46 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.8 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.95 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.797 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.78 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.62 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.729 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 1.2 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.71 ' SD ' HG21 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 1.04 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.27 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.579 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 1.01 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.9 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.35 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 1.36 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.69 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.42 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 1.4 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.77 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.28 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 4.03 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 2.46 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.52 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 2.29 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.575 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.51 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.63 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.48 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.9 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.575 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.57 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 1.22 111.539 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 1.07 109.432 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.61 111.813 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 2.15 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 1.04 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.456 ' NE2' HD21 ' A' ' 16' ' ' ASN . 6.6 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.84 111.873 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 2.01 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.92 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 2.22 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.73 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 1.11 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.567 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.3 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 1.0 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.603 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.79 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.18 111.619 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 1.06 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.89 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 2.0 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.579 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.28 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 1.04 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 2.43 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.63 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 1.08 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 2.44 109.297 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 1.13 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 2.06 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.33 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.65 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 1.05 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 1.04 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 2.15 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 1.08 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 2.26 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 4.92 111.31 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 3.65 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.84 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 1.13 110.686 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.91 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 1.06 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.11 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 1.1 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 1.04 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.48 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 1.06 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.76 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.47 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.49 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.85 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 1.44 110.475 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 2.42 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.35 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 1.07 109.404 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 2.28 109.337 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 1.18 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.93 110.272 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 1.09 110.608 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.47 109.951 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 1.36 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 1.07 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.97 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.35 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.583 HG21 ' CD ' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 1.1 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.501 ' HB2' HD11 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 1.06 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.21 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.416 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.48 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 1.09 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 1.21 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.76 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.7 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.45 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.6 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.87 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 140' ' ' MET . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 1.04 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 2.25 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.761 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 1.18 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.45 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 1.14 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.761 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 1.15 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 1.14 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.84 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 1.16 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.669 ' CD2' HD21 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.38 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.779 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 1.03 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 1.37 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 3.01 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.7 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 1.11 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.31 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.28 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 1.01 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.779 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.96 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 1.08 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.642 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.95 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 2.2 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.707 -0.479 . . . . 2.08 109.707 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.29 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 1.0 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.716 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.9 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 1.07 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 1.06 110.937 -174.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 1.15 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.61 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.91 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.31 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.77 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.81 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.41 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 1.09 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 66' ' ' PHE . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 1.3 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.21 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 1.12 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 1.09 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.545 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.37 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.86 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 2.46 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.8 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 27' ' ' LYS . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.95 110.71 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.713 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.78 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.62 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 1.04 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.573 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 1.2 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.669 ' SD ' HG22 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 1.04 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.27 110.943 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 1.01 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.9 109.614 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.35 112.501 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 1.36 109.34 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.69 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.42 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 1.4 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.77 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.28 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 4.03 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.436 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 2.46 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.52 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 2.29 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.51 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.63 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.48 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.9 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' CG ' ' HD3' ' A' ' 49' ' ' ARG . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.57 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 1.22 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 1.07 109.745 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.61 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' SER . 3.8 t-20 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 2.15 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 1.04 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.84 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 2.01 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.92 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 2.22 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.483 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.73 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 1.11 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.3 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.492 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 1.0 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.79 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.18 111.187 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.669 HG22 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 1.06 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 68' ' ' SER . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.89 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 2.0 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.28 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.751 HG23 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 1.04 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 2.43 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.646 ' O ' HG21 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.63 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 1.08 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 2.44 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.646 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 1.13 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 2.06 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.33 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.65 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 1.05 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.411 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 1.04 110.357 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 2.15 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 1.08 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 2.26 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 2.44 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.573 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 4.92 111.452 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.642 -0.503 . . . . 3.65 109.642 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.84 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 1.13 110.504 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.91 108.918 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 1.06 113.156 -167.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.11 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.1 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 1.04 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 1.06 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.76 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.47 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.408 ' O ' HG21 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.49 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.85 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 1.44 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 2.42 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.35 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 1.07 108.941 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 2.28 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 1.18 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.93 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 1.09 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.47 109.446 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.426 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 1.36 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 122' ' ' ILE . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 1.07 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.97 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.35 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 1.1 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 1.06 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.751 ' SD ' HG23 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.21 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.469 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.48 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 1.09 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.76 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.7 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.45 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.6 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.87 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 1.04 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 2.25 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.735 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 1.18 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' HG23 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.45 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 1.14 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.735 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 1.15 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 1.14 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.84 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 1.16 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.605 ' CD2' HD22 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.38 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 1.03 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 1.37 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 3.01 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.508 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 4.2 t-20 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.7 111.237 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 1.11 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.546 ' CB ' HD11 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.31 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.28 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 1.01 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.508 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.96 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.656 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 1.08 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.95 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 2.2 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.221 0.534 . . . . 2.08 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.29 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 1.0 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.9 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 73' ' ' PHE . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 1.07 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 1.06 110.621 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.524 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 1.15 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.61 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.91 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.31 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.77 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.81 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.41 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 1.09 110.432 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 HD22 ' CD1' ' A' ' 66' ' ' PHE . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.3 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.21 109.735 -174.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 1.12 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 1.09 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.37 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.86 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 2.46 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.8 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.95 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.648 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.62 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 1.04 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.617 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 1.2 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.767 ' SD ' HG21 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 1.04 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.401 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.27 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 1.01 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.9 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.35 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 1.36 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.69 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.42 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 1.4 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.77 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.28 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG11 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 4.03 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 2.46 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.52 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 2.29 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.51 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.63 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.48 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.9 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.57 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 1.22 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.61 112.657 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 t30 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 2.15 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 1.04 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.84 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 2.01 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.92 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 2.22 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.73 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 1.11 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.3 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.676 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.79 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.18 110.381 171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.767 HG21 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 1.06 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.89 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 2.0 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.28 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.801 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 1.04 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 2.43 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.63 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 1.08 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 2.44 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 1.13 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 2.06 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.33 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.65 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 1.05 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 1.04 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 2.15 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 1.08 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 2.26 109.562 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 2.44 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.617 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 4.92 111.534 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.54 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.157 -0.312 . . . . 3.65 110.157 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.84 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.485 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 1.13 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.548 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.91 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 1.06 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.11 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.584 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 1.1 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 1.04 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.941 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.48 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 1.06 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HZ3' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.76 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.47 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.49 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.85 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 1.44 110.462 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 2.42 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.35 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 1.07 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 2.28 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 1.18 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.93 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 1.09 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.47 110.3 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.516 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 1.36 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 1.07 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.401 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.97 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.35 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 102' ' ' PHE . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 1.1 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 142' ' ' LYS . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 1.06 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.941 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.21 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.48 111.76 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 1.09 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 1.21 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.76 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.7 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.45 110.395 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.6 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.87 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 140' ' ' MET . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 1.04 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 2.25 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.677 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 1.18 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.45 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 1.14 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.677 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 1.15 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 1.14 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.84 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 1.16 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.7 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 1.03 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 1.37 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.519 ' HB2' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 3.01 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.7 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 1.11 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.31 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.28 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 1.01 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.7 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.96 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 1.08 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.95 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.581 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 2.2 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.433 0.635 . . . . 2.08 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.29 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 1.0 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.7 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.9 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 1.07 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 1.06 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 1.15 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.61 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.91 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.31 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.77 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.81 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.41 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 1.09 109.964 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 1.3 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.21 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 1.12 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.7 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 1.09 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.531 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.86 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 2.46 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.8 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.95 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.78 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.3 t30 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.62 110.326 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 1.04 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.697 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 1.2 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 1.04 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.27 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.562 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 1.01 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.9 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.35 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 1.36 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.69 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.42 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 1.4 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.77 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.28 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.509 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 4.03 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 2.46 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.52 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 2.29 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.51 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.63 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.48 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.9 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.57 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 1.22 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 1.07 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.61 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.494 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.5 t-20 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 2.15 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 1.04 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.84 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 2.01 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.92 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 2.22 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.73 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 1.11 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 70' ' ' ILE . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.3 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 1.0 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.79 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.18 111.107 173.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.644 ' O ' HG11 ' A' ' 74' ' ' VAL . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 1.06 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.89 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 2.0 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.28 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.817 HG13 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 1.04 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 2.43 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.703 ' O ' HG21 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.63 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.08 111.511 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 2.44 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 1.13 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 2.06 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.33 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.65 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 HD12 ' HE2' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 1.05 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.45 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 1.04 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HG ' HD11 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 2.15 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 1.08 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 3.6 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 2.26 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 2.44 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.697 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 . . . . . 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 4.92 111.647 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.611 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.951 -0.759 . . . . 3.65 108.951 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.611 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.84 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.452 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 1.13 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.586 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.91 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 1.06 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.11 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 1.1 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 1.04 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.876 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.48 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.638 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.76 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.47 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.443 ' O ' HG21 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.49 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.85 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 1.44 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 2.42 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.35 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 1.07 109.767 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 2.28 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 1.18 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.93 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 1.09 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.47 109.791 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 1.36 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.428 ' HA ' HG21 ' A' ' 122' ' ' ILE . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 1.07 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.97 112.042 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.35 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 1.1 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 1.06 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.876 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.21 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.48 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 1.09 110.197 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 1.21 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.76 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.7 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.45 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.6 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.87 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.617 HD22 ' SD ' ' A' ' 140' ' ' MET . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 1.04 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 2.25 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.673 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 1.18 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 138' ' ' LYS . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.45 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 1.14 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.673 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 1.15 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 1.14 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.84 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 1.16 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CD2' HD22 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.38 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 1.03 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 1.37 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HB2' HD23 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 3.01 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.7 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 1.11 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.31 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.28 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 1.01 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.96 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 1.08 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.95 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 2.2 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.034 0.445 . . . . 2.08 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.29 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 1.0 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.672 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.9 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' CD2' ' A' ' 73' ' ' PHE . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 1.07 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 1.06 110.563 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 1.15 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.61 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.91 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.31 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.77 110.359 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.81 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.41 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 1.09 110.024 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' CD1' ' A' ' 66' ' ' PHE . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 1.3 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.21 109.523 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 1.12 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 1.09 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.37 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.86 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 2.46 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.8 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.95 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.78 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.62 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 1.04 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.625 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 1.2 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' HG22 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.27 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 1.01 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.9 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.35 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 1.36 109.785 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.69 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.42 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 1.4 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.77 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.28 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 4.03 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 2.46 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.52 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 2.29 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.51 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.63 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.48 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.9 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.57 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 1.22 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 1.07 109.603 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.61 112.043 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 2.15 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 1.04 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.84 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 2.01 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.43 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.92 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 2.22 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.73 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 1.11 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.533 ' O ' HG13 ' A' ' 70' ' ' ILE . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.3 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 1.0 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.79 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.18 111.003 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.671 HG22 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 1.06 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.89 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 2.0 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.28 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 1.04 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 2.43 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.63 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.08 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 2.44 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 1.13 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 2.06 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.33 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.65 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.435 HD12 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 1.05 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 1.04 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 2.15 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 1.08 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 2.26 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 2.44 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.625 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 4.92 111.121 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.087 -0.338 . . . . 3.65 110.087 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.84 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 1.13 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.547 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.91 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 1.06 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.11 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 1.1 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 1.04 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.871 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.48 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 1.06 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.506 ' HD2' HG23 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.76 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.47 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.49 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.85 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 1.44 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 2.42 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.35 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 1.07 109.391 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 2.28 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 1.18 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.93 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 1.09 110.553 171.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.47 109.521 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 1.36 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 1.07 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.97 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.35 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 1.1 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.464 ' HB2' HD13 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 1.06 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.871 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.21 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.49 ' N ' ' HG3' ' A' ' 125' ' ' MET . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.48 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 1.09 108.949 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 1.21 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 131' ' ' GLY . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.76 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.7 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.45 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.6 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.87 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.693 HD23 ' SD ' ' A' ' 140' ' ' MET . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 1.04 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 2.25 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.707 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 1.18 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' N ' HG21 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.45 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 1.14 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.707 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 1.15 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 1.14 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.84 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 1.16 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.38 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.73 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 1.03 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 1.37 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.583 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 3.01 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.7 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 1.11 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.513 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.31 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.28 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 1.01 113.021 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.73 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.96 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 1.08 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.95 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 2.2 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 2.08 111.612 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.29 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 1.0 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.9 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 1.07 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 1.06 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.591 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 1.15 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.61 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.91 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.31 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.77 108.856 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.81 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.41 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 1.09 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 66' ' ' PHE . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 1.3 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.21 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 1.12 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.684 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 1.09 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.37 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.86 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 2.46 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.8 110.738 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.95 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.642 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.78 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.62 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 1.04 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.682 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 1.2 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.65 ' SD ' HG21 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.27 111.059 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.9 109.883 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.35 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.426 HG21 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 1.36 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.69 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.42 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 1.4 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.77 111.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.28 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' HA ' HG13 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 4.03 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 2.46 111.295 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.52 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 2.29 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.51 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.63 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.48 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.9 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.57 111.301 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 1.22 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 65' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 1.07 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.61 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.8 t-20 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 2.15 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 1.04 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.84 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 2.01 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.92 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 2.22 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.73 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 1.11 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.575 ' O ' HG13 ' A' ' 70' ' ' ILE . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.3 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 1.0 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.79 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.18 111.341 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.658 ' O ' HG11 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 1.06 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.89 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 2.0 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.28 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 1.04 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 2.43 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.533 ' O ' HG21 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.63 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 1.08 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 2.44 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 1.13 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 2.06 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.33 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.65 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 1.05 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 1.04 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 2.15 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 1.08 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 2.26 110.15 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 2.44 108.501 -171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.682 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 4.92 111.845 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.063 -0.347 . . . . 3.65 110.063 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.84 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.13 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.91 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 1.06 110.88 -167.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.11 110.742 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.588 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 1.1 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 1.04 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.48 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 1.06 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.76 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.47 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.49 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.85 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 1.44 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 2.42 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.35 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 1.07 109.714 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 2.28 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 1.18 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.93 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 1.09 110.061 172.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.47 109.955 -172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 1.36 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 78' ' ' LYS . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 1.07 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.97 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.35 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 1.1 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' HD13 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 1.06 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.878 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.21 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.48 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 1.09 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 1.21 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91 112.599 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.76 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.7 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.45 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.6 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.87 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.04 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 2.25 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 1.18 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.45 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 1.14 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.551 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 1.15 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 1.14 109.326 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.468 ' O ' HG11 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.84 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' HE1' ' A' ' 140' ' ' MET . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 1.16 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.551 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.38 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 1.03 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 1.37 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 3.01 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.7 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 1.11 110.357 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.31 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.28 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 1.01 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.96 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 1.08 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.95 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.605 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 2.2 111.524 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 1.8 mp0 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.085 0.469 . . . . 3.68 110.424 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -54.73 -45.9 74.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.43 -0.804 . . . . 2.38 109.915 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -97.08 123.04 40.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.084 0.469 . . . . 2.08 109.991 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.29 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 1.0 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.9 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 1.07 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 1.06 110.604 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 1.15 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.61 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.91 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.31 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.77 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.81 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.41 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 1.09 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' A' ' 66' ' ' PHE . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 1.3 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.21 109.436 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 1.12 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.739 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 1.09 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.37 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.86 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 2.46 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.8 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.95 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.641 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.78 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 m120 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.62 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 1.04 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 1.2 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.568 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 1.04 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 3' ' ' GLU . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.27 110.709 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.586 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 1.01 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.9 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.35 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 1.36 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.69 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.42 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 1.4 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.77 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.28 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 4.03 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 2.46 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.638 HG13 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.52 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.537 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 2.29 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.51 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.63 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.48 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.9 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.57 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 1.22 111.567 -171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HD22 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 1.07 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.61 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.2 t-20 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 2.15 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 1.04 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.84 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 2.01 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.92 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 2.22 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.414 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.73 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 1.11 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.3 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.535 ' O ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.79 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.18 112.088 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 1.06 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.89 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 2.0 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.28 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 1.04 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 2.43 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.687 ' O ' HG21 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.63 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 80' ' ' ILE . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 1.08 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 2.44 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.687 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 1.13 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 2.06 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.33 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.65 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 1.05 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 1.04 110.372 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 2.15 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 1.08 110.047 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 2.26 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.549 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 2.44 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 -53.91 -36.94 63.27 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 4.92 111.714 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.83 -17.28 64.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.647 0.379 . . . . 2.22 111.796 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 m -81.9 -18.17 44.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 1.99 110.811 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.8 t -118.14 -35.22 3.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 2.06 110.802 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.543 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 -94.16 134.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 108.971 -0.752 . . . . 3.65 108.971 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.84 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 1.13 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.91 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 1.06 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.11 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.455 ' CD1' HD13 ' A' ' 86' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 1.1 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 1.04 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.48 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.607 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 1.06 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.585 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.76 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.47 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.49 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.85 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 1.44 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 2.42 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.35 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 1.07 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 2.28 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 1.18 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.93 110.09 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 1.09 110.578 171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.47 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 1.36 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 1.07 110.624 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.97 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.35 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.585 HG23 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 1.1 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 1.06 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.483 ' HG3' HG23 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.21 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.48 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 67' ' ' TYR . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 1.09 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.513 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 1.21 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.76 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.7 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.45 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.6 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.87 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.898 HD21 ' SD ' ' A' ' 140' ' ' MET . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 1.04 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 2.25 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.606 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 1.18 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.45 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 1.14 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 1.15 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 1.14 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.84 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 1.16 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.607 ' CD2' HD21 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.38 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 1.37 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.6 ' O ' HG22 ' A' ' 151' ' ' THR . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 3.01 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.423 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.7 111.294 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 1.11 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.31 109.305 168.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.28 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 1.01 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.96 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 1.08 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.771 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.95 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 2.2 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.29 0.567 . . . . 3.68 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -92.37 -51.73 5.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.743 -0.662 . . . . 2.38 110.333 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -64.78 132.46 49.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 2.08 110.511 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.704 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.29 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 1.0 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.722 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.9 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 1.07 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 1.06 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.558 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 1.15 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.61 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.91 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.31 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.77 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.81 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.558 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.41 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 1.09 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 66' ' ' PHE . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 1.3 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG21 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.21 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 1.12 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.722 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 1.09 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.595 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.37 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.704 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.86 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 2.46 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.8 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.95 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.63 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.78 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.62 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.515 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 1.2 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 1.04 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.27 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 1.01 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.9 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.35 112.106 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 1.36 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.69 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.42 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.568 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 1.4 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.77 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.28 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.491 ' HA ' HG11 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 4.03 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 2.46 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.52 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 2.29 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.51 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.63 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.48 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.9 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' HB3' HG21 ' A' ' 21' ' ' ILE . 3.9 t-20 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.57 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 1.22 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 1.07 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.61 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.453 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 2.15 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 1.04 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.84 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 2.01 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.92 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.559 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 2.22 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.73 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' ILE . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.3 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.526 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 1.0 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.79 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.18 110.77 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.656 ' O ' HG12 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 1.06 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.89 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 2.0 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.28 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.772 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 1.04 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.702 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 2.43 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.63 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.72 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 2.44 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 1.13 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 2.06 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.33 113.355 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.65 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 1.05 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 2.15 109.121 174.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 1.08 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 2.26 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 2.44 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 -77.67 -23.76 49.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 4.92 110.637 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.4 -15.66 63.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 2.22 110.59 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 m -93.67 -19.16 21.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.045 -0.525 . . . . 1.99 110.351 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 m -95.58 -36.66 11.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.049 -0.523 . . . . 2.06 110.736 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 -97.62 144.18 27.51 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.822 -0.626 . . . . 3.65 109.5 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.84 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.559 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 1.13 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.553 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.91 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 1.06 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.11 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 1.1 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 1.04 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.48 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.634 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 1.06 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.76 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.47 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.49 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.85 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 1.44 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 2.42 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.35 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 1.07 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 2.28 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 1.18 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.93 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 1.09 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.47 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.464 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 1.36 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' CB ' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 1.07 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.97 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.35 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.522 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 1.1 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.507 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 1.06 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.853 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.432 ' N ' ' HG3' ' A' ' 125' ' ' MET . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.48 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 1.09 109.726 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.489 HD13 ' HG3' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 1.21 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.435 ' HB3' ' HH ' ' A' ' 67' ' ' TYR . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.553 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.76 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.7 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.526 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.45 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.6 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.87 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.686 HD21 ' SD ' ' A' ' 140' ' ' MET . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 1.04 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.501 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 2.25 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.636 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 1.18 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.591 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.45 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 1.14 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.686 ' SD ' HD21 ' A' ' 135' ' ' LEU . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 1.15 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 1.14 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.84 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 1.16 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.634 ' CD2' HD21 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.38 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.764 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 1.03 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 1.37 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 3.01 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17 112.243 -176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.7 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 1.11 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.489 ' HG3' HD13 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.31 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.28 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 1.01 113.269 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.764 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.96 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.657 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 1.08 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.645 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.95 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.72 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 2.2 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.445 0.164 . . . . 3.68 111.381 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.7 -34.65 73.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.295 0.48 . . . . 2.38 112.295 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.44 124.34 22.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 2.08 110.91 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.29 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 1.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.658 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.9 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 1.07 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 1.06 110.513 -175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.475 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 1.15 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.61 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.91 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.31 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.77 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.81 111.41 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.41 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 1.09 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 66' ' ' PHE . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 1.3 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.21 109.579 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 1.12 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.658 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 1.09 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.536 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.37 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.86 110.823 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 2.46 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.8 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.95 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.539 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.62 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 1.04 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.724 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 1.2 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 1.04 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.27 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.568 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 1.01 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.9 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.35 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 1.36 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.69 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.42 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 1.4 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.77 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.28 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.619 ' HA ' HG13 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 4.03 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 2.46 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.52 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 2.29 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.51 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.63 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.48 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.9 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.57 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 1.22 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 65' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 1.07 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.61 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 2.15 109.842 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 1.04 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.84 111.117 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 2.01 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.92 111.203 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 2.22 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 1.11 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.514 ' O ' HG13 ' A' ' 70' ' ' ILE . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.3 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 1.0 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.56 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.79 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.18 111.34 175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.708 HG21 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 1.06 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.89 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 2.0 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.568 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 1.04 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 2.43 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.63 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 1.08 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.666 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 2.44 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 1.13 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 2.06 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.33 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.65 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 HD13 ' HE2' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 1.05 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.435 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.04 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 2.15 108.986 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 2.26 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 2.44 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.724 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 -64.96 -28.16 69.33 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 4.92 111.369 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -64.79 -20.32 66.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.489 0.551 . . . . 2.22 112.489 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -93.21 -26.39 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.813 -0.355 . . . . 1.99 111.448 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 t -94.41 -33.84 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 2.06 110.739 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.48 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 -95.64 135.77 22.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.879 -0.601 . . . . 3.65 109.698 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.84 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 1.13 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.634 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.91 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 1.06 111.584 -169.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.11 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.507 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 1.1 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 1.04 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.404 ' HB2' ' HZ1' ' A' ' 104' ' ' LYS . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.48 109.957 173.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.635 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 1.06 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HE3' HG21 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.76 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.47 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.476 ' O ' HG21 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.49 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.85 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 1.44 110.619 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 2.42 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.35 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 1.07 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 2.28 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 1.18 111.732 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.93 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 1.09 109.824 171.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.47 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 1.36 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG12 ' CB ' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 1.07 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.432 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.97 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.35 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.482 HG21 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 1.1 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 1.06 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.469 ' HG3' HG23 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.21 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.437 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.48 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 1.09 110.409 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.545 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 1.21 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.406 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.634 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.76 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.7 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.468 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.45 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.6 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.87 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.563 HD22 ' SD ' ' A' ' 140' ' ' MET . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 1.04 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 2.25 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.672 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 1.18 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.45 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 1.14 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.672 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 1.15 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 1.14 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.522 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.84 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 1.16 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.635 ' CD2' HD22 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.38 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 1.03 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 1.37 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HB2' HD23 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 3.01 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.451 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.7 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.488 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 1.11 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.31 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.28 115.217 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 1.01 113.355 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.451 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.96 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 1.08 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.95 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.666 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 2.2 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.146 0.498 . . . . 3.68 110.293 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.77 -54.66 5.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 2.38 109.944 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.93 130.56 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.059 -0.348 . . . . 2.08 110.059 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.559 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.29 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 1.0 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.773 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.9 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 1.07 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 1.06 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 1.15 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.61 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.91 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.31 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.77 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.81 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.587 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.41 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 1.09 110.251 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 9' ' ' LEU . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 1.3 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.21 109.572 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 1.12 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.704 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 1.09 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.37 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.86 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 2.46 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.8 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.95 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.773 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.78 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.62 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 1.04 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 HD23 ' CZ ' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 1.2 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.663 ' SD ' HG22 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 1.04 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.27 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 1.01 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.9 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.35 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 1.36 109.289 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.69 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.42 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 1.4 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.77 113.028 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.28 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.584 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 4.03 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 2.46 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.52 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 2.29 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.51 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.63 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.48 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.9 111.388 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.458 HD21 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.57 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' HD21 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 1.22 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG22 HD22 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 1.07 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.61 112.035 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 2.15 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 HG22 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 1.04 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.84 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 2.01 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.92 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' CE ' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 2.22 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.73 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 1.11 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.559 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.3 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.578 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 1.0 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.79 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.18 110.794 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 1.06 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.89 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 2.0 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.28 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.747 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 1.04 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 2.43 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.63 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' HG12 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 1.08 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 2.44 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 1.13 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 2.06 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.33 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.65 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 1.05 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.506 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 2.15 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 1.08 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 2.26 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 2.44 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 -61.4 -35.02 76.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 4.92 111.24 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -35.34 74.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.311 0.577 . . . . 2.22 110.867 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 t -67.63 -37.22 82.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.628 -0.714 . . . . 1.99 110.745 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.0 m -97.97 -35.52 10.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.308 0.484 . . . . 2.06 112.308 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.561 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 -97.78 145.06 29.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.594 -0.521 . . . . 3.65 109.594 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.84 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.499 HG12 ' CE ' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 1.13 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.91 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 1.06 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.11 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 1.1 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.48 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.653 HD23 ' CD2' ' A' ' 145' ' ' PHE . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 1.06 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.76 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.47 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.49 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.85 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 1.44 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 2.42 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.35 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 1.07 109.98 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 2.28 109.548 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 1.18 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.93 110.592 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 1.09 110.85 172.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.47 110.097 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 1.36 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 1.07 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.97 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.35 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.464 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 1.1 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 1.06 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.21 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.54 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.48 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.45 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 1.09 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 132' ' ' SER . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 1.21 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.76 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.7 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.45 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.6 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.87 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.529 HD11 ' CD2' ' A' ' 145' ' ' PHE . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 1.04 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.505 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 2.25 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.707 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 1.18 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.45 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 1.14 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.707 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 1.15 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 1.14 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.84 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.425 ' HB3' ' HE2' ' A' ' 140' ' ' MET . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 1.16 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.653 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.38 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 1.03 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 1.37 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.514 ' HB2' HD23 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 3.01 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.7 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 1.11 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.31 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.28 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 1.01 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.96 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 1.08 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.95 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.483 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 2.2 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.113 0.482 . . . . 3.68 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.5 -43.5 23.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.192 0.52 . . . . 2.38 110.381 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.7 118.33 30.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.913 -0.403 . . . . 2.08 109.913 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.29 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 1.0 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.745 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.9 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 1.07 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 1.06 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.625 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 1.15 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.61 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.91 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.31 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.77 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.81 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.625 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.41 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 1.09 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.437 HD22 ' CD1' ' A' ' 66' ' ' PHE . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 1.3 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.21 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 HD11 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 1.12 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.727 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 1.09 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.546 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.697 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.86 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 2.46 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.8 109.458 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.95 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.745 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.78 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.62 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 1.04 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 1.2 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.613 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 1.04 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.411 ' O ' HD23 ' A' ' 84' ' ' LEU . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.27 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 1.01 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.9 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.35 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 1.36 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.69 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.42 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 1.4 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.457 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.77 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.28 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG11 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 4.03 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 2.46 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.52 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 2.29 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.51 110.995 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.63 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.48 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.9 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.57 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 1.22 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 65' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 1.07 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.61 112.316 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 2.15 111.066 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 1.04 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.84 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 2.01 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.92 111.07 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 2.22 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.73 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' O ' HD11 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 1.11 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 70' ' ' ILE . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.3 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.52 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 1.0 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.412 ' O ' ' SG ' ' A' ' 71' ' ' CYS . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.79 110.914 178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.18 111.192 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.642 ' O ' HG12 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 1.06 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 68' ' ' SER . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.89 109.894 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.7 mm100 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 2.0 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.566 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.28 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.692 HG23 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 1.04 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 2.43 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.63 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 1.08 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.699 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 2.44 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 1.13 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 2.06 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.33 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.65 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 1.05 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.489 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 1.04 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 1.08 110.277 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 8.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 2.26 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 2.44 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.638 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 -71.59 -19.69 62.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 4.92 111.754 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.82 -19.46 65.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 2.22 111.031 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -86.73 -3.91 59.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 1.99 110.95 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -115.59 -34.66 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.027 0.441 . . . . 2.06 110.513 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.638 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 -95.58 141.24 22.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.702 -0.481 . . . . 3.65 109.702 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.84 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.489 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 1.13 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.91 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 1.06 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.11 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.596 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 1.1 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.437 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 1.04 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.872 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.48 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 1.06 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.634 ' CD ' HG21 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.76 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.47 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.49 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.85 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 1.44 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 2.42 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.35 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 1.07 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 14.0 m120 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 2.28 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 1.18 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 1.09 111.135 174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.47 109.537 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 1.36 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 1.07 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.97 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.35 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.634 HG21 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 1.1 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.485 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 1.06 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.872 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.21 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.403 ' N ' ' HG3' ' A' ' 125' ' ' MET . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.48 110.051 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 1.09 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.519 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 1.21 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 131' ' ' GLY . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.76 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.7 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.413 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.45 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.6 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.87 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 145' ' ' PHE . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 1.04 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.406 HG21 ' N ' ' A' ' 138' ' ' LYS . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 1.18 110.153 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' N ' HG21 ' A' ' 137' ' ' VAL . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.45 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 1.14 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.539 ' HE1' ' SD ' ' A' ' 144' ' ' MET . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 1.15 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 1.14 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' O ' HG13 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.84 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.539 ' SD ' ' HE1' ' A' ' 140' ' ' MET . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 1.16 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.535 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.38 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.653 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 1.03 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 1.37 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 3.01 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.7 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 1.11 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.519 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.31 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.28 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 1.01 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.96 110.742 166.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 1.08 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.95 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.699 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 2.2 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.017 0.436 . . . . 3.68 110.346 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.52 -31.2 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.683 -0.689 . . . . 2.38 110.092 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -78.97 125.9 29.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 2.08 110.396 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.29 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 1.0 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.776 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.9 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 1.07 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 1.06 110.645 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.616 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 1.15 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.61 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.91 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.31 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.77 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.81 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.616 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.41 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 1.09 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD21 ' CD1' ' A' ' 66' ' ' PHE . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 1.3 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.21 109.491 -173.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 1.12 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.776 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 1.09 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.37 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HE3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.86 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 2.46 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.8 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.95 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.78 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.62 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 1.04 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 1.2 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.591 ' SD ' HG22 ' A' ' 70' ' ' ILE . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 1.04 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.27 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.602 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 1.01 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HG2' ' CE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.9 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.495 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.35 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 1.36 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.69 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.42 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 1.4 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 41' ' ' VAL . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.77 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.28 111.146 -174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.534 ' HA ' ' CG1' ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 4.03 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 2.46 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93 110.605 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.52 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.483 ' N ' HG13 ' A' ' 47' ' ' VAL . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 2.29 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.51 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.63 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.48 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.9 111.464 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.57 110.47 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 1.22 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG21 HD23 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 1.07 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.61 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 2.15 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 1.04 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.84 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 2.01 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.92 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 2.22 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.73 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 1.11 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.546 ' O ' HG13 ' A' ' 70' ' ' ILE . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.3 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.79 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.18 111.485 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.621 ' O ' HG12 ' A' ' 74' ' ' VAL . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 1.06 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.89 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 mm100 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 2.0 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.602 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.28 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.761 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 1.04 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.618 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 2.43 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 80' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.63 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 1.08 111.789 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 2.44 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 1.13 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 2.06 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.33 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.65 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 1.05 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 1.04 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD13 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 2.15 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 1.08 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 2.26 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 2.44 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.594 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 -69.14 -36.31 77.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 4.92 110.466 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -67.27 -17.28 64.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.007 -0.542 . . . . 2.22 110.548 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 m -80.07 -16.63 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.022 -0.536 . . . . 1.99 110.483 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -112.68 -31.53 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 2.06 110.514 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.503 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 -95.23 141.88 23.83 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.308 -0.627 . . . . 3.65 109.308 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.503 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.84 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 1.13 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.91 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 1.06 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.11 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 1.1 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 1.04 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.87 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.48 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 1.06 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.76 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.47 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.49 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.85 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.629 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 1.44 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 2.42 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.35 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 1.07 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 2.28 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 1.18 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.93 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 1.09 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.47 109.958 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 1.36 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 1.07 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.97 112.984 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.35 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 1.1 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.427 ' HB2' HD11 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 1.06 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.87 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.21 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.471 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.48 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.525 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 1.09 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.508 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 1.21 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.76 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.7 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.418 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.45 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.6 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.87 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 140' ' ' MET . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 1.04 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 2.25 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.726 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 1.18 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.45 111.254 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 1.14 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 135' ' ' LEU . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 1.15 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 1.14 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.84 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 1.16 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.38 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.654 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 1.03 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 1.37 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.545 ' O ' HG21 ' A' ' 151' ' ' THR . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 3.01 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.7 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 1.11 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.31 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.28 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.525 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 1.01 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 1.08 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.654 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.95 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 2.2 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.039 0.447 . . . . 3.68 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 1.2 mp0 -67.94 -45.24 74.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 2.38 111.076 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -66.64 136.78 56.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.227 0.537 . . . . 2.08 111.153 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.29 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HB1' ' CZ3' ' A' ' 23' ' ' TRP . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 1.0 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.644 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.9 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 1.07 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 1.06 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 1.15 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.61 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.91 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.31 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.77 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.81 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.41 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 1.09 110.23 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 66' ' ' PHE . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 1.3 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.21 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 1.12 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.644 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 1.09 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.583 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.37 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.553 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.86 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 2.46 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.8 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.95 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.78 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.62 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 1.04 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 1.2 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG21 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 1.04 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.27 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.601 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 1.01 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.9 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.35 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 1.36 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.69 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.42 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 1.4 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.77 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.28 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' HA ' HG13 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 4.03 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 2.46 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.52 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 2.29 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.51 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.63 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.48 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.9 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.57 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 1.22 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 1.07 109.971 -175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.61 111.555 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 2.15 110.748 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 1.04 111.464 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.84 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 2.01 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.92 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 2.22 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.73 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 1.11 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.522 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.3 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.79 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.18 111.582 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.675 HG21 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 1.06 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.89 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 2.0 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.601 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.28 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 1.04 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 2.43 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG21 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.63 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 1.08 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.701 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 2.44 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.672 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 1.13 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 2.06 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.33 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.65 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 1.05 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 1.04 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 2.15 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 1.08 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 2.26 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 2.44 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 -65.27 -32.52 74.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 4.92 111.159 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -65.13 -27.5 68.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.621 . . . . 2.22 111.442 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -89.5 -18.81 25.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 1.99 110.619 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t -92.35 -34.71 14.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.964 0.411 . . . . 2.06 110.295 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 -95.59 150.04 36.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.915 -0.772 . . . . 3.65 108.915 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.84 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 1.13 110.531 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.604 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.91 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 1.06 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.11 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 1.1 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 1.04 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.48 110.26 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 1.06 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.76 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.47 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.49 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.85 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 1.44 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 2.42 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.35 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 1.07 109.636 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 2.28 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 1.18 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.93 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 1.09 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.47 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 1.36 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 1.07 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.516 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.97 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.35 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.427 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 1.1 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 1.06 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.21 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.48 111.15 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 1.09 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 1.21 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.76 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.7 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.45 111.548 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.6 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.87 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' SD ' ' A' ' 140' ' ' MET . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 1.04 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 2.25 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.659 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 1.18 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.45 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 1.14 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.659 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 1.15 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 1.14 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.535 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.84 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 1.16 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.38 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 1.03 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 1.37 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.537 ' HB2' HD23 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 3.01 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17 112.027 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.418 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 3.5 t-20 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.7 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 1.11 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.31 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.28 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.639 ' HB2' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 1.01 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.96 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 1.08 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.95 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.701 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 2.2 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.572 0.225 . . . . 3.68 110.785 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 27' ' ' LYS . 37.2 mt-10 72.83 -52.9 0.71 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.42 0.688 . . . . 2.38 112.823 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -55.6 129.47 39.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 2.08 111.208 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.665 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.29 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 1.0 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.715 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.9 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 1.07 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 1.06 111.052 -174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 1.15 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.61 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.91 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.31 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.77 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.81 111.577 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.41 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 1.09 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' HB2' HG22 ' A' ' 56' ' ' ILE . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 1.3 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.21 110.26 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 1.12 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.715 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 1.09 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.495 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.37 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.86 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 2.46 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.8 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.95 111.614 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.679 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.78 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.62 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 1.04 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.638 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 1.2 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.575 ' SD ' HG21 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 1.04 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.423 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.27 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 1.01 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.9 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.35 112.904 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.471 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 1.36 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.69 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.42 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 1.4 111.175 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.77 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.28 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.499 ' HA ' HG13 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 4.03 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 2.46 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.52 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 2.29 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.51 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.63 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.48 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.9 111.968 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.468 ' HB3' HG22 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.57 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 1.22 112.102 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 1.07 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.61 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 2.15 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 1.04 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.84 111.568 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 2.01 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.549 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.92 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.564 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 2.22 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.73 111.657 -173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 1.11 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.578 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.3 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.452 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 1.0 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.79 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.18 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 1.06 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.89 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 2.0 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.28 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 1.04 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 2.43 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.63 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.432 ' HB3' HG13 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 1.08 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 2.44 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 1.13 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 2.06 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.471 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.33 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.65 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD13 ' HE1' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 1.05 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 1.04 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 2.15 109.381 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 1.08 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.653 ' OE1' ' HB3' ' A' ' 91' ' ' ASP . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 2.26 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 2.44 107.832 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.638 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 -62.05 -52.75 62.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 4.92 111.443 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.653 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -55.11 -32.86 62.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 2.22 111.744 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -84.18 -10.16 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.625 0.25 . . . . 1.99 111.494 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 t -118.09 -34.27 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.192 -0.317 . . . . 2.06 111.74 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 -95.63 146.88 32.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.98 -0.378 . . . . 3.65 109.98 -175.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.84 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.564 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 1.13 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' CB ' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.91 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.403 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.11 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 1.1 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 1.04 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.48 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 1.06 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HE2' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.76 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.47 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.49 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.85 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 1.44 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 2.42 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.35 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 1.07 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 2.28 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 1.18 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.93 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 1.09 110.624 170.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.47 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 1.36 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 1.07 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.97 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.35 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 1.1 109.721 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.433 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 1.06 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.479 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.21 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.48 110.923 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 1.09 110.387 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.472 HD23 HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 1.21 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 98' ' ' VAL . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.76 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.7 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.45 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.501 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.87 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.706 HD23 ' SD ' ' A' ' 140' ' ' MET . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 1.04 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 2.25 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.678 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 1.18 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.45 111.171 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 1.14 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.706 ' SD ' HD23 ' A' ' 135' ' ' LEU . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 1.15 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 1.14 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.433 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 1.16 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.68 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.38 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.705 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 1.03 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 1.37 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.542 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 3.01 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.7 111.612 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 1.11 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.31 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.28 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 1.01 113.401 173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.96 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 1.08 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.705 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.95 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 2.2 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.305 0.574 . . . . 3.68 109.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.4 -44.88 8.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.727 -0.67 . . . . 2.38 111.214 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -77.21 129.88 36.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.958 0.408 . . . . 2.08 110.726 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.29 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 1.0 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.784 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.9 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 1.07 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 1.06 110.878 -174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 1.15 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.61 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.91 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.31 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.77 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.81 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.41 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 1.09 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 9' ' ' LEU . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 1.3 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.21 109.811 -174.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 HD12 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 1.12 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.715 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 1.09 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.37 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.86 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 2.46 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.8 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.95 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.784 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.78 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.62 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 1.04 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.684 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 1.2 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.654 ' SD ' HG21 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 1.04 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.27 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 1.01 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.9 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.35 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 1.36 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.69 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.42 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 1.4 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.77 112.886 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.28 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.401 ' HA ' HG11 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 4.03 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 2.46 110.792 177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 2.29 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.63 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.48 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.9 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.57 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 1.22 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.442 HD11 ' O ' ' A' ' 65' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 1.07 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.61 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 2.15 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 1.04 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.84 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 2.01 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.92 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 2.22 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.73 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' O ' HD11 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 1.11 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.3 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 1.0 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.79 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.18 111.508 175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.654 HG21 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 1.06 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.89 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 2.0 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.553 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.28 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 1.04 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 2.43 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.714 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.63 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 1.08 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 2.44 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.714 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 1.13 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 2.06 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.33 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.65 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 1.05 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 1.04 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 2.15 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 1.08 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 2.26 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 2.44 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 -57.45 -20.08 28.16 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 4.92 111.986 175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.35 -19.13 64.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 2.22 111.572 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -23.49 58.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.15 0.5 . . . . 1.99 110.545 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -108.73 -34.31 6.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 2.06 110.486 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -89.58 135.39 30.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.764 -0.653 . . . . 3.65 111.839 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.84 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.473 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 1.13 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.91 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 HG11 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 1.06 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.11 110.156 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.584 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 1.1 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 1.04 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.48 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.664 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 1.06 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.439 ' HE3' HG23 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.76 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.47 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.49 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.85 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 1.44 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 2.42 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.35 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 2.28 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 1.18 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.93 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' CA ' ' HG1' ' A' ' 85' ' ' THR . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 1.09 110.362 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.47 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 1.36 112.324 -173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.447 ' O ' HG12 ' A' ' 122' ' ' ILE . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 1.07 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.97 112.155 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.35 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 119' ' ' VAL . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 1.1 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.497 ' HB2' HD13 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 1.06 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.439 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.21 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.48 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 1.09 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 134' ' ' SER . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 1.21 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 131' ' ' GLY . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.76 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.7 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.45 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.6 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.87 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 145' ' ' PHE . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 1.04 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 2.25 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.663 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 1.18 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.45 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 1.14 111.224 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.663 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 1.15 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 1.14 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.84 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 1.16 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.664 ' CD2' HD21 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.757 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 1.03 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 1.37 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HB2' HD22 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 3.01 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.7 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 1.11 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.31 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.28 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 1.01 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.757 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.96 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.613 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 1.08 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.95 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 2.2 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.464 0.172 . . . . 3.68 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.82 -28.32 19.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 2.38 111.453 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -95.57 117.99 31.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.387 -0.37 . . . . 2.08 110.754 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.29 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HB1' ' CZ3' ' A' ' 23' ' ' TRP . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 1.0 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.74 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.9 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 1.07 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 1.06 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 1.15 108.336 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.61 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.91 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.31 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.77 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.456 HD21 ' NE2' ' A' ' 60' ' ' GLN . 93.0 m-20 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.81 111.394 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.41 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 1.09 110.208 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 66' ' ' PHE . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 1.3 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.21 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 1.12 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.74 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 1.09 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.544 ' CZ3' ' HB1' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.37 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.86 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 2.46 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.8 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.95 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.797 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.78 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.62 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.729 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 1.2 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.71 ' SD ' HG21 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 1.04 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.27 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.579 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 1.01 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.9 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.35 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 1.36 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.69 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.42 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 1.4 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.77 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.28 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.514 ' HA ' HG11 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 4.03 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 2.46 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.52 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 2.29 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.575 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.51 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.63 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.48 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.9 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.575 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.57 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 1.22 111.539 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 1.07 109.432 -171.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.61 111.813 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 2.15 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 1.04 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.456 ' NE2' HD21 ' A' ' 16' ' ' ASN . 6.6 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.84 111.873 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 2.01 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.92 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 2.22 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.73 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 1.11 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.567 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.3 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 1.0 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.603 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.79 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.18 111.619 176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.71 HG21 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 1.06 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.89 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 2.0 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.579 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.28 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 1.04 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 2.43 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.63 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 1.08 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 2.44 109.297 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 1.13 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 2.06 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.33 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.65 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD12 ' HE1' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 1.05 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 1.04 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 2.15 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 1.08 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 2.26 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.729 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 -58.8 -32.56 69.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 4.92 111.31 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.615 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 17.8 p-10 -68.36 -18.05 64.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.313 -0.403 . . . . 2.22 111.246 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -91.01 -9.43 45.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 1.99 110.566 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.6 t -117.87 -36.56 3.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 2.06 111.057 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -97.39 147.81 33.51 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 3.65 110.49 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.84 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 1.13 110.686 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.615 ' HE2' ' O ' ' A' ' 91' ' ' ASP . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.91 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 1.06 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.11 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 1.1 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 1.04 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.48 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 1.06 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.583 ' CD ' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.76 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.47 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.49 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.85 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 1.44 110.475 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 2.42 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.35 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 1.07 109.404 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 2.28 109.337 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 1.18 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.93 110.272 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 1.09 110.608 170.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.47 109.951 -175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 1.36 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.424 HG13 ' CB ' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 1.07 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.97 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.35 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.583 HG21 ' CD ' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 1.1 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.501 ' HB2' HD11 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 1.06 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.458 ' HG3' HG23 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.21 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.416 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.48 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 1.09 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 1.21 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.423 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.76 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.7 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.45 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.6 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.87 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 140' ' ' MET . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 1.04 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 2.25 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.761 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 1.18 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.45 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 1.14 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.761 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 1.15 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 1.14 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' HG13 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.84 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 1.16 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.669 ' CD2' HD21 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.38 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.779 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 1.03 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 1.37 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' HB2' HD23 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 3.01 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.7 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 1.11 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.31 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.28 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 1.01 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.779 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.96 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.605 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 1.08 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.642 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.95 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 2.2 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.462 0.173 . . . . 3.68 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.86 -57.37 12.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.628 0.252 . . . . 2.38 110.711 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -83.3 126.52 32.77 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.12 -0.632 . . . . 2.08 109.707 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.29 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 1.0 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.716 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.9 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 1.07 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 1.06 110.937 -174.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 1.15 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.61 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.91 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.31 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.77 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.81 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.41 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 1.09 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' A' ' 66' ' ' PHE . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 1.3 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.21 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 1.12 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 1.09 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.545 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.37 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.86 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 2.46 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.8 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 27' ' ' LYS . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.95 110.71 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.713 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.78 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.62 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 1.04 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.573 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 1.2 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.669 ' SD ' HG22 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 1.04 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.27 110.943 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.555 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 1.01 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.9 109.614 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.35 112.501 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 1.36 109.34 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.69 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.42 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 1.4 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.77 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.28 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.495 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 4.03 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.436 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 2.46 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.52 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 2.29 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.51 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.63 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.48 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.9 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' CG ' ' HD3' ' A' ' 49' ' ' ARG . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.57 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 1.22 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 1.07 109.745 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.61 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' SER . 3.8 t-20 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 2.15 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 1.04 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.84 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 2.01 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.92 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 2.22 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.483 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.73 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 1.11 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.3 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.492 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 1.0 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.507 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.79 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.18 111.187 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.669 HG22 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 1.06 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 68' ' ' SER . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.89 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 2.0 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.28 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.751 HG23 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 1.04 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 2.43 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.646 ' O ' HG21 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.63 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 1.08 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 2.44 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.646 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 1.13 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 2.06 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.33 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.65 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 1.05 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.411 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 1.04 110.357 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.497 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 2.15 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 1.08 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 2.26 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 2.44 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.573 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 -62.13 -48.04 81.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 4.92 111.452 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 97' ' ' LYS . 1.8 m-20 -57.18 -23.18 45.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.896 0.379 . . . . 2.22 111.718 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -87.03 -15.55 38.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.304 -0.407 . . . . 1.99 111.337 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.5 m -118.66 -35.31 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.755 0.312 . . . . 2.06 111.779 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 -96.14 145.26 29.26 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.642 -0.503 . . . . 3.65 109.642 -177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.84 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 1.13 110.504 175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 91' ' ' ASP . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.91 108.918 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 1.06 113.156 -167.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.11 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 1.1 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 1.04 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 1.06 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.508 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.76 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.47 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.408 ' O ' HG21 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.49 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.85 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 1.44 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 2.42 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.35 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 1.07 108.941 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 2.28 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 1.18 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.93 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 1.09 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.47 109.446 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.426 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 1.36 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HA ' HG22 ' A' ' 122' ' ' ILE . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 1.07 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.97 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.35 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.508 HG23 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 1.1 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.498 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 1.06 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.751 ' SD ' HG23 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.21 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.469 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.48 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 1.09 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.76 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.7 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.443 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.45 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.6 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.87 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 1.04 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 2.25 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.735 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 1.18 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' HG23 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.45 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 1.14 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.735 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 1.15 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 1.14 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.84 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 1.16 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.605 ' CD2' HD22 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.38 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 1.03 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 1.37 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 3.01 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.508 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 4.2 t-20 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.7 111.237 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 1.11 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.546 ' CB ' HD11 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.31 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.28 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 127' ' ' VAL . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 1.01 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.508 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.96 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.656 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 1.08 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.95 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 2.2 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.851 0.357 . . . . 3.68 110.584 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.511 ' HB3' ' C ' ' A' ' 26' ' ' GLU . 37.4 mt-10 -84.38 -26.87 28.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.35 -0.386 . . . . 2.38 111.509 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.89 133.59 56.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 2.08 111.339 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.29 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 1.0 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.9 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 ' CD2' ' A' ' 73' ' ' PHE . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 1.07 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 1.06 110.621 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.524 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 1.15 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.61 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.91 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.31 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.77 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.81 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.41 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 1.09 110.432 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 HD22 ' CD1' ' A' ' 66' ' ' PHE . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 1.3 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.21 109.735 -174.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 1.12 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 1.09 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.577 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.37 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.86 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 2.46 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' C ' ' HB3' ' A' ' 4' ' ' GLU . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.8 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.95 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.648 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.78 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.62 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 1.04 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.617 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 1.2 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.767 ' SD ' HG21 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 1.04 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.401 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.27 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.556 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 1.01 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.9 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.35 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 1.36 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.69 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.42 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 1.4 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.77 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.28 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG11 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 4.03 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 2.46 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.52 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 2.29 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.51 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.63 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.48 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.9 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.57 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 1.22 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 1.07 108.861 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.61 112.657 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 t30 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 2.15 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 1.04 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.84 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 2.01 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.92 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 2.22 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.73 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 1.11 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CZ ' HD22 ' A' ' 32' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.3 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.676 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.79 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.18 110.381 171.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.767 HG21 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 1.06 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.89 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 2.0 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.28 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.801 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 1.04 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 2.43 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.63 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 1.08 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 2.44 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 1.13 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 2.06 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.33 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.65 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 1.05 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.444 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 1.04 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.584 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 2.15 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 1.08 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 2.26 109.562 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 2.44 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.617 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 -64.77 -43.31 93.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 4.92 111.534 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.75 -33.52 35.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 2.22 111.356 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.5 m -71.22 -31.25 67.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 1.99 111.583 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 m -100.75 -36.63 9.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 2.06 111.804 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.54 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 -97.36 146.92 32.2 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.383 -0.371 . . . . 3.65 110.157 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.84 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.485 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 1.13 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.91 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 1.06 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.11 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.584 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 1.1 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 1.04 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.941 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.48 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 1.06 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.47 ' HZ3' HG13 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.76 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.47 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.49 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HB2' ' HZ2' ' A' ' 107' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.85 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 1.44 110.462 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 2.42 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.35 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 1.07 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 2.28 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 1.18 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.93 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.444 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 1.09 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.47 110.3 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.516 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 1.36 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 1.07 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.401 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.97 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.35 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 102' ' ' PHE . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 1.1 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.477 ' HB3' ' HE3' ' A' ' 142' ' ' LYS . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 1.06 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.941 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.21 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.48 111.76 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 1.09 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.455 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 1.21 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.76 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.7 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.45 110.395 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.6 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.87 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 140' ' ' MET . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 1.04 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 2.25 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.677 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 1.18 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.436 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.45 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 1.14 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.677 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 1.15 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 1.14 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.84 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 1.16 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.38 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.7 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 1.03 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 1.37 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.519 ' HB2' HD23 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 3.01 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.7 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 1.11 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.31 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.28 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 1.01 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.7 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.96 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 1.08 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.95 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.581 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 2.2 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.536 0.208 . . . . 3.68 111.374 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.22 -63.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.611 0.243 . . . . 2.38 110.796 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -88.77 115.44 26.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 2.08 110.479 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.29 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' CZ3' ' A' ' 23' ' ' TRP . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 1.0 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.7 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.9 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 1.07 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 1.06 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 1.15 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.61 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.91 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.31 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.77 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.81 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.41 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 1.09 109.964 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.514 HD23 ' CD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 1.3 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.21 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 1.12 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.7 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 1.09 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.531 ' CZ3' ' HB3' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.37 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.86 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 2.46 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.454 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.8 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.95 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.78 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.3 t30 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.62 110.326 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 1.04 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.697 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 1.2 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 1.04 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.27 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.562 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 1.01 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.9 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.35 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 1.36 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.69 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.42 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 1.4 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.77 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.28 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.509 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 4.03 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 2.46 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.52 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 2.29 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.51 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.63 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.48 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.9 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.57 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 1.22 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 65' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 1.07 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.61 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.494 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.5 t-20 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 2.15 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 1.04 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.84 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 2.01 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.92 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 2.22 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.73 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 1.11 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 70' ' ' ILE . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.3 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 1.0 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.79 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.18 111.107 173.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.644 ' O ' HG11 ' A' ' 74' ' ' VAL . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 1.06 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.89 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 2.0 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.28 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.817 HG13 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 1.04 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 2.43 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.703 ' O ' HG21 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.63 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.08 111.511 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 2.44 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 1.13 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 2.06 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.33 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.65 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 HD12 ' HE2' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 1.05 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.45 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 1.04 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HG ' HD11 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 2.15 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 1.08 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 3.6 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 2.26 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 2.44 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.697 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 -57.42 -32.04 66.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 4.92 111.647 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.07 -12.98 59.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.346 -0.388 . . . . 2.22 111.765 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 t -93.96 -15.07 25.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.625 0.25 . . . . 1.99 111.064 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -116.5 -36.03 4.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.081 0.467 . . . . 2.06 110.852 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.611 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 -95.98 129.42 34.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.951 -0.759 . . . . 3.65 108.951 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.611 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.84 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.452 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 1.13 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.586 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.91 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 1.06 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.11 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 1.1 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 1.04 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.876 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.48 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.638 HD22 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 1.06 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.76 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.47 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.443 ' O ' HG21 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.49 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.85 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 1.44 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 2.42 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.35 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 1.07 109.767 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 2.28 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 1.18 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.93 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 1.09 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.47 109.791 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 1.36 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.428 ' HA ' HG21 ' A' ' 122' ' ' ILE . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 1.07 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.97 112.042 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.35 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.527 HG23 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 1.1 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 142' ' ' LYS . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 1.06 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.876 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.21 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.48 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 1.09 110.197 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 1.21 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.76 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.7 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.45 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.6 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.87 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.617 HD22 ' SD ' ' A' ' 140' ' ' MET . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 1.04 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 2.25 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.673 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 1.18 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 138' ' ' LYS . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.45 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 1.14 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.673 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 1.15 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 1.14 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.84 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 1.16 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.638 ' CD2' HD22 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.38 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 1.03 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 1.37 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HB2' HD23 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 3.01 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.415 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.7 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 1.11 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.31 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.28 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 1.01 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.415 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.96 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.604 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 1.08 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.95 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 2.2 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.669 0.271 . . . . 3.68 110.949 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.2 -54.18 7.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 2.38 110.713 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -84.42 125.81 32.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.585 -0.446 . . . . 2.08 110.042 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.29 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' VAL . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 1.0 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.672 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.9 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 ' CD2' ' A' ' 73' ' ' PHE . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 1.07 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 1.06 110.563 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.641 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 1.15 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.61 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.91 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.31 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.77 110.359 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.81 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.41 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 1.09 110.024 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD21 ' CD1' ' A' ' 66' ' ' PHE . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 1.3 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.21 109.523 -173.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 1.12 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 1.09 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.37 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.86 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 2.46 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.8 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.95 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.78 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.62 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 1.04 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.625 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 1.2 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' HG22 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.27 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.538 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 1.01 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.9 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.35 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 1.36 109.785 172.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.69 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.42 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 1.4 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.77 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.28 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 4.03 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 2.46 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.52 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 2.29 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.51 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.63 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.48 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.9 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.57 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 1.22 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 1.07 109.603 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.61 112.043 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 2.15 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 1.04 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.84 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 2.01 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.43 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.92 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 2.22 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.73 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 1.11 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.533 ' O ' HG13 ' A' ' 70' ' ' ILE . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.3 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 1.0 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.79 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.18 111.003 174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.671 HG22 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 1.06 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.89 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.499 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 2.0 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.538 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.28 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.813 HG13 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 1.04 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 2.43 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.63 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.08 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 2.44 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 1.13 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 2.06 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.33 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.65 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.435 HD12 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 1.05 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 1.04 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.452 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 2.15 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 1.08 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 2.26 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 2.44 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.625 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 -63.99 -22.87 67.11 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 4.92 111.121 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -68.16 -16.74 64.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.964 -0.562 . . . . 2.22 112.315 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -93.74 -24.01 17.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.802 -0.359 . . . . 1.99 111.439 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 t -98.86 -35.16 10.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 2.06 110.634 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.21 139.87 21.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.202 -0.454 . . . . 3.65 110.087 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.84 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 1.13 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.547 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.91 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 1.06 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.11 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 1.1 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 1.04 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.871 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.48 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 1.06 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.506 ' HD2' HG23 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.76 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.47 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.49 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.85 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 1.44 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 2.42 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.35 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 1.07 109.391 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 2.28 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 1.18 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.93 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 1.09 110.553 171.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.47 109.521 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.432 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 1.36 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 1.07 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.97 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.35 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 1.1 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.464 ' HB2' HD13 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 1.06 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.871 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.21 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.49 ' N ' ' HG3' ' A' ' 125' ' ' MET . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.48 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 1.09 108.949 172.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 1.21 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 131' ' ' GLY . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.623 ' HE2' ' HA ' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.76 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.7 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.45 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.6 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.87 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.693 HD23 ' SD ' ' A' ' 140' ' ' MET . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 1.04 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 2.25 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.707 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 1.18 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' N ' HG21 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.45 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 1.14 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.707 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 1.15 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 1.14 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.523 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.84 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 1.16 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.38 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.73 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 1.03 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 1.37 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.583 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 3.01 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.7 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 1.11 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.513 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.31 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.28 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 1.01 113.021 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.73 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.96 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 1.08 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.95 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 2.2 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.523 0.202 . . . . 3.68 111.363 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.34 -58.97 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.372 0.508 . . . . 2.38 112.372 -173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -57.09 131.76 50.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 2.08 111.612 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.29 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 1.0 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.9 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 1.07 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 1.06 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.591 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 1.15 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.61 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.91 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.31 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.77 108.856 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.81 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.41 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 1.09 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 66' ' ' PHE . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 1.3 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.21 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 1.12 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.684 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 1.09 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.37 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.86 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 2.46 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.8 110.738 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.95 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.642 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.78 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.62 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 1.04 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.682 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 1.2 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.65 ' SD ' HG21 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.27 111.059 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' A' ' 73' ' ' PHE . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.9 109.883 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.35 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.426 HG21 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 1.36 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.69 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.42 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 1.4 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.77 111.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.28 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' HA ' HG13 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 4.03 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 2.46 111.295 176.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.52 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 2.29 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.51 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.63 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.48 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.9 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.57 111.301 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 1.22 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 HD12 ' O ' ' A' ' 65' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 1.07 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.61 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.443 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.8 t-20 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 2.15 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD22 HG21 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 1.04 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.84 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 2.01 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.92 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 2.22 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.73 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 1.11 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.575 ' O ' HG13 ' A' ' 70' ' ' ILE . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.3 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 1.0 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.79 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.18 111.341 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.658 ' O ' HG11 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 1.06 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.89 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 2.0 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.551 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.28 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.826 HG13 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 1.04 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 2.43 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.533 ' O ' HG21 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.63 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB3' HG12 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 1.08 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 2.44 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 1.13 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 2.06 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.33 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.65 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 HD12 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 1.05 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' HG1' ' HA ' ' A' ' 116' ' ' PRO . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 1.04 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 2.15 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 1.08 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.445 ' HG3' ' OD2' ' A' ' 91' ' ' ASP . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 2.26 110.15 175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 2.44 108.501 -171.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.682 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 -56.24 -33.36 65.33 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 4.92 111.845 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 88' ' ' GLN . 13.0 p-10 -66.97 -15.05 63.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.113 0.412 . . . . 2.22 112.113 -172.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 m -87.32 -19.17 28.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.865 0.364 . . . . 1.99 111.052 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -110.97 -34.55 6.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.158 0.504 . . . . 2.06 110.485 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.9 143.48 26.19 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.0 -0.545 . . . . 3.65 110.063 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.84 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 1.13 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.91 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 1.06 110.88 -167.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.11 110.742 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.588 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 1.1 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 1.04 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.878 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.48 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 1.06 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.76 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.47 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.49 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.85 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 1.44 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 2.42 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.35 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 1.07 109.714 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 2.28 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 1.18 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.93 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HA ' ' HG1' ' A' ' 85' ' ' THR . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 1.09 110.061 172.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.47 109.955 -172.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 1.36 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 78' ' ' LYS . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 1.07 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.97 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.35 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 1.1 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.466 ' HB2' HD13 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 1.06 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.878 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.21 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.425 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.48 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 1.09 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 1.21 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91 112.599 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.76 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.7 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.45 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.6 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.87 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.04 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 2.25 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 1.18 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.45 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 1.14 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.551 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 1.15 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 1.14 109.326 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' O ' HG11 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.84 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' HE1' ' A' ' 140' ' ' MET . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 1.16 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.551 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.38 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 1.03 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 1.37 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' HB2' HD22 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 3.01 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.7 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 1.11 110.357 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.31 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.28 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 1.01 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.96 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 1.08 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.95 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.605 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 2.2 111.524 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.084 0.469 . . . . 1.6100000000000001 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 0.17999999999999999 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.75 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.56999999999999995 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 HD11 HD22 ' A' ' 19' ' ' LEU . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 0.16 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 0.19 110.604 -176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.535 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 0.90000000000000002 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.60999999999999999 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.3100000000000001 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.23 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.3 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.39000000000000001 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 0.40000000000000002 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 0.57999999999999996 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.19 109.436 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 0.28000000000000003 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.75 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 0.23999999999999999 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.31 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.3600000000000001 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 1.9399999999999999 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.45 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.3500000000000001 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.742 HG21 HG11 ' A' ' 22' ' ' VAL . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.1599999999999999 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.0600000000000001 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 0.20999999999999999 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.736 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 0.38 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.20000000000000001 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.23000000000000001 110.709 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 0.16 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.3799999999999999 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.34999999999999998 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 0.85999999999999999 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.1600000000000001 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.4199999999999999 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 0.72999999999999998 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.68000000000000005 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.2799999999999998 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 3.3399999999999999 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 1.9399999999999999 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93000000000000005 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.0700000000000001 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 1.6599999999999999 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.0 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.2599999999999998 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.46000000000000002 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.4300000000000002 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 21' ' ' ILE . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 0.54000000000000004 111.567 -171.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.695 HG23 HD21 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 0.25 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.23 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' SER . 64.1 t30 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 1.3999999999999999 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.695 HD21 HG23 ' A' ' 56' ' ' ILE . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.33000000000000002 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.76 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 1.5900000000000001 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 1.6799999999999999 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.0700000000000001 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 0.34000000000000002 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.23999999999999999 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 0.40000000000000002 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.22 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.17000000000000001 112.088 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 0.17999999999999999 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.1000000000000001 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.65 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 1.8200000000000001 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.20000000000000001 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 0.28000000000000003 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 1.8500000000000001 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.3100000000000001 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.23999999999999999 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 1.8799999999999999 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 0.33000000000000002 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 1.47 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.26000000000000001 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.0600000000000001 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 0.17000000000000001 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.20999999999999999 110.372 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 0.26000000000000001 110.047 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 1.9299999999999999 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 1.79 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 . . . . . 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 3.9500000000000002 111.714 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.971 -0.752 . . . . 2.8500000000000001 108.971 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.68999999999999995 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.427 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 0.35999999999999999 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.3799999999999999 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.1100000000000001 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 0.34999999999999998 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.458 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 0.33000000000000002 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.34000000000000002 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 0.25 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.22 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.41999999999999998 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.3100000000000001 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.27 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 0.79000000000000004 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.28999999999999998 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 0.31 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 1.8500000000000001 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 0.46999999999999997 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.9299999999999999 110.09 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 0.68000000000000005 110.578 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.40999999999999998 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 0.70999999999999996 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 0.23000000000000001 110.624 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.3500000000000001 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.761 HG22 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 0.37 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 0.22 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.1599999999999999 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.22 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 0.27000000000000002 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 0.42999999999999999 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.29 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.44 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.23 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.3 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.44 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 148' ' ' ARG . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.37 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 1.6599999999999999 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.634 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 0.51000000000000001 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.0600000000000001 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.39000000000000001 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 0.78000000000000003 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.1100000000000001 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66000000000000003 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 0.47999999999999998 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.29999999999999999 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.782 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.19 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 0.84999999999999998 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.796 ' HB2' HD21 ' A' ' 135' ' ' LEU . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 2.48 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17000000000000001 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.4199999999999999 111.294 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 0.40000000000000002 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.305 168.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.25 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 0.19 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.4199999999999999 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.28000000000000003 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.782 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.4399999999999999 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 1.8100000000000001 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.705 0.288 . . . . 1.6100000000000001 110.511 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.717 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.26000000000000001 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 0.17999999999999999 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.736 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.56999999999999995 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 0.16 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 0.19 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 0.90000000000000002 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.60999999999999999 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.3700000000000001 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.3100000000000001 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.23 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.3 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.39000000000000001 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 0.40000000000000002 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 69' ' ' GLY . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.19 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 53' ' ' ASN . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.28000000000000003 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 28' ' ' VAL . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 0.23999999999999999 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.31 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.717 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.3600000000000001 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 1.9399999999999999 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.3500000000000001 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG21 HG11 ' A' ' 22' ' ' VAL . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.1599999999999999 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.3 t30 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.0600000000000001 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 0.20999999999999999 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.38 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.598 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 0.16 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.3799999999999999 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.34999999999999998 112.106 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.1600000000000001 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.4199999999999999 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 0.72999999999999998 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' HG12 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.68000000000000005 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 3.3399999999999999 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93000000000000005 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.0700000000000001 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 1.6599999999999999 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.2599999999999998 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.46000000000000002 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.4300000000000002 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 21' ' ' ILE . 51.2 t30 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.0499999999999998 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 0.54000000000000004 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 0.25 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.23 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 0.33000000000000002 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.76 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 1.5900000000000001 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.9199999999999999 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.0700000000000001 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 56' ' ' ILE . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HD1' HD11 ' A' ' 19' ' ' LEU . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.23999999999999999 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 0.40000000000000002 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.22 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.17000000000000001 110.77 174.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 0.17999999999999999 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.1000000000000001 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.8200000000000001 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.20000000000000001 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.823 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 1.8500000000000001 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.3100000000000001 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 0.23999999999999999 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 1.8799999999999999 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 0.33000000000000002 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 1.47 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 113.355 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.0600000000000001 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 0.17000000000000001 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 0.20999999999999999 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 1.51 109.121 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 0.26000000000000001 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 1.9299999999999999 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 1.79 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 3.9500000000000002 110.637 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.5 -0.555 . . . . 2.8500000000000001 109.5 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.68999999999999995 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 0.35999999999999999 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.3799999999999999 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.1100000000000001 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.34999999999999998 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 0.33000000000000002 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.83 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.34000000000000002 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 0.25 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.572 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.22 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.41999999999999998 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.3100000000000001 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.27 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 0.79000000000000004 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 1.8500000000000001 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.28999999999999998 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 0.31 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 0.46999999999999997 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.9299999999999999 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 0.68000000000000005 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.40999999999999998 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 0.70999999999999996 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 0.23000000000000001 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.3500000000000001 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.3500000000000001 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.37 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.22 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.83 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.22 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.27000000000000002 109.726 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.633 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 0.42999999999999999 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91000000000000003 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.29 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.44 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.23 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.3 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.44 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 0.37 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 1.6599999999999999 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.662 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 0.51000000000000001 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.672 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.0600000000000001 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.39000000000000001 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.662 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 0.78000000000000003 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.47999999999999998 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.29999999999999999 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 0.19 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 0.84999999999999998 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HB2' HD21 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 2.48 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17000000000000001 112.243 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.4199999999999999 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 0.40000000000000002 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.599 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.3100000000000001 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.25 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 0.19 113.269 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.771 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.4199999999999999 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 0.28000000000000003 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.661 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.4399999999999999 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.731 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 1.8100000000000001 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.058 0.456 . . . . 1.6100000000000001 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 0.17999999999999999 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.56999999999999995 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.16 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 0.19 110.513 -175.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 0.90000000000000002 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.60999999999999999 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.3700000000000001 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.3100000000000001 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.23 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.3 111.41 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.39000000000000001 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 0.40000000000000002 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.669 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 0.57999999999999996 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.19 109.579 -175.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 0.28000000000000003 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.666 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 0.23999999999999999 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.31 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.3600000000000001 110.823 -172.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 1.9399999999999999 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.45 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.1599999999999999 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.0600000000000001 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.743 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 0.38 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 0.20000000000000001 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.16 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.3799999999999999 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.34999999999999998 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 0.85999999999999999 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.1600000000000001 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.4199999999999999 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 0.72999999999999998 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.68000000000000005 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.2799999999999998 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.656 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 3.3399999999999999 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 1.9399999999999999 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93000000000000005 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.0700000000000001 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 1.6599999999999999 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.0 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.2599999999999998 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.46000000000000002 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.4300000000000002 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.0499999999999998 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 0.54000000000000004 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 0.25 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.23 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 1.3999999999999999 109.842 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 0.33000000000000002 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.76 111.117 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 1.5900000000000001 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.9199999999999999 111.203 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 1.6799999999999999 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.0700000000000001 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 0.34000000000000002 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.609 ' HD1' HD11 ' A' ' 19' ' ' LEU . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.23999999999999999 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 0.40000000000000002 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.22 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.17000000000000001 111.34 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 0.17999999999999999 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.1000000000000001 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 1.8200000000000001 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.20000000000000001 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 0.28000000000000003 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 1.8500000000000001 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.608 ' O ' HG23 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 0.23999999999999999 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 1.8799999999999999 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 0.33000000000000002 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.449 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 1.47 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.26000000000000001 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.0600000000000001 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 0.17000000000000001 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.20999999999999999 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 1.51 108.986 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 1.9299999999999999 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 1.79 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 3.9500000000000002 111.369 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.698 -0.482 . . . . 2.8500000000000001 109.698 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.68999999999999995 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.433 HD12 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 0.35999999999999999 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.64 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.3799999999999999 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 0.33000000000000002 111.584 -169.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.1100000000000001 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.34999999999999998 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 0.33000000000000002 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.957 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 0.25 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE3' HG22 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.22 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.41999999999999998 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.27 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.79000000000000004 110.619 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 1.8500000000000001 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.28999999999999998 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.31 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 1.8500000000000001 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 111.732 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.9299999999999999 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 0.68000000000000005 109.824 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.446 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 0.23000000000000001 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.3500000000000001 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.3500000000000001 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.507 HG22 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 0.37 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 0.22 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.464 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.1599999999999999 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.454 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.22 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 0.27000000000000002 110.409 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.666 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 0.42999999999999999 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91000000000000003 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.64 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.29 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.44 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.23 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.3 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.44 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.666 HD12 HD21 ' A' ' 128' ' ' LEU . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 0.37 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.623 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 1.6599999999999999 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.698 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 0.51000000000000001 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 0.39000000000000001 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.698 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.78000000000000003 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 0.44 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66000000000000003 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 0.47999999999999998 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.29999999999999999 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 0.19 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.48 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17000000000000001 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.4199999999999999 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.491 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 0.40000000000000002 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.528 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.3100000000000001 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.25 115.217 171.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 0.19 113.355 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.488 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.4199999999999999 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.4399999999999999 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.681 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 1.8100000000000001 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.059 -0.348 . . . . 1.6100000000000001 110.059 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.566 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.26000000000000001 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 0.17999999999999999 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.56999999999999995 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 0.16 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 0.19 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.599 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 0.90000000000000002 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.60999999999999999 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.3700000000000001 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.3100000000000001 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.23 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.3 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.599 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.39000000000000001 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 0.40000000000000002 110.251 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD11 ' HD1' ' A' ' 66' ' ' PHE . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 0.57999999999999996 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.19 109.572 -174.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.713 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.23999999999999999 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.31 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.3600000000000001 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 1.9399999999999999 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.45 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.3500000000000001 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.785 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.1599999999999999 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.0600000000000001 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.20999999999999999 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 0.38 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.20000000000000001 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 0.16 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.3799999999999999 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.34999999999999998 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 83' ' ' LYS . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 0.85999999999999999 109.289 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.1600000000000001 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.4199999999999999 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 0.72999999999999998 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.68000000000000005 113.028 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.2799999999999998 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.678 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 3.3399999999999999 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 1.9399999999999999 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93000000000000005 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.0700000000000001 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 1.6599999999999999 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.0 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.2599999999999998 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.46000000000000002 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.4300000000000002 111.388 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.0499999999999998 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' N ' HD22 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 0.54000000000000004 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.561 HG23 HD21 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 0.25 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.23 112.035 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 1.3999999999999999 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 0.33000000000000002 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 1.5900000000000001 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.9199999999999999 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.524 ' HE2' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 1.6799999999999999 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 0.34000000000000002 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.627 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.23999999999999999 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 0.40000000000000002 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.22 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.17000000000000001 110.794 173.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 0.17999999999999999 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.1000000000000001 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.20000000000000001 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.8 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 0.28000000000000003 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 1.8500000000000001 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.3100000000000001 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 0.23999999999999999 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 1.8799999999999999 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 0.33000000000000002 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 1.47 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.26000000000000001 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HD3' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.0600000000000001 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 0.17000000000000001 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 1.51 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 0.26000000000000001 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 1.9299999999999999 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 1.79 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 3.9500000000000002 111.24 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.594 -0.521 . . . . 2.8500000000000001 109.594 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.68999999999999995 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.524 HG12 ' HE2' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 0.35999999999999999 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.3799999999999999 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.33000000000000002 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.1100000000000001 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.535 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 0.34999999999999998 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.33000000000000002 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.826 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' ASP . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 0.25 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.22 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.41999999999999998 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.3100000000000001 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.27 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 0.79000000000000004 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 1.8500000000000001 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.28999999999999998 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.31 109.98 -176.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 1.8500000000000001 109.548 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 0.46999999999999997 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.9299999999999999 110.592 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 0.68000000000000005 110.85 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.40999999999999998 110.097 -174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.683 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 0.23000000000000001 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.3500000000000001 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.3500000000000001 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.472 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 0.37 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.688 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.22 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.826 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.1599999999999999 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.22 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 0.42999999999999999 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91000000000000003 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.29 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.44 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.494 ' O ' HD23 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.23 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.3 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.44 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.37 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.724 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.51000000000000001 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.0600000000000001 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 0.39000000000000001 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.724 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 0.78000000000000003 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 0.44 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.1100000000000001 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66000000000000003 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 0.47999999999999998 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.29999999999999999 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 0.84999999999999998 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.695 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 2.48 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17000000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.4199999999999999 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 0.40000000000000002 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.3100000000000001 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.25 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 0.19 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.4199999999999999 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 0.28000000000000003 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.4399999999999999 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.509 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 1.8100000000000001 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.913 -0.403 . . . . 1.6100000000000001 109.913 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.26000000000000001 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 0.17999999999999999 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 0.16 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 0.19 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.634 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 0.90000000000000002 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.60999999999999999 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.3700000000000001 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.3100000000000001 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.23 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.3 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.39000000000000001 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 0.40000000000000002 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 0.57999999999999996 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.19 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.738 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 0.23999999999999999 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.31 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.3600000000000001 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 1.9399999999999999 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.45 109.458 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.3500000000000001 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.755 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.1599999999999999 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.0600000000000001 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 0.20999999999999999 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 0.38 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.614 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 0.20000000000000001 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 0.16 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.3799999999999999 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.34999999999999998 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 0.85999999999999999 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.1600000000000001 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.4199999999999999 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 0.72999999999999998 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.68000000000000005 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 3.3399999999999999 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 1.9399999999999999 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93000000000000005 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.0700000000000001 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 1.6599999999999999 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.0 110.995 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.2599999999999998 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.46000000000000002 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.4300000000000002 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.0499999999999998 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 0.54000000000000004 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.604 HG23 HD21 ' A' ' 59' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.23 112.316 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 1.3999999999999999 111.066 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 56' ' ' ILE . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 0.33000000000000002 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.76 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 1.5900000000000001 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.9199999999999999 111.07 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 1.6799999999999999 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.0700000000000001 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 0.34000000000000002 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.636 ' HD1' HD11 ' A' ' 19' ' ' LEU . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 0.40000000000000002 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.22 110.914 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.748 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.17000000000000001 111.192 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 0.17999999999999999 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.1000000000000001 109.894 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 87.2 mm-40 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.20000000000000001 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.28000000000000003 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 1.8500000000000001 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.3100000000000001 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.76 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 0.23999999999999999 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.709 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 1.8799999999999999 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.33000000000000002 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 1.47 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.26000000000000001 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.0600000000000001 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 0.17000000000000001 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.427 ' N ' HD13 ' A' ' 84' ' ' LEU . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 0.20999999999999999 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 0.26000000000000001 110.277 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 50.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 1.9299999999999999 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 1.79 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 3.9500000000000002 111.754 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.702 -0.481 . . . . 2.8500000000000001 109.702 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.68999999999999995 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.492 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 0.35999999999999999 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.3799999999999999 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 0.33000000000000002 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.1100000000000001 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 0.34999999999999998 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.34000000000000002 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 0.25 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.22 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.41999999999999998 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.3100000000000001 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.27 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 0.79000000000000004 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.28999999999999998 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 0.31 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 83.1 m-20 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 1.8500000000000001 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 0.68000000000000005 111.135 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.496 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 109.537 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.76 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.3500000000000001 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.3500000000000001 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.653 HG22 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 0.37 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.627 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 0.22 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.1599999999999999 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.22 110.051 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 0.27000000000000002 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 0.42999999999999999 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91000000000000003 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.29 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.44 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.23 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.3 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.44 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 148' ' ' ARG . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.37 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 0.51000000000000001 110.153 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.0600000000000001 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 0.39000000000000001 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.499 ' CB ' ' HB ' ' A' ' 108' ' ' VAL . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 0.78000000000000003 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.44 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.1100000000000001 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66000000000000003 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 0.47999999999999998 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.526 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.66 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.19 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 0.84999999999999998 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 2.48 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17000000000000001 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.4199999999999999 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 0.40000000000000002 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.603 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.3100000000000001 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.25 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 0.19 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.4199999999999999 110.742 166.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 0.28000000000000003 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.4399999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.709 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 1.8100000000000001 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.26000000000000001 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 0.17999999999999999 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.784 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.56999999999999995 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 0.16 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 0.19 110.645 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.631 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.60999999999999999 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.3700000000000001 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.3100000000000001 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.23 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.3 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.39000000000000001 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 0.40000000000000002 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.75 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 0.57999999999999996 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.19 109.491 -173.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 0.28000000000000003 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.784 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 0.23999999999999999 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.31 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HD2' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.3600000000000001 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 1.9399999999999999 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.45 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.3500000000000001 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.1599999999999999 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.0600000000000001 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 0.20999999999999999 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 0.38 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.618 ' HG2' HD12 ' A' ' 86' ' ' LEU . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 0.20000000000000001 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.23000000000000001 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 0.16 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.34999999999999998 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 0.85999999999999999 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.1600000000000001 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.4199999999999999 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 0.72999999999999998 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.68000000000000005 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' HD1' ' A' ' 46' ' ' PHE . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.146 -174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 1.9399999999999999 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 43' ' ' GLU . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93000000000000005 110.605 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.0700000000000001 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 1.6599999999999999 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.0 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.46000000000000002 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.4300000000000002 111.464 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB3' HG23 ' A' ' 21' ' ' ILE . 51.4 t30 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.0499999999999998 110.47 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 0.54000000000000004 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.632 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 0.25 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.23 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 1.3999999999999999 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 HG23 ' A' ' 56' ' ' ILE . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 0.33000000000000002 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.76 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 1.5900000000000001 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.9199999999999999 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 1.6799999999999999 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.0700000000000001 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 0.34000000000000002 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' HD1' HD11 ' A' ' 19' ' ' LEU . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.23999999999999999 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 0.40000000000000002 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.22 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.75 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.17000000000000001 111.485 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.57 HG23 ' SD ' ' A' ' 33' ' ' MET . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 0.17999999999999999 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.1000000000000001 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 mm-40 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 1.8200000000000001 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.20000000000000001 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.811 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 0.28000000000000003 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 1.8500000000000001 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HG3' HD13 ' A' ' 21' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.3100000000000001 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 0.23999999999999999 111.789 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 1.8799999999999999 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 0.33000000000000002 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 1.47 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.26000000000000001 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.0600000000000001 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 0.17000000000000001 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 0.20999999999999999 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.26000000000000001 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 1.9299999999999999 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 1.79 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.636 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 3.9500000000000002 110.466 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.512 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.308 -0.627 . . . . 2.8500000000000001 109.308 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.68999999999999995 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 0.35999999999999999 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.3799999999999999 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 0.33000000000000002 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.1100000000000001 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.567 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 0.34999999999999998 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.33000000000000002 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.846 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.34000000000000002 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 0.25 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.22 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.41999999999999998 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.3100000000000001 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.27 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.79000000000000004 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.28999999999999998 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 0.31 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 1.8500000000000001 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.46999999999999997 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.9299999999999999 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 0.68000000000000005 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.521 ' HD1' HD22 ' A' ' 111' ' ' LEU . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.40999999999999998 109.958 -173.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 120' ' ' GLN . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 0.70999999999999996 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 0.23000000000000001 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.3500000000000001 112.984 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.3500000000000001 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 0.37 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 0.22 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.846 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.1599999999999999 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.22 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 0.27000000000000002 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 0.42999999999999999 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91000000000000003 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.29 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.44 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.23 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.3 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.44 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.37 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 1.6599999999999999 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.743 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 0.51000000000000001 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' N ' HG22 ' A' ' 137' ' ' VAL . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.0600000000000001 111.254 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 0.39000000000000001 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.743 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 0.78000000000000003 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 0.44 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.1100000000000001 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66000000000000003 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 0.47999999999999998 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.637 ' CD2' HD23 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.29999999999999999 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.659 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 0.19 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 0.84999999999999998 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 135' ' ' LEU . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 2.48 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17000000000000001 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.4199999999999999 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 0.40000000000000002 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.3100000000000001 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.25 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 0.19 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.659 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.4399999999999999 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 1.8100000000000001 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.26000000000000001 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 0.17999999999999999 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.653 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.56999999999999995 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 0.16 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 0.19 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.90000000000000002 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.60999999999999999 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.3700000000000001 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.3100000000000001 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.23 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.3 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.39000000000000001 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 0.40000000000000002 110.23 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 0.57999999999999996 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.19 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 0.28000000000000003 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.653 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 0.23999999999999999 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.31 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.3600000000000001 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 1.9399999999999999 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.45 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.3500000000000001 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.0600000000000001 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HB2' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 0.38 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 0.20000000000000001 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 0.16 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.3799999999999999 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.34999999999999998 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.1600000000000001 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.4199999999999999 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 0.72999999999999998 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.68000000000000005 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.2799999999999998 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.536 ' HA ' HG12 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 3.3399999999999999 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93000000000000005 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 1.6599999999999999 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.0 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.2599999999999998 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.46000000000000002 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.4300000000000002 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.0499999999999998 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.54000000000000004 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 59' ' ' LEU . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 0.25 109.971 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.23 111.555 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 1.3999999999999999 110.748 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 56' ' ' ILE . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 0.33000000000000002 111.464 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.76 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 1.5900000000000001 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.9199999999999999 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 1.6799999999999999 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.0700000000000001 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 0.34000000000000002 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.23999999999999999 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 0.40000000000000002 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.22 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.17000000000000001 111.582 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 0.17999999999999999 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.1000000000000001 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 1.8200000000000001 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.20000000000000001 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 0.28000000000000003 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 1.8500000000000001 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.3100000000000001 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 1.8799999999999999 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 0.33000000000000002 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 1.47 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.26000000000000001 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.0600000000000001 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 0.17000000000000001 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 0.20999999999999999 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.448 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 0.26000000000000001 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 1.9299999999999999 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 1.79 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 3.9500000000000002 111.159 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.915 -0.772 . . . . 2.8500000000000001 108.915 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.68999999999999995 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 63' ' ' LYS . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.35999999999999999 110.531 174.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.3799999999999999 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 0.33000000000000002 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.1100000000000001 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 0.34999999999999998 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 0.33000000000000002 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.34000000000000002 110.26 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 0.25 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.22 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.41999999999999998 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.3100000000000001 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.27 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.79000000000000004 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 1.8500000000000001 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.28999999999999998 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 0.31 109.636 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 0.46999999999999997 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.9299999999999999 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 0.68000000000000005 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.40999999999999998 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.431 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 0.70999999999999996 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.53 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.3500000000000001 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.3500000000000001 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 0.37 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 0.22 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.1599999999999999 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.22 111.15 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.523 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 0.27000000000000002 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 0.42999999999999999 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91000000000000003 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.609 ' HE3' ' C ' ' A' ' 97' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.29 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.44 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.23 111.548 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.3 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.44 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 148' ' ' ARG . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 0.37 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 1.6599999999999999 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.687 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 0.51000000000000001 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.0600000000000001 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 0.39000000000000001 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.687 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 0.78000000000000003 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 0.44 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.1100000000000001 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66000000000000003 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.574 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.29999999999999999 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 0.19 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 0.84999999999999998 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 2.48 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17000000000000001 112.027 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 50.4 t30 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.4199999999999999 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 0.40000000000000002 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.3100000000000001 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.25 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 0.19 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.4199999999999999 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 0.28000000000000003 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.4399999999999999 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 1.8100000000000001 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 1.6100000000000001 111.208 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.681 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.26000000000000001 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 0.17999999999999999 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.725 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.56999999999999995 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 32' ' ' LEU . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 0.16 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 0.19 111.052 -174.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.60999999999999999 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.3700000000000001 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.3100000000000001 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.23 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.3 111.577 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 0.40000000000000002 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 HD11 ' A' ' 59' ' ' LEU . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 0.57999999999999996 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.19 110.26 -171.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 0.28000000000000003 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 0.23999999999999999 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.31 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.3600000000000001 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 1.9399999999999999 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.45 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.3500000000000001 111.614 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.1599999999999999 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.0600000000000001 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.646 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 0.38 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 0.20000000000000001 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 0.16 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.3799999999999999 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.34999999999999998 112.904 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.526 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 0.85999999999999999 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.1600000000000001 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.4199999999999999 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.175 -171.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.482 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.68000000000000005 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.2799999999999998 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 3.3399999999999999 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 1.9399999999999999 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93000000000000005 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.0700000000000001 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 1.6599999999999999 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.0 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.0 t30 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.2599999999999998 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.46000000000000002 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.4300000000000002 111.968 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB3' HG23 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.0499999999999998 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 21' ' ' ILE . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 0.54000000000000004 112.102 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.555 HG23 HD21 ' A' ' 59' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.23 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 1.3999999999999999 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 19' ' ' LEU . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.33000000000000002 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.76 111.568 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 1.5900000000000001 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.9199999999999999 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 1.6799999999999999 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 111.657 -173.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 0.34000000000000002 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.23999999999999999 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 0.40000000000000002 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.22 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.17000000000000001 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 0.17999999999999999 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.1000000000000001 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 1.8200000000000001 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.20000000000000001 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 1.8500000000000001 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.3100000000000001 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.23999999999999999 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 1.8799999999999999 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 0.33000000000000002 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 1.47 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.26000000000000001 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.0600000000000001 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.473 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 0.17000000000000001 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.20999999999999999 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 1.51 109.381 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 0.26000000000000001 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 1.9299999999999999 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 1.79 107.832 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 3.9500000000000002 111.443 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.98 -0.378 . . . . 2.8500000000000001 109.98 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.68999999999999995 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.35999999999999999 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.3799999999999999 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 0.33000000000000002 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.1100000000000001 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 0.33000000000000002 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 0.25 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.575 ' HE2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.22 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.41999999999999998 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.3100000000000001 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.27 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 1.8500000000000001 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.28999999999999998 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 0.31 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 0.46999999999999997 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.9299999999999999 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 0.68000000000000005 110.624 170.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.575 HG13 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 0.70999999999999996 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.67 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.3500000000000001 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 104' ' ' LYS . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.37 109.721 173.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 0.22 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.461 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.22 110.923 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.387 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 0.42999999999999999 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 131' ' ' GLY . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91000000000000003 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.29 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.44 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.23 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.3 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.44 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 0.37 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 1.6599999999999999 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 0.51000000000000001 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 138' ' ' LYS . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.0600000000000001 111.171 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 0.39000000000000001 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 0.78000000000000003 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 0.44 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66000000000000003 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.693 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.716 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 0.19 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 0.84999999999999998 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.782 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 2.48 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17000000000000001 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.475 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.4199999999999999 111.612 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 0.40000000000000002 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.3100000000000001 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.25 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 0.19 113.401 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.475 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.28000000000000003 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.716 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.4399999999999999 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 1.8100000000000001 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.958 0.408 . . . . 1.6100000000000001 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.54 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.26000000000000001 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 0.17999999999999999 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.794 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.56999999999999995 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 0.16 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 0.19 110.878 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.60999999999999999 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.3700000000000001 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.3100000000000001 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.23 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.3 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.39000000000000001 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 0.40000000000000002 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.644 HD12 ' HA3' ' A' ' 69' ' ' GLY . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 0.57999999999999996 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.19 109.811 -174.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.482 HD13 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 0.28000000000000003 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 0.23999999999999999 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.31 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.3600000000000001 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.45 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.3500000000000001 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.1599999999999999 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.0600000000000001 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 0.38 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.626 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.20000000000000001 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 0.16 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.3799999999999999 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.34999999999999998 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 0.85999999999999999 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.1600000000000001 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.4199999999999999 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 0.72999999999999998 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.68000000000000005 112.886 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.2799999999999998 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HA ' HG12 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 3.3399999999999999 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 1.9399999999999999 110.792 177.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93000000000000005 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 1.6599999999999999 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.0 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.2599999999999998 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.46000000000000002 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.4300000000000002 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.0499999999999998 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 0.54000000000000004 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.56 HG23 HD21 ' A' ' 59' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 0.25 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.23 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 1.3999999999999999 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 56' ' ' ILE . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 0.33000000000000002 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.76 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 1.5900000000000001 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.9199999999999999 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 1.6799999999999999 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.0700000000000001 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 0.34000000000000002 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.59 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.23999999999999999 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 0.40000000000000002 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.17000000000000001 111.508 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.626 HG23 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 0.17999999999999999 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.1000000000000001 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 1.8200000000000001 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 0.28000000000000003 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 1.8500000000000001 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.3100000000000001 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 0.23999999999999999 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 1.8799999999999999 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 0.33000000000000002 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 1.47 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.26000000000000001 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.0600000000000001 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 0.17000000000000001 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.20999999999999999 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 1.51 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 0.26000000000000001 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 1.9299999999999999 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 1.79 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.708 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 . . . . . 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 3.9500000000000002 111.986 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 32' ' ' LEU . 15.4 m-85 . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.009 0.433 . . . . 2.8500000000000001 111.839 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.68999999999999995 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.48 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 0.35999999999999999 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.3799999999999999 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 0.33000000000000002 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.1100000000000001 110.156 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 0.34999999999999998 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.34000000000000002 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.25 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.22 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.41999999999999998 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.3100000000000001 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.27 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 0.79000000000000004 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 1.8500000000000001 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.28999999999999998 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 0.31 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 1.8500000000000001 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.9299999999999999 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 0.68000000000000005 110.362 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.40999999999999998 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.70999999999999996 112.324 -173.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 0.23000000000000001 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 118' ' ' VAL . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.3500000000000001 112.155 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.3500000000000001 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 104' ' ' LYS . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 0.37 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 0.22 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.438 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.1599999999999999 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.431 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.22 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 0.27000000000000002 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.624 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 0.42999999999999999 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 98' ' ' VAL . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91000000000000003 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.29 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.44 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.23 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.44 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD12 HD21 ' A' ' 128' ' ' LEU . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.37 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 1.6599999999999999 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 0.51000000000000001 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.0600000000000001 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.39000000000000001 111.224 -175.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.671 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.1100000000000001 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66000000000000003 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 0.47999999999999998 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.672 ' CD2' HD23 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.29999999999999999 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.762 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.19 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 0.84999999999999998 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 2.48 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17000000000000001 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.4199999999999999 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 0.40000000000000002 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.3100000000000001 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.25 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 0.19 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.4199999999999999 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 0.28000000000000003 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.4399999999999999 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 1.8100000000000001 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.687 0.28 . . . . 1.6100000000000001 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.26000000000000001 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 0.17999999999999999 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.745 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.56999999999999995 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 0.16 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 0.19 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.409 ' CE2' ' HA2' ' A' ' 17' ' ' GLY . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 173.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.60999999999999999 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.3700000000000001 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.3100000000000001 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.23 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.3 111.394 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.39000000000000001 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 0.40000000000000002 110.208 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.671 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 0.57999999999999996 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.19 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 53' ' ' ASN . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 0.28000000000000003 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.745 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 0.23999999999999999 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.31 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.3600000000000001 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 1.9399999999999999 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.45 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.3500000000000001 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.805 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.0600000000000001 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.20999999999999999 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.749 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 0.38 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 0.20000000000000001 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.23000000000000001 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 0.16 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.3799999999999999 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.34999999999999998 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 0.85999999999999999 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.1600000000000001 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.4199999999999999 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.532 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.72999999999999998 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.68000000000000005 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.2799999999999998 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.547 ' HA ' HG12 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 3.3399999999999999 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 1.9399999999999999 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93000000000000005 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.0700000000000001 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 1.6599999999999999 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.0 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.46000000000000002 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.4300000000000002 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.0499999999999998 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 21' ' ' ILE . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 0.54000000000000004 111.539 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 0.25 109.432 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.23 111.813 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 1.3999999999999999 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 0.33000000000000002 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.76 111.873 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 1.5900000000000001 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.9199999999999999 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 1.6799999999999999 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 0.34000000000000002 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.23999999999999999 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 0.40000000000000002 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.22 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.619 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.675 HG23 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 0.17999999999999999 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.1000000000000001 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 1.8200000000000001 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.20000000000000001 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.28000000000000003 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 1.8500000000000001 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 0.23999999999999999 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 1.8799999999999999 109.297 176.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 0.33000000000000002 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 1.47 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.26000000000000001 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.0600000000000001 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 0.17000000000000001 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 0.20999999999999999 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 1.51 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 0.26000000000000001 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 1.9299999999999999 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 1.79 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 3.9500000000000002 111.31 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 2.8500000000000001 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 63' ' ' LYS . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.35999999999999999 110.686 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.3799999999999999 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 0.33000000000000002 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 0.34999999999999998 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 0.33000000000000002 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.34000000000000002 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.686 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 0.25 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.668 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.22 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.41999999999999998 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.3100000000000001 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.27 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 0.79000000000000004 110.475 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.28999999999999998 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 0.31 109.404 177.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 1.8500000000000001 109.337 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 0.46999999999999997 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.9299999999999999 110.272 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 0.68000000000000005 110.608 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.40999999999999998 109.951 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 0.70999999999999996 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.23000000000000001 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.3500000000000001 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.3500000000000001 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.668 HG22 ' HD2' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 0.37 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.624 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 0.22 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.439 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.1599999999999999 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.22 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 0.27000000000000002 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 0.42999999999999999 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91000000000000003 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.29 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.44 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.23 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.3 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.44 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 148' ' ' ARG . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 0.37 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 1.6599999999999999 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.783 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 0.51000000000000001 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.0600000000000001 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 0.39000000000000001 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.783 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.44 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66000000000000003 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 0.47999999999999998 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.686 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.29999999999999999 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.783 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.19 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 0.84999999999999998 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HB2' HD21 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 2.48 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17000000000000001 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.4199999999999999 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 0.40000000000000002 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.25 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 0.19 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.783 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.4199999999999999 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 0.28000000000000003 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.4399999999999999 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.707 -0.479 . . . . 1.6100000000000001 109.707 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.26000000000000001 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 0.17999999999999999 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.724 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.56999999999999995 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 0.16 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 0.19 110.937 -174.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.60999999999999999 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.3700000000000001 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.23 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.3 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 0.40000000000000002 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 0.57999999999999996 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.19 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.682 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 0.28000000000000003 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 0.23999999999999999 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.31 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.3600000000000001 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 1.9399999999999999 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.45 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.3500000000000001 110.71 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.723 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.0600000000000001 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 0.20999999999999999 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 0.38 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.643 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.20000000000000001 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.943 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 0.16 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.3799999999999999 109.614 179.164 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.34999999999999998 112.501 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 83' ' ' LYS . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.34 172.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.1600000000000001 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.4199999999999999 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 0.72999999999999998 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.68000000000000005 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.2799999999999998 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 3.3399999999999999 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 1.9399999999999999 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93000000000000005 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.0700000000000001 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 1.6599999999999999 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.0 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.2599999999999998 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.46000000000000002 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.4300000000000002 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.682 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.0499999999999998 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 0.25 109.745 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.23 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 15' ' ' SER . 58.5 t30 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 1.3999999999999999 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 56' ' ' ILE . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 0.33000000000000002 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.76 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 1.5900000000000001 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.9199999999999999 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 1.6799999999999999 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 0.34000000000000002 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.23999999999999999 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 0.40000000000000002 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.22 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.17000000000000001 111.187 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.643 HG23 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 0.17999999999999999 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.1000000000000001 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.20000000000000001 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.76 HG21 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 0.28000000000000003 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 1.8500000000000001 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.3100000000000001 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 0.23999999999999999 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 1.8799999999999999 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 0.33000000000000002 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 1.47 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.26000000000000001 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.0600000000000001 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.17000000000000001 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 110.357 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 1.51 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 0.26000000000000001 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 1.9299999999999999 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 1.79 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 3.9500000000000002 111.452 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.642 -0.503 . . . . 2.8500000000000001 109.642 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.68999999999999995 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 66' ' ' PHE . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 0.35999999999999999 110.504 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.3799999999999999 108.918 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 0.33000000000000002 113.156 -167.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.1100000000000001 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.511 ' HB3' ' CE ' ' A' ' 125' ' ' MET . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.34999999999999998 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 0.33000000000000002 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.34000000000000002 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 0.25 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.566 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.22 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.41999999999999998 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.3100000000000001 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.27 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 0.79000000000000004 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 1.8500000000000001 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.28999999999999998 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 1.8500000000000001 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.9299999999999999 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 0.68000000000000005 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 109.446 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 0.70999999999999996 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.23000000000000001 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.3500000000000001 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.566 HG22 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 0.37 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.76 ' SD ' HG21 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.1599999999999999 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.22 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 0.27000000000000002 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.628 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 0.42999999999999999 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91000000000000003 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.29 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.44 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.23 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.3 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.44 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.37 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.759 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.0600000000000001 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 0.39000000000000001 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.759 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 0.78000000000000003 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1100000000000001 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66000000000000003 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 0.47999999999999998 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.29999999999999999 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.507 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 0.19 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 0.84999999999999998 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.629 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 2.48 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.4199999999999999 111.237 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 0.40000000000000002 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.3100000000000001 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.25 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 0.19 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.4199999999999999 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.658 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.4399999999999999 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.506 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 1.8100000000000001 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.221 0.534 . . . . 1.6100000000000001 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.26000000000000001 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 0.17999999999999999 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.72 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.56999999999999995 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 0.16 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 0.19 110.621 -175.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.90000000000000002 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.60999999999999999 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.3100000000000001 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.23 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.3 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.39000000000000001 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 0.40000000000000002 110.432 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 0.57999999999999996 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.19 109.735 -174.164 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 0.28000000000000003 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 0.23999999999999999 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.31 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.3600000000000001 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 1.9399999999999999 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.45 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.3500000000000001 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.0600000000000001 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 0.20999999999999999 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.626 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 0.38 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.725 ' SD ' HG23 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 0.20000000000000001 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.16 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.3799999999999999 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.34999999999999998 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 0.85999999999999999 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.1600000000000001 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.4199999999999999 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 0.72999999999999998 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.68000000000000005 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.2799999999999998 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 3.3399999999999999 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93000000000000005 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.0700000000000001 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 1.6599999999999999 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.2599999999999998 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.46000000000000002 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.4300000000000002 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.0499999999999998 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.54000000000000004 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 59' ' ' LEU . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 0.25 108.861 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.23 112.657 -175.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 1.3999999999999999 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 56' ' ' ILE . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 0.33000000000000002 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.76 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 1.5900000000000001 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.9199999999999999 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 0.34000000000000002 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.23999999999999999 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.684 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 0.40000000000000002 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.22 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.17000000000000001 110.381 171.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.725 HG23 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 0.17999999999999999 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.1000000000000001 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 1.8200000000000001 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.20000000000000001 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.781 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 0.28000000000000003 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 1.8500000000000001 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.3100000000000001 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 0.23999999999999999 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG2' HG22 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 0.33000000000000002 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 1.47 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.26000000000000001 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.0600000000000001 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 0.17000000000000001 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 84' ' ' LEU . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 0.20999999999999999 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.79 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 1.51 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 0.26000000000000001 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 7.6 tp60 -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 1.9299999999999999 109.562 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 1.79 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.626 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 3.9500000000000002 111.534 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.157 -0.312 . . . . 2.8500000000000001 110.157 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.68999999999999995 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.533 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.35999999999999999 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.3799999999999999 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.33000000000000002 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.1100000000000001 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 0.34999999999999998 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 0.33000000000000002 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.916 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.25 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.22 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.41999999999999998 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.3100000000000001 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.27 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 0.79000000000000004 110.462 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 1.8500000000000001 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.28999999999999998 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 0.31 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 1.8500000000000001 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 0.46999999999999997 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.9299999999999999 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 115' ' ' GLU . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 0.68000000000000005 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.532 ' HD1' HD22 ' A' ' 111' ' ' LEU . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.3 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.499 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 0.70999999999999996 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.722 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 0.23000000000000001 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.414 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.3500000000000001 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.3500000000000001 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' HE2' ' A' ' 104' ' ' LYS . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 0.37 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 0.22 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.916 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.1599999999999999 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.22 111.76 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 0.27000000000000002 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.463 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 0.42999999999999999 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91000000000000003 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.29 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.44 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 128' ' ' LEU . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.23 110.395 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.3 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 148' ' ' ARG . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.37 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 0.51000000000000001 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.458 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 0.78000000000000003 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 0.44 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66000000000000003 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 0.47999999999999998 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.29999999999999999 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.704 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 0.19 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 0.84999999999999998 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 2.48 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17000000000000001 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.4199999999999999 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 0.40000000000000002 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.25 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 0.19 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.704 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 0.28000000000000003 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.582 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 1.8100000000000001 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.433 0.635 . . . . 1.6100000000000001 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.26000000000000001 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 0.17999999999999999 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 19' ' ' LEU . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 0.16 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 0.19 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.60999999999999999 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.3700000000000001 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.3100000000000001 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.23 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.3 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.39000000000000001 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 0.40000000000000002 109.964 174.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.623 HD11 ' HD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 0.57999999999999996 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.19 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 0.28000000000000003 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 0.23999999999999999 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.3600000000000001 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 1.9399999999999999 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.45 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.3500000000000001 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.0600000000000001 110.326 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 0.20999999999999999 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.38 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.609 ' SD ' HG23 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 0.20000000000000001 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 0.16 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.3799999999999999 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 0.85999999999999999 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.1600000000000001 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.4199999999999999 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.72999999999999998 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.68000000000000005 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 3.3399999999999999 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 1.9399999999999999 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93000000000000005 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.0700000000000001 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.0 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.2599999999999998 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.46000000000000002 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.4300000000000002 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.0499999999999998 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 0.54000000000000004 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 0.25 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.23 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.9 t30 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 1.3999999999999999 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 0.33000000000000002 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.76 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 1.5900000000000001 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.9199999999999999 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 1.6799999999999999 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.0700000000000001 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.623 ' HD1' HD11 ' A' ' 19' ' ' LEU . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.23999999999999999 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 0.40000000000000002 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.22 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.17000000000000001 111.107 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.609 HG23 ' SD ' ' A' ' 33' ' ' MET . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 0.17999999999999999 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.1000000000000001 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 1.8200000000000001 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.20000000000000001 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 0.28000000000000003 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 1.8500000000000001 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.3100000000000001 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.23999999999999999 111.511 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 1.8799999999999999 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 0.33000000000000002 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 1.47 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.26000000000000001 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.0600000000000001 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.17000000000000001 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 1.51 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 0.26000000000000001 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.3 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 1.9299999999999999 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 1.79 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 . . . . . 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 3.9500000000000002 111.647 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.629 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.951 -0.759 . . . . 2.8500000000000001 108.951 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.629 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.68999999999999995 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.35999999999999999 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.3799999999999999 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.34999999999999998 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.34000000000000002 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 0.25 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 1.011 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.22 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.41999999999999998 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.3100000000000001 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.27 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 0.79000000000000004 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.8500000000000001 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.28999999999999998 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.507 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.31 109.767 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 1.8500000000000001 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.46999999999999997 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.9299999999999999 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 0.68000000000000005 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.507 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.40999999999999998 109.791 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 120' ' ' GLN . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 0.70999999999999996 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 0.23000000000000001 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.47 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.3500000000000001 112.042 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.3500000000000001 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.011 HG22 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 0.37 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 0.22 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.857 ' SD ' HG11 ' A' ' 74' ' ' VAL . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.1599999999999999 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 71' ' ' CYS . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 0.27000000000000002 110.197 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 0.42999999999999999 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91000000000000003 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.29 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.44 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.23 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.3 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.44 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 148' ' ' ARG . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 0.37 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.7 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 0.51000000000000001 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 137' ' ' VAL . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.0600000000000001 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 0.39000000000000001 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.7 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 0.78000000000000003 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 0.44 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66000000000000003 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 0.47999999999999998 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.29999999999999999 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 0.19 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 0.84999999999999998 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 2.48 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17000000000000001 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.4199999999999999 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 0.40000000000000002 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.3100000000000001 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.25 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.787 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 0.19 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.4199999999999999 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.4399999999999999 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 1.8100000000000001 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.034 0.445 . . . . 1.6100000000000001 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.26000000000000001 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 0.17999999999999999 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.68 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.56999999999999995 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 19' ' ' LEU . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 0.16 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.563 -174.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.654 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 0.90000000000000002 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.60999999999999999 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.3700000000000001 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.3100000000000001 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 57' ' ' ARG . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.23 110.359 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.3 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.654 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.39000000000000001 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 0.40000000000000002 110.024 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 0.57999999999999996 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.19 109.523 -173.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.68 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 0.23999999999999999 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.31 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.674 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 1.9399999999999999 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.45 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.3500000000000001 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.1599999999999999 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.0600000000000001 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 0.20999999999999999 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.644 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.20000000000000001 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.16 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.3799999999999999 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.425 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 0.85999999999999999 109.785 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.1600000000000001 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.4199999999999999 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 0.72999999999999998 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.68000000000000005 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.2799999999999998 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 3.3399999999999999 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 1.9399999999999999 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93000000000000005 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.0700000000000001 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 1.6599999999999999 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.0 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.2599999999999998 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.4300000000000002 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' OE2' HG21 ' A' ' 18' ' ' THR . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 0.54000000000000004 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 HD21 ' A' ' 59' ' ' LEU . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 0.25 109.603 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' HD3' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.23 112.043 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 1.3999999999999999 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 56' ' ' ILE . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 0.33000000000000002 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.76 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 1.5900000000000001 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.9199999999999999 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 1.6799999999999999 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.0700000000000001 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 0.34000000000000002 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.599 ' HD1' HD11 ' A' ' 19' ' ' LEU . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.23999999999999999 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 0.40000000000000002 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.22 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.17000000000000001 111.003 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.644 HG23 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 0.17999999999999999 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.1000000000000001 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 1.8200000000000001 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.20000000000000001 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 0.28000000000000003 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 1.8500000000000001 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.3100000000000001 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.23999999999999999 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 1.8799999999999999 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 1.47 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.26000000000000001 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.0600000000000001 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 0.17000000000000001 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.20999999999999999 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 0.26000000000000001 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 1.9299999999999999 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 1.79 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.641 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 3.9500000000000002 111.121 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.087 -0.338 . . . . 2.8500000000000001 110.087 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.68999999999999995 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 0.35999999999999999 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.3799999999999999 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 0.33000000000000002 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.1100000000000001 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 0.34999999999999998 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.848 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.34000000000000002 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 0.25 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.22 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.41999999999999998 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.3100000000000001 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.27 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 1.8500000000000001 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.28999999999999998 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 1.8500000000000001 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 0.46999999999999997 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 0.68000000000000005 110.553 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.40999999999999998 109.521 -174.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 0.70999999999999996 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 0.23000000000000001 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.3500000000000001 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.3500000000000001 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 0.37 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 0.22 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.848 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.1599999999999999 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.22 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 0.27000000000000002 108.949 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.522 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 0.42999999999999999 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91000000000000003 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.29 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.44 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.23 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.3 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.44 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 148' ' ' ARG . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 0.37 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 1.6599999999999999 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 0.51000000000000001 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.0600000000000001 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.39000000000000001 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.733 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 0.78000000000000003 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 0.44 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66000000000000003 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 0.47999999999999998 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.639 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.29999999999999999 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 0.84999999999999998 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 2.48 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17000000000000001 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.4199999999999999 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 0.40000000000000002 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.522 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.3100000000000001 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.25 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 0.19 113.021 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.737 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.4199999999999999 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 0.28000000000000003 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.4399999999999999 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 1.8100000000000001 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 1.6100000000000001 111.612 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.26000000000000001 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 0.17999999999999999 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.697 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.56999999999999995 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 0.16 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 0.19 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 0.90000000000000002 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.60999999999999999 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.3700000000000001 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 58' ' ' ASN . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.23 108.856 176.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.39000000000000001 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 0.40000000000000002 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.57999999999999996 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.19 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.28000000000000003 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 28' ' ' VAL . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 0.23999999999999999 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.31 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.3600000000000001 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 1.9399999999999999 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.45 110.738 -176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.3500000000000001 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.722 HG21 HG11 ' A' ' 22' ' ' VAL . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.1599999999999999 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.0600000000000001 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 0.20999999999999999 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.38 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 0.20000000000000001 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.23000000000000001 111.059 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 0.16 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.3799999999999999 109.883 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.34999999999999998 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 0.85999999999999999 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.1600000000000001 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.4199999999999999 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.72999999999999998 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.68000000000000005 111.934 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.2799999999999998 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.498 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 3.3399999999999999 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 1.9399999999999999 111.295 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93000000000000005 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.0700000000000001 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 1.6599999999999999 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.0 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.46000000000000002 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.4300000000000002 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.0499999999999998 111.301 175.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 0.54000000000000004 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 0.25 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.23 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.5 t30 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 1.3999999999999999 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 0.33000000000000002 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.76 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 1.5900000000000001 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.9199999999999999 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.6799999999999999 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 0.34000000000000002 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.651 ' HD1' HD11 ' A' ' 19' ' ' LEU . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.23999999999999999 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 0.40000000000000002 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.22 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.17000000000000001 111.341 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 0.17999999999999999 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.1000000000000001 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.20000000000000001 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 0.28000000000000003 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 1.8500000000000001 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.3100000000000001 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.23999999999999999 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 1.8799999999999999 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 0.33000000000000002 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 1.47 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.26000000000000001 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.0600000000000001 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.476 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 0.17000000000000001 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 0.20999999999999999 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 0.26000000000000001 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 1.9299999999999999 110.15 175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 1.79 108.501 -171.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.701 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 3.9500000000000002 111.845 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.063 -0.347 . . . . 2.8500000000000001 110.063 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.68999999999999995 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.35999999999999999 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.568 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.3799999999999999 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 110.88 -167.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.742 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 0.33000000000000002 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.856 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.34000000000000002 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 0.25 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.22 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.41999999999999998 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.3100000000000001 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.27 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.79000000000000004 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 1.8500000000000001 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.28999999999999998 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 0.31 109.714 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 1.8500000000000001 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.46999999999999997 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.9299999999999999 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 0.68000000000000005 110.061 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.40999999999999998 109.955 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 0.70999999999999996 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.669 HG11 ' HB1' ' A' ' 77' ' ' ALA . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.3500000000000001 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.3500000000000001 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 0.37 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 0.22 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.864 ' SD ' HG11 ' A' ' 74' ' ' VAL . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.1599999999999999 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.22 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 0.27000000000000002 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 0.42999999999999999 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91000000000000003 112.599 176.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.29 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.44 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.23 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.3 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 0.37 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 1.6599999999999999 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 0.51000000000000001 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.0600000000000001 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 0.78000000000000003 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 0.44 109.326 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66000000000000003 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.47999999999999998 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.548 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.19 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 2.48 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17000000000000001 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.4199999999999999 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 148' ' ' ARG . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 0.40000000000000002 110.357 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.3100000000000001 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.25 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 0.19 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.4199999999999999 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 0.28000000000000003 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.4399999999999999 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.614 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 1.8100000000000001 111.524 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 1.8 mp0 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.085 0.469 . . . . 3.6800000000000002 110.424 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 1.8 mp0 -54.73 -45.9 74.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.43 -0.804 . . . . 2.3799999999999999 109.915 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -97.08 123.04 40.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.084 0.469 . . . . 1.6100000000000001 109.991 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 0.17999999999999999 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.75 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.56999999999999995 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 HD11 HD22 ' A' ' 19' ' ' LEU . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 0.16 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 0.19 110.604 -176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 0.90000000000000002 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.60999999999999999 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.3100000000000001 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.23 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.3 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.39000000000000001 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 0.40000000000000002 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 0.57999999999999996 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.19 109.436 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 0.28000000000000003 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.75 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 0.23999999999999999 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.31 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.3600000000000001 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 1.9399999999999999 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.45 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.3500000000000001 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.742 HG21 HG11 ' A' ' 22' ' ' VAL . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.1599999999999999 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.0600000000000001 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 0.20999999999999999 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.736 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 0.38 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.20000000000000001 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 3' ' ' GLU . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.23000000000000001 110.709 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 0.16 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.3799999999999999 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.34999999999999998 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 0.85999999999999999 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.1600000000000001 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.4199999999999999 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 0.72999999999999998 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.68000000000000005 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.2799999999999998 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 3.3399999999999999 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 1.9399999999999999 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93000000000000005 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.0700000000000001 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 1.6599999999999999 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.0 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.2599999999999998 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.46000000000000002 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.4300000000000002 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 21' ' ' ILE . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 0.54000000000000004 111.567 -171.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.695 HG23 HD21 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 0.25 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.23 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' SER . 64.1 t30 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 1.3999999999999999 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.695 HD21 HG23 ' A' ' 56' ' ' ILE . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.33000000000000002 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.76 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 1.5900000000000001 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 1.6799999999999999 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.0700000000000001 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 0.34000000000000002 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.23999999999999999 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 0.40000000000000002 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.22 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.17000000000000001 112.088 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 0.17999999999999999 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.1000000000000001 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.65 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 1.8200000000000001 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.20000000000000001 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 0.28000000000000003 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 1.8500000000000001 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.3100000000000001 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.23999999999999999 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 1.8799999999999999 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 0.33000000000000002 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 1.47 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.26000000000000001 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.0600000000000001 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 0.17000000000000001 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.20999999999999999 110.372 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 0.26000000000000001 110.047 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 1.9299999999999999 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 1.79 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 -53.91 -36.94 63.27 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 3.9500000000000002 111.714 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.83 -17.28 64.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.647 0.379 . . . . 2.2200000000000002 111.796 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 m -81.9 -18.17 44.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 1.78 110.811 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.8 t -118.14 -35.22 3.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 1.6299999999999999 110.802 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 -94.16 134.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 108.971 -0.752 . . . . 2.8500000000000001 108.971 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.68999999999999995 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.427 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 0.35999999999999999 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.3799999999999999 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.1100000000000001 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 0.34999999999999998 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.458 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 0.33000000000000002 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.34000000000000002 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 0.25 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.22 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.41999999999999998 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.3100000000000001 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.27 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 0.79000000000000004 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.28999999999999998 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 0.31 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 1.8500000000000001 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 0.46999999999999997 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.9299999999999999 110.09 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 0.68000000000000005 110.578 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.40999999999999998 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 0.70999999999999996 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 0.23000000000000001 110.624 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.3500000000000001 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.761 HG22 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 0.37 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 0.22 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.1599999999999999 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.22 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 0.27000000000000002 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 0.42999999999999999 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.29 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.44 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.23 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.3 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.44 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 148' ' ' ARG . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.37 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 1.6599999999999999 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 0.51000000000000001 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.0600000000000001 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.39000000000000001 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 0.78000000000000003 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.1100000000000001 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66000000000000003 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 0.47999999999999998 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.29999999999999999 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.782 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.19 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 0.84999999999999998 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.796 ' HB2' HD21 ' A' ' 135' ' ' LEU . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 2.48 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17000000000000001 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.4199999999999999 111.294 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 0.40000000000000002 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.305 168.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.25 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 0.19 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.4199999999999999 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.28000000000000003 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.782 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.4399999999999999 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 1.8100000000000001 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.29 0.567 . . . . 3.6800000000000002 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -92.37 -51.73 5.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.743 -0.662 . . . . 2.3799999999999999 110.333 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -64.78 132.46 49.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 1.6100000000000001 110.511 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.717 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.26000000000000001 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 0.17999999999999999 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.736 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.56999999999999995 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 0.16 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 0.19 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 0.90000000000000002 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.60999999999999999 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.3700000000000001 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.3100000000000001 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.23 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.3 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.39000000000000001 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 0.40000000000000002 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 69' ' ' GLY . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.19 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 53' ' ' ASN . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.28000000000000003 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 28' ' ' VAL . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 0.23999999999999999 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.31 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.717 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.3600000000000001 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 1.9399999999999999 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.3500000000000001 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG21 HG11 ' A' ' 22' ' ' VAL . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.1599999999999999 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.3 t30 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.0600000000000001 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 0.20999999999999999 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.38 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.598 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 0.16 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.3799999999999999 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.34999999999999998 112.106 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.1600000000000001 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.4199999999999999 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 0.72999999999999998 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' HG12 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.68000000000000005 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 3.3399999999999999 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93000000000000005 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.0700000000000001 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 1.6599999999999999 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.2599999999999998 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.46000000000000002 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.4300000000000002 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 21' ' ' ILE . 51.2 t30 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.0499999999999998 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 0.54000000000000004 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 0.25 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.23 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 0.33000000000000002 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.76 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 1.5900000000000001 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.9199999999999999 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.0700000000000001 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 56' ' ' ILE . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HD1' HD11 ' A' ' 19' ' ' LEU . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.23999999999999999 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 0.40000000000000002 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.22 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.17000000000000001 110.77 174.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 0.17999999999999999 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.1000000000000001 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.8200000000000001 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.20000000000000001 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 1.8500000000000001 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.3100000000000001 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 0.23999999999999999 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 1.8799999999999999 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 0.33000000000000002 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 1.47 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 113.355 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.0600000000000001 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 0.17000000000000001 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 0.20999999999999999 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 1.51 109.121 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 0.26000000000000001 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 1.9299999999999999 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 1.79 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 -77.67 -23.76 49.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 3.9500000000000002 110.637 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.4 -15.66 63.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 2.2200000000000002 110.59 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 m -93.67 -19.16 21.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.045 -0.525 . . . . 1.78 110.351 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 m -95.58 -36.66 11.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.049 -0.523 . . . . 1.6299999999999999 110.736 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 -97.62 144.18 27.51 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.822 -0.626 . . . . 2.8500000000000001 109.5 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.68999999999999995 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 0.35999999999999999 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.3799999999999999 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.1100000000000001 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.34999999999999998 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 0.33000000000000002 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.83 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.34000000000000002 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 0.25 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.572 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.22 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.41999999999999998 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.3100000000000001 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.27 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 0.79000000000000004 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 1.8500000000000001 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.28999999999999998 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 0.31 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 0.46999999999999997 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.9299999999999999 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 0.68000000000000005 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.40999999999999998 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 0.70999999999999996 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 0.23000000000000001 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.3500000000000001 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.3500000000000001 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.37 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.22 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.83 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.22 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.27000000000000002 109.726 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.633 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 0.42999999999999999 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91000000000000003 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.29 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.44 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.23 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.3 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.44 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 0.37 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 1.6599999999999999 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.662 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 0.51000000000000001 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.672 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.0600000000000001 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.39000000000000001 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.662 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 0.78000000000000003 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.47999999999999998 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.29999999999999999 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 0.19 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 0.84999999999999998 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HB2' HD21 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 2.48 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17000000000000001 112.243 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.4199999999999999 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 0.40000000000000002 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.599 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.3100000000000001 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.25 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 0.19 113.269 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.771 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.4199999999999999 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 0.28000000000000003 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.661 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.4399999999999999 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.731 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 1.8100000000000001 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.445 0.164 . . . . 3.6800000000000002 111.381 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.7 -34.65 73.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.295 0.48 . . . . 2.3799999999999999 112.295 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.44 124.34 22.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 1.6100000000000001 110.91 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 0.17999999999999999 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.56999999999999995 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.16 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 0.19 110.513 -175.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 0.90000000000000002 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.60999999999999999 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.3700000000000001 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.3100000000000001 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.23 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.3 111.41 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.39000000000000001 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 0.40000000000000002 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.669 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 0.57999999999999996 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.19 109.579 -175.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 0.28000000000000003 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.666 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 0.23999999999999999 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.31 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.3600000000000001 110.823 -172.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 1.9399999999999999 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.45 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.1599999999999999 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.0600000000000001 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.743 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 0.38 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 0.20000000000000001 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.16 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.3799999999999999 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.34999999999999998 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 0.85999999999999999 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.1600000000000001 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.4199999999999999 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 0.72999999999999998 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.68000000000000005 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.2799999999999998 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.656 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 3.3399999999999999 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 1.9399999999999999 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93000000000000005 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.0700000000000001 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 1.6599999999999999 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.0 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.2599999999999998 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.46000000000000002 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.4300000000000002 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.0499999999999998 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 0.54000000000000004 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 0.25 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.23 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 1.3999999999999999 109.842 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 0.33000000000000002 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.76 111.117 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 1.5900000000000001 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.9199999999999999 111.203 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 1.6799999999999999 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.0700000000000001 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 0.34000000000000002 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.609 ' HD1' HD11 ' A' ' 19' ' ' LEU . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.23999999999999999 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 0.40000000000000002 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.22 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.17000000000000001 111.34 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 0.17999999999999999 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.1000000000000001 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 1.8200000000000001 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.20000000000000001 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 0.28000000000000003 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 1.8500000000000001 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.608 ' O ' HG23 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 0.23999999999999999 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 1.8799999999999999 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 0.33000000000000002 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 1.47 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.26000000000000001 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.0600000000000001 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 0.17000000000000001 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.20999999999999999 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 1.51 108.986 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 1.9299999999999999 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 1.79 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 -64.96 -28.16 69.33 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 3.9500000000000002 111.369 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -64.79 -20.32 66.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.489 0.551 . . . . 2.2200000000000002 112.489 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -93.21 -26.39 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.813 -0.355 . . . . 1.78 111.448 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 t -94.41 -33.84 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 1.6299999999999999 110.739 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 -95.64 135.77 22.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.879 -0.601 . . . . 2.8500000000000001 109.698 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.68999999999999995 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.433 HD12 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 0.35999999999999999 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.64 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.3799999999999999 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 0.33000000000000002 111.584 -169.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.1100000000000001 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.34999999999999998 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 0.33000000000000002 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.957 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 0.25 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE3' HG22 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.22 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.41999999999999998 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.27 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.79000000000000004 110.619 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 1.8500000000000001 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.28999999999999998 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.31 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 1.8500000000000001 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 111.732 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.9299999999999999 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 0.68000000000000005 109.824 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.446 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 0.23000000000000001 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.3500000000000001 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.3500000000000001 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.507 HG22 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 0.37 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 0.22 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.464 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.1599999999999999 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.454 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.22 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 0.27000000000000002 110.409 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.666 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 0.42999999999999999 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91000000000000003 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.64 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.29 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.44 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.23 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.3 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.44 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.666 HD12 HD21 ' A' ' 128' ' ' LEU . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 0.37 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.623 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 1.6599999999999999 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.698 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 0.51000000000000001 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 0.39000000000000001 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.698 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.78000000000000003 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 0.44 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66000000000000003 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 0.47999999999999998 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.29999999999999999 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 0.19 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.48 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17000000000000001 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.4199999999999999 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.491 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 0.40000000000000002 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.528 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.3100000000000001 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.25 115.217 171.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 0.19 113.355 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.488 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.4199999999999999 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.4399999999999999 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.681 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 1.8100000000000001 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.146 0.498 . . . . 3.6800000000000002 110.293 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.77 -54.66 5.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 2.3799999999999999 109.944 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.93 130.56 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.059 -0.348 . . . . 1.6100000000000001 110.059 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.566 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.26000000000000001 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 0.17999999999999999 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.56999999999999995 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 0.16 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 0.19 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.599 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 0.90000000000000002 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.60999999999999999 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.3700000000000001 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.3100000000000001 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.23 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.3 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.599 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.39000000000000001 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 0.40000000000000002 110.251 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD11 ' HD1' ' A' ' 66' ' ' PHE . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 0.57999999999999996 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.19 109.572 -174.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.713 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.23999999999999999 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.31 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.3600000000000001 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 1.9399999999999999 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.45 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.3500000000000001 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.785 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.1599999999999999 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.0600000000000001 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.20999999999999999 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 0.38 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.20000000000000001 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 0.16 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.3799999999999999 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.34999999999999998 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 83' ' ' LYS . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 0.85999999999999999 109.289 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.1600000000000001 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.4199999999999999 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 0.72999999999999998 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.68000000000000005 113.028 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.2799999999999998 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.678 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 3.3399999999999999 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 1.9399999999999999 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93000000000000005 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.0700000000000001 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 1.6599999999999999 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.0 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.2599999999999998 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.46000000000000002 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.4300000000000002 111.388 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.0499999999999998 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' N ' HD22 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 0.54000000000000004 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.561 HG23 HD21 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 0.25 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.23 112.035 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 1.3999999999999999 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 0.33000000000000002 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 1.5900000000000001 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.9199999999999999 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' HE2' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 1.6799999999999999 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 0.34000000000000002 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.627 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.23999999999999999 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 0.40000000000000002 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.22 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.17000000000000001 110.794 173.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 0.17999999999999999 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.1000000000000001 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.20000000000000001 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.8 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 0.28000000000000003 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 1.8500000000000001 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.3100000000000001 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 0.23999999999999999 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 1.8799999999999999 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 0.33000000000000002 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 1.47 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.26000000000000001 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HD3' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.0600000000000001 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 0.17000000000000001 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 1.51 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 0.26000000000000001 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 1.9299999999999999 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 1.79 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 -61.4 -35.02 76.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 3.9500000000000002 111.24 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -35.34 74.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.311 0.577 . . . . 2.2200000000000002 110.867 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 t -67.63 -37.22 82.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.628 -0.714 . . . . 1.78 110.745 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.0 m -97.97 -35.52 10.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.308 0.484 . . . . 1.6299999999999999 112.308 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 -97.78 145.06 29.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.594 -0.521 . . . . 2.8500000000000001 109.594 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.68999999999999995 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.524 HG12 ' HE2' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 0.35999999999999999 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.3799999999999999 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.33000000000000002 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.1100000000000001 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.535 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 0.34999999999999998 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.33000000000000002 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.826 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' ASP . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 0.25 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.22 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.41999999999999998 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.3100000000000001 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.27 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 0.79000000000000004 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 1.8500000000000001 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.28999999999999998 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.31 109.98 -176.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 1.8500000000000001 109.548 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 0.46999999999999997 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.9299999999999999 110.592 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 0.68000000000000005 110.85 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.40999999999999998 110.097 -174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.683 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 0.23000000000000001 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.3500000000000001 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.3500000000000001 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.472 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 0.37 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.688 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.22 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.826 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.1599999999999999 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.22 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 0.42999999999999999 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91000000000000003 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.29 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.44 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.494 ' O ' HD23 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.23 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.3 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.44 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.37 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.724 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.51000000000000001 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.0600000000000001 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 0.39000000000000001 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.724 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 0.78000000000000003 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 0.44 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.1100000000000001 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66000000000000003 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 0.47999999999999998 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.29999999999999999 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 0.84999999999999998 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.695 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 2.48 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17000000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.4199999999999999 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 0.40000000000000002 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.3100000000000001 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.25 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 0.19 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.4199999999999999 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 0.28000000000000003 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.4399999999999999 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.509 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 1.8100000000000001 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.113 0.482 . . . . 3.6800000000000002 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.5 -43.5 23.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.192 0.52 . . . . 2.3799999999999999 110.381 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.7 118.33 30.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.913 -0.403 . . . . 1.6100000000000001 109.913 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.26000000000000001 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 0.17999999999999999 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 0.16 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 0.19 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.634 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 0.90000000000000002 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.60999999999999999 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.3700000000000001 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.3100000000000001 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.23 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.3 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.39000000000000001 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 0.40000000000000002 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 0.57999999999999996 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.19 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.738 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 0.23999999999999999 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.31 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.3600000000000001 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 1.9399999999999999 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.45 109.458 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.3500000000000001 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.755 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.1599999999999999 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.0600000000000001 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 0.20999999999999999 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 0.38 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.614 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 0.20000000000000001 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 0.16 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.3799999999999999 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.34999999999999998 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 0.85999999999999999 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.1600000000000001 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.4199999999999999 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 0.72999999999999998 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.68000000000000005 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 3.3399999999999999 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 1.9399999999999999 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93000000000000005 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.0700000000000001 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 1.6599999999999999 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.0 110.995 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.2599999999999998 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.46000000000000002 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.4300000000000002 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.0499999999999998 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 0.54000000000000004 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.604 HG23 HD21 ' A' ' 59' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.23 112.316 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 1.3999999999999999 111.066 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 56' ' ' ILE . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 0.33000000000000002 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.76 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 1.5900000000000001 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.9199999999999999 111.07 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 1.6799999999999999 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.0700000000000001 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 0.34000000000000002 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.636 ' HD1' HD11 ' A' ' 19' ' ' LEU . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 0.40000000000000002 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.22 110.914 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.748 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.17000000000000001 111.192 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 0.17999999999999999 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.1000000000000001 109.894 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 87.2 mm-40 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.20000000000000001 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.28000000000000003 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 1.8500000000000001 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.3100000000000001 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.76 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 0.23999999999999999 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.709 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 1.8799999999999999 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.33000000000000002 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 1.47 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.26000000000000001 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.0600000000000001 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 0.17000000000000001 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.427 ' N ' HD13 ' A' ' 84' ' ' LEU . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 0.20999999999999999 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 0.26000000000000001 110.277 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 50.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 1.9299999999999999 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 1.79 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 -71.59 -19.69 62.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 3.9500000000000002 111.754 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.82 -19.46 65.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 2.2200000000000002 111.031 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -86.73 -3.91 59.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 1.78 110.95 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -115.59 -34.66 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.513 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 -95.58 141.24 22.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.702 -0.481 . . . . 2.8500000000000001 109.702 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.68999999999999995 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.492 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 0.35999999999999999 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.3799999999999999 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 0.33000000000000002 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.1100000000000001 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 0.34999999999999998 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.34000000000000002 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 0.25 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.22 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.41999999999999998 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.3100000000000001 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.27 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 0.79000000000000004 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.28999999999999998 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 0.31 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 83.1 m-20 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 1.8500000000000001 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 0.68000000000000005 111.135 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.496 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 109.537 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.76 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.3500000000000001 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.3500000000000001 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.653 HG22 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 0.37 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.627 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 0.22 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.1599999999999999 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.22 110.051 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 0.27000000000000002 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 0.42999999999999999 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91000000000000003 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.29 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.44 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.23 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.3 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.44 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 148' ' ' ARG . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.37 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 0.51000000000000001 110.153 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.0600000000000001 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 0.39000000000000001 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.499 ' CB ' ' HB ' ' A' ' 108' ' ' VAL . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 0.78000000000000003 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.44 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.1100000000000001 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66000000000000003 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 0.47999999999999998 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.526 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.66 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.19 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 0.84999999999999998 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 2.48 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17000000000000001 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.4199999999999999 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 0.40000000000000002 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.603 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.3100000000000001 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.25 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 0.19 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.4199999999999999 110.742 166.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 0.28000000000000003 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.4399999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.709 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 1.8100000000000001 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.017 0.436 . . . . 3.6800000000000002 110.346 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.52 -31.2 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.683 -0.689 . . . . 2.3799999999999999 110.092 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -78.97 125.9 29.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 110.396 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.26000000000000001 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 0.17999999999999999 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.784 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.56999999999999995 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 0.16 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 0.19 110.645 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.631 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.60999999999999999 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.3700000000000001 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.3100000000000001 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.23 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.3 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.39000000000000001 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 0.40000000000000002 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.75 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 0.57999999999999996 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.19 109.491 -173.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 0.28000000000000003 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.784 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 0.23999999999999999 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.31 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HD2' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.3600000000000001 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 1.9399999999999999 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.45 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.3500000000000001 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.1599999999999999 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.0600000000000001 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 0.20999999999999999 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 0.38 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.618 ' HG2' HD12 ' A' ' 86' ' ' LEU . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 0.20000000000000001 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.23000000000000001 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 0.16 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.34999999999999998 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 0.85999999999999999 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.1600000000000001 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.4199999999999999 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 0.72999999999999998 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.68000000000000005 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' HD1' ' A' ' 46' ' ' PHE . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.146 -174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 1.9399999999999999 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 43' ' ' GLU . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93000000000000005 110.605 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.0700000000000001 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 1.6599999999999999 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.0 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.4 t30 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.46000000000000002 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.4300000000000002 111.464 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB3' HG23 ' A' ' 21' ' ' ILE . 51.4 t30 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.0499999999999998 110.47 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 0.54000000000000004 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.632 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 0.25 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.23 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 1.3999999999999999 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 HG23 ' A' ' 56' ' ' ILE . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 0.33000000000000002 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.76 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 1.5900000000000001 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.9199999999999999 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 1.6799999999999999 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.0700000000000001 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 0.34000000000000002 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' HD1' HD11 ' A' ' 19' ' ' LEU . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.23999999999999999 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 0.40000000000000002 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.22 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.75 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.17000000000000001 111.485 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.57 HG23 ' SD ' ' A' ' 33' ' ' MET . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 0.17999999999999999 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.1000000000000001 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 33.0 mm-40 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 1.8200000000000001 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.20000000000000001 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.811 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 0.28000000000000003 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 1.8500000000000001 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HG3' HD13 ' A' ' 21' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.3100000000000001 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 0.23999999999999999 111.789 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 1.8799999999999999 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 0.33000000000000002 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 1.47 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.26000000000000001 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.0600000000000001 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 0.17000000000000001 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 0.20999999999999999 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.26000000000000001 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 1.9299999999999999 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 1.79 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.636 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 -69.14 -36.31 77.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 3.9500000000000002 110.466 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -67.27 -17.28 64.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.007 -0.542 . . . . 2.2200000000000002 110.548 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 m -80.07 -16.63 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.022 -0.536 . . . . 1.78 110.483 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -112.68 -31.53 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 1.6299999999999999 110.514 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.512 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 -95.23 141.88 23.83 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.308 -0.627 . . . . 2.8500000000000001 109.308 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.68999999999999995 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 0.35999999999999999 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.3799999999999999 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 0.33000000000000002 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.1100000000000001 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.567 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 0.34999999999999998 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.33000000000000002 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.846 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.34000000000000002 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 0.25 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.22 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.41999999999999998 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.3100000000000001 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.27 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.79000000000000004 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.28999999999999998 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 0.31 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 1.8500000000000001 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.46999999999999997 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.9299999999999999 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 0.68000000000000005 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.521 ' HD1' HD22 ' A' ' 111' ' ' LEU . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.40999999999999998 109.958 -173.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 120' ' ' GLN . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 0.70999999999999996 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 0.23000000000000001 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.3500000000000001 112.984 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.3500000000000001 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 0.37 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 0.22 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.846 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.1599999999999999 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.22 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 0.27000000000000002 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 0.42999999999999999 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91000000000000003 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.29 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.44 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.23 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.3 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.44 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.37 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 1.6599999999999999 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.743 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 0.51000000000000001 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' N ' HG22 ' A' ' 137' ' ' VAL . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.0600000000000001 111.254 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 0.39000000000000001 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.743 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 0.78000000000000003 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 0.44 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.1100000000000001 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66000000000000003 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 0.47999999999999998 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.637 ' CD2' HD23 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.29999999999999999 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.659 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 0.19 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 0.84999999999999998 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 135' ' ' LEU . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 2.48 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17000000000000001 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.4199999999999999 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 0.40000000000000002 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.3100000000000001 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.25 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 0.19 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.659 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.4399999999999999 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 1.8100000000000001 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.039 0.447 . . . . 3.6800000000000002 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 1.2 mp0 -67.94 -45.24 74.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 2.3799999999999999 111.076 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -66.64 136.78 56.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 111.153 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.26000000000000001 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 0.17999999999999999 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.653 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.56999999999999995 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 0.16 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 0.19 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.90000000000000002 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.60999999999999999 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.3700000000000001 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.3100000000000001 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.23 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.3 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.39000000000000001 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 0.40000000000000002 110.23 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 0.57999999999999996 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.19 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 0.28000000000000003 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.653 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 0.23999999999999999 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.31 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.3600000000000001 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 1.9399999999999999 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.45 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.3500000000000001 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.0600000000000001 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HB2' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 0.38 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 0.20000000000000001 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 0.16 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.3799999999999999 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.34999999999999998 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.1600000000000001 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.4199999999999999 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 0.72999999999999998 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.68000000000000005 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.2799999999999998 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.536 ' HA ' HG12 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 3.3399999999999999 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93000000000000005 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 1.6599999999999999 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.0 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.2599999999999998 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.46000000000000002 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.4300000000000002 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.0499999999999998 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.54000000000000004 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 59' ' ' LEU . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 0.25 109.971 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.23 111.555 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 1.3999999999999999 110.748 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 56' ' ' ILE . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 0.33000000000000002 111.464 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.76 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 1.5900000000000001 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.9199999999999999 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 1.6799999999999999 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.0700000000000001 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 0.34000000000000002 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.23999999999999999 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 0.40000000000000002 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.22 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.17000000000000001 111.582 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 0.17999999999999999 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.1000000000000001 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 1.8200000000000001 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.20000000000000001 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 0.28000000000000003 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 1.8500000000000001 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.3100000000000001 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 1.8799999999999999 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 0.33000000000000002 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 1.47 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.26000000000000001 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.0600000000000001 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 0.17000000000000001 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 0.20999999999999999 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.448 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 0.26000000000000001 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 1.9299999999999999 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 1.79 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 -65.27 -32.52 74.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 3.9500000000000002 111.159 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -65.13 -27.5 68.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.621 . . . . 2.2200000000000002 111.442 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -89.5 -18.81 25.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 1.78 110.619 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t -92.35 -34.71 14.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.964 0.411 . . . . 1.6299999999999999 110.295 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 -95.59 150.04 36.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.915 -0.772 . . . . 2.8500000000000001 108.915 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.68999999999999995 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 63' ' ' LYS . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.35999999999999999 110.531 174.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.3799999999999999 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 0.33000000000000002 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.1100000000000001 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 0.34999999999999998 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 0.33000000000000002 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.34000000000000002 110.26 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 0.25 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.22 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.41999999999999998 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.3100000000000001 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.27 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.79000000000000004 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 1.8500000000000001 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.28999999999999998 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 0.31 109.636 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 0.46999999999999997 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.9299999999999999 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 0.68000000000000005 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.40999999999999998 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.431 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 0.70999999999999996 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.53 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.3500000000000001 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.3500000000000001 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 0.37 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 0.22 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.1599999999999999 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.22 111.15 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 0.27000000000000002 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 0.42999999999999999 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91000000000000003 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.609 ' HE3' ' C ' ' A' ' 97' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.29 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.44 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.23 111.548 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.3 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.44 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 148' ' ' ARG . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 0.37 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 1.6599999999999999 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.687 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 0.51000000000000001 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.0600000000000001 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 0.39000000000000001 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.687 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 0.78000000000000003 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 0.44 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.1100000000000001 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66000000000000003 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.574 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.29999999999999999 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 0.19 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 0.84999999999999998 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 2.48 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17000000000000001 112.027 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 50.4 t30 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.4199999999999999 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 0.40000000000000002 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.3100000000000001 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.25 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 0.19 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.4199999999999999 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 0.28000000000000003 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.4399999999999999 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 1.8100000000000001 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.572 0.225 . . . . 3.6800000000000002 110.785 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 27' ' ' LYS . 37.2 mt-10 72.83 -52.9 0.71 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.42 0.688 . . . . 2.3799999999999999 112.823 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -55.6 129.47 39.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 1.6100000000000001 111.208 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.681 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.26000000000000001 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 0.17999999999999999 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.725 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.56999999999999995 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 32' ' ' LEU . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 0.16 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 0.19 111.052 -174.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.60999999999999999 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.3700000000000001 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.3100000000000001 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.23 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.3 111.577 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 0.40000000000000002 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 HD11 ' A' ' 59' ' ' LEU . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 0.57999999999999996 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.19 110.26 -171.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 0.28000000000000003 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 0.23999999999999999 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.31 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.3600000000000001 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 1.9399999999999999 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.45 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.3500000000000001 111.614 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.1599999999999999 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.0600000000000001 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.646 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 0.38 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 0.20000000000000001 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 0.16 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.3799999999999999 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.34999999999999998 112.904 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.526 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 0.85999999999999999 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.1600000000000001 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.4199999999999999 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.175 -171.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.68000000000000005 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.2799999999999998 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 3.3399999999999999 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 1.9399999999999999 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93000000000000005 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.0700000000000001 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 1.6599999999999999 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.0 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.0 t30 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.2599999999999998 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.46000000000000002 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.4300000000000002 111.968 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB3' HG23 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.0499999999999998 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 21' ' ' ILE . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 0.54000000000000004 112.102 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.555 HG23 HD21 ' A' ' 59' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.23 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 1.3999999999999999 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 19' ' ' LEU . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.33000000000000002 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.76 111.568 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 1.5900000000000001 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.9199999999999999 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 1.6799999999999999 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 111.657 -173.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 0.34000000000000002 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.23999999999999999 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 0.40000000000000002 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.22 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.17000000000000001 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 0.17999999999999999 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.1000000000000001 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 1.8200000000000001 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.20000000000000001 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 1.8500000000000001 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.3100000000000001 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.23999999999999999 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 1.8799999999999999 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 0.33000000000000002 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 1.47 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.26000000000000001 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.0600000000000001 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.473 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 0.17000000000000001 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.20999999999999999 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 1.51 109.381 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 0.26000000000000001 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 91' ' ' ASP . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 1.9299999999999999 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 1.79 107.832 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 -62.05 -52.75 62.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 3.9500000000000002 111.443 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.664 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -55.11 -32.86 62.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 2.2200000000000002 111.744 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -84.18 -10.16 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.625 0.25 . . . . 1.78 111.494 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 t -118.09 -34.27 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.192 -0.317 . . . . 1.6299999999999999 111.74 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 -95.63 146.88 32.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.98 -0.378 . . . . 2.8500000000000001 109.98 -175.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.68999999999999995 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.35999999999999999 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.3799999999999999 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 0.33000000000000002 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.1100000000000001 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 0.33000000000000002 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 0.25 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.575 ' HE2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.22 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.41999999999999998 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.3100000000000001 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.27 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 1.8500000000000001 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.28999999999999998 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 0.31 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 0.46999999999999997 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.9299999999999999 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 0.68000000000000005 110.624 170.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.575 HG13 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 0.70999999999999996 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.67 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.3500000000000001 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 104' ' ' LYS . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.37 109.721 173.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 0.22 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.461 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.22 110.923 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.387 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 0.42999999999999999 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 131' ' ' GLY . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91000000000000003 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.29 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.44 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.23 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.3 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.44 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 0.37 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 1.6599999999999999 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 0.51000000000000001 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 138' ' ' LYS . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.0600000000000001 111.171 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 0.39000000000000001 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 0.78000000000000003 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 0.44 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66000000000000003 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.693 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.716 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 0.19 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 0.84999999999999998 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.782 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 2.48 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17000000000000001 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.475 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.4199999999999999 111.612 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 0.40000000000000002 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.3100000000000001 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.25 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 0.19 113.401 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.475 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.28000000000000003 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.716 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.4399999999999999 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 1.8100000000000001 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.305 0.574 . . . . 3.6800000000000002 109.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.4 -44.88 8.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.727 -0.67 . . . . 2.3799999999999999 111.214 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -77.21 129.88 36.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.958 0.408 . . . . 1.6100000000000001 110.726 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.54 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.26000000000000001 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 0.17999999999999999 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.794 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.56999999999999995 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 0.16 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 0.19 110.878 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.60999999999999999 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.3700000000000001 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.3100000000000001 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.23 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.3 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.39000000000000001 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 0.40000000000000002 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.644 HD12 ' HA3' ' A' ' 69' ' ' GLY . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 0.57999999999999996 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.19 109.811 -174.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.482 HD13 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 0.28000000000000003 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 0.23999999999999999 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.31 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.3600000000000001 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.45 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.3500000000000001 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.1599999999999999 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.0600000000000001 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 0.38 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.626 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.20000000000000001 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 0.16 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.3799999999999999 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.34999999999999998 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 0.85999999999999999 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.1600000000000001 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.4199999999999999 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 0.72999999999999998 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.68000000000000005 112.886 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.2799999999999998 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HA ' HG12 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 3.3399999999999999 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 1.9399999999999999 110.792 177.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93000000000000005 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 1.6599999999999999 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.0 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.2599999999999998 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.46000000000000002 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.4300000000000002 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.0499999999999998 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 0.54000000000000004 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.56 HG23 HD21 ' A' ' 59' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 0.25 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.23 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 1.3999999999999999 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 56' ' ' ILE . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 0.33000000000000002 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.76 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 1.5900000000000001 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.9199999999999999 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 1.6799999999999999 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.0700000000000001 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 0.34000000000000002 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.59 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.23999999999999999 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 0.40000000000000002 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.17000000000000001 111.508 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.626 HG23 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 0.17999999999999999 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.1000000000000001 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 1.8200000000000001 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 0.28000000000000003 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 1.8500000000000001 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.3100000000000001 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 0.23999999999999999 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 1.8799999999999999 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 0.33000000000000002 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 1.47 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.26000000000000001 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.0600000000000001 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 0.17000000000000001 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.20999999999999999 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 1.51 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 0.26000000000000001 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 1.9299999999999999 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 1.79 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.708 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 -57.45 -20.08 28.16 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 3.9500000000000002 111.986 175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.35 -19.13 64.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 2.2200000000000002 111.572 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -23.49 58.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.15 0.5 . . . . 1.78 110.545 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -108.73 -34.31 6.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 1.6299999999999999 110.486 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 32' ' ' LEU . 15.4 m-85 -89.58 135.39 30.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.764 -0.653 . . . . 2.8500000000000001 111.839 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.68999999999999995 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.48 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 0.35999999999999999 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.3799999999999999 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 0.33000000000000002 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.1100000000000001 110.156 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 0.34999999999999998 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.34000000000000002 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.25 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.22 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.41999999999999998 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.3100000000000001 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.27 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 0.79000000000000004 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 1.8500000000000001 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.28999999999999998 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 0.31 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 1.8500000000000001 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.9299999999999999 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 0.68000000000000005 110.362 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.40999999999999998 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.70999999999999996 112.324 -173.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 0.23000000000000001 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 118' ' ' VAL . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.3500000000000001 112.155 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.3500000000000001 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 104' ' ' LYS . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 0.37 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 0.22 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.438 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.1599999999999999 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.431 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.22 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 0.27000000000000002 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.624 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 0.42999999999999999 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 98' ' ' VAL . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91000000000000003 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.29 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.44 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.23 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.44 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD12 HD21 ' A' ' 128' ' ' LEU . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.37 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 1.6599999999999999 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 0.51000000000000001 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.0600000000000001 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.39000000000000001 111.224 -175.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.671 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.1100000000000001 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66000000000000003 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 0.47999999999999998 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.672 ' CD2' HD23 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.29999999999999999 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.762 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.19 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 0.84999999999999998 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 2.48 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17000000000000001 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.4199999999999999 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 0.40000000000000002 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.3100000000000001 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.25 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 0.19 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.4199999999999999 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 0.28000000000000003 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.4399999999999999 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 1.8100000000000001 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.464 0.172 . . . . 3.6800000000000002 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.82 -28.32 19.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 2.3799999999999999 111.453 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -95.57 117.99 31.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 110.754 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.26000000000000001 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 0.17999999999999999 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.745 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.56999999999999995 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 0.16 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 0.19 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' CE2' ' HA2' ' A' ' 17' ' ' GLY . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 173.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.60999999999999999 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.3700000000000001 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.3100000000000001 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.23 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.3 111.394 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.39000000000000001 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 0.40000000000000002 110.208 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.671 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 0.57999999999999996 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.19 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 53' ' ' ASN . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 0.28000000000000003 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.745 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 0.23999999999999999 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.31 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.3600000000000001 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 1.9399999999999999 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.45 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.3500000000000001 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.805 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.0600000000000001 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.20999999999999999 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.749 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 0.38 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 0.20000000000000001 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.23000000000000001 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 0.16 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.3799999999999999 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.34999999999999998 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 0.85999999999999999 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.1600000000000001 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.4199999999999999 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.532 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.72999999999999998 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.68000000000000005 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.2799999999999998 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.547 ' HA ' HG12 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 3.3399999999999999 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 1.9399999999999999 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93000000000000005 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.0700000000000001 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 1.6599999999999999 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.0 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.46000000000000002 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.4300000000000002 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.0499999999999998 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 21' ' ' ILE . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 0.54000000000000004 111.539 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 0.25 109.432 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.23 111.813 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 1.3999999999999999 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 0.33000000000000002 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.76 111.873 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 1.5900000000000001 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.9199999999999999 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 1.6799999999999999 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 0.34000000000000002 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.23999999999999999 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 0.40000000000000002 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.22 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.619 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.675 HG23 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 0.17999999999999999 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.1000000000000001 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 1.8200000000000001 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.20000000000000001 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.28000000000000003 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 1.8500000000000001 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 0.23999999999999999 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 1.8799999999999999 109.297 176.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 0.33000000000000002 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 1.47 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.26000000000000001 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.0600000000000001 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 0.17000000000000001 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 0.20999999999999999 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 1.51 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 0.26000000000000001 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 1.9299999999999999 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 1.79 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 -58.8 -32.56 69.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 3.9500000000000002 111.31 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.633 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 17.8 p-10 -68.36 -18.05 64.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.313 -0.403 . . . . 2.2200000000000002 111.246 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -91.01 -9.43 45.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 1.78 110.566 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.6 t -117.87 -36.56 3.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 1.6299999999999999 111.057 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -97.39 147.81 33.51 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 2.8500000000000001 110.49 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 63' ' ' LYS . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.35999999999999999 110.686 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.633 ' HE2' ' O ' ' A' ' 91' ' ' ASP . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.3799999999999999 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 0.33000000000000002 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 0.34999999999999998 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 0.33000000000000002 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.34000000000000002 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.686 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 0.25 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.668 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.22 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.41999999999999998 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.3100000000000001 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.27 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 0.79000000000000004 110.475 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.28999999999999998 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 0.31 109.404 177.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 1.8500000000000001 109.337 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 0.46999999999999997 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.9299999999999999 110.272 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 0.68000000000000005 110.608 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.40999999999999998 109.951 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 0.70999999999999996 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.23000000000000001 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.3500000000000001 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.3500000000000001 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.668 HG22 ' HD2' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 0.37 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.624 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 0.22 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.439 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.1599999999999999 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.22 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 0.27000000000000002 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 0.42999999999999999 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91000000000000003 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.29 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.44 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.23 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.3 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.44 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 148' ' ' ARG . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 0.37 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 1.6599999999999999 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.783 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 0.51000000000000001 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.0600000000000001 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 0.39000000000000001 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.783 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.44 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66000000000000003 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 0.47999999999999998 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.686 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.29999999999999999 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.783 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.19 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 0.84999999999999998 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HB2' HD21 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 2.48 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17000000000000001 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.4199999999999999 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 0.40000000000000002 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.25 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 0.19 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.783 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.4199999999999999 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 0.28000000000000003 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.4399999999999999 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.462 0.173 . . . . 3.6800000000000002 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.86 -57.37 12.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.628 0.252 . . . . 2.3799999999999999 110.711 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -83.3 126.52 32.77 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.12 -0.632 . . . . 1.6100000000000001 109.707 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.26000000000000001 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 0.17999999999999999 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.724 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.56999999999999995 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 0.16 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 0.19 110.937 -174.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.60999999999999999 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.3700000000000001 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.23 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.3 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 0.40000000000000002 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 0.57999999999999996 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.19 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.682 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 0.28000000000000003 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 0.23999999999999999 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.31 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.3600000000000001 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 1.9399999999999999 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.45 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.3500000000000001 110.71 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.723 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.0600000000000001 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 0.20999999999999999 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 0.38 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.643 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.20000000000000001 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.943 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 0.16 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.3799999999999999 109.614 179.164 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.34999999999999998 112.501 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 83' ' ' LYS . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.34 172.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.1600000000000001 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.4199999999999999 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 0.72999999999999998 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.68000000000000005 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.2799999999999998 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 3.3399999999999999 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 1.9399999999999999 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93000000000000005 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.0700000000000001 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 1.6599999999999999 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.0 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.2599999999999998 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.46000000000000002 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.4300000000000002 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.682 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.0499999999999998 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 0.25 109.745 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.23 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 15' ' ' SER . 58.5 t30 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 1.3999999999999999 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 56' ' ' ILE . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 0.33000000000000002 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.76 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 1.5900000000000001 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.9199999999999999 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 1.6799999999999999 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 0.34000000000000002 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.23999999999999999 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 0.40000000000000002 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.22 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.17000000000000001 111.187 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.643 HG23 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 0.17999999999999999 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.1000000000000001 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.20000000000000001 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.76 HG21 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 0.28000000000000003 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 1.8500000000000001 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.3100000000000001 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 0.23999999999999999 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 1.8799999999999999 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 0.33000000000000002 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 1.47 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.26000000000000001 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.0600000000000001 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.17000000000000001 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 110.357 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 1.51 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 0.26000000000000001 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 1.9299999999999999 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 1.79 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 -62.13 -48.04 81.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 3.9500000000000002 111.452 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 97' ' ' LYS . 1.8 m-20 -57.18 -23.18 45.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.896 0.379 . . . . 2.2200000000000002 111.718 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -87.03 -15.55 38.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.304 -0.407 . . . . 1.78 111.337 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.5 m -118.66 -35.31 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.755 0.312 . . . . 1.6299999999999999 111.779 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 -96.14 145.26 29.26 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.642 -0.503 . . . . 2.8500000000000001 109.642 -177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.68999999999999995 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 66' ' ' PHE . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 0.35999999999999999 110.504 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' OD1' ' A' ' 91' ' ' ASP . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.3799999999999999 108.918 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 0.33000000000000002 113.156 -167.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.1100000000000001 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.511 ' HB3' ' CE ' ' A' ' 125' ' ' MET . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.34999999999999998 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 0.33000000000000002 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.34000000000000002 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 0.25 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.566 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.22 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.41999999999999998 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.3100000000000001 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.27 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 0.79000000000000004 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 1.8500000000000001 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.28999999999999998 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 1.8500000000000001 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.9299999999999999 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 0.68000000000000005 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 109.446 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 0.70999999999999996 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.23000000000000001 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.3500000000000001 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.566 HG22 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 0.37 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.76 ' SD ' HG21 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.1599999999999999 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.22 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 0.27000000000000002 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.628 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 0.42999999999999999 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91000000000000003 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.29 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.44 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.23 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.3 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.44 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.37 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.759 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.0600000000000001 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 0.39000000000000001 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.759 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 0.78000000000000003 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1100000000000001 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66000000000000003 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 0.47999999999999998 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.29999999999999999 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.507 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 0.19 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 0.84999999999999998 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.629 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 2.48 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.4199999999999999 111.237 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 0.40000000000000002 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.3100000000000001 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.25 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 0.19 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.4199999999999999 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.658 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.4399999999999999 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.506 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 1.8100000000000001 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.851 0.357 . . . . 3.6800000000000002 110.584 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' ' C ' ' A' ' 26' ' ' GLU . 37.4 mt-10 -84.38 -26.87 28.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.35 -0.386 . . . . 2.3799999999999999 111.509 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.89 133.59 56.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 1.6100000000000001 111.339 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.26000000000000001 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 0.17999999999999999 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.72 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.56999999999999995 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 0.16 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 0.19 110.621 -175.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.90000000000000002 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.60999999999999999 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.3100000000000001 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.23 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.3 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.39000000000000001 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 0.40000000000000002 110.432 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 0.57999999999999996 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.19 109.735 -174.164 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 0.28000000000000003 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 0.23999999999999999 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.31 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.3600000000000001 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 1.9399999999999999 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' C ' ' HB3' ' A' ' 4' ' ' GLU . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.45 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.3500000000000001 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.0600000000000001 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 0.20999999999999999 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.626 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 0.38 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.725 ' SD ' HG23 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 0.20000000000000001 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.16 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.3799999999999999 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.34999999999999998 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 0.85999999999999999 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.1600000000000001 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.4199999999999999 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 0.72999999999999998 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.68000000000000005 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.2799999999999998 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 3.3399999999999999 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93000000000000005 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.0700000000000001 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 1.6599999999999999 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.2599999999999998 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.46000000000000002 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.4300000000000002 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.0499999999999998 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.54000000000000004 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 59' ' ' LEU . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 0.25 108.861 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.23 112.657 -175.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 1.3999999999999999 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 56' ' ' ILE . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 0.33000000000000002 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.76 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 1.5900000000000001 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.9199999999999999 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 0.34000000000000002 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.23999999999999999 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.684 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 0.40000000000000002 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.22 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.17000000000000001 110.381 171.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.725 HG23 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 0.17999999999999999 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.1000000000000001 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 1.8200000000000001 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.20000000000000001 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.781 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 0.28000000000000003 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 1.8500000000000001 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.3100000000000001 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 0.23999999999999999 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG2' HG22 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 0.33000000000000002 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 1.47 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.26000000000000001 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.0600000000000001 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 0.17000000000000001 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 84' ' ' LEU . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 0.20999999999999999 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.79 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 1.51 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 0.26000000000000001 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 7.6 tp60 -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 1.9299999999999999 109.562 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 1.79 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.626 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 -64.77 -43.31 93.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 3.9500000000000002 111.534 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.75 -33.52 35.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 2.2200000000000002 111.356 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.5 m -71.22 -31.25 67.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 1.78 111.583 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 m -100.75 -36.63 9.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 111.804 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 -97.36 146.92 32.2 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.383 -0.371 . . . . 2.8500000000000001 110.157 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.68999999999999995 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.533 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.35999999999999999 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.3799999999999999 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.33000000000000002 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.1100000000000001 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 0.34999999999999998 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 0.33000000000000002 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.916 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.25 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.22 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.41999999999999998 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.3100000000000001 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.27 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 0.79000000000000004 110.462 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 1.8500000000000001 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.28999999999999998 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 0.31 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 1.8500000000000001 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 0.46999999999999997 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.9299999999999999 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 115' ' ' GLU . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 0.68000000000000005 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.532 ' HD1' HD22 ' A' ' 111' ' ' LEU . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.3 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.499 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 0.70999999999999996 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.722 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 0.23000000000000001 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.414 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.3500000000000001 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.3500000000000001 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' HE2' ' A' ' 104' ' ' LYS . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 0.37 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 0.22 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.916 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.1599999999999999 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.22 111.76 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 0.27000000000000002 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.463 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 0.42999999999999999 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91000000000000003 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.29 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.44 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 128' ' ' LEU . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.23 110.395 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.3 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 148' ' ' ARG . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.37 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 0.51000000000000001 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.458 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 0.78000000000000003 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 0.44 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66000000000000003 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 0.47999999999999998 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.29999999999999999 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.704 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 0.19 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 0.84999999999999998 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 2.48 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17000000000000001 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.4199999999999999 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 0.40000000000000002 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.25 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 0.19 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.704 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 0.28000000000000003 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.582 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 1.8100000000000001 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.536 0.208 . . . . 3.6800000000000002 111.374 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.22 -63.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.611 0.243 . . . . 2.3799999999999999 110.796 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -88.77 115.44 26.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 1.6100000000000001 110.479 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.26000000000000001 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 0.17999999999999999 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 19' ' ' LEU . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 0.16 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 0.19 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.60999999999999999 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.3700000000000001 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.3100000000000001 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.23 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.3 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.39000000000000001 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 0.40000000000000002 109.964 174.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.623 HD11 ' HD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 0.57999999999999996 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.19 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 0.28000000000000003 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 0.23999999999999999 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.3600000000000001 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 1.9399999999999999 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.45 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.3500000000000001 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.0600000000000001 110.326 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 0.20999999999999999 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.38 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.609 ' SD ' HG23 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 0.20000000000000001 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 0.16 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.3799999999999999 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 0.85999999999999999 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.1600000000000001 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.4199999999999999 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.72999999999999998 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.68000000000000005 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 3.3399999999999999 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 1.9399999999999999 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93000000000000005 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.0700000000000001 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.0 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.2599999999999998 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.46000000000000002 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.4300000000000002 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.0499999999999998 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 0.54000000000000004 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 0.25 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.23 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.9 t30 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 1.3999999999999999 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 0.33000000000000002 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.76 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 1.5900000000000001 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.9199999999999999 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 1.6799999999999999 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.0700000000000001 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.623 ' HD1' HD11 ' A' ' 19' ' ' LEU . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.23999999999999999 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 0.40000000000000002 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.22 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.17000000000000001 111.107 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.609 HG23 ' SD ' ' A' ' 33' ' ' MET . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 0.17999999999999999 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.1000000000000001 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 1.8200000000000001 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.20000000000000001 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 0.28000000000000003 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 1.8500000000000001 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.3100000000000001 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.23999999999999999 111.511 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 1.8799999999999999 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 0.33000000000000002 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 1.47 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.26000000000000001 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.0600000000000001 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.17000000000000001 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 1.51 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 0.26000000000000001 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.3 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 1.9299999999999999 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 1.79 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 -57.42 -32.04 66.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 3.9500000000000002 111.647 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.07 -12.98 59.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.346 -0.388 . . . . 2.2200000000000002 111.765 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 t -93.96 -15.07 25.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.625 0.25 . . . . 1.78 111.064 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -116.5 -36.03 4.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.081 0.467 . . . . 1.6299999999999999 110.852 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.629 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 -95.98 129.42 34.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.951 -0.759 . . . . 2.8500000000000001 108.951 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.629 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.68999999999999995 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.35999999999999999 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.3799999999999999 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.34999999999999998 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.34000000000000002 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 0.25 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 1.011 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.22 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.41999999999999998 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.3100000000000001 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.27 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 0.79000000000000004 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.8500000000000001 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.28999999999999998 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.507 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.31 109.767 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 1.8500000000000001 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.46999999999999997 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.9299999999999999 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 0.68000000000000005 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.507 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.40999999999999998 109.791 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 120' ' ' GLN . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 0.70999999999999996 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 0.23000000000000001 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.47 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.3500000000000001 112.042 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.3500000000000001 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.011 HG22 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 0.37 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 0.22 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.857 ' SD ' HG11 ' A' ' 74' ' ' VAL . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.1599999999999999 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 71' ' ' CYS . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 0.27000000000000002 110.197 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 0.42999999999999999 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91000000000000003 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.29 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.44 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.23 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.3 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.44 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 148' ' ' ARG . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 0.37 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.7 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 0.51000000000000001 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 137' ' ' VAL . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.0600000000000001 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 0.39000000000000001 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.7 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 0.78000000000000003 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 0.44 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66000000000000003 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 0.47999999999999998 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.29999999999999999 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 0.19 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 0.84999999999999998 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 2.48 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17000000000000001 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.4199999999999999 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 0.40000000000000002 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.3100000000000001 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.25 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.787 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 0.19 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.4199999999999999 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.4399999999999999 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 1.8100000000000001 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.669 0.271 . . . . 3.6800000000000002 110.949 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.2 -54.18 7.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 2.3799999999999999 110.713 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -84.42 125.81 32.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.585 -0.446 . . . . 1.6100000000000001 110.042 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.26000000000000001 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 0.17999999999999999 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.68 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.56999999999999995 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 19' ' ' LEU . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 0.16 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.563 -174.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.654 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 0.90000000000000002 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.60999999999999999 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.3700000000000001 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.3100000000000001 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 57' ' ' ARG . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.23 110.359 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.3 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.654 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.39000000000000001 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 0.40000000000000002 110.024 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 0.57999999999999996 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.19 109.523 -173.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.68 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 0.23999999999999999 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.31 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.674 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 1.9399999999999999 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.45 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.3500000000000001 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.1599999999999999 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.0600000000000001 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 0.20999999999999999 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.644 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.20000000000000001 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.16 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.3799999999999999 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.425 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 0.85999999999999999 109.785 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.1600000000000001 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.4199999999999999 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 0.72999999999999998 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.68000000000000005 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.2799999999999998 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 3.3399999999999999 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 1.9399999999999999 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93000000000000005 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.0700000000000001 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 1.6599999999999999 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.0 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.2599999999999998 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.4300000000000002 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' OE2' HG21 ' A' ' 18' ' ' THR . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 0.54000000000000004 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 HD21 ' A' ' 59' ' ' LEU . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 0.25 109.603 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' HD3' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.23 112.043 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 1.3999999999999999 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 56' ' ' ILE . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 0.33000000000000002 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.76 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 1.5900000000000001 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.9199999999999999 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 1.6799999999999999 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.0700000000000001 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 0.34000000000000002 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.599 ' HD1' HD11 ' A' ' 19' ' ' LEU . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.23999999999999999 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 0.40000000000000002 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.22 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.17000000000000001 111.003 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.644 HG23 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 0.17999999999999999 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.1000000000000001 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 1.8200000000000001 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.20000000000000001 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 0.28000000000000003 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 1.8500000000000001 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.3100000000000001 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.23999999999999999 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 1.8799999999999999 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 1.47 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.26000000000000001 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.0600000000000001 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 0.17000000000000001 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.20999999999999999 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 0.26000000000000001 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 1.9299999999999999 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 1.79 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.641 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 -63.99 -22.87 67.11 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 3.9500000000000002 111.121 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 8.0 p-10 -68.16 -16.74 64.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.964 -0.562 . . . . 2.2200000000000002 112.315 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -93.74 -24.01 17.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.802 -0.359 . . . . 1.78 111.439 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 t -98.86 -35.16 10.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 1.6299999999999999 110.634 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.21 139.87 21.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.202 -0.454 . . . . 2.8500000000000001 110.087 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.68999999999999995 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 0.35999999999999999 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.3799999999999999 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 0.33000000000000002 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.1100000000000001 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 0.34999999999999998 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.848 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.34000000000000002 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 0.25 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.22 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.41999999999999998 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.3100000000000001 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.27 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 1.8500000000000001 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.28999999999999998 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 1.8500000000000001 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 0.46999999999999997 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 0.68000000000000005 110.553 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.40999999999999998 109.521 -174.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 0.70999999999999996 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 0.23000000000000001 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.3500000000000001 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.3500000000000001 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 0.37 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 0.22 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.848 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.1599999999999999 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.22 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 0.27000000000000002 108.949 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.522 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 0.42999999999999999 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91000000000000003 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.29 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.44 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.23 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.3 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.44 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 148' ' ' ARG . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 0.37 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 1.6599999999999999 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 0.51000000000000001 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.0600000000000001 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.39000000000000001 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.733 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 0.78000000000000003 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 0.44 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66000000000000003 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 0.47999999999999998 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.639 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.29999999999999999 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 0.84999999999999998 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 2.48 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17000000000000001 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.4199999999999999 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 0.40000000000000002 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.522 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.3100000000000001 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.25 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 0.19 113.021 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.737 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.4199999999999999 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 0.28000000000000003 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.4399999999999999 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 1.8100000000000001 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.523 0.202 . . . . 3.6800000000000002 111.363 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.34 -58.97 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.372 0.508 . . . . 2.3799999999999999 112.372 -173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -57.09 131.76 50.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 1.6100000000000001 111.612 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.26000000000000001 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 0.17999999999999999 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.697 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.56999999999999995 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 0.16 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 0.19 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 0.90000000000000002 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.60999999999999999 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.3700000000000001 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 58' ' ' ASN . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.23 108.856 176.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.39000000000000001 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 0.40000000000000002 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.57999999999999996 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.19 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.28000000000000003 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 28' ' ' VAL . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 0.23999999999999999 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.31 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.3600000000000001 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 1.9399999999999999 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.45 110.738 -176.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.3500000000000001 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.722 HG21 HG11 ' A' ' 22' ' ' VAL . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.1599999999999999 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.0600000000000001 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 0.20999999999999999 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.38 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 0.20000000000000001 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.23000000000000001 111.059 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 0.16 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.3799999999999999 109.883 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.34999999999999998 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 0.85999999999999999 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.1600000000000001 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.4199999999999999 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.72999999999999998 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.68000000000000005 111.934 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.2799999999999998 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.498 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 3.3399999999999999 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 1.9399999999999999 111.295 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93000000000000005 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.0700000000000001 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 1.6599999999999999 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.0 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.46000000000000002 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.4300000000000002 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.0499999999999998 111.301 175.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 0.54000000000000004 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 0.25 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.23 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.5 t30 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 1.3999999999999999 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 0.33000000000000002 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.76 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 1.5900000000000001 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.9199999999999999 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.6799999999999999 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 0.34000000000000002 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.651 ' HD1' HD11 ' A' ' 19' ' ' LEU . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.23999999999999999 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 0.40000000000000002 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.22 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.17000000000000001 111.341 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 0.17999999999999999 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.1000000000000001 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.20000000000000001 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 0.28000000000000003 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 1.8500000000000001 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.3100000000000001 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.23999999999999999 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 1.8799999999999999 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 0.33000000000000002 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 1.47 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.26000000000000001 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.0600000000000001 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.476 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 0.17000000000000001 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 0.20999999999999999 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 0.26000000000000001 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.464 ' HG3' ' OD2' ' A' ' 91' ' ' ASP . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 1.9299999999999999 110.15 175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 1.79 108.501 -171.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.701 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 -56.24 -33.36 65.33 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 3.9500000000000002 111.845 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 88' ' ' GLN . 13.0 p-10 -66.97 -15.05 63.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.113 0.412 . . . . 2.2200000000000002 112.113 -172.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 m -87.32 -19.17 28.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.865 0.364 . . . . 1.78 111.052 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -110.97 -34.55 6.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.158 0.504 . . . . 1.6299999999999999 110.485 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.9 143.48 26.19 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.0 -0.545 . . . . 2.8500000000000001 110.063 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.68999999999999995 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.35999999999999999 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.568 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.3799999999999999 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 110.88 -167.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.742 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 0.33000000000000002 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.856 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.34000000000000002 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 0.25 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.22 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.41999999999999998 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.3100000000000001 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.27 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.79000000000000004 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 1.8500000000000001 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.28999999999999998 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 0.31 109.714 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 1.8500000000000001 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.46999999999999997 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.9299999999999999 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 0.68000000000000005 110.061 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.40999999999999998 109.955 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 0.70999999999999996 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.669 HG11 ' HB1' ' A' ' 77' ' ' ALA . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.3500000000000001 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.3500000000000001 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 0.37 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 0.22 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.864 ' SD ' HG11 ' A' ' 74' ' ' VAL . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.1599999999999999 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.22 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 0.27000000000000002 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 0.42999999999999999 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91000000000000003 112.599 176.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.29 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.44 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.23 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.3 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 0.37 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 1.6599999999999999 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 0.51000000000000001 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.0600000000000001 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 0.78000000000000003 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 0.44 109.326 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66000000000000003 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.47999999999999998 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.548 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.19 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 2.48 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17000000000000001 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.4199999999999999 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 148' ' ' ARG . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 0.40000000000000002 110.357 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.3100000000000001 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.25 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 0.19 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.4199999999999999 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 0.28000000000000003 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.4399999999999999 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.614 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 1.8100000000000001 111.524 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.084 0.469 . . . . 1.6100000000000001 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 0.17999999999999999 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.75 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.56999999999999995 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 HD11 HD22 ' A' ' 19' ' ' LEU . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 0.16 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 0.19 110.604 -176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.535 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 0.90000000000000002 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.60999999999999999 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.3100000000000001 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.23 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.3 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.39000000000000001 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 0.40000000000000002 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 0.57999999999999996 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.19 109.436 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 0.28000000000000003 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.75 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 0.23999999999999999 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.31 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.3600000000000001 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 1.9399999999999999 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.637 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.45 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.3500000000000001 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.742 HG21 HG11 ' A' ' 22' ' ' VAL . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.1599999999999999 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 m120 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.0600000000000001 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 0.20999999999999999 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.736 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 0.38 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.20000000000000001 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.23000000000000001 110.709 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 0.16 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.3799999999999999 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.34999999999999998 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 0.85999999999999999 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.1600000000000001 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.4199999999999999 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 0.72999999999999998 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.68000000000000005 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.2799999999999998 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 3.3399999999999999 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 1.9399999999999999 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93000000000000005 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.0700000000000001 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 1.6599999999999999 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.0 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.2599999999999998 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.46000000000000002 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.4300000000000002 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 21' ' ' ILE . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 0.54000000000000004 111.567 -171.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.695 HG23 HD21 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 0.25 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.23 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.2 t-20 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 1.3999999999999999 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.695 HD21 HG23 ' A' ' 56' ' ' ILE . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.33000000000000002 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.76 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 1.5900000000000001 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.427 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 1.6799999999999999 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.0700000000000001 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 0.34000000000000002 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.23999999999999999 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 0.40000000000000002 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.22 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.17000000000000001 112.088 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 0.17999999999999999 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.1000000000000001 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.65 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 1.8200000000000001 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.20000000000000001 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 0.28000000000000003 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 1.8500000000000001 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.3100000000000001 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.23999999999999999 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 1.8799999999999999 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 0.33000000000000002 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 1.47 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.26000000000000001 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.0600000000000001 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 0.17000000000000001 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.20999999999999999 110.372 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 0.26000000000000001 110.047 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 1.9299999999999999 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 1.79 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 . . . . . 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 3.9500000000000002 111.714 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.971 -0.752 . . . . 2.8500000000000001 108.971 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.68999999999999995 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.427 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 0.35999999999999999 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.3799999999999999 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.1100000000000001 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 0.34999999999999998 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.458 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 0.33000000000000002 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.34000000000000002 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 0.25 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.22 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.41999999999999998 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.3100000000000001 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.27 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 0.79000000000000004 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.28999999999999998 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 0.31 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 1.8500000000000001 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 0.46999999999999997 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.9299999999999999 110.09 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 0.68000000000000005 110.578 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.40999999999999998 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 0.70999999999999996 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 0.23000000000000001 110.624 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.3500000000000001 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.761 HG22 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 0.37 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 0.22 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.1599999999999999 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.22 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 0.27000000000000002 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 0.42999999999999999 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.29 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.44 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.23 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.3 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.44 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 148' ' ' ARG . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.37 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 1.6599999999999999 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.634 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 0.51000000000000001 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.0600000000000001 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.39000000000000001 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 0.78000000000000003 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.1100000000000001 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66000000000000003 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 0.47999999999999998 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.29999999999999999 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.782 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.19 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 0.84999999999999998 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.796 ' HB2' HD21 ' A' ' 135' ' ' LEU . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 2.48 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17000000000000001 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.4199999999999999 111.294 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 0.40000000000000002 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.305 168.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.25 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 0.19 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.4199999999999999 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.28000000000000003 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.782 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.4399999999999999 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 1.8100000000000001 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.705 0.288 . . . . 1.6100000000000001 110.511 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.717 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.26000000000000001 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 0.17999999999999999 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.736 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.56999999999999995 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 0.16 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 0.19 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 0.90000000000000002 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.60999999999999999 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.3700000000000001 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.3100000000000001 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.23 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.3 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.39000000000000001 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 0.40000000000000002 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 69' ' ' GLY . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.19 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 53' ' ' ASN . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.28000000000000003 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 28' ' ' VAL . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 0.23999999999999999 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.31 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.717 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.3600000000000001 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 1.9399999999999999 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.3500000000000001 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG21 HG11 ' A' ' 22' ' ' VAL . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.1599999999999999 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.0600000000000001 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 0.20999999999999999 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.38 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.598 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 0.16 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.3799999999999999 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.34999999999999998 112.106 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.1600000000000001 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.4199999999999999 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 0.72999999999999998 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' HG12 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.68000000000000005 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 3.3399999999999999 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93000000000000005 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.0700000000000001 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 1.6599999999999999 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.2599999999999998 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.46000000000000002 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.4300000000000002 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 21' ' ' ILE . 3.9 t-20 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.0499999999999998 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 0.54000000000000004 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 0.25 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.23 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 0.33000000000000002 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.76 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 1.5900000000000001 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.9199999999999999 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.0700000000000001 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 56' ' ' ILE . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HD1' HD11 ' A' ' 19' ' ' LEU . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.23999999999999999 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 0.40000000000000002 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.22 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.17000000000000001 110.77 174.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 0.17999999999999999 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.1000000000000001 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.8200000000000001 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.20000000000000001 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.823 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 1.8500000000000001 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.3100000000000001 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 0.23999999999999999 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 1.8799999999999999 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 0.33000000000000002 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 1.47 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 113.355 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.0600000000000001 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 0.17000000000000001 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 0.20999999999999999 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 1.51 109.121 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 0.26000000000000001 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 1.9299999999999999 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 1.79 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 3.9500000000000002 110.637 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.5 -0.555 . . . . 2.8500000000000001 109.5 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.68999999999999995 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 0.35999999999999999 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.3799999999999999 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.1100000000000001 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.34999999999999998 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 0.33000000000000002 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.83 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.34000000000000002 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 0.25 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.572 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.22 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.41999999999999998 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.3100000000000001 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.27 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 0.79000000000000004 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 1.8500000000000001 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.28999999999999998 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 0.31 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 0.46999999999999997 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.9299999999999999 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 0.68000000000000005 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.40999999999999998 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 0.70999999999999996 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 0.23000000000000001 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.3500000000000001 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.3500000000000001 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.37 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.22 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.83 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.22 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.27000000000000002 109.726 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.633 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 0.42999999999999999 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91000000000000003 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.29 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.44 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.23 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.3 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.44 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 0.37 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 1.6599999999999999 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.662 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 0.51000000000000001 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.672 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.0600000000000001 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.39000000000000001 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.662 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 0.78000000000000003 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.47999999999999998 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.29999999999999999 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 0.19 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 0.84999999999999998 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HB2' HD21 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 2.48 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17000000000000001 112.243 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.4199999999999999 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 0.40000000000000002 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.599 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.3100000000000001 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.25 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 0.19 113.269 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.771 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.4199999999999999 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 0.28000000000000003 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.661 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.4399999999999999 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.731 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 1.8100000000000001 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.058 0.456 . . . . 1.6100000000000001 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 0.17999999999999999 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.666 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.56999999999999995 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.16 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 0.19 110.513 -175.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 0.90000000000000002 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.60999999999999999 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.3700000000000001 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.3100000000000001 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.23 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.432 HD22 ' NE2' ' A' ' 60' ' ' GLN . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.3 111.41 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.39000000000000001 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 0.40000000000000002 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.669 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 0.57999999999999996 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.19 109.579 -175.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.541 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 0.28000000000000003 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.666 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 0.23999999999999999 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.31 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.3600000000000001 110.823 -172.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 1.9399999999999999 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.45 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.1599999999999999 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.0600000000000001 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.743 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 0.38 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 0.20000000000000001 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.16 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.3799999999999999 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.34999999999999998 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 0.85999999999999999 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.1600000000000001 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.4199999999999999 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 0.72999999999999998 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.68000000000000005 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.2799999999999998 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.656 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 3.3399999999999999 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 1.9399999999999999 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93000000000000005 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.0700000000000001 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 1.6599999999999999 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.0 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.2599999999999998 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.46000000000000002 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.4300000000000002 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.0499999999999998 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 0.54000000000000004 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 0.25 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.23 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 1.3999999999999999 109.842 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 0.33000000000000002 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.432 ' NE2' HD22 ' A' ' 16' ' ' ASN . 3.8 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.76 111.117 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 1.5900000000000001 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.9199999999999999 111.203 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 1.6799999999999999 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.0700000000000001 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 0.34000000000000002 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.609 ' HD1' HD11 ' A' ' 19' ' ' LEU . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.23999999999999999 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 0.40000000000000002 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.22 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.17000000000000001 111.34 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 0.17999999999999999 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.1000000000000001 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 1.8200000000000001 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.20000000000000001 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 0.28000000000000003 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 1.8500000000000001 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.608 ' O ' HG23 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 0.23999999999999999 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 1.8799999999999999 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 0.33000000000000002 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.449 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 1.47 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.26000000000000001 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.0600000000000001 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 0.17000000000000001 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.20999999999999999 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 1.51 108.986 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 1.9299999999999999 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 1.79 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 3.9500000000000002 111.369 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.698 -0.482 . . . . 2.8500000000000001 109.698 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.68999999999999995 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.433 HD12 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 0.35999999999999999 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.64 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.3799999999999999 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 0.33000000000000002 111.584 -169.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.1100000000000001 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.34999999999999998 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 0.33000000000000002 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.957 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 0.25 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE3' HG22 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.22 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.41999999999999998 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.27 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.79000000000000004 110.619 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 1.8500000000000001 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.28999999999999998 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.31 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 1.8500000000000001 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 111.732 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.9299999999999999 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 0.68000000000000005 109.824 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.446 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 0.23000000000000001 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.3500000000000001 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.3500000000000001 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.507 HG22 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 0.37 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 0.22 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.464 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.1599999999999999 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.454 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.22 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 0.27000000000000002 110.409 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.666 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 0.42999999999999999 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91000000000000003 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.64 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.29 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.44 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.23 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.3 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.44 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.666 HD12 HD21 ' A' ' 128' ' ' LEU . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 0.37 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.623 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 1.6599999999999999 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.698 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 0.51000000000000001 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 0.39000000000000001 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.698 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.78000000000000003 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 0.44 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66000000000000003 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 0.47999999999999998 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.29999999999999999 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 0.19 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.48 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17000000000000001 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.4199999999999999 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.491 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 0.40000000000000002 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.528 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.3100000000000001 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.25 115.217 171.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 0.19 113.355 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.488 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.4199999999999999 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.4399999999999999 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.681 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 1.8100000000000001 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.059 -0.348 . . . . 1.6100000000000001 110.059 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.566 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.26000000000000001 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 0.17999999999999999 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.56999999999999995 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 0.16 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 0.19 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.599 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 0.90000000000000002 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.60999999999999999 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.3700000000000001 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.3100000000000001 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.23 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.3 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.599 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.39000000000000001 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 0.40000000000000002 110.251 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.627 HD11 ' HD1' ' A' ' 66' ' ' PHE . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 0.57999999999999996 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.19 109.572 -174.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.713 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.23999999999999999 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.31 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.3600000000000001 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 1.9399999999999999 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.45 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.3500000000000001 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.785 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.1599999999999999 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.0600000000000001 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.20999999999999999 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 0.38 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.20000000000000001 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 0.16 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.3799999999999999 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.34999999999999998 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 83' ' ' LYS . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 0.85999999999999999 109.289 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.1600000000000001 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.4199999999999999 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 0.72999999999999998 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.68000000000000005 113.028 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.2799999999999998 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.678 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 3.3399999999999999 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 1.9399999999999999 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93000000000000005 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.0700000000000001 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 1.6599999999999999 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.0 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.2599999999999998 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.46000000000000002 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.4300000000000002 111.388 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.0499999999999998 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' N ' HD22 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 0.54000000000000004 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.561 HG23 HD21 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 0.25 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.23 112.035 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 1.3999999999999999 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 0.33000000000000002 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 1.5900000000000001 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.9199999999999999 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.524 ' HE2' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 1.6799999999999999 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 0.34000000000000002 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.627 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.23999999999999999 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 0.40000000000000002 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.22 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.17000000000000001 110.794 173.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 0.17999999999999999 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.1000000000000001 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.20000000000000001 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.8 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 0.28000000000000003 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 1.8500000000000001 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.3100000000000001 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 0.23999999999999999 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 1.8799999999999999 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 0.33000000000000002 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 1.47 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.26000000000000001 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HD3' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.0600000000000001 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 0.17000000000000001 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 1.51 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 0.26000000000000001 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 1.9299999999999999 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 1.79 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 3.9500000000000002 111.24 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.594 -0.521 . . . . 2.8500000000000001 109.594 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.68999999999999995 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.524 HG12 ' HE2' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 0.35999999999999999 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.3799999999999999 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.33000000000000002 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.1100000000000001 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.535 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 0.34999999999999998 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.33000000000000002 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.826 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' ASP . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 0.25 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.22 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.41999999999999998 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.3100000000000001 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.27 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 0.79000000000000004 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 1.8500000000000001 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.28999999999999998 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.31 109.98 -176.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 1.8500000000000001 109.548 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 0.46999999999999997 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.9299999999999999 110.592 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 0.68000000000000005 110.85 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.40999999999999998 110.097 -174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.683 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 0.23000000000000001 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.3500000000000001 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.3500000000000001 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.472 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 0.37 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.688 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.22 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.826 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.1599999999999999 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.22 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 0.42999999999999999 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91000000000000003 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.29 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.44 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.494 ' O ' HD23 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.23 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.3 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.44 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.37 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.724 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.51000000000000001 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.0600000000000001 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 0.39000000000000001 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.724 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 0.78000000000000003 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 0.44 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.1100000000000001 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66000000000000003 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 0.47999999999999998 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.29999999999999999 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 0.84999999999999998 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.695 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 2.48 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17000000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.4199999999999999 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 0.40000000000000002 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.3100000000000001 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.25 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 0.19 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.4199999999999999 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 0.28000000000000003 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.4399999999999999 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.509 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 1.8100000000000001 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 109.913 -0.403 . . . . 1.6100000000000001 109.913 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.26000000000000001 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 0.17999999999999999 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 0.16 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 0.19 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.634 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 0.90000000000000002 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.60999999999999999 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.3700000000000001 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.3100000000000001 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.23 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.3 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.39000000000000001 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 0.40000000000000002 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 0.57999999999999996 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.19 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.738 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 0.23999999999999999 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.31 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.3600000000000001 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 1.9399999999999999 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.45 109.458 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.3500000000000001 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.755 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.1599999999999999 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.0600000000000001 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 0.20999999999999999 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 0.38 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.614 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 0.20000000000000001 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 0.16 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.3799999999999999 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.34999999999999998 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 0.85999999999999999 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.1600000000000001 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.4199999999999999 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 0.72999999999999998 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.68000000000000005 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 3.3399999999999999 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 1.9399999999999999 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93000000000000005 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.0700000000000001 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 1.6599999999999999 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.0 110.995 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.2599999999999998 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.46000000000000002 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.4300000000000002 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.0499999999999998 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 0.54000000000000004 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.604 HG23 HD21 ' A' ' 59' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.23 112.316 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 1.3999999999999999 111.066 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 56' ' ' ILE . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 0.33000000000000002 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.76 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 1.5900000000000001 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.9199999999999999 111.07 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 1.6799999999999999 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.0700000000000001 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 0.34000000000000002 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.636 ' HD1' HD11 ' A' ' 19' ' ' LEU . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 0.40000000000000002 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.22 110.914 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.748 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.17000000000000001 111.192 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 0.17999999999999999 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.1000000000000001 109.894 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.7 mm100 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.20000000000000001 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.28000000000000003 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 1.8500000000000001 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.3100000000000001 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.76 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 0.23999999999999999 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.709 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 1.8799999999999999 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.33000000000000002 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 1.47 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.26000000000000001 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.0600000000000001 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 0.17000000000000001 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.427 ' N ' HD13 ' A' ' 84' ' ' LEU . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 0.20999999999999999 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 0.26000000000000001 110.277 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 8.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 1.9299999999999999 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 1.79 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 3.9500000000000002 111.754 -174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.702 -0.481 . . . . 2.8500000000000001 109.702 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.68999999999999995 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.492 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 0.35999999999999999 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.3799999999999999 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 0.33000000000000002 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.1100000000000001 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 0.34999999999999998 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.34000000000000002 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 0.25 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.22 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.41999999999999998 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.3100000000000001 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.27 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 0.79000000000000004 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.28999999999999998 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 0.31 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 14.0 m120 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 1.8500000000000001 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 0.68000000000000005 111.135 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.496 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 109.537 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.76 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.3500000000000001 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.3500000000000001 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.653 HG22 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 0.37 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.627 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 0.22 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.1599999999999999 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.22 110.051 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 0.27000000000000002 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 0.42999999999999999 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91000000000000003 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.29 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.44 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.23 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.3 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.44 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 148' ' ' ARG . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.37 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 0.51000000000000001 110.153 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.0600000000000001 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 0.39000000000000001 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.499 ' CB ' ' HB ' ' A' ' 108' ' ' VAL . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 0.78000000000000003 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.44 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.1100000000000001 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66000000000000003 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 0.47999999999999998 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.526 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.66 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.19 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 0.84999999999999998 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 2.48 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17000000000000001 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.4199999999999999 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 0.40000000000000002 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.603 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.3100000000000001 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.25 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 0.19 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.4199999999999999 110.742 166.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 0.28000000000000003 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.4399999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.709 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 1.8100000000000001 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 110.396 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.26000000000000001 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 0.17999999999999999 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.784 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.56999999999999995 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 0.16 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 0.19 110.645 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.631 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.60999999999999999 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.3700000000000001 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.3100000000000001 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.23 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.3 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.39000000000000001 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 0.40000000000000002 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.75 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 0.57999999999999996 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.19 109.491 -173.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 0.28000000000000003 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.784 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 0.23999999999999999 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.31 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HD2' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.3600000000000001 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 1.9399999999999999 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.45 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.3500000000000001 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.1599999999999999 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.0600000000000001 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 0.20999999999999999 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 0.38 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.618 ' HG2' HD12 ' A' ' 86' ' ' LEU . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 0.20000000000000001 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.23000000000000001 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 0.16 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.34999999999999998 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 0.85999999999999999 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.1600000000000001 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.4199999999999999 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 0.72999999999999998 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.68000000000000005 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' HD1' ' A' ' 46' ' ' PHE . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.146 -174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 1.9399999999999999 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 43' ' ' GLU . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93000000000000005 110.605 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.0700000000000001 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 1.6599999999999999 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.0 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.46000000000000002 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.4300000000000002 111.464 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB3' HG23 ' A' ' 21' ' ' ILE . 3.3 t-20 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.0499999999999998 110.47 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 0.54000000000000004 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.632 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 0.25 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.23 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 1.3999999999999999 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 HG23 ' A' ' 56' ' ' ILE . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 0.33000000000000002 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.76 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 1.5900000000000001 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.9199999999999999 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 1.6799999999999999 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.0700000000000001 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 0.34000000000000002 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' HD1' HD11 ' A' ' 19' ' ' LEU . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.23999999999999999 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 0.40000000000000002 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.22 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.75 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.17000000000000001 111.485 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.57 HG23 ' SD ' ' A' ' 33' ' ' MET . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 0.17999999999999999 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.1000000000000001 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 mm100 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 1.8200000000000001 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.20000000000000001 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.811 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 0.28000000000000003 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 1.8500000000000001 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HG3' HD13 ' A' ' 21' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.3100000000000001 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 0.23999999999999999 111.789 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 1.8799999999999999 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 0.33000000000000002 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 1.47 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.26000000000000001 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.0600000000000001 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 0.17000000000000001 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 0.20999999999999999 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.26000000000000001 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 1.9299999999999999 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 1.79 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.636 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 3.9500000000000002 110.466 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.512 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.308 -0.627 . . . . 2.8500000000000001 109.308 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.68999999999999995 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 0.35999999999999999 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.3799999999999999 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 0.33000000000000002 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.1100000000000001 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.567 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 0.34999999999999998 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.33000000000000002 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.846 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.34000000000000002 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 0.25 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.22 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.41999999999999998 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.3100000000000001 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.27 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.79000000000000004 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.28999999999999998 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 0.31 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 1.8500000000000001 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.46999999999999997 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.9299999999999999 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 0.68000000000000005 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.521 ' HD1' HD22 ' A' ' 111' ' ' LEU . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.40999999999999998 109.958 -173.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 120' ' ' GLN . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 0.70999999999999996 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 0.23000000000000001 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.3500000000000001 112.984 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.3500000000000001 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 0.37 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 0.22 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.846 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.1599999999999999 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.22 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 0.27000000000000002 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 0.42999999999999999 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91000000000000003 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.29 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.44 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.23 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.3 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.44 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.37 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 1.6599999999999999 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.743 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 0.51000000000000001 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' N ' HG22 ' A' ' 137' ' ' VAL . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.0600000000000001 111.254 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 0.39000000000000001 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.743 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 0.78000000000000003 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 0.44 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.1100000000000001 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66000000000000003 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 0.47999999999999998 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.637 ' CD2' HD23 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.29999999999999999 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.659 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 0.19 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 0.84999999999999998 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 135' ' ' LEU . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 2.48 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17000000000000001 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.4199999999999999 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 0.40000000000000002 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.3100000000000001 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.25 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 0.19 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.659 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.4399999999999999 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 1.8100000000000001 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 111.153 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.26000000000000001 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 0.17999999999999999 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.653 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.56999999999999995 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 0.16 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 0.19 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.90000000000000002 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.60999999999999999 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.3700000000000001 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.3100000000000001 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.23 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.3 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.39000000000000001 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 0.40000000000000002 110.23 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 0.57999999999999996 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.19 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 0.28000000000000003 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.653 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 0.23999999999999999 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.31 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.3600000000000001 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 1.9399999999999999 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.45 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.3500000000000001 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.0600000000000001 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HB2' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 0.38 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 0.20000000000000001 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 0.16 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.3799999999999999 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.34999999999999998 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.1600000000000001 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.4199999999999999 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 0.72999999999999998 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.68000000000000005 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.2799999999999998 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.536 ' HA ' HG12 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 3.3399999999999999 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93000000000000005 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 1.6599999999999999 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.0 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.2599999999999998 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.46000000000000002 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.4300000000000002 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.0499999999999998 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.54000000000000004 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 59' ' ' LEU . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 0.25 109.971 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.23 111.555 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 1.3999999999999999 110.748 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 56' ' ' ILE . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 0.33000000000000002 111.464 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.76 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 1.5900000000000001 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.9199999999999999 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 1.6799999999999999 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.0700000000000001 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 0.34000000000000002 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.23999999999999999 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 0.40000000000000002 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.22 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.17000000000000001 111.582 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 0.17999999999999999 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.1000000000000001 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 1.8200000000000001 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.20000000000000001 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 0.28000000000000003 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 1.8500000000000001 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.3100000000000001 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 1.8799999999999999 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 0.33000000000000002 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 1.47 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.26000000000000001 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.0600000000000001 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 0.17000000000000001 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 0.20999999999999999 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.448 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 0.26000000000000001 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 1.9299999999999999 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 1.79 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 3.9500000000000002 111.159 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 108.915 -0.772 . . . . 2.8500000000000001 108.915 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.68999999999999995 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 63' ' ' LYS . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.35999999999999999 110.531 174.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.3799999999999999 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 0.33000000000000002 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.1100000000000001 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 0.34999999999999998 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 0.33000000000000002 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.34000000000000002 110.26 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 0.25 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.22 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.41999999999999998 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.3100000000000001 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.27 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.79000000000000004 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 1.8500000000000001 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.28999999999999998 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 0.31 109.636 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 0.46999999999999997 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.9299999999999999 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 0.68000000000000005 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.40999999999999998 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.431 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 0.70999999999999996 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.53 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.3500000000000001 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.3500000000000001 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 0.37 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 0.22 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.1599999999999999 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.22 111.15 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.523 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 0.27000000000000002 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 0.42999999999999999 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91000000000000003 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.609 ' HE3' ' C ' ' A' ' 97' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.29 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.44 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.23 111.548 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.3 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.44 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 148' ' ' ARG . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 0.37 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 1.6599999999999999 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.687 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 0.51000000000000001 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.0600000000000001 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 0.39000000000000001 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.687 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 0.78000000000000003 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 0.44 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.1100000000000001 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66000000000000003 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.574 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.29999999999999999 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 0.19 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 0.84999999999999998 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 2.48 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17000000000000001 112.027 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 3.5 t-20 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.4199999999999999 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 0.40000000000000002 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.3100000000000001 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.25 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 0.19 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.4199999999999999 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 0.28000000000000003 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.4399999999999999 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 1.8100000000000001 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 1.6100000000000001 111.208 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.681 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.26000000000000001 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 0.17999999999999999 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.725 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.56999999999999995 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 32' ' ' LEU . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 0.16 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 0.19 111.052 -174.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.60999999999999999 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.3700000000000001 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.3100000000000001 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.23 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.3 111.577 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 0.40000000000000002 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 HD11 ' A' ' 59' ' ' LEU . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 0.57999999999999996 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.19 110.26 -171.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 0.28000000000000003 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 0.23999999999999999 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.31 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.3600000000000001 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 1.9399999999999999 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.45 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.3500000000000001 111.614 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.1599999999999999 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.0600000000000001 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.646 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 0.38 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 0.20000000000000001 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 0.16 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.3799999999999999 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.34999999999999998 112.904 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.526 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 0.85999999999999999 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.1600000000000001 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.4199999999999999 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.175 -171.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.482 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.68000000000000005 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.2799999999999998 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 3.3399999999999999 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 1.9399999999999999 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93000000000000005 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.0700000000000001 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 1.6599999999999999 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.0 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.2599999999999998 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.46000000000000002 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.4300000000000002 111.968 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB3' HG23 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.0499999999999998 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 21' ' ' ILE . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 0.54000000000000004 112.102 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.555 HG23 HD21 ' A' ' 59' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.23 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 1.3999999999999999 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 19' ' ' LEU . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.33000000000000002 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 60' ' ' GLN . 3.6 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.76 111.568 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 1.5900000000000001 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.9199999999999999 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 1.6799999999999999 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 111.657 -173.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 0.34000000000000002 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.23999999999999999 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 0.40000000000000002 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.22 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.17000000000000001 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 0.17999999999999999 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.1000000000000001 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 1.8200000000000001 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.20000000000000001 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 1.8500000000000001 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.3100000000000001 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.23999999999999999 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 1.8799999999999999 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 0.33000000000000002 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 1.47 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.26000000000000001 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.0600000000000001 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.473 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 0.17000000000000001 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.20999999999999999 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 1.51 109.381 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 0.26000000000000001 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 1.9299999999999999 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 1.79 107.832 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 3.9500000000000002 111.443 176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.98 -0.378 . . . . 2.8500000000000001 109.98 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.68999999999999995 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.35999999999999999 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.3799999999999999 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 0.33000000000000002 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.1100000000000001 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 0.33000000000000002 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 0.25 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.575 ' HE2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.22 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.41999999999999998 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.3100000000000001 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.27 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 1.8500000000000001 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.28999999999999998 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 0.31 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 0.46999999999999997 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.9299999999999999 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 0.68000000000000005 110.624 170.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.575 HG13 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 0.70999999999999996 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.67 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.3500000000000001 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 104' ' ' LYS . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.37 109.721 173.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 0.22 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.461 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.22 110.923 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.387 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 0.42999999999999999 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 131' ' ' GLY . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91000000000000003 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.29 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.44 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.23 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.3 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.44 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 0.37 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 1.6599999999999999 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 0.51000000000000001 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 138' ' ' LYS . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.0600000000000001 111.171 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 0.39000000000000001 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 0.78000000000000003 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 0.44 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66000000000000003 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.693 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.716 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 0.19 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 0.84999999999999998 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.782 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 2.48 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17000000000000001 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.475 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.4199999999999999 111.612 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 0.40000000000000002 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.3100000000000001 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.25 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 0.19 113.401 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.475 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.28000000000000003 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.716 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.4399999999999999 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 1.8100000000000001 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.958 0.408 . . . . 1.6100000000000001 110.726 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.54 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.26000000000000001 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 0.17999999999999999 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.794 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.56999999999999995 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 0.16 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 0.19 110.878 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.60999999999999999 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.3700000000000001 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.3100000000000001 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.23 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.3 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.39000000000000001 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 0.40000000000000002 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.644 HD12 ' HA3' ' A' ' 69' ' ' GLY . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 0.57999999999999996 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.19 109.811 -174.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.482 HD13 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 0.28000000000000003 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 0.23999999999999999 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.31 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.3600000000000001 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.45 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.3500000000000001 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.1599999999999999 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.0600000000000001 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 0.38 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.626 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.20000000000000001 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 0.16 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.3799999999999999 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.34999999999999998 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 0.85999999999999999 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.1600000000000001 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.4199999999999999 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 0.72999999999999998 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.68000000000000005 112.886 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.2799999999999998 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HA ' HG12 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 3.3399999999999999 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 1.9399999999999999 110.792 177.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93000000000000005 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 1.6599999999999999 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.0 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.2599999999999998 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.46000000000000002 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.4300000000000002 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.0499999999999998 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 0.54000000000000004 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.56 HG23 HD21 ' A' ' 59' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 0.25 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.23 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 1.3999999999999999 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 56' ' ' ILE . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 0.33000000000000002 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.76 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 1.5900000000000001 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.9199999999999999 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 1.6799999999999999 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.0700000000000001 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 0.34000000000000002 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.59 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.23999999999999999 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 0.40000000000000002 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.17000000000000001 111.508 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.626 HG23 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 0.17999999999999999 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.1000000000000001 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 1.8200000000000001 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 0.28000000000000003 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 1.8500000000000001 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.3100000000000001 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 0.23999999999999999 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 1.8799999999999999 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 0.33000000000000002 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 1.47 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.26000000000000001 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.0600000000000001 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 0.17000000000000001 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.20999999999999999 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 1.51 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 0.26000000000000001 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 1.9299999999999999 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 1.79 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.708 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 . . . . . 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 3.9500000000000002 111.986 175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 32' ' ' LEU . 15.4 m-85 . . . . . 0 CA--C 1.516 -0.358 0 CA-C-O 121.009 0.433 . . . . 2.8500000000000001 111.839 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.68999999999999995 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.48 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 0.35999999999999999 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.3799999999999999 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 0.33000000000000002 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.1100000000000001 110.156 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 0.34999999999999998 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.34000000000000002 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.25 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.22 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.41999999999999998 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.3100000000000001 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.27 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 0.79000000000000004 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 1.8500000000000001 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.28999999999999998 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 0.31 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 1.8500000000000001 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.9299999999999999 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 0.68000000000000005 110.362 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.40999999999999998 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.70999999999999996 112.324 -173.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 0.23000000000000001 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 118' ' ' VAL . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.3500000000000001 112.155 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.3500000000000001 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 104' ' ' LYS . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 0.37 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 0.22 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.438 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.1599999999999999 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.431 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.22 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 0.27000000000000002 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.624 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 0.42999999999999999 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 98' ' ' VAL . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91000000000000003 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.29 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.44 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.23 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.44 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD12 HD21 ' A' ' 128' ' ' LEU . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.37 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 1.6599999999999999 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 0.51000000000000001 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.0600000000000001 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.39000000000000001 111.224 -175.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.671 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.1100000000000001 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66000000000000003 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 0.47999999999999998 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.672 ' CD2' HD23 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.29999999999999999 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.762 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.19 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 0.84999999999999998 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 2.48 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17000000000000001 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.4199999999999999 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 0.40000000000000002 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.3100000000000001 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.25 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 0.19 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.4199999999999999 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 0.28000000000000003 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.4399999999999999 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 1.8100000000000001 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.687 0.28 . . . . 1.6100000000000001 110.754 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.26000000000000001 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 0.17999999999999999 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.745 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.56999999999999995 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 0.16 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 0.19 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.409 ' CE2' ' HA2' ' A' ' 17' ' ' GLY . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 173.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.60999999999999999 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.3700000000000001 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.3100000000000001 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.23 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.492 HD22 ' NE2' ' A' ' 60' ' ' GLN . 93.0 m-20 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.3 111.394 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.39000000000000001 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 0.40000000000000002 110.208 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.671 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 0.57999999999999996 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.19 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 53' ' ' ASN . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 0.28000000000000003 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.745 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 0.23999999999999999 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.31 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.3600000000000001 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 1.9399999999999999 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.45 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.3500000000000001 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.805 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.0600000000000001 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.20999999999999999 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.749 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 0.38 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 0.20000000000000001 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.23000000000000001 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 0.16 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.3799999999999999 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.34999999999999998 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 0.85999999999999999 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.1600000000000001 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.4199999999999999 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.532 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.72999999999999998 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.68000000000000005 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.2799999999999998 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.547 ' HA ' HG12 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 3.3399999999999999 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 1.9399999999999999 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93000000000000005 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.0700000000000001 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 1.6599999999999999 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.0 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.46000000000000002 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.4300000000000002 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.0499999999999998 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 21' ' ' ILE . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 0.54000000000000004 111.539 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 0.25 109.432 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.23 111.813 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 1.3999999999999999 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 0.33000000000000002 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.492 ' NE2' HD22 ' A' ' 16' ' ' ASN . 6.6 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.76 111.873 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 1.5900000000000001 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.9199999999999999 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 1.6799999999999999 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 0.34000000000000002 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.23999999999999999 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 0.40000000000000002 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.22 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.619 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.675 HG23 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 0.17999999999999999 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.1000000000000001 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 1.8200000000000001 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.20000000000000001 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.28000000000000003 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 1.8500000000000001 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 0.23999999999999999 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 1.8799999999999999 109.297 176.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 0.33000000000000002 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 1.47 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.26000000000000001 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.0600000000000001 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 0.17000000000000001 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 0.20999999999999999 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 1.51 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 0.26000000000000001 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 1.9299999999999999 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 1.79 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 3.9500000000000002 111.31 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.761 0.315 . . . . 2.8500000000000001 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 63' ' ' LYS . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.35999999999999999 110.686 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.3799999999999999 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 0.33000000000000002 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 0.34999999999999998 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 0.33000000000000002 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.34000000000000002 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.686 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 0.25 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.668 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.22 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.41999999999999998 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.3100000000000001 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.27 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 0.79000000000000004 110.475 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.28999999999999998 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 0.31 109.404 177.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 1.8500000000000001 109.337 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 0.46999999999999997 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.9299999999999999 110.272 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 0.68000000000000005 110.608 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.40999999999999998 109.951 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 0.70999999999999996 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.23000000000000001 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.3500000000000001 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.3500000000000001 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.668 HG22 ' HD2' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 0.37 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.624 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 0.22 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.439 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.1599999999999999 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.22 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 0.27000000000000002 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 0.42999999999999999 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91000000000000003 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.29 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.44 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.23 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.3 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.44 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 148' ' ' ARG . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 0.37 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 1.6599999999999999 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.783 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 0.51000000000000001 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.0600000000000001 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 0.39000000000000001 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.783 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.44 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66000000000000003 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 0.47999999999999998 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.686 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.29999999999999999 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.783 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.19 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 0.84999999999999998 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HB2' HD21 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 2.48 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17000000000000001 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.4199999999999999 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 0.40000000000000002 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.25 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 0.19 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.783 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.4199999999999999 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 0.28000000000000003 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.4399999999999999 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.707 -0.479 . . . . 1.6100000000000001 109.707 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.26000000000000001 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 0.17999999999999999 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.724 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.56999999999999995 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 0.16 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 0.19 110.937 -174.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.60999999999999999 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.3700000000000001 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.23 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.3 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 0.40000000000000002 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 0.57999999999999996 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.19 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.682 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 0.28000000000000003 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 0.23999999999999999 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.31 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.3600000000000001 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 1.9399999999999999 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.45 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.3500000000000001 110.71 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.723 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.0600000000000001 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 0.20999999999999999 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 0.38 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.643 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.20000000000000001 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.943 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 0.16 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.3799999999999999 109.614 179.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.34999999999999998 112.501 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 83' ' ' LYS . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.34 172.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.1600000000000001 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.4199999999999999 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 0.72999999999999998 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.68000000000000005 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.2799999999999998 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 3.3399999999999999 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 1.9399999999999999 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93000000000000005 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.0700000000000001 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 1.6599999999999999 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.0 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.2599999999999998 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.46000000000000002 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.4300000000000002 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.682 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.0499999999999998 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 0.25 109.745 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.23 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 15' ' ' SER . 3.8 t-20 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 1.3999999999999999 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 56' ' ' ILE . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 0.33000000000000002 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.76 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 1.5900000000000001 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.9199999999999999 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 1.6799999999999999 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 0.34000000000000002 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.23999999999999999 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 0.40000000000000002 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.22 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.17000000000000001 111.187 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.643 HG23 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 0.17999999999999999 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.1000000000000001 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.20000000000000001 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.76 HG21 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 0.28000000000000003 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 1.8500000000000001 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.3100000000000001 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 0.23999999999999999 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 1.8799999999999999 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 0.33000000000000002 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 1.47 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.26000000000000001 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.0600000000000001 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.17000000000000001 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 110.357 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 1.51 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 0.26000000000000001 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 1.9299999999999999 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 1.79 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 3.9500000000000002 111.452 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.642 -0.503 . . . . 2.8500000000000001 109.642 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.68999999999999995 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 66' ' ' PHE . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 0.35999999999999999 110.504 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.3799999999999999 108.918 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 0.33000000000000002 113.156 -167.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.1100000000000001 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.511 ' HB3' ' CE ' ' A' ' 125' ' ' MET . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.34999999999999998 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 0.33000000000000002 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.34000000000000002 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 0.25 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.566 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.22 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.41999999999999998 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.3100000000000001 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.27 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 0.79000000000000004 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 1.8500000000000001 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.28999999999999998 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 1.8500000000000001 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.9299999999999999 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 0.68000000000000005 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 109.446 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 0.70999999999999996 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.23000000000000001 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.3500000000000001 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.566 HG22 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 0.37 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.76 ' SD ' HG21 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.1599999999999999 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.22 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 0.27000000000000002 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.628 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 0.42999999999999999 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91000000000000003 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.29 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.44 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.23 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.3 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.44 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.37 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.759 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.0600000000000001 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 0.39000000000000001 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.759 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 0.78000000000000003 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1100000000000001 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66000000000000003 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 0.47999999999999998 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.29999999999999999 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.507 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 0.19 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 0.84999999999999998 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.629 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 2.48 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.4199999999999999 111.237 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 0.40000000000000002 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.3100000000000001 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.25 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 0.19 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.4199999999999999 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.658 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.4399999999999999 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.506 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 1.8100000000000001 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.221 0.534 . . . . 1.6100000000000001 111.339 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.26000000000000001 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 0.17999999999999999 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.72 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.56999999999999995 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 0.16 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 0.19 110.621 -175.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.90000000000000002 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.60999999999999999 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.3100000000000001 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.23 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.3 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.39000000000000001 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 0.40000000000000002 110.432 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 0.57999999999999996 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.19 109.735 -174.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 0.28000000000000003 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 0.23999999999999999 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.31 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.3600000000000001 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 1.9399999999999999 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.45 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.3500000000000001 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.0600000000000001 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 0.20999999999999999 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.626 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 0.38 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.725 ' SD ' HG23 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 0.20000000000000001 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.16 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.3799999999999999 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.34999999999999998 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 0.85999999999999999 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.1600000000000001 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.4199999999999999 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 0.72999999999999998 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.68000000000000005 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.2799999999999998 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 3.3399999999999999 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93000000000000005 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.0700000000000001 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 1.6599999999999999 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.2599999999999998 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.46000000000000002 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.4300000000000002 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.0499999999999998 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.54000000000000004 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 59' ' ' LEU . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 0.25 108.861 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.23 112.657 -175.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 t30 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 1.3999999999999999 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 56' ' ' ILE . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 0.33000000000000002 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.76 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 1.5900000000000001 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.9199999999999999 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 0.34000000000000002 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.23999999999999999 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.684 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 0.40000000000000002 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.22 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.17000000000000001 110.381 171.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.725 HG23 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 0.17999999999999999 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.1000000000000001 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 1.8200000000000001 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.20000000000000001 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.781 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 0.28000000000000003 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 1.8500000000000001 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.3100000000000001 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 0.23999999999999999 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG2' HG22 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 0.33000000000000002 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 1.47 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.26000000000000001 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.0600000000000001 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 0.17000000000000001 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 84' ' ' LEU . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 0.20999999999999999 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.79 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 1.51 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 0.26000000000000001 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 1.9299999999999999 109.562 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 1.79 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.626 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 3.9500000000000002 111.534 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.157 -0.312 . . . . 2.8500000000000001 110.157 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.68999999999999995 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.533 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.35999999999999999 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.551 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.3799999999999999 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.33000000000000002 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.1100000000000001 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 0.34999999999999998 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 0.33000000000000002 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.916 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.25 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.22 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.41999999999999998 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.3100000000000001 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.27 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 0.79000000000000004 110.462 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 1.8500000000000001 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.28999999999999998 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 0.31 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 1.8500000000000001 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 0.46999999999999997 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.9299999999999999 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 115' ' ' GLU . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 0.68000000000000005 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.532 ' HD1' HD22 ' A' ' 111' ' ' LEU . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.3 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.499 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 0.70999999999999996 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.722 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 0.23000000000000001 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.414 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.3500000000000001 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.3500000000000001 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' HE2' ' A' ' 104' ' ' LYS . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 0.37 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 0.22 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.916 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.1599999999999999 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.22 111.76 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 0.27000000000000002 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.463 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 0.42999999999999999 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91000000000000003 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.29 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.44 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 128' ' ' LEU . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.23 110.395 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.3 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 148' ' ' ARG . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.37 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 0.51000000000000001 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.458 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 0.78000000000000003 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 0.44 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66000000000000003 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 0.47999999999999998 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.29999999999999999 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.704 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 0.19 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 0.84999999999999998 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 2.48 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17000000000000001 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.4199999999999999 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 0.40000000000000002 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.25 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 0.19 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.704 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 0.28000000000000003 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.582 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 1.8100000000000001 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.433 0.635 . . . . 1.6100000000000001 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.26000000000000001 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 0.17999999999999999 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 19' ' ' LEU . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 0.16 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 0.19 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.60999999999999999 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.3700000000000001 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.3100000000000001 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.23 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.3 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.39000000000000001 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 0.40000000000000002 109.964 174.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.623 HD11 ' HD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 0.57999999999999996 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.19 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 0.28000000000000003 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 0.23999999999999999 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.3600000000000001 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 1.9399999999999999 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.45 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.3500000000000001 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.444 HD22 HG12 ' A' ' 10' ' ' VAL . 15.3 t30 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.0600000000000001 110.326 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 0.20999999999999999 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.38 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.609 ' SD ' HG23 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 0.20000000000000001 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 0.16 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.3799999999999999 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 0.85999999999999999 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.1600000000000001 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.4199999999999999 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.72999999999999998 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.68000000000000005 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 3.3399999999999999 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 1.9399999999999999 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93000000000000005 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.0700000000000001 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.0 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.2599999999999998 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.46000000000000002 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.4300000000000002 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.0499999999999998 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 0.54000000000000004 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 0.25 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.23 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.5 t-20 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 1.3999999999999999 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 0.33000000000000002 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.76 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 1.5900000000000001 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.9199999999999999 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 1.6799999999999999 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.0700000000000001 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.623 ' HD1' HD11 ' A' ' 19' ' ' LEU . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.23999999999999999 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 0.40000000000000002 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.22 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.17000000000000001 111.107 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.609 HG23 ' SD ' ' A' ' 33' ' ' MET . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 0.17999999999999999 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.1000000000000001 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 1.8200000000000001 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.20000000000000001 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 0.28000000000000003 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 1.8500000000000001 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.3100000000000001 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.23999999999999999 111.511 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 1.8799999999999999 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 0.33000000000000002 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 1.47 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.26000000000000001 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.0600000000000001 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.17000000000000001 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 1.51 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 0.26000000000000001 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 3.6 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 1.9299999999999999 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 1.79 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 . . . . . 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 3.9500000000000002 111.647 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.629 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 108.951 -0.759 . . . . 2.8500000000000001 108.951 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.629 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.68999999999999995 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.35999999999999999 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.3799999999999999 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.34999999999999998 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.34000000000000002 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 0.25 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 1.011 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.22 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.41999999999999998 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.3100000000000001 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.27 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 0.79000000000000004 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.8500000000000001 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.28999999999999998 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.507 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.31 109.767 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 1.8500000000000001 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.46999999999999997 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.9299999999999999 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 0.68000000000000005 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.507 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.40999999999999998 109.791 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 120' ' ' GLN . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 0.70999999999999996 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 0.23000000000000001 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.47 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.3500000000000001 112.042 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.3500000000000001 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.011 HG22 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 0.37 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 0.22 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.857 ' SD ' HG11 ' A' ' 74' ' ' VAL . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.1599999999999999 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 71' ' ' CYS . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 0.27000000000000002 110.197 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 0.42999999999999999 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91000000000000003 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.29 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.44 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.23 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.3 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.44 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 148' ' ' ARG . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 0.37 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.7 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 0.51000000000000001 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 137' ' ' VAL . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.0600000000000001 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 0.39000000000000001 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.7 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 0.78000000000000003 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 0.44 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66000000000000003 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 0.47999999999999998 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.29999999999999999 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 0.19 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 0.84999999999999998 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 2.48 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17000000000000001 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.4199999999999999 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 0.40000000000000002 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.3100000000000001 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.25 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.787 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 0.19 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.4199999999999999 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.4399999999999999 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 1.8100000000000001 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.034 0.445 . . . . 1.6100000000000001 110.042 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.26000000000000001 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 0.17999999999999999 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.68 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.56999999999999995 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 19' ' ' LEU . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 0.16 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.563 -174.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.654 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 0.90000000000000002 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.60999999999999999 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.3700000000000001 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.3100000000000001 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 57' ' ' ARG . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.23 110.359 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.3 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.654 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.39000000000000001 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 0.40000000000000002 110.024 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 0.57999999999999996 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.19 109.523 -173.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.68 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 0.23999999999999999 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.31 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.674 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 1.9399999999999999 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.45 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.3500000000000001 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.1599999999999999 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.0600000000000001 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 0.20999999999999999 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.644 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.20000000000000001 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.16 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.3799999999999999 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.425 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 0.85999999999999999 109.785 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.1600000000000001 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.4199999999999999 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 0.72999999999999998 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.68000000000000005 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.2799999999999998 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 3.3399999999999999 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 1.9399999999999999 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93000000000000005 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.0700000000000001 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 1.6599999999999999 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.0 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.2599999999999998 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.4300000000000002 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' OE2' HG21 ' A' ' 18' ' ' THR . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 0.54000000000000004 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 HD21 ' A' ' 59' ' ' LEU . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 0.25 109.603 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' HD3' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.23 112.043 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 1.3999999999999999 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 56' ' ' ILE . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 0.33000000000000002 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.76 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 1.5900000000000001 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.9199999999999999 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 1.6799999999999999 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.0700000000000001 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 0.34000000000000002 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.599 ' HD1' HD11 ' A' ' 19' ' ' LEU . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.23999999999999999 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 0.40000000000000002 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.22 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.17000000000000001 111.003 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.644 HG23 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 0.17999999999999999 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.1000000000000001 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 1.8200000000000001 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.20000000000000001 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 0.28000000000000003 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 1.8500000000000001 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.3100000000000001 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.23999999999999999 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 1.8799999999999999 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 1.47 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.26000000000000001 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.0600000000000001 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 0.17000000000000001 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.20999999999999999 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 0.26000000000000001 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 1.9299999999999999 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 1.79 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.641 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 3.9500000000000002 111.121 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.087 -0.338 . . . . 2.8500000000000001 110.087 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.68999999999999995 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 0.35999999999999999 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.3799999999999999 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 0.33000000000000002 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.1100000000000001 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 0.34999999999999998 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.848 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.34000000000000002 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 0.25 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.22 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.41999999999999998 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.3100000000000001 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.27 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 1.8500000000000001 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.28999999999999998 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 1.8500000000000001 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 0.46999999999999997 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 0.68000000000000005 110.553 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.40999999999999998 109.521 -174.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 0.70999999999999996 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 0.23000000000000001 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.3500000000000001 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.3500000000000001 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 0.37 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 0.22 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.848 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.1599999999999999 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.22 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 0.27000000000000002 108.949 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.522 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 0.42999999999999999 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91000000000000003 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.29 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.44 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.23 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.3 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.44 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 148' ' ' ARG . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 0.37 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 1.6599999999999999 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 0.51000000000000001 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.0600000000000001 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.39000000000000001 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.733 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 0.78000000000000003 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 0.44 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66000000000000003 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 0.47999999999999998 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.639 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.29999999999999999 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 0.84999999999999998 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 2.48 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17000000000000001 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.4199999999999999 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 0.40000000000000002 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.522 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.3100000000000001 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.25 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 0.19 113.021 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.737 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.4199999999999999 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 0.28000000000000003 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.4399999999999999 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 1.8100000000000001 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 1.6100000000000001 111.612 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.26000000000000001 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 0.17999999999999999 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.697 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.56999999999999995 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 0.16 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 0.19 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 0.90000000000000002 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.60999999999999999 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.3700000000000001 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 58' ' ' ASN . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.23 108.856 176.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.39000000000000001 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 0.40000000000000002 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.57999999999999996 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.19 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.28000000000000003 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 28' ' ' VAL . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 0.23999999999999999 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.31 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.3600000000000001 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 1.9399999999999999 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.45 110.738 -176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.3500000000000001 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.722 HG21 HG11 ' A' ' 22' ' ' VAL . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.1599999999999999 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.0600000000000001 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 0.20999999999999999 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.701 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.38 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 0.20000000000000001 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.23000000000000001 111.059 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 0.16 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.3799999999999999 109.883 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.34999999999999998 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 0.85999999999999999 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.1600000000000001 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.4199999999999999 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.72999999999999998 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.4 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.68000000000000005 111.934 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.2799999999999998 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.498 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 3.3399999999999999 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 1.9399999999999999 111.295 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93000000000000005 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.0700000000000001 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 1.6599999999999999 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.0 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.46000000000000002 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.4300000000000002 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.0499999999999998 111.301 175.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 0.54000000000000004 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 0.25 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.23 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.8 t-20 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 1.3999999999999999 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 0.33000000000000002 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.76 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 1.5900000000000001 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.9199999999999999 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.6799999999999999 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 0.34000000000000002 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.651 ' HD1' HD11 ' A' ' 19' ' ' LEU . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.23999999999999999 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.523 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 0.40000000000000002 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.22 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.17000000000000001 111.341 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 0.17999999999999999 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.1000000000000001 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.20000000000000001 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 0.28000000000000003 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 1.8500000000000001 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.3100000000000001 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.23999999999999999 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 1.8799999999999999 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 0.33000000000000002 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 1.47 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.26000000000000001 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.0600000000000001 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.476 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 0.17000000000000001 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 0.20999999999999999 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 0.26000000000000001 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 1.9299999999999999 110.15 175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 1.79 108.501 -171.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.701 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 3.9500000000000002 111.845 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.063 -0.347 . . . . 2.8500000000000001 110.063 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.68999999999999995 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.35999999999999999 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.568 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.3799999999999999 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 110.88 -167.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.742 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.528 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 0.33000000000000002 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.856 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.34000000000000002 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 0.25 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.22 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.41999999999999998 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.3100000000000001 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.27 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.79000000000000004 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 1.8500000000000001 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.28999999999999998 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 0.31 109.714 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 1.8500000000000001 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.46999999999999997 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.9299999999999999 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 0.68000000000000005 110.061 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.40999999999999998 109.955 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 0.70999999999999996 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.669 HG11 ' HB1' ' A' ' 77' ' ' ALA . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.3500000000000001 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.3500000000000001 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 0.37 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 0.22 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.864 ' SD ' HG11 ' A' ' 74' ' ' VAL . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.1599999999999999 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.22 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 0.27000000000000002 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 0.42999999999999999 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91000000000000003 112.599 176.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.29 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.44 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.23 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.3 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 0.37 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 1.6599999999999999 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 0.51000000000000001 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.0600000000000001 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 0.78000000000000003 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 0.44 109.326 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66000000000000003 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.47999999999999998 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.548 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.19 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 2.48 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17000000000000001 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.4199999999999999 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 148' ' ' ARG . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 0.40000000000000002 110.357 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.3100000000000001 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.25 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 0.19 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.4199999999999999 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 0.28000000000000003 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.4399999999999999 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.614 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 1.8100000000000001 111.524 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 1.8 mp0 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.085 0.469 . . . . 3.6800000000000002 110.424 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 1.8 mp0 -54.73 -45.9 74.18 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.43 -0.804 . . . . 2.3799999999999999 109.915 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -97.08 123.04 40.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.084 0.469 . . . . 1.6100000000000001 109.991 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.67 -162.96 29.52 Favored Glycine 0 C--N 1.321 -0.254 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 111.496 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -120.28 153.03 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.456 . . . . 0.17999999999999999 111.301 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.75 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 10.4 m-85 -132.1 132.32 43.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.454 -0.339 . . . . 0.56999999999999995 110.877 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 HD11 HD22 ' A' ' 19' ' ' LEU . 2.8 tm? -89.39 120.97 31.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.586 -0.894 . . . . 0.16 108.586 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -122.06 148.92 25.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 116.62 -0.264 . . . . 0.19 110.604 -176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.535 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 69.4 t80 -107.09 131.57 53.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.661 -0.496 . . . . 0.90000000000000002 109.661 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -122.62 154.89 37.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.85 -0.426 . . . . 0.60999999999999999 109.85 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -79.61 -2.42 42.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.171 -0.468 . . . . 2.3700000000000001 111.229 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.47 131.95 47.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.367 -0.379 . . . . 1.3100000000000001 110.578 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 28.2 m 58.11 26.7 13.97 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.23 110.954 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.3 m120 59.86 30.68 20.22 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.538 -0.755 . . . . 1.3 111.013 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 141.47 102.42 0.47 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.554 -0.831 . . . . 0.39000000000000001 112.466 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.7 m -133.29 147.67 51.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.379 -0.23 . . . . 0.40000000000000002 110.379 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.1 mt -103.7 144.77 31.02 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 121.36 0.6 . . . . 0.57999999999999996 110.124 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -135.75 128.53 31.05 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.984 -1.007 . . . . 0.19 109.436 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 HD13 ' HG3' ' A' ' 76' ' ' GLU . 4.5 tt -109.96 114.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.54 0.686 . . . . 0.28000000000000003 110.291 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.75 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -91.05 122.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.166 -0.925 . . . . 0.23999999999999999 110.746 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 25.3 m95 -100.01 105.98 17.71 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.619 -0.882 . . . . 0.31 108.619 170.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -145.07 174.16 11.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.65 0.738 . . . . 1.3600000000000001 111.302 -171.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -121.15 23.55 10.5 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.212 -1.358 . . . . 1.9399999999999999 107.697 175.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.637 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 49.0 mt-10 -125.31 172.13 9.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.114 -1.403 . . . . 1.45 111.225 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 99.77 12.56 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.2 -0.909 . . . . 2.3500000000000001 111.287 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.742 HG21 HG11 ' A' ' 22' ' ' VAL . 61.3 t -88.53 135.19 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.682 -0.69 . . . . 1.1599999999999999 110.081 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -112.84 174.28 5.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.633 -0.258 . . . . 1.98 111.3 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 m120 65.25 25.63 12.24 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.854 -0.612 . . . . 2.0600000000000001 110.95 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.39 148.71 21.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.067 -0.515 . . . . 0.20999999999999999 110.772 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.736 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -95.77 -24.51 16.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.723 -0.671 . . . . 0.38 109.649 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 70' ' ' ILE . 74.9 mtp -149.15 170.03 19.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.81 -0.632 . . . . 0.20000000000000001 110.702 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 3' ' ' GLU . 79.8 t80 -148.81 155.24 40.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.838 0.352 . . . . 0.23000000000000001 110.709 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 81.7 mt -128.0 131.53 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.253 -0.647 . . . . 0.16 109.253 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 36' ' ' LYS . 1.4 tmmm? -117.36 111.15 40.28 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 109.921 -0.4 . . . . 2.3799999999999999 109.921 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.68 133.3 10.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.869 2.379 . . . . 0.34999999999999998 112.071 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.7 p -83.45 -44.39 14.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.438 0.637 . . . . 0.85999999999999999 110.327 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -95.79 173.47 7.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.083 -0.962 . . . . 2.1600000000000001 110.159 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.64 143.81 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.369 0.604 . . . . 2.4199999999999999 111.365 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 133.69 27.42 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.489 -0.778 . . . . 0.72999999999999998 110.433 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 88.0 Cg_exo -46.86 121.08 4.62 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.694 2.929 . . . . 0.68000000000000005 112.583 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 47' ' ' VAL . 37.6 tt0 -72.03 -32.11 66.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.889 -0.596 . . . . 2.2799999999999998 111.201 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.679 ' HA ' HG12 ' A' ' 47' ' ' VAL . 31.1 t80 -65.38 -26.15 67.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 3.3399999999999999 110.785 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 14.2 mptt -73.4 -27.71 61.61 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.649 -0.705 . . . . 1.9399999999999999 110.183 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 20.7 m-85 -78.02 -48.25 16.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.87 -0.604 . . . . 0.93000000000000005 110.424 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 44' ' ' PHE . 5.0 p -76.87 -47.4 28.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.527 0.565 . . . . 1.0700000000000001 112.527 -172.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.546 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . 10.1 t30 -71.99 -38.51 69.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.189 0.519 . . . . 1.6599999999999999 111.133 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 17.7 mtp180 -88.21 -10.19 50.59 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.892 -0.594 . . . . 2.0 111.023 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 t30 61.69 15.32 6.82 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.767 0.794 . . . . 2.2599999999999998 110.398 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.4 -14.65 64.71 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.196 -0.911 . . . . 0.46000000000000002 112.327 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -106.17 133.83 50.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.182 0.515 . . . . 2.4300000000000002 111.027 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.18 118.88 7.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.27 -0.423 . . . . 2.0499999999999998 109.892 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.99 117.91 27.18 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.399 0.619 . . . . 1.47 109.612 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 21' ' ' ILE . 22.1 mt -79.92 -64.07 1.27 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.84 -1.073 . . . . 0.54000000000000004 111.567 -171.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.695 HG23 HD21 ' A' ' 59' ' ' LEU . 19.9 tt -141.47 147.07 22.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.449 -0.796 . . . . 0.25 109.522 -174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -130.41 172.24 12.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.93 0.395 . . . . 2.23 112.048 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.2 t-20 58.76 43.54 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.008 -0.997 . . . . 1.3999999999999999 111.485 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.695 HD21 HG23 ' A' ' 56' ' ' ILE . 66.4 mt -63.41 -19.8 65.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.992 -0.549 . . . . 0.33000000000000002 111.001 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -49.79 -46.01 50.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.389 -0.823 . . . . 1.76 112.356 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.8 p -68.31 -20.27 64.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.871 -0.604 . . . . 1.5900000000000001 111.705 -170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 15.8 t0 -166.65 121.42 1.11 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.803 -0.635 . . . . 1.9199999999999999 110.727 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.427 ' CE ' HG12 ' A' ' 96' ' ' ILE . 7.0 ptmt -64.8 -24.79 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 1.6799999999999999 110.379 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 33.8 mmtp -69.96 -23.07 63.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.514 . . . . 1.0700000000000001 111.398 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 73.3 mt -57.8 -37.83 74.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.436 -0.347 . . . . 0.34000000000000002 110.874 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' O ' HG13 ' A' ' 70' ' ' ILE . 15.7 t80 -60.59 -38.04 83.34 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.979 -0.378 . . . . 0.23999999999999999 109.979 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' O ' HG21 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -61.65 -54.28 44.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.75 -0.833 . . . . 0.40000000000000002 108.75 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 28.1 t -55.64 -43.03 75.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.777 -1.101 . . . . 1.22 110.87 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.03 -34.59 79.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.4 -0.905 . . . . 0.17000000000000001 112.088 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 66' ' ' PHE . 77.1 mt -64.33 -42.02 94.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.854 -0.173 . . . . 0.17999999999999999 111.461 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.5 p -63.75 -36.84 85.19 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.457 -0.571 . . . . 1.1000000000000001 109.457 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.65 ' HG3' ' O ' ' A' ' 68' ' ' SER . 62.3 mt-30 -64.95 -29.95 70.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.219 -0.9 . . . . 1.8200000000000001 110.186 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.83 -49.85 23.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.676 -0.693 . . . . 0.20000000000000001 110.883 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.2 m -69.83 -23.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.209 0.528 . . . . 0.28000000000000003 109.962 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 21.6 tttm -52.74 -41.9 64.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.243 -0.889 . . . . 1.8500000000000001 110.292 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.669 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.8 mm-40 -65.69 -41.33 92.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 1.3100000000000001 109.795 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -63.56 -39.9 95.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.23999999999999999 111.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 5.4 pttm -76.47 -19.76 57.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.386 0.612 . . . . 1.8799999999999999 109.894 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.1 -47.61 17.88 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.541 -0.754 . . . . 1.77 110.958 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.95 -10.97 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.721 0.772 . . . . 0.33000000000000002 109.865 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 73.15 54.3 0.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 113.63 -1.623 . . . . 1.47 111.008 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -109.52 -145.9 11.18 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.21 -0.905 . . . . 0.26000000000000001 112.624 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.08 153.36 38.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 123.068 0.547 . . . . 1.0600000000000001 109.609 178.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.4 tm? -110.22 133.7 52.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.915 -0.314 . . . . 0.17000000000000001 110.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.2 m -122.13 125.08 45.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.892 -0.595 . . . . 0.20999999999999999 110.372 177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.516 HD12 ' HG2' ' A' ' 33' ' ' MET . 4.8 tp -98.17 106.62 18.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.178 174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 51.1 mt -74.32 150.7 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.047 -0.353 . . . . 0.26000000000000001 110.047 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.5 tt0 -121.32 135.7 55.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.544 -0.539 . . . . 1.9299999999999999 109.544 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 18.6 t60 159.9 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 O-C-N 124.293 0.996 . . . . 1.79 108.732 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.736 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 29.5 p90 -53.91 -36.94 63.27 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.322 -0.854 . . . . 3.9500000000000002 111.714 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -64.83 -17.28 64.1 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.647 0.379 . . . . 2.2200000000000002 111.796 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.5 m -81.9 -18.17 44.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.89 0.376 . . . . 1.78 110.811 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.8 t -118.14 -35.22 3.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 1.6299999999999999 110.802 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 10.6 t80 -94.16 134.33 26.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 108.971 -0.752 . . . . 2.8500000000000001 108.971 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.562 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 64.4 Cg_endo -71.78 20.92 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.03 2.486 . . . . 0.68999999999999995 114.267 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.427 HG12 ' CE ' ' A' ' 63' ' ' LYS . 7.7 mt -125.99 115.6 43.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.044 0.45 . . . . 0.35999999999999999 110.771 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -123.65 117.64 25.47 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.671 -0.695 . . . . 1.3799999999999999 109.958 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 26.5 m -139.76 167.93 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.18 -172.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' OD2' ' HE2' ' A' ' 130' ' ' LYS . 5.8 p-10 -137.28 133.15 34.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.819 0.819 . . . . 1.1100000000000001 110.88 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.5 mp -87.32 149.78 24.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.875 -1.057 . . . . 0.34999999999999998 111.915 -169.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.458 ' HE1' ' OD1' ' A' ' 99' ' ' ASP . 4.7 m-85 -130.97 141.26 50.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.189 -0.46 . . . . 0.33000000000000002 110.525 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -114.11 153.31 29.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.12 0.486 . . . . 0.34000000000000002 109.877 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -109.31 125.0 51.86 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.091 -1.077 . . . . 0.25 108.091 174.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.11 112.1 11.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 1.22 110.771 175.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.97 -109.12 2.7 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.104 -0.798 . . . . 0.41999999999999998 111.104 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -119.57 7.56 11.13 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.713 -0.477 . . . . 1.3100000000000001 109.713 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -109.12 140.86 42.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.145 0.498 . . . . 2.27 110.903 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 p -103.45 137.62 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.537 -0.756 . . . . 0.79000000000000004 109.9 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.3 mmt -132.67 124.17 18.75 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.089 -0.505 . . . . 1.8500000000000001 110.827 -177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.53 159.49 32.21 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.535 2.157 . . . . 0.28999999999999998 111.78 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.88 136.59 34.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.915 -0.584 . . . . 0.31 109.696 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -88.31 128.15 35.49 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.66 -0.866 . . . . 1.8500000000000001 108.66 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 22.2 m -58.36 121.96 12.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.78 -0.645 . . . . 0.46999999999999997 111.559 -174.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.39 21.12 75.85 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.912 -0.585 . . . . 0.38 113.033 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 33.6 tt0 -118.05 129.96 25.03 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.09 -0.337 . . . . 1.9299999999999999 110.09 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.6 Cg_exo -64.71 113.08 2.17 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.468 2.112 . . . . 0.68000000000000005 110.578 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -118.38 144.47 45.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.866 -0.606 . . . . 0.40999999999999998 110.358 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -56.83 114.43 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.68 . . . . 0.70999999999999996 112.475 -174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.506 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.2 p -121.54 -13.56 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.366 -0.833 . . . . 0.23000000000000001 110.624 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.36 -55.76 30.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 112.847 -172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -107.87 39.83 1.86 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.887 0.375 . . . . 2.3500000000000001 111.485 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.761 HG22 ' HD2' ' A' ' 104' ' ' LYS . 43.0 pt -74.33 159.85 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.332 0.587 . . . . 0.37 110.592 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.535 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.4 m-20 -85.56 -45.27 11.92 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.355 -0.839 . . . . 0.5 109.261 172.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.65 162.02 39.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.24 -0.891 . . . . 0.22 110.707 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.472 ' HG3' HG21 ' A' ' 74' ' ' VAL . 2.1 tmt? -137.26 154.3 50.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.545 -0.539 . . . . 1.1599999999999999 109.545 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 62.8 p -150.39 159.05 44.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.864 0.364 . . . . 1.22 110.17 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.5 t -112.54 106.95 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.112 -0.699 . . . . 0.27000000000000002 109.112 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 2.1 mp -104.51 149.58 37.56 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 115.508 -0.769 . . . . 0.42999999999999999 109.871 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 98' ' ' VAL . 73.2 Cg_endo -78.31 168.75 21.17 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.994 2.463 . . . . 0.91000000000000003 110.575 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.0 mmpt? -36.95 -36.72 0.13 Allowed 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.464 0.478 . . . . 3.29 112.107 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.37 60.33 3.61 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.113 -0.795 . . . . 0.44 111.113 169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.3 p -86.64 -2.24 58.35 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.292 0.637 . . . . 1.23 112.124 -173.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 27.1 t -56.85 -6.76 0.37 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.59 0.589 . . . . 1.3 112.59 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 m -53.71 -45.2 70.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.014 0.435 . . . . 0.44 110.607 171.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.796 HD21 ' HB2' ' A' ' 148' ' ' ARG . 86.1 mt -116.05 11.86 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.37 111.381 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 33.5 ttpt -89.88 79.17 6.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.971 0.415 . . . . 1.6599999999999999 110.657 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -138.46 169.38 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.188 -0.46 . . . . 0.51000000000000001 109.821 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -62.93 -44.26 96.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.14 0.495 . . . . 2.0600000000000001 110.724 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.42 150.01 41.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.39000000000000001 110.206 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 135' ' ' LEU . 1.3 mtp -143.32 157.22 44.66 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.868 0.692 . . . . 0.78000000000000003 112.868 -170.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.77 134.44 33.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.345 -0.843 . . . . 0.44 110.27 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 58.7 tttm -61.35 -31.14 71.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.674 . . . . 1.1100000000000001 111.038 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.27 -41.34 63.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.612 0.72 . . . . 0.66000000000000003 110.019 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 ttt -67.64 -39.85 84.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.882 -1.054 . . . . 0.47999999999999998 110.488 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 29.5 t80 -52.78 -52.62 55.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.713 -0.676 . . . . 0.29999999999999999 111.235 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.782 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -67.67 -45.01 85.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.938 -0.574 . . . . 0.19 111.823 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 33.5 t -63.48 -36.88 85.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.084 0.468 . . . . 0.84999999999999998 110.694 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.796 ' HB2' HD21 ' A' ' 135' ' ' LEU . 32.5 mmt180 -68.84 -50.4 50.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 2.48 110.925 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.77 93.09 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.569 -0.824 . . . . 0.17000000000000001 111.703 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.63 -39.16 90.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.416 0.15 . . . . 1.4199999999999999 111.294 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 148' ' ' ARG . 3.3 t -77.2 -22.79 51.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.682 -0.488 . . . . 0.40000000000000002 109.682 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.29 -15.25 60.98 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.546 0.689 . . . . 1.3100000000000001 109.305 168.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.4 -13.61 33.23 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 114.668 -1.151 . . . . 0.25 114.328 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.45 125.41 14.4 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 118.731 1.266 . . . . 0.19 113.096 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 19.8 p -145.83 158.23 43.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.061 0.458 . . . . 1.4199999999999999 111.2 168.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 18.9 tt -156.17 115.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.28000000000000003 109.366 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.782 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 38.9 m -124.63 146.97 48.8 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.484 0.55 . . . . 1.4399999999999999 112.484 -172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 23.1 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.771 -0.633 . . . . 1.8100000000000001 109.903 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.29 0.567 . . . . 3.6800000000000002 109.931 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -92.37 -51.73 5.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.743 -0.662 . . . . 2.3799999999999999 110.333 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -64.78 132.46 49.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 1.6100000000000001 110.511 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.717 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 149.86 -151.62 23.68 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.553 -0.832 . . . . 0.26000000000000001 111.502 -176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.01 153.02 41.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.691 0.246 . . . . 0.17999999999999999 110.46 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.736 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 8.4 m-85 -130.03 133.32 46.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.695 -0.23 . . . . 0.56999999999999995 110.55 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.5 118.16 26.78 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.476 -0.935 . . . . 0.16 108.476 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.25 147.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 116.487 -0.324 . . . . 0.19 110.672 -175.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.571 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 87.5 t80 -99.09 129.26 45.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.164 -0.68 . . . . 0.90000000000000002 109.164 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -121.27 153.67 37.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.505 -0.316 . . . . 0.60999999999999999 110.169 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -83.14 0.4 45.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.339 -0.391 . . . . 2.3700000000000001 111.822 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 126.89 29.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.833 -0.432 . . . . 1.3100000000000001 109.833 173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.1 m 58.69 25.17 13.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.23 110.995 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 57.83 29.77 18.01 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.576 -0.738 . . . . 1.3 111.401 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 154.23 99.42 0.17 Allowed Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.616 -0.802 . . . . 0.39000000000000001 112.045 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.4 m -134.23 148.3 50.82 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.904 -0.406 . . . . 0.40000000000000002 109.904 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 69' ' ' GLY . 19.9 mt -103.08 140.26 37.54 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 109.684 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.3 OUTLIER -132.69 128.16 36.38 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.174 -0.921 . . . . 0.19 109.459 -174.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 53' ' ' ASN . 6.6 tt -106.17 113.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.621 0.724 . . . . 0.28000000000000003 109.724 174.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.737 HG11 HG21 ' A' ' 28' ' ' VAL . 7.6 p -91.02 127.55 43.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.307 -0.86 . . . . 0.23999999999999999 110.561 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' CZ3' HG11 ' A' ' 41' ' ' VAL . 49.1 m95 -104.19 113.01 26.26 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.107 -0.701 . . . . 0.31 109.107 172.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.717 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -150.93 175.19 12.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.451 0.643 . . . . 1.3600000000000001 110.796 -171.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -112.6 4.72 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.724 -1.125 . . . . 1.9399999999999999 108.642 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.88 178.18 5.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.404 -1.271 . . . . 1.45 110.686 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 ptmm? -84.46 138.95 32.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.818 0.342 . . . . 2.3500000000000001 111.409 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG21 HG11 ' A' ' 22' ' ' VAL . 95.5 t -121.79 105.2 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 1.1599999999999999 109.923 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.02 176.65 4.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.522 -0.308 . . . . 1.98 111.205 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 67.35 19.65 10.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.82 -0.627 . . . . 2.0600000000000001 110.808 177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.37 144.97 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.095 -0.502 . . . . 0.20999999999999999 110.986 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -94.53 -21.8 18.63 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.936 -0.574 . . . . 0.38 109.555 -175.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.598 ' SD ' HG23 ' A' ' 70' ' ' ILE . 75.1 mtp -149.57 169.71 20.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.897 -0.592 . . . . 0.20000000000000001 110.575 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 80.7 t80 -149.58 155.89 41.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.804 -174.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -127.21 124.96 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.95 -0.759 . . . . 0.16 108.95 177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 109.86 53.77 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.551 -0.537 . . . . 2.3799999999999999 109.551 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 10.1 Cg_exo -74.64 138.03 23.42 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.691 2.261 . . . . 0.34999999999999998 112.106 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.1 p -76.47 -50.03 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.594 0.711 . . . . 0.85999999999999999 109.433 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -89.43 173.31 8.42 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.774 -1.103 . . . . 2.1600000000000001 108.4 172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -69.85 144.72 52.48 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.317 -0.553 . . . . 2.4199999999999999 109.944 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.1 OUTLIER -82.16 140.53 45.95 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.423 -0.808 . . . . 0.72999999999999998 110.986 -173.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' HG12 ' A' ' 41' ' ' VAL . 85.4 Cg_exo -40.56 120.74 1.01 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 124.044 3.163 . . . . 0.68000000000000005 112.955 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -68.92 -38.47 79.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 112.608 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.517 ' HA ' HG12 ' A' ' 47' ' ' VAL . 97.5 m-85 -73.51 -21.04 60.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.006 0.431 . . . . 3.3399999999999999 110.615 -174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.2 mptt -65.55 -28.03 68.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.007 -0.542 . . . . 1.9399999999999999 110.71 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -72.7 -55.38 6.88 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.909 -0.587 . . . . 0.93000000000000005 110.251 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -67.02 -38.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.878 -0.601 . . . . 1.0700000000000001 111.408 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.11 -41.21 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.296 -0.411 . . . . 1.6599999999999999 111.286 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -89.09 -7.3 56.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.555 -0.293 . . . . 2.0 110.727 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 64.3 t30 66.03 14.82 9.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.92 0.867 . . . . 2.2599999999999998 109.591 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 -14.64 44.72 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.926 -1.034 . . . . 0.46000000000000002 112.249 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -107.84 125.15 51.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.653 0.263 . . . . 2.4300000000000002 110.967 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 21' ' ' ILE . 3.9 t-20 -141.37 119.13 11.75 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.653 -0.419 . . . . 2.0499999999999998 110.936 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -87.36 121.65 30.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.379 0.609 . . . . 1.47 109.956 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.85 -63.61 1.33 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.894 -1.048 . . . . 0.54000000000000004 111.757 -175.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 20.7 tt -145.5 146.65 19.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.526 -0.761 . . . . 0.25 109.637 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.1 ppt_? -131.49 171.75 13.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.978 0.362 . . . . 2.23 111.978 -173.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 55.2 t30 66.19 41.62 3.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 110.676 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -67.84 -20.21 65.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.587 -0.733 . . . . 0.33000000000000002 110.501 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.65 -46.49 74.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.672 0.748 . . . . 1.76 111.711 177.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -82.09 -15.21 54.26 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.684 -1.143 . . . . 1.5900000000000001 111.471 -169.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 14.6 t70 -161.23 117.91 2.24 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.807 -0.633 . . . . 1.9199999999999999 110.413 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 28.1 mtmt -68.87 -32.89 72.87 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 111.461 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.2 mmtp -60.92 -24.08 65.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.425 -0.807 . . . . 1.0700000000000001 111.439 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' O ' HD13 ' A' ' 56' ' ' ILE . 81.4 mt -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.144 -0.48 . . . . 0.34000000000000002 110.956 174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.667 ' HD1' HD11 ' A' ' 19' ' ' LEU . 7.9 t80 -61.6 -36.09 79.71 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 109.885 -0.413 . . . . 0.23999999999999999 109.885 176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -59.26 -57.07 14.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.339 0.59 . . . . 0.40000000000000002 109.983 -178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 14.9 m -69.03 -31.29 69.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.598 -0.728 . . . . 1.22 111.352 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.85 -33.45 63.48 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.88 -1.153 . . . . 0.17000000000000001 110.77 174.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' HG13 ' A' ' 74' ' ' VAL . 99.5 mt -63.99 -48.34 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.314 -0.443 . . . . 0.17999999999999999 111.219 174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -63.94 -37.32 86.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.194 0.521 . . . . 1.1000000000000001 109.95 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 mm-40 -64.06 -28.51 69.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.8200000000000001 110.491 175.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.567 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 71.8 t80 -74.69 -49.86 19.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.914 -0.585 . . . . 0.20000000000000001 110.615 175.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.823 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -63.98 -26.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.189 0.518 . . . . 0.28000000000000003 109.975 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.7 tttm -55.5 -43.82 76.01 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.329 -0.851 . . . . 1.8500000000000001 110.671 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.717 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 mm-40 -63.12 -32.23 73.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.692 -0.484 . . . . 1.3100000000000001 109.692 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -71.31 -37.39 71.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.069 -0.514 . . . . 0.23999999999999999 111.327 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.731 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 2.8 ptmm? -76.23 -21.0 56.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.633 0.73 . . . . 1.8799999999999999 109.428 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.49 -48.42 27.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.786 -1.097 . . . . 1.77 111.721 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.717 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.55 -9.91 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.66 0.743 . . . . 0.33000000000000002 110.037 -177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 72.32 58.45 0.14 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.603 -1.635 . . . . 1.47 111.141 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . -115.54 -143.15 7.87 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 113.355 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.76 156.06 33.96 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.386 0.674 . . . . 1.0600000000000001 109.63 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -114.3 135.11 54.43 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.854 -0.424 . . . . 0.17000000000000001 109.854 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 96.5 m -123.12 128.71 50.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.922 -0.581 . . . . 0.20999999999999999 110.742 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -98.35 109.93 22.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.121 -0.696 . . . . 1.51 109.121 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.5 mt -82.48 148.29 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.5 -0.555 . . . . 0.26000000000000001 109.5 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 53.9 tt0 -122.96 135.87 54.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.501 -0.48 . . . . 1.9299999999999999 110.172 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.6 p80 157.49 -46.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.734 1.214 . . . . 1.79 109.111 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 49.7 t80 -77.67 -23.76 49.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.1 0.476 . . . . 3.9500000000000002 110.637 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -67.4 -15.66 63.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 2.2200000000000002 110.59 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.4 m -93.67 -19.16 21.37 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.045 -0.525 . . . . 1.78 110.351 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.3 m -95.58 -36.66 11.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.049 -0.523 . . . . 1.6299999999999999 110.736 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 4.0 t80 -97.62 144.18 27.51 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.822 -0.626 . . . . 2.8500000000000001 109.5 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 99.0 Cg_endo -76.32 25.44 0.43 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.656 2.237 . . . . 0.68999999999999995 113.935 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 3.9 mt -117.53 113.3 42.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.213 -0.595 . . . . 0.35999999999999999 111.032 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.557 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 96.2 mttt -118.17 134.27 55.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 1.3799999999999999 109.785 177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 30.4 m -151.86 167.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.014 -0.539 . . . . 0.33000000000000002 110.921 -174.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 33.6 m-20 -129.85 135.0 47.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 1.1100000000000001 109.967 173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 100' ' ' LEU . 4.7 mp -91.64 133.27 35.71 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.719 -0.673 . . . . 0.34999999999999998 110.64 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 4.7 m-85 -126.99 141.87 51.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.563 -0.29 . . . . 0.33000000000000002 110.491 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.83 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.3 m-30 -113.72 142.78 45.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.006 0.431 . . . . 0.34000000000000002 111.223 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.647 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -103.77 122.87 46.0 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.06 -1.089 . . . . 0.25 108.06 173.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.572 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.8 mppt? -134.19 110.77 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.746 0.308 . . . . 1.22 111.05 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.07 -106.68 2.19 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.518 -1.033 . . . . 0.41999999999999998 110.518 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 139' ' ' THR . 3.7 p -119.34 -7.45 10.23 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.812 0.339 . . . . 1.3100000000000001 110.265 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -102.28 145.77 28.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.667 0.746 . . . . 2.27 111.085 -176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -109.78 137.39 42.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.022 -0.99 . . . . 0.79000000000000004 110.396 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.3 mmt -137.99 126.56 14.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.124 -0.489 . . . . 1.8500000000000001 110.625 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.1 Cg_endo -75.4 160.22 39.07 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.871 2.38 . . . . 0.28999999999999998 112.849 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.06 136.05 34.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 0.31 109.976 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.34 140.01 30.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.035 0.445 . . . . 1.8500000000000001 110.002 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 m -60.35 120.31 9.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.542 -0.754 . . . . 0.46999999999999997 111.925 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.33 15.64 72.77 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.555 -0.748 . . . . 0.38 113.637 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -111.67 122.94 35.92 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 110.161 -0.311 . . . . 1.9299999999999999 110.161 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.51 112.08 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.119 1.88 . . . . 0.68000000000000005 110.245 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -117.41 143.97 45.46 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.507 -0.77 . . . . 0.40999999999999998 110.051 -171.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 3.8 p -55.8 112.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.797 0.665 . . . . 0.70999999999999996 112.797 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 77' ' ' ALA . 10.5 p -119.84 -17.37 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.155 -0.93 . . . . 0.23000000000000001 110.449 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.38 -54.59 41.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 1.3500000000000001 112.372 -174.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -114.02 67.09 0.67 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.397 0.618 . . . . 2.3500000000000001 110.313 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 104' ' ' LYS . 40.1 pt -104.95 174.66 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.37 110.072 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -96.16 -47.24 6.13 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.878 -0.601 . . . . 0.5 109.385 174.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.5 160.5 39.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.541 -0.754 . . . . 0.22 111.075 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.83 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 11.3 ttt -132.32 149.77 52.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.946 -0.57 . . . . 1.1599999999999999 109.634 170.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 38.9 m -144.69 157.3 44.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.743 0.306 . . . . 1.22 110.421 176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.67 109.14 23.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.27000000000000002 109.726 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.633 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -106.57 140.27 21.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 109.738 -0.467 . . . . 0.42999999999999999 109.738 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 85.6 Cg_endo -83.17 122.9 3.38 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.305 2.003 . . . . 0.91000000000000003 113.227 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.67 -76.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.588 0.959 . . . . 3.29 113.588 177.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.46 65.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.576 -0.61 . . . . 0.44 111.576 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 11.5 p -73.72 -4.82 36.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.018 0.437 . . . . 1.23 111.122 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 15.6 m -56.89 -12.38 1.94 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.509 -0.768 . . . . 1.3 111.813 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 m -48.78 -41.96 34.2 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.097 0.475 . . . . 0.44 110.864 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.8 mt -117.76 21.88 12.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.938 -0.574 . . . . 0.37 111.439 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -102.8 82.27 2.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 1.6599999999999999 111.08 -176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.662 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.1 p -140.63 162.74 23.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.43 -0.581 . . . . 0.51000000000000001 109.43 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.672 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -54.53 -46.14 73.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.419 0.628 . . . . 2.0600000000000001 110.456 179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -134.76 154.6 51.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.39000000000000001 110.433 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.662 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.4 mtp -153.6 156.22 37.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.571 0.582 . . . . 0.78000000000000003 112.571 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.51 138.45 31.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.437 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 53.9 tttm -63.6 -31.23 72.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.566 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.22 -38.91 65.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.164 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 14.0 ttt -69.65 -40.21 76.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.47999999999999998 110.125 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.647 ' CD2' HD23 ' A' ' 103' ' ' LEU . 21.7 t80 -54.69 -49.56 70.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.551 -0.749 . . . . 0.29999999999999999 111.222 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.771 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -69.52 -46.55 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.971 -0.559 . . . . 0.19 111.569 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.7 m -58.27 -43.61 88.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.312 0.577 . . . . 0.84999999999999998 110.571 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.664 ' HB2' HD21 ' A' ' 135' ' ' LEU . 20.4 mmt180 -61.11 -51.51 68.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 2.48 110.877 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -65.79 -41.69 95.55 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.853 -0.689 . . . . 0.17000000000000001 112.243 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.41 -38.75 81.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.496 0.184 . . . . 1.4199999999999999 111.496 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 148' ' ' ARG . 5.9 t -77.44 -18.46 57.19 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.534 -0.466 . . . . 0.40000000000000002 110.384 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.599 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.6 mm-40 -83.82 -9.61 58.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.823 0.821 . . . . 1.3100000000000001 109.068 171.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.07 -13.82 34.02 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.5 -1.227 . . . . 0.25 114.584 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.09 126.1 14.55 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.118 1.459 . . . . 0.19 113.269 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.771 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 13.2 t -149.95 166.11 30.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.333 0.587 . . . . 1.4199999999999999 110.557 165.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.66 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.1 tt -158.92 117.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.793 -1.094 . . . . 0.28000000000000003 109.418 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.661 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.8 m -122.54 144.92 48.78 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.689 -0.632 . . . . 1.4399999999999999 112.006 -176.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.731 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 2.7 m-85 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.62 -0.718 . . . . 1.8100000000000001 110.859 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.445 0.164 . . . . 3.6800000000000002 111.381 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.7 -34.65 73.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.295 0.48 . . . . 2.3799999999999999 112.295 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -65.44 124.34 22.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.058 0.456 . . . . 1.6100000000000001 110.91 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.25 -163.77 29.57 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 112.002 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -118.2 149.48 41.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.828 0.314 . . . . 0.17999999999999999 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.666 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.0 m-85 -127.08 133.03 50.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.588 0.232 . . . . 0.56999999999999995 111.018 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.4 tm? -89.22 119.52 29.78 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.16 108.198 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.78 145.34 24.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.612 -0.267 . . . . 0.19 110.513 -175.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.5 t80 -97.04 130.85 44.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 0.90000000000000002 109.644 173.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.89 150.98 40.24 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.517 -0.549 . . . . 0.60999999999999999 109.517 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -84.63 -1.65 56.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.25 -0.432 . . . . 2.3700000000000001 111.493 -175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.53 132.03 51.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 1.3100000000000001 109.967 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.9 m 58.9 26.56 15.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.202 0.525 . . . . 1.23 110.332 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.432 HD22 ' NE2' ' A' ' 60' ' ' GLN . 88.4 m-20 58.75 22.74 10.38 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.125 -0.943 . . . . 1.3 111.41 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 156.09 104.62 0.22 Allowed Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.755 -0.736 . . . . 0.39000000000000001 112.35 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.4 m -137.88 150.18 46.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.176 -0.305 . . . . 0.40000000000000002 110.176 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.669 HD12 ' HA3' ' A' ' 69' ' ' GLY . 18.6 mt -103.73 147.35 27.37 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.172 0.51 . . . . 0.57999999999999996 110.195 174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -137.4 128.14 27.07 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.207 -0.906 . . . . 0.19 109.579 -175.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.541 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.3 tt -107.91 114.23 45.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.595 0.712 . . . . 0.28000000000000003 109.604 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.666 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.6 p -94.78 119.31 42.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.309 -0.859 . . . . 0.23999999999999999 110.835 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 44.1 m95 -96.77 106.75 19.1 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.962 -0.755 . . . . 0.31 108.962 172.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -145.26 173.99 11.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.668 -0.696 . . . . 1.3600000000000001 110.823 -172.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -113.98 11.13 17.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.825 -1.079 . . . . 1.9399999999999999 108.735 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.99 177.88 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.299 -1.319 . . . . 1.45 110.467 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -91.17 129.84 37.12 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.835 0.35 . . . . 2.3500000000000001 110.962 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -117.66 139.56 44.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.239 -1.023 . . . . 1.1599999999999999 108.239 169.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.26 -177.24 3.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.802 -0.359 . . . . 1.98 111.573 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 63.74 26.55 14.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.753 0.787 . . . . 2.0600000000000001 110.174 -177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.27 147.13 23.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 110.419 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.743 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -97.27 -28.06 14.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.525 -0.761 . . . . 0.38 109.456 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 82.3 mtp -145.39 169.82 17.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.893 -0.594 . . . . 0.20000000000000001 111.187 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 71.6 t80 -149.31 154.16 38.58 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 110.894 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 76.8 mt -127.17 133.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.16 109.602 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -114.67 110.84 46.48 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 110.041 -0.355 . . . . 2.3799999999999999 110.041 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -75.11 127.13 10.36 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.133 1.889 . . . . 0.34999999999999998 111.925 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.1 p -88.18 -33.05 18.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.701 0.762 . . . . 0.85999999999999999 109.147 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.51 157.08 19.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.541 -1.208 . . . . 2.1600000000000001 108.65 173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.39 131.7 47.98 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.289 -0.634 . . . . 2.4199999999999999 109.289 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.47 131.3 61.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 0.72999999999999998 111.475 -166.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 71.4 Cg_exo -47.06 121.35 5.07 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 124.213 3.275 . . . . 0.68000000000000005 113.018 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -65.74 -39.19 90.87 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.646 -0.707 . . . . 2.2799999999999998 111.991 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.656 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.4 t80 -66.62 -24.47 66.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.047 0.451 . . . . 3.3399999999999999 110.463 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 1.1 mptm? -72.52 -20.39 61.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.952 -0.567 . . . . 1.9399999999999999 111.092 176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -87.2 -54.3 4.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.973 0.416 . . . . 0.93000000000000005 110.455 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.656 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.7 p -67.42 -38.33 80.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 1.0700000000000001 111.739 -172.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -77.06 -27.17 54.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.311 0.577 . . . . 1.6599999999999999 110.44 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.441 ' CG ' ' HB2' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -88.01 -22.59 24.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.975 -0.557 . . . . 2.0 110.683 -176.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 t30 68.82 11.29 8.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.363 -0.835 . . . . 2.2599999999999998 109.089 -172.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.24 24.27 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.77 -1.105 . . . . 0.46000000000000002 112.689 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -108.32 126.71 53.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.907 -0.172 . . . . 2.4300000000000002 110.896 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.441 ' HB2' ' CG ' ' A' ' 49' ' ' ARG . 2.9 t-20 -148.3 119.69 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.728 -0.389 . . . . 2.0499999999999998 111.387 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.89 121.41 28.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.408 0.623 . . . . 1.47 109.342 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.9 mt -80.68 -61.59 1.93 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.876 -1.056 . . . . 0.54000000000000004 111.836 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.8 tt -148.9 145.25 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.19 -0.914 . . . . 0.25 109.153 -171.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 1.0 OUTLIER -136.85 172.37 13.11 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.497 -0.481 . . . . 2.23 111.778 -172.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 26.0 t-20 74.47 32.78 0.91 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 124.263 0.977 . . . . 1.3999999999999999 109.842 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 41.1 mt -64.81 -20.74 66.55 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.165 -0.925 . . . . 0.33000000000000002 111.766 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.432 ' NE2' HD22 ' A' ' 16' ' ' ASN . 3.8 tt0 -60.19 -45.27 93.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.118 0.485 . . . . 1.76 111.117 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 t -77.64 -8.57 58.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.588 -0.733 . . . . 1.5900000000000001 111.18 -172.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.84 122.09 1.34 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.22 -0.446 . . . . 1.9199999999999999 111.203 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -66.12 -38.6 88.58 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.501 -0.772 . . . . 1.6799999999999999 111.507 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 74.7 mmtt -59.41 -27.49 66.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.515 -0.766 . . . . 1.0700000000000001 111.72 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.5 mt -54.77 -41.96 71.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.176 -0.465 . . . . 0.34000000000000002 111.259 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.609 ' HD1' HD11 ' A' ' 19' ' ' LEU . 16.1 t80 -62.54 -36.26 82.05 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 110.267 -0.272 . . . . 0.23999999999999999 110.267 176.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -60.69 -56.02 26.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.497 0.665 . . . . 0.40000000000000002 109.284 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 30.7 t -64.52 -34.2 77.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.131 -0.94 . . . . 1.22 111.003 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.669 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.05 -33.78 64.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.093 -1.051 . . . . 0.17000000000000001 111.34 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 85.0 mt -64.28 -47.64 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 115.397 -0.402 . . . . 0.17999999999999999 111.45 174.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 13.4 p -63.15 -36.48 83.75 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.264 -0.643 . . . . 1.1000000000000001 109.264 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 68' ' ' SER . 37.4 mt-30 -60.81 -34.15 74.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.269 -0.878 . . . . 1.8200000000000001 110.725 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.573 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -72.03 -50.68 26.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.825 -0.625 . . . . 0.20000000000000001 110.882 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -67.2 -22.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.147 0.498 . . . . 0.28000000000000003 110.331 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.646 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 12.3 tmtt? -57.36 -30.59 64.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.382 -0.826 . . . . 1.8500000000000001 110.982 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.608 ' O ' HG23 ' A' ' 80' ' ' ILE . 41.8 mm-40 -73.3 -40.53 64.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.175 176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.558 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.74 -34.16 77.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.112 -0.495 . . . . 0.23999999999999999 111.084 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.681 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 3.9 ptmm? -76.83 -20.68 56.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.523 0.678 . . . . 1.8799999999999999 109.637 176.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.6 -48.92 15.69 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.743 -1.117 . . . . 1.77 111.15 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -85.96 -13.6 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 121.676 0.751 . . . . 0.33000000000000002 109.916 -179.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.449 ' C ' ' HB3' ' A' ' 120' ' ' GLN . 35.0 mmtp 74.98 55.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 113.744 -1.571 . . . . 1.47 111.988 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.85 -135.33 5.87 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.551 -0.833 . . . . 0.26000000000000001 113.386 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.16 160.98 24.0 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.182 0.593 . . . . 1.0600000000000001 109.931 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.4 tm? -121.2 135.35 55.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.876 -0.416 . . . . 0.17000000000000001 109.876 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 99.7 m -123.55 127.28 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 0.20999999999999999 110.846 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.9 tm? -95.2 106.01 18.0 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.986 -0.746 . . . . 1.51 108.986 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.07 152.45 36.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.338 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 53.8 tt0 -120.67 136.16 54.92 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.964 -0.384 . . . . 1.9299999999999999 109.964 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 53.9 t-80 159.06 -49.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.69 -1.141 . . . . 1.79 108.292 -172.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.743 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 20.1 p90 -64.96 -28.16 69.33 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.009 -0.996 . . . . 3.9500000000000002 111.369 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -64.79 -20.32 66.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.489 0.551 . . . . 2.2200000000000002 112.489 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -93.21 -26.39 17.4 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.813 -0.355 . . . . 1.78 111.448 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 t -94.41 -33.84 12.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 1.6299999999999999 110.739 -177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 1.7 t80 -95.64 135.77 22.83 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.879 -0.601 . . . . 2.8500000000000001 109.698 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 60.9 Cg_endo -73.06 7.15 2.19 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.805 2.337 . . . . 0.68999999999999995 113.576 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.433 HD12 ' CE1' ' A' ' 94' ' ' PHE . 69.7 mt -108.74 115.13 48.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.271 0.557 . . . . 0.35999999999999999 111.213 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.64 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 2.1 mptp? -114.46 128.34 56.29 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.249 -0.887 . . . . 1.3799999999999999 108.693 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 23.2 m -150.6 168.11 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 121.065 0.46 . . . . 0.33000000000000002 111.584 -169.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 31.6 m-20 -133.79 134.17 42.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.576 -0.738 . . . . 1.1100000000000001 110.278 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.23 136.24 35.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.927 -0.579 . . . . 0.34999999999999998 110.568 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.3 m-85 -129.33 146.22 51.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.887 0.375 . . . . 0.33000000000000002 110.771 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -115.47 148.99 38.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.713 -0.676 . . . . 0.34000000000000002 109.957 173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -104.98 126.06 51.64 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.693 -0.854 . . . . 0.25 108.693 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE3' HG22 ' A' ' 122' ' ' ILE . 5.9 mptt -124.14 101.56 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.67 0.214 . . . . 1.22 110.906 175.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.29 -98.02 0.49 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.461 -0.876 . . . . 0.41999999999999998 111.048 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 139' ' ' THR . 33.4 m -123.59 1.52 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.018 0.437 . . . . 1.3100000000000001 110.126 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -100.85 117.64 35.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.913 0.387 . . . . 2.27 110.937 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -91.56 136.59 23.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.032 0.444 . . . . 0.79000000000000004 110.619 177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.6 121.51 14.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.899 -0.591 . . . . 1.8500000000000001 110.945 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.9 Cg_endo -73.67 158.81 46.75 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.811 2.341 . . . . 0.28999999999999998 112.619 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 135.15 34.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.07 -0.514 . . . . 0.31 109.983 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -90.57 136.03 33.32 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.572 -0.529 . . . . 1.8500000000000001 109.572 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.42 ' CG2' ' HB2' ' A' ' 88' ' ' GLN . 59.9 m -60.21 121.72 12.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 111.732 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.66 73.86 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.509 -0.769 . . . . 0.38 113.056 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.84 128.21 25.88 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.782 -0.451 . . . . 1.9299999999999999 109.782 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.04 110.9 2.07 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.82 1.68 . . . . 0.68000000000000005 109.824 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.88 142.77 46.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.574 -0.739 . . . . 0.40999999999999998 110.158 -172.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.446 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -58.91 112.81 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 112.57 -173.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.558 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.5 p -115.15 -19.11 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.03 -0.987 . . . . 0.23000000000000001 110.303 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.449 ' HB3' ' C ' ' A' ' 81' ' ' LYS . 3.3 pt20 -58.49 -32.73 69.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.514 -0.766 . . . . 1.3500000000000001 111.491 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -122.32 70.23 0.98 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.807 -0.633 . . . . 2.3500000000000001 110.058 -175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.507 HG22 ' HE3' ' A' ' 104' ' ' LYS . 42.3 pt -125.52 166.82 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.659 -0.7 . . . . 0.37 110.359 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 158' ' ' PHE . 2.8 m-20 -103.42 -33.61 9.02 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.344 -0.843 . . . . 0.5 110.144 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.67 158.49 31.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.801 -0.636 . . . . 0.22 110.351 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.464 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -137.91 148.48 45.36 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.245 -0.65 . . . . 1.1599999999999999 109.245 176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.454 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 63.0 m -153.42 159.76 42.44 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 1.22 111.81 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.8 t -124.86 111.07 26.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.766 -0.652 . . . . 0.27000000000000002 110.409 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.666 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -104.2 139.48 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.706 -0.479 . . . . 0.42999999999999999 109.706 177.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 87.8 Cg_endo -82.01 122.06 3.73 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.23 1.954 . . . . 0.91000000000000003 112.329 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.64 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 52.11 -76.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.069 0.948 . . . . 3.29 113.454 -178.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.36 80.75 0.21 Allowed Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 112.134 -0.386 . . . . 0.44 112.134 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 65.1 p -77.97 -4.07 45.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.426 -0.387 . . . . 1.23 111.037 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.5 m -56.49 -16.14 5.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.889 -0.596 . . . . 1.3 112.327 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.6 m -48.93 -46.1 42.66 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.112 0.482 . . . . 0.44 110.538 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.666 HD12 HD21 ' A' ' 128' ' ' LEU . 84.5 mt -118.28 10.59 12.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.789 . . . . 0.37 111.689 -175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.623 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 20.9 ttmm -91.77 77.76 5.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.668 0.271 . . . . 1.6599999999999999 111.096 -176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.698 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.4 p -139.63 172.48 12.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.622 -0.51 . . . . 0.51000000000000001 109.622 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -64.29 -46.57 83.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 110.586 -178.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' SER . 0.2 OUTLIER -136.46 148.21 47.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.473 -0.785 . . . . 0.39000000000000001 110.565 -177.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.698 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.6 mtp -150.52 154.81 38.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.361 0.504 . . . . 0.78000000000000003 112.361 -173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.47 145.97 24.94 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.555 -0.748 . . . . 0.44 111.206 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.0 tttm -65.43 -32.76 74.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.251 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -39.69 70.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.504 -0.771 . . . . 0.66000000000000003 110.008 -176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.7 ttt -74.18 -38.82 63.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.054 -0.975 . . . . 0.47999999999999998 110.536 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 22.7 t80 -54.13 -54.95 32.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.81 -0.632 . . . . 0.29999999999999999 111.142 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.7 OUTLIER -63.46 -42.39 96.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.982 -0.554 . . . . 0.19 111.615 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.4 t -65.32 -40.11 93.32 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.776 0.322 . . . . 0.84999999999999998 110.554 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.5 mmp_? -63.68 -45.87 88.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.953 -0.567 . . . . 2.48 111.392 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -68.43 -41.12 86.07 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.568 -0.825 . . . . 0.17000000000000001 112.318 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 28.5 t-20 -60.98 -37.6 83.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.926 0.343 . . . . 1.4199999999999999 111.926 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.491 HG21 ' NH2' ' A' ' 148' ' ' ARG . 3.7 t -72.73 -30.39 64.13 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.844 -0.343 . . . . 0.40000000000000002 110.378 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.528 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -74.84 -9.91 59.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.44 0.638 . . . . 1.3100000000000001 110.183 170.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 110.04 -12.84 31.7 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.013 -0.994 . . . . 0.25 115.217 171.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.5 125.78 15.6 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.394 1.597 . . . . 0.19 113.355 172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.488 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 35.7 p -148.64 162.56 39.46 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.006 -0.543 . . . . 1.4199999999999999 110.819 166.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.3 tt -155.63 119.0 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 109.266 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.8 p -107.5 145.44 33.09 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.051 0.389 . . . . 1.4399999999999999 112.051 -172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.681 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.667 -0.682 . . . . 1.8100000000000001 110.705 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.146 0.498 . . . . 3.6800000000000002 110.293 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.77 -54.66 5.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.062 -0.517 . . . . 2.3799999999999999 109.944 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -85.93 130.56 34.51 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.059 -0.348 . . . . 1.6100000000000001 110.059 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.566 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.85 -153.53 25.05 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.65 -0.786 . . . . 0.26000000000000001 111.78 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -124.56 145.24 49.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.534 0.167 . . . . 0.17999999999999999 111.026 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.785 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 8.1 m-85 -122.91 135.05 54.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.612 0.244 . . . . 0.56999999999999995 110.491 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 HD22 ' A' ' 19' ' ' LEU . 2.4 tm? -90.82 118.53 30.3 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.363 -0.977 . . . . 0.16 108.363 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.86 145.76 24.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 120.784 0.326 . . . . 0.19 110.687 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.599 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 83.7 t80 -98.2 134.37 41.35 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.473 -0.565 . . . . 0.90000000000000002 109.473 174.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.12 155.76 36.34 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.772 0.32 . . . . 0.60999999999999999 110.216 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -85.59 -5.18 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.749 -0.659 . . . . 2.3700000000000001 111.677 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 133.46 56.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.019 -0.363 . . . . 1.3100000000000001 110.019 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.9 m 56.98 27.58 13.43 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.985 0.422 . . . . 1.23 110.968 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 m120 56.75 27.04 12.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.378 -0.828 . . . . 1.3 111.706 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.599 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 152.51 105.27 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.429 -0.891 . . . . 0.39000000000000001 112.754 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 52.1 m -137.74 148.72 45.85 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.251 -0.277 . . . . 0.40000000000000002 110.251 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.627 HD11 ' HD1' ' A' ' 66' ' ' PHE . 18.7 mt -103.94 147.38 27.42 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.214 0.53 . . . . 0.57999999999999996 110.298 174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 52' ' ' LYS . 0.4 OUTLIER -140.11 128.49 22.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.011 -0.995 . . . . 0.19 109.572 -174.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 7.7 tt -107.85 114.21 45.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.449 0.642 . . . . 0.28000000000000003 109.848 175.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.713 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.1 p -96.97 122.45 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.23999999999999999 111.008 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.506 ' HB3' ' CD2' ' A' ' 46' ' ' PHE . 63.6 m95 -97.16 106.7 19.08 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.092 -0.707 . . . . 0.31 109.092 172.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.47 174.55 10.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.728 -0.669 . . . . 1.3600000000000001 110.755 -171.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -120.71 14.3 11.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.951 -1.022 . . . . 1.9399999999999999 108.574 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 12.0 pt-20 -132.63 165.56 24.16 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.898 -1.047 . . . . 1.45 110.021 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -77.64 137.99 38.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.183 0.516 . . . . 2.3500000000000001 111.39 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.785 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 67.8 t -121.71 135.94 60.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.322 -0.853 . . . . 1.1599999999999999 109.246 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.81 176.6 4.97 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.171 -0.212 . . . . 1.98 110.914 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 m120 66.25 23.15 10.86 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.682 0.614 . . . . 2.0600000000000001 110.695 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.31 148.49 24.62 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.486 -0.779 . . . . 0.20999999999999999 110.739 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -95.58 -27.56 15.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.186 -0.915 . . . . 0.38 109.775 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.678 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.3 mtp -147.42 170.37 17.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.20000000000000001 111.225 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 81.7 t80 -150.01 154.87 38.93 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 110.702 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 82.0 mt -127.2 130.41 71.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.028 -0.73 . . . . 0.16 109.028 176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.49 110.71 37.04 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.725 -0.472 . . . . 2.3799999999999999 109.725 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.83 129.79 10.12 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.598 2.199 . . . . 0.34999999999999998 112.545 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 83' ' ' LYS . 20.2 p -89.75 -27.62 19.92 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.945 0.879 . . . . 0.85999999999999999 109.289 171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.88 167.55 14.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.233 -1.349 . . . . 2.1600000000000001 108.433 172.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.32 139.33 47.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.4199999999999999 109.472 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -86.95 133.29 39.58 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.987 -0.551 . . . . 0.72999999999999998 111.497 -170.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 83.0 Cg_exo -48.99 122.34 8.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.848 3.032 . . . . 0.68000000000000005 113.028 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 47' ' ' VAL . 8.7 tp10 -66.66 -37.02 83.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.524 -0.762 . . . . 2.2799999999999998 111.383 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.678 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.6 t80 -65.23 -28.5 69.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.594 . . . . 3.3399999999999999 111.269 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -69.44 -23.26 63.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.716 0.293 . . . . 1.9399999999999999 110.749 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 23' ' ' TRP . 57.9 m-85 -86.35 -53.34 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.93000000000000005 110.415 174.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 44' ' ' PHE . 6.0 p -69.6 -38.59 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.501 0.556 . . . . 1.0700000000000001 112.501 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -74.21 -42.55 59.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.994 0.426 . . . . 1.6599999999999999 110.802 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.22 -11.18 47.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.848 -0.615 . . . . 2.0 111.498 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 63.55 17.42 10.36 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.642 0.734 . . . . 2.2599999999999998 110.142 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.03 -14.72 59.82 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 114.623 -1.171 . . . . 0.46000000000000002 112.673 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 40.7 mtmt -107.58 129.95 54.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 2.4300000000000002 111.388 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.493 HD22 ' N ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -149.69 119.61 7.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.71 0.291 . . . . 2.0499999999999998 110.367 177.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' N ' HD22 ' A' ' 53' ' ' ASN . 4.8 mp0 -84.57 122.71 29.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.839 -0.43 . . . . 1.47 109.839 175.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -82.46 -63.88 1.29 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.549 -0.751 . . . . 0.54000000000000004 111.996 -174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.561 HG23 HD21 ' A' ' 59' ' ' LEU . 20.2 tt -146.56 147.65 17.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.491 -0.777 . . . . 0.25 109.289 -170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.0 ppt_? -135.43 172.6 12.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.467 -0.493 . . . . 2.23 112.035 -174.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 69.05 39.83 1.7 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.045 -0.979 . . . . 1.3999999999999999 110.692 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.561 HD21 HG23 ' A' ' 56' ' ' ILE . 37.1 mt -66.62 -20.4 65.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.679 -0.691 . . . . 0.33000000000000002 111.071 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.75 -45.57 91.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.608 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 t -78.25 -12.54 60.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.178 -0.465 . . . . 1.5900000000000001 110.854 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 18.8 t70 -159.65 112.62 2.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.857 -0.61 . . . . 1.9199999999999999 110.239 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' HE2' HG12 ' A' ' 96' ' ' ILE . 4.6 ptmt -66.68 -28.66 68.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.152 -0.476 . . . . 1.6799999999999999 110.463 -175.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 36.1 mmtm -70.34 -22.89 62.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 111.502 -174.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 80.9 mt -56.74 -36.01 69.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.6 -0.273 . . . . 0.34000000000000002 110.881 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.627 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -64.05 -37.74 88.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.786 -0.45 . . . . 0.23999999999999999 109.786 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.579 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.7 OUTLIER -62.65 -55.89 22.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.395 0.617 . . . . 0.40000000000000002 109.796 -177.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.5 m -66.82 -31.81 72.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.632 -0.713 . . . . 1.22 111.121 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.7 -38.42 91.77 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.147 -1.025 . . . . 0.17000000000000001 110.794 173.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 33' ' ' MET . 80.4 mt -59.3 -48.38 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.263 -0.469 . . . . 0.17999999999999999 111.42 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 2.7 p -61.42 -38.45 87.18 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.1000000000000001 110.204 -176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -64.29 -34.86 79.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.34 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.555 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.6 t80 -66.02 -50.01 65.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.731 -0.668 . . . . 0.20000000000000001 110.393 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.8 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -64.64 -27.41 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 0.28000000000000003 110.029 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 ttpp -59.46 -38.16 80.07 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.722 -0.672 . . . . 1.8500000000000001 110.782 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.573 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.5 mm-40 -61.4 -36.53 80.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.301 0.572 . . . . 1.3100000000000001 109.659 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -70.48 -31.67 68.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.8 -0.637 . . . . 0.23999999999999999 111.01 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 22.5 mtpt -73.23 -24.44 60.49 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.105 -0.702 . . . . 1.8799999999999999 109.105 174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.5 -46.37 26.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.514 -0.766 . . . . 1.77 111.341 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.16 -8.61 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.786 0.803 . . . . 0.33000000000000002 109.588 -179.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 68.05 52.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 113.619 -1.628 . . . . 1.47 111.307 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.86 -139.51 9.04 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.491 -0.777 . . . . 0.26000000000000001 112.957 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' HD3' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -122.3 155.32 36.19 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.458 -0.571 . . . . 1.0600000000000001 109.458 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.3 136.46 53.08 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.904 -0.406 . . . . 0.17000000000000001 109.904 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.9 m -122.26 129.54 52.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 110.831 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -100.95 113.32 26.18 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.554 -0.536 . . . . 1.51 109.554 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.9 mt -88.18 147.53 24.83 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.72 -0.844 . . . . 0.26000000000000001 108.72 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 48.8 tt0 -123.71 136.11 54.26 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.142 -0.623 . . . . 1.9299999999999999 109.838 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 6.9 t60 165.89 -47.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.403 -0.962 . . . . 1.79 108.403 -173.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.2 t80 -61.4 -35.02 76.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.542 -1.208 . . . . 3.9500000000000002 111.24 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -35.34 74.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.311 0.577 . . . . 2.2200000000000002 110.867 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 t -67.63 -37.22 82.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.628 -0.714 . . . . 1.78 110.745 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.0 m -97.97 -35.52 10.43 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.308 0.484 . . . . 1.6299999999999999 112.308 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 8.8 t80 -97.78 145.06 29.09 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.594 -0.521 . . . . 2.8500000000000001 109.594 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 57.2 Cg_endo -69.51 22.35 0.16 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.895 2.396 . . . . 0.68999999999999995 114.373 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.524 HG12 ' HE2' ' A' ' 63' ' ' LYS . 26.3 mt -118.37 118.1 56.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.99 -0.374 . . . . 0.35999999999999999 109.99 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -123.92 118.64 27.53 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.569 -0.53 . . . . 1.3799999999999999 109.569 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 129' ' ' PRO . 35.5 m -141.59 170.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.988 0.423 . . . . 0.33000000000000002 112.119 -172.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' OD1' ' HE1' ' A' ' 101' ' ' TYR . 1.9 p-10 -151.9 138.21 18.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.409 -0.814 . . . . 1.1100000000000001 109.52 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.535 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.0 mp -87.56 140.59 29.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.167 -0.924 . . . . 0.34999999999999998 112.329 -166.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' PRO . 5.1 m-85 -124.33 132.74 53.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.988 -0.551 . . . . 0.33000000000000002 110.743 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.826 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 5.7 m-30 -105.53 146.66 29.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.986 -0.552 . . . . 0.34000000000000002 110.568 175.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' ASP . 1.1 tm? -102.63 113.7 27.31 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.564 -1.273 . . . . 0.25 107.564 172.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' CG ' HG22 ' A' ' 122' ' ' ILE . 51.5 mtpt -127.49 97.91 5.04 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.979 0.419 . . . . 1.22 111.495 -176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.88 -100.21 1.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.6 -1.0 . . . . 0.41999999999999998 110.6 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.1 p -122.71 -12.25 8.1 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.364 0.602 . . . . 1.3100000000000001 109.781 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -93.87 116.77 29.25 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.771 -0.65 . . . . 2.27 110.741 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -78.13 128.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.489 -0.56 . . . . 0.79000000000000004 109.489 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.7 mtt -128.8 115.23 19.18 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.904 -0.589 . . . . 1.8500000000000001 110.743 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 101' ' ' TYR . 72.9 Cg_endo -74.17 156.16 46.83 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.461 2.107 . . . . 0.28999999999999998 112.273 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.4 140.01 31.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.036 -0.529 . . . . 0.31 109.98 -176.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 80.0 m-20 -89.82 142.06 28.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.548 -0.538 . . . . 1.8500000000000001 109.548 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.3 m -64.05 120.4 11.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.168 0.508 . . . . 0.46999999999999997 111.492 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.69 25.68 73.96 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.38 113.354 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 30.5 tt0 -123.54 126.48 25.8 Favored Pre-proline 0 C--N 1.32 -0.686 0 O-C-N 122.692 -0.299 . . . . 1.9299999999999999 110.592 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.28 112.03 1.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.334 2.023 . . . . 0.68000000000000005 110.85 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.4 t80 -117.0 145.04 43.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.373 -0.831 . . . . 0.40999999999999998 110.097 -174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.66 107.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.913 -0.585 . . . . 0.70999999999999996 112.347 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.683 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.0 p -108.41 -21.51 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.806 -0.633 . . . . 0.23000000000000001 110.295 175.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -56.41 -37.22 69.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.449 -0.796 . . . . 1.3500000000000001 111.71 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -114.64 57.75 0.71 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.337 0.589 . . . . 2.3500000000000001 110.573 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.472 HG22 ' CG ' ' A' ' 104' ' ' LYS . 26.5 pt -116.55 159.08 16.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.842 -0.617 . . . . 0.37 110.192 175.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.688 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.5 m-20 -91.05 -42.37 10.54 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.08 -0.964 . . . . 0.5 109.568 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.17 159.89 40.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.167 -0.924 . . . . 0.22 110.349 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.826 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 8.7 ttt -130.93 154.33 48.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.416 -0.587 . . . . 1.1599999999999999 109.416 171.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.53 ' N ' ' HG3' ' A' ' 125' ' ' MET . 63.7 p -144.16 160.08 41.54 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 1.22 109.758 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.4 t -115.8 107.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.984 -0.747 . . . . 0.27000000000000002 108.984 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -104.44 139.16 19.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.879 -0.6 . . . . 0.42999999999999999 109.828 -178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.498 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 74.1 Cg_endo -84.69 122.47 2.7 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.916 2.411 . . . . 0.91000000000000003 112.404 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? 32.6 -75.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 115.159 1.54 . . . . 3.29 115.159 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -66.29 63.52 0.16 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.904 -0.479 . . . . 0.44 111.904 172.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.494 ' O ' HD23 ' A' ' 128' ' ' LEU . 17.8 m -75.26 0.07 17.83 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.386 1.074 . . . . 1.23 112.159 -176.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 4.6 m -55.55 -7.33 0.25 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.776 0.658 . . . . 1.3 112.776 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.8 m -50.36 -44.51 54.62 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 121.017 0.437 . . . . 0.44 110.863 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.5 mt -115.7 11.51 15.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.37 111.526 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 27.6 ttpp -89.64 76.88 7.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 1.6599999999999999 110.053 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.724 ' CG1' ' HG2' ' A' ' 140' ' ' MET . 2.7 p -134.05 151.83 33.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.51000000000000001 109.573 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -44.14 -44.28 7.56 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.552 0.575 . . . . 2.0600000000000001 112.552 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 149.76 41.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.528 -0.305 . . . . 0.39000000000000001 110.274 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.724 ' HG2' ' CG1' ' A' ' 137' ' ' VAL . 2.0 mmm -139.1 154.61 48.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.61 0.719 . . . . 0.78000000000000003 112.784 -172.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 145' ' ' PHE . . . -91.34 140.8 29.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.477 -1.238 . . . . 0.44 110.607 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 81.2 tttt -64.87 -32.64 74.45 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.085 0.469 . . . . 1.1100000000000001 110.327 175.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.74 -42.86 49.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.484 -0.78 . . . . 0.66000000000000003 110.296 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 12.6 ttt -74.57 -34.2 62.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.381 -0.827 . . . . 0.47999999999999998 110.912 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.681 ' CD2' HD23 ' A' ' 103' ' ' LEU . 35.7 t80 -53.39 -52.43 59.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.209 0.528 . . . . 0.29999999999999999 110.68 -175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.11 -44.35 95.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.53 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 22.9 t -63.62 -37.41 87.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.971 0.415 . . . . 0.84999999999999998 110.594 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.695 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.3 mmp_? -67.71 -50.1 59.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.28 -0.418 . . . . 2.48 111.035 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.86 80.15 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.578 -0.82 . . . . 0.17000000000000001 112.132 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -59.25 -42.14 90.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.071 0.396 . . . . 1.4199999999999999 112.071 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.6 t -76.42 -21.55 55.82 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.099 0.476 . . . . 0.40000000000000002 109.983 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -78.6 -10.14 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.837 0.827 . . . . 1.3100000000000001 109.606 170.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.64 -15.42 38.03 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 114.515 -1.22 . . . . 0.25 114.546 169.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -146.38 126.26 13.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.803 1.301 . . . . 0.19 112.963 170.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.9 p -140.29 158.68 43.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.049 -0.523 . . . . 1.4199999999999999 110.811 166.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.8 tt -154.22 116.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.917 -0.583 . . . . 0.28000000000000003 109.45 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -116.08 146.36 42.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.316 -0.402 . . . . 1.4399999999999999 111.13 -172.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.509 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 1.2 m-85 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.709 -0.663 . . . . 1.8100000000000001 110.876 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.113 0.482 . . . . 3.6800000000000002 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.5 -43.5 23.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.192 0.52 . . . . 2.3799999999999999 110.381 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HB3' ' NZ ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -91.7 118.33 30.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.913 -0.403 . . . . 1.6100000000000001 109.913 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 155.34 -157.57 27.79 Favored Glycine 0 C--N 1.319 -0.41 0 C-N-CA 120.476 -0.869 . . . . 0.26000000000000001 112.854 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.02 154.41 43.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.733 0.302 . . . . 0.17999999999999999 111.411 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.755 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 15.1 m-85 -131.63 137.04 48.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.193 -0.458 . . . . 0.56999999999999995 110.669 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -90.36 120.37 31.43 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.434 -0.95 . . . . 0.16 108.434 175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.5 150.88 23.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 120.796 0.332 . . . . 0.19 110.605 -176.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.634 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 81.2 t80 -96.31 148.72 22.46 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.632 -0.877 . . . . 0.90000000000000002 108.632 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -134.74 142.22 46.7 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.157 -0.683 . . . . 0.60999999999999999 109.157 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -75.17 -8.92 57.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 2.3700000000000001 110.631 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 138.47 50.72 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.016 -0.538 . . . . 1.3100000000000001 110.336 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 60.53 20.29 10.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.057 0.456 . . . . 1.23 110.353 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.7 m120 57.32 32.91 22.53 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.492 -0.776 . . . . 1.3 111.232 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 142.36 99.31 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.652 -0.785 . . . . 0.39000000000000001 112.056 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.8 m -136.38 146.94 47.03 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.245 -0.279 . . . . 0.40000000000000002 110.245 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.9 mt -104.74 147.63 27.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.28 0.562 . . . . 0.57999999999999996 110.762 175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -138.08 130.03 28.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.952 -1.022 . . . . 0.19 109.504 -176.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 76' ' ' GLU . 8.8 tt -110.99 115.38 49.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.644 0.735 . . . . 0.28000000000000003 109.769 175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.738 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -95.7 129.67 45.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.18 -0.918 . . . . 0.23999999999999999 111.182 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.9 m95 -108.56 107.13 17.51 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.288 -0.634 . . . . 0.31 109.288 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.701 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -146.77 161.84 39.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.42 -0.809 . . . . 1.3600000000000001 110.688 -170.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.14 20.47 18.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.811 0.815 . . . . 1.9399999999999999 109.346 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 12.4 pt-20 -132.73 172.18 12.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.318 -1.31 . . . . 1.45 109.458 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -87.76 127.4 35.31 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.595 -0.442 . . . . 2.3500000000000001 110.719 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.755 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 97.2 t -104.43 131.38 53.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 1.1599999999999999 109.855 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -103.65 174.23 5.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.185 -0.461 . . . . 1.98 110.436 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 67.67 15.65 9.73 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.637 0.586 . . . . 2.0600000000000001 110.907 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.7 151.29 20.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.276 0.56 . . . . 0.20999999999999999 111.155 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.42 -29.03 13.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.21 -0.905 . . . . 0.38 109.766 -175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.614 ' SD ' HG23 ' A' ' 70' ' ' ILE . 86.3 mtp -143.4 170.25 16.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.361 -0.381 . . . . 0.20000000000000001 110.787 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.4 t80 -148.63 154.36 39.6 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.965 -173.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.2 mt -130.84 131.45 64.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.832 -0.803 . . . . 0.16 108.832 177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -118.78 109.63 39.49 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 120.37 -0.532 . . . . 2.3799999999999999 109.875 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.1 126.54 7.89 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.853 2.368 . . . . 0.34999999999999998 112.5 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -90.11 -32.4 16.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.925 0.869 . . . . 0.85999999999999999 108.76 171.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.34 152.59 22.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.113 -1.403 . . . . 2.1600000000000001 108.342 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -63.87 135.61 56.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.264 0.554 . . . . 2.4199999999999999 110.688 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -82.05 139.6 46.01 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.92 -1.037 . . . . 0.72999999999999998 110.647 -178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.4 Cg_exo -46.88 121.26 4.83 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.801 3.001 . . . . 0.68000000000000005 112.62 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.47 -38.5 74.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.909 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.492 ' HA ' HG12 ' A' ' 47' ' ' VAL . 98.2 m-85 -71.46 -24.43 62.01 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.843 -0.343 . . . . 3.3399999999999999 110.512 -175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.0 mptt -64.33 -32.7 74.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.477 -0.329 . . . . 1.9399999999999999 111.0 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.66 -49.72 69.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.303 -0.408 . . . . 0.93000000000000005 110.847 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.3 p -75.69 -35.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.401 . . . . 1.0700000000000001 111.706 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.28 -41.71 66.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.77 0.319 . . . . 1.6599999999999999 111.324 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -85.92 -15.94 40.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.829 0.347 . . . . 2.0 110.995 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 67.53 13.26 9.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.364 0.602 . . . . 2.2599999999999998 109.861 -173.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.76 -15.04 54.44 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.233 -0.894 . . . . 0.46000000000000002 112.214 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -106.9 124.62 49.88 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.659 0.266 . . . . 2.4300000000000002 110.555 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -143.68 119.34 10.44 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.447 -0.501 . . . . 2.0499999999999998 111.244 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.36 134.51 35.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.682 -0.69 . . . . 1.47 109.783 175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.2 mt -92.62 -62.49 1.38 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.23 -0.895 . . . . 0.54000000000000004 111.514 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.604 HG23 HD21 ' A' ' 59' ' ' LEU . 19.3 tt -148.64 151.61 13.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.178 -171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.7 ppt_? -137.91 172.26 13.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.498 . . . . 2.23 112.316 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 4.5 t-20 60.16 46.45 10.49 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.761 -1.109 . . . . 1.3999999999999999 111.066 -178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD21 HG23 ' A' ' 56' ' ' ILE . 44.4 mt -67.61 -14.41 62.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.67 0.748 . . . . 0.33000000000000002 110.18 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -53.46 -46.85 70.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.813 -1.085 . . . . 1.76 113.149 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -85.73 -16.89 37.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.019 0.438 . . . . 1.5900000000000001 111.221 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 1.1 m-20 -149.87 114.11 5.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.729 -0.669 . . . . 1.9199999999999999 111.07 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD2' HG12 ' A' ' 96' ' ' ILE . 23.2 mtmm -59.91 -41.82 92.53 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.756 -0.656 . . . . 1.6799999999999999 110.582 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 31.8 mmtp -59.77 -21.88 61.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.624 -1.171 . . . . 1.0700000000000001 112.097 -173.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.46 ' O ' HD13 ' A' ' 56' ' ' ILE . 42.8 mt -61.29 -36.2 79.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.656 -0.247 . . . . 0.34000000000000002 110.878 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.636 ' HD1' HD11 ' A' ' 19' ' ' LEU . 9.3 t80 -65.07 -35.55 81.5 Favored 'General case' 0 C--O 1.226 -0.154 0 N-CA-C 109.387 -0.597 . . . . 0.23999999999999999 109.387 174.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.532 ' CD1' ' HA ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -63.67 -54.17 39.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 0.40000000000000002 109.149 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.3 t -62.11 -36.37 81.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.114 -0.948 . . . . 1.22 110.914 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.748 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.24 -36.43 82.74 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.088 -1.053 . . . . 0.17000000000000001 111.192 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 74' ' ' VAL . 85.3 mt -63.71 -46.36 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.441 -0.38 . . . . 0.17999999999999999 111.163 174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.7 p -63.57 -38.23 90.35 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.556 -0.458 . . . . 1.1000000000000001 109.894 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.7 mm100 -64.31 -31.02 72.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.664 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.57 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 90.4 t80 -72.28 -52.15 17.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.165 -0.471 . . . . 0.20000000000000001 110.529 176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.6 m -64.66 -22.98 32.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.043 0.449 . . . . 0.28000000000000003 110.101 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.622 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 29.9 tttm -55.5 -48.08 75.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.025 -0.989 . . . . 1.8500000000000001 111.037 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.8 mm-40 -59.77 -35.51 74.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.293 0.568 . . . . 1.3100000000000001 110.097 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.76 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -65.94 -30.21 70.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.681 -0.691 . . . . 0.23999999999999999 111.278 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.709 ' HD2' ' CE1' ' A' ' 158' ' ' PHE . 13.2 mttm -78.77 -21.25 48.15 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.64 -0.504 . . . . 1.8799999999999999 109.64 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.96 -44.27 20.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.272 -176.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -91.36 -12.55 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.33000000000000002 109.966 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 73.73 52.34 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.052 -1.431 . . . . 1.47 111.425 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.1 -143.98 11.37 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.641 -0.709 . . . . 0.26000000000000001 113.059 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -122.31 156.45 33.85 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.026 -0.731 . . . . 1.0600000000000001 109.026 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 HD13 ' N ' ' A' ' 85' ' ' THR . 2.5 tm? -113.64 136.79 52.44 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.907 -0.317 . . . . 0.17000000000000001 110.238 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.427 ' N ' HD13 ' A' ' 84' ' ' LEU . 90.6 m -127.64 128.54 45.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.998 0.427 . . . . 0.20999999999999999 110.771 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 33' ' ' MET . 16.2 tp -95.1 104.6 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.133 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' H ' ' HA ' ' A' ' 33' ' ' MET . 58.8 mt -73.87 150.45 40.92 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.804 0.335 . . . . 0.26000000000000001 110.277 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 8.8 tt0 -122.57 135.54 54.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.055 -0.72 . . . . 1.9299999999999999 109.055 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.3 t60 164.01 -61.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.935 0.772 . . . . 1.79 109.88 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.636 ' CE1' ' HB2' ' A' ' 94' ' ' PHE . 52.5 t80 -71.59 -19.69 62.1 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.857 -0.61 . . . . 3.9500000000000002 111.754 -174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.82 -19.46 65.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 2.2200000000000002 111.031 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -86.73 -3.91 59.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 1.78 110.95 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -115.59 -34.66 4.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.027 0.441 . . . . 1.6299999999999999 110.513 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.636 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 1.3 t80 -95.58 141.24 22.92 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.702 -0.481 . . . . 2.8500000000000001 109.702 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.01 -1.13 10.05 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.338 2.025 . . . . 0.68999999999999995 113.237 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.492 HG12 ' HD2' ' A' ' 63' ' ' LYS . 5.8 mt -99.57 113.24 34.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.267 0.556 . . . . 0.35999999999999999 111.006 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 130' ' ' LYS . 83.3 mttt -121.94 130.92 53.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.427 -0.953 . . . . 1.3799999999999999 108.427 176.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.6 m -143.14 168.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.678 0.622 . . . . 0.33000000000000002 112.678 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -129.24 132.37 47.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.071 -0.968 . . . . 1.1100000000000001 109.765 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.1 mp -97.38 132.32 43.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.861 -0.609 . . . . 0.34999999999999998 110.925 -174.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.439 ' O ' ' HZ ' ' A' ' 145' ' ' PHE . 4.3 m-85 -124.84 137.4 54.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.33000000000000002 110.769 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.85 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.9 m-30 -109.05 137.96 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.717 . . . . 0.34000000000000002 111.135 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.627 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -94.1 112.9 24.77 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.617 -1.253 . . . . 0.25 107.617 171.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.653 ' CD ' HG22 ' A' ' 122' ' ' ILE . 1.3 mtmp? -124.89 91.72 3.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.926 0.393 . . . . 1.22 110.664 -177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.63 -100.31 2.16 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.69 -0.964 . . . . 0.41999999999999998 110.69 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -126.7 -7.6 6.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.324 0.583 . . . . 1.3100000000000001 109.894 170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -93.65 115.03 27.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.616 -0.72 . . . . 2.27 110.602 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.499 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 5.8 p -75.09 131.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.806 -0.634 . . . . 0.79000000000000004 110.233 172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.3 mmm -130.3 122.27 19.94 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.432 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.23 154.1 46.27 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.576 2.184 . . . . 0.28999999999999998 112.303 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.33 144.51 28.8 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.295 -0.632 . . . . 0.31 109.295 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 14.0 m120 -100.38 138.18 37.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.758 -0.46 . . . . 1.8500000000000001 109.758 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.9 m -61.79 125.17 22.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.505 . . . . 0.46999999999999997 111.313 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 29.9 73.09 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 115.892 -0.595 . . . . 0.38 113.035 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 15.5 tp10 -126.41 118.71 23.17 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.86 112.56 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.286 1.99 . . . . 0.68000000000000005 111.135 174.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.496 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.8 t80 -113.41 137.76 51.06 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 109.537 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 7.4 p -59.51 119.63 4.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.779 -0.646 . . . . 0.70999999999999996 111.443 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.76 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.6 p -119.26 -12.71 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 0.23000000000000001 111.016 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -58.41 -43.04 88.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.722 0.638 . . . . 1.3500000000000001 112.722 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -110.66 15.39 22.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 111.966 0.358 . . . . 2.3500000000000001 111.966 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.653 HG22 ' CD ' ' A' ' 104' ' ' LYS . 6.4 pt -72.96 158.64 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 0.37 109.767 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.627 ' HB2' HD12 ' A' ' 103' ' ' LEU . 3.0 m-20 -88.88 -40.48 13.08 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.638 -0.71 . . . . 0.5 110.928 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 122' ' ' ILE . . . -157.51 161.43 38.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.076 -0.511 . . . . 0.22 110.781 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.85 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 12.6 ttt -136.56 153.04 51.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.79 -0.448 . . . . 1.1599999999999999 109.79 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.9 p -137.52 164.94 27.51 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.051 -0.352 . . . . 1.22 110.051 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.5 t -122.66 107.31 19.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.327 -0.619 . . . . 0.27000000000000002 109.327 174.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.603 ' HG ' ' HG2' ' A' ' 152' ' ' GLU . 0.3 OUTLIER -105.56 136.12 19.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.626 -0.509 . . . . 0.42999999999999999 109.626 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 81.1 Cg_endo -84.72 120.13 2.33 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.256 1.971 . . . . 0.91000000000000003 112.234 176.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.2 mmpt? 48.73 -73.21 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.849 1.26 . . . . 3.29 114.129 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -67.18 73.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.83 -0.508 . . . . 0.44 111.83 173.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 38.3 p -75.24 -4.49 39.29 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 123.213 0.605 . . . . 1.23 111.12 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.6 m -55.72 -19.87 12.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 1.3 112.427 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.3 m -49.6 -45.1 47.62 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.102 0.477 . . . . 0.44 110.719 174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 148' ' ' ARG . 73.1 mt -116.23 22.37 12.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.37 111.536 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.8 ttmt -102.25 81.57 2.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.25 -0.432 . . . . 1.6599999999999999 110.413 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.82 158.24 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.49 -0.323 . . . . 0.51000000000000001 110.153 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 31.0 ttpt -39.24 -55.21 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.479 0.712 . . . . 2.0600000000000001 111.895 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.36 146.83 44.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.615 -0.513 . . . . 0.39000000000000001 109.615 178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.499 ' CB ' ' HB ' ' A' ' 108' ' ' VAL . 9.5 tpt -124.12 127.55 47.96 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.125 -0.488 . . . . 0.78000000000000003 110.966 -165.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -74.91 126.82 31.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.262 -0.644 . . . . 0.44 109.262 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 85.4 tttt -63.07 -25.61 68.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.997 0.427 . . . . 1.1100000000000001 110.604 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -73.02 -48.55 35.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.499 -0.773 . . . . 0.66000000000000003 109.689 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.508 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 17.4 ttt -71.68 -32.42 67.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.917 -1.038 . . . . 0.47999999999999998 110.343 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.526 ' CD2' HD13 ' A' ' 135' ' ' LEU . 61.6 t80 -53.81 -58.64 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 110.719 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.66 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.7 OUTLIER -65.15 -42.62 94.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.19 111.249 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 39.2 t -62.25 -43.62 98.4 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.742 0.306 . . . . 0.84999999999999998 111.095 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.9 mmp_? -63.35 -48.36 78.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.968 0.413 . . . . 2.48 110.881 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.12 95.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.609 -0.805 . . . . 0.17000000000000001 111.64 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -59.51 -43.23 93.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 122.286 0.234 . . . . 1.4199999999999999 111.416 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 148' ' ' ARG . 8.2 t -76.26 -23.74 54.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.593 -0.443 . . . . 0.40000000000000002 109.989 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.603 ' HG2' ' HG ' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.21 -12.48 60.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.574 0.702 . . . . 1.3100000000000001 109.538 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.1 -14.05 37.16 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 114.763 -1.108 . . . . 0.25 114.257 171.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.72 125.04 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 118.63 1.215 . . . . 0.19 112.946 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 22.7 p -145.46 159.23 43.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.976 -0.556 . . . . 1.4199999999999999 110.742 166.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.622 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.2 tt -155.83 115.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.632 -0.713 . . . . 0.28000000000000003 109.148 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.66 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 64.4 m -123.29 137.88 54.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.03 0.443 . . . . 1.4399999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.709 ' CE1' ' HD2' ' A' ' 78' ' ' LYS . 78.6 m-85 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.487 -0.768 . . . . 1.8100000000000001 110.082 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.017 0.436 . . . . 3.6800000000000002 110.346 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.52 -31.2 15.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.683 -0.689 . . . . 2.3799999999999999 110.092 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -78.97 125.9 29.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 110.396 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.71 -153.72 24.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.607 -1.397 . . . . 0.26000000000000001 109.607 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -123.72 143.62 50.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 118.175 0.987 . . . . 0.17999999999999999 111.089 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.784 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 25.4 m-85 -119.25 132.75 55.96 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.529 0.204 . . . . 0.56999999999999995 111.114 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -87.67 122.18 31.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.144 -1.058 . . . . 0.16 108.144 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -123.08 149.04 26.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 120.68 0.276 . . . . 0.19 110.645 -176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.631 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 63.6 t80 -100.81 132.26 46.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.089 -0.505 . . . . 0.90000000000000002 109.796 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.74 146.46 46.45 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.828 -0.805 . . . . 0.60999999999999999 108.828 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -85.07 6.28 26.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 2.3700000000000001 111.39 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.01 132.9 54.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.45 -0.574 . . . . 1.3100000000000001 109.45 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 t 60.74 22.27 12.23 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.246 0.546 . . . . 1.23 110.155 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 57.64 32.54 22.01 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.087 -0.96 . . . . 1.3 111.01 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.631 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 149.97 102.74 0.26 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.703 -0.761 . . . . 0.39000000000000001 112.459 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 95.1 m -138.17 148.17 44.59 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 110.136 -0.32 . . . . 0.40000000000000002 110.136 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.75 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.1 mt -104.39 148.0 26.91 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.336 0.589 . . . . 0.57999999999999996 110.432 175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -140.99 129.35 22.4 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.857 -1.065 . . . . 0.19 109.491 -173.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.49 HD13 ' HG3' ' A' ' 76' ' ' GLU . 7.1 tt -108.46 114.22 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.665 0.745 . . . . 0.28000000000000003 110.086 174.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.784 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -96.53 120.9 46.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.27 -0.877 . . . . 0.23999999999999999 110.87 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.515 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 89.1 m95 -96.26 110.97 23.19 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.011 -0.737 . . . . 0.31 109.011 173.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HD2' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -152.55 168.05 26.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 1.3600000000000001 110.552 -174.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -106.92 13.52 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.618 . . . . 1.9399999999999999 109.804 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.9 pt-20 -123.71 174.67 7.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.38 -0.827 . . . . 1.45 109.99 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -92.07 127.36 37.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.179 0.514 . . . . 2.3500000000000001 110.811 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.875 HG23 ' HD2' ' A' ' 24' ' ' LYS . 69.5 t -106.61 118.21 53.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.761 -0.654 . . . . 1.1599999999999999 109.701 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -87.53 165.64 15.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.389 -0.369 . . . . 1.98 110.673 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.24 23.43 7.82 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.617 0.722 . . . . 2.0600000000000001 109.695 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.69 147.98 22.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.597 -0.728 . . . . 0.20999999999999999 109.93 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.11 -25.98 14.74 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.443 -0.799 . . . . 0.38 109.786 -173.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.618 ' HG2' HD12 ' A' ' 86' ' ' LEU . 81.5 mtp -151.48 169.6 21.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.457 . . . . 0.20000000000000001 110.472 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 90.1 t80 -150.07 151.51 33.34 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.753 0.311 . . . . 0.23000000000000001 110.538 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.688 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.1 mt -121.17 137.19 55.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.554 -0.536 . . . . 0.16 109.554 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 34' ' ' PHE . 15.7 mmmt -115.13 109.48 46.72 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 111.105 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 41' ' ' VAL . 5.3 Cg_exo -85.17 124.69 2.91 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.435 1.423 . . . . 0.34999999999999998 111.236 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -88.05 -36.35 17.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.752 0.787 . . . . 0.85999999999999999 109.909 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -88.03 173.28 8.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.727 -1.124 . . . . 2.1600000000000001 109.612 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -56.73 125.32 21.79 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.643 0.735 . . . . 2.4199999999999999 109.518 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' HB ' ' CB ' ' A' ' 37' ' ' PRO . 2.5 p -97.7 131.48 26.85 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.635 -1.166 . . . . 0.72999999999999998 110.447 -172.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 55.2 Cg_exo -40.49 120.58 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 124.492 3.461 . . . . 0.68000000000000005 113.595 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HA ' ' HD1' ' A' ' 46' ' ' PHE . 1.5 tm-20 -74.15 -32.55 63.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.603 -0.726 . . . . 2.2799999999999998 111.146 -174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' HG12 ' A' ' 47' ' ' VAL . 74.4 m-85 -66.07 -24.43 66.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 3.3399999999999999 110.974 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 42' ' ' PRO . 13.3 mptt -63.99 -28.2 69.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.05 0.452 . . . . 1.9399999999999999 110.576 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 43' ' ' GLU . 92.0 m-85 -86.09 -49.49 7.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.93000000000000005 110.605 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.6 p -82.42 -50.65 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.618 0.599 . . . . 1.0700000000000001 112.618 -173.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 44' ' ' PHE . 9.9 t30 -72.9 -33.12 65.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.786 0.327 . . . . 1.6599999999999999 111.43 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -88.54 -4.46 58.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.507 -0.315 . . . . 2.0 110.505 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 64.17 14.69 8.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.015 0.912 . . . . 2.2599999999999998 109.649 -175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.38 -13.49 60.04 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.011 -0.995 . . . . 0.46000000000000002 112.295 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 20.2 ptmt -106.92 128.11 54.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.943 0.402 . . . . 2.4300000000000002 111.464 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB3' HG23 ' A' ' 21' ' ' ILE . 3.3 t-20 -148.72 120.18 7.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.401 -0.363 . . . . 2.0499999999999998 110.47 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -85.38 136.78 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.399 0.619 . . . . 1.47 110.478 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 mt -97.0 -63.47 1.13 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 0.54000000000000004 111.764 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.632 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -144.78 151.23 15.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.599 -0.519 . . . . 0.25 109.599 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.4 ppt_? -135.83 171.57 14.27 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.599 -0.44 . . . . 2.23 112.022 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.498 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 61.3 t30 65.83 42.81 3.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.205 -0.907 . . . . 1.3999999999999999 110.906 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.632 HD21 HG23 ' A' ' 56' ' ' ILE . 50.4 mt -69.82 -18.65 63.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.672 -0.694 . . . . 0.33000000000000002 111.887 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -59.75 -43.25 94.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.758 0.313 . . . . 1.76 111.59 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 81.1 p -69.17 -15.89 63.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 1.5900000000000001 111.586 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 30.9 t70 -164.3 127.14 2.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.378 0.609 . . . . 1.9199999999999999 111.543 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.1 mmmm -62.65 -40.05 95.82 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.874 -1.057 . . . . 1.6799999999999999 111.925 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 43.1 mmtm -65.28 -24.64 67.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.621 -0.718 . . . . 1.0700000000000001 111.864 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 64.4 mt -55.95 -39.99 72.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.246 -0.433 . . . . 0.34000000000000002 111.283 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' HD1' HD11 ' A' ' 19' ' ' LEU . 8.5 t80 -63.25 -36.48 83.79 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.646 -0.502 . . . . 0.23999999999999999 109.646 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.501 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.44 -54.17 44.12 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.177 -0.675 . . . . 0.40000000000000002 109.177 -179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 24.0 t -60.03 -38.67 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.129 -0.941 . . . . 1.22 110.913 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.75 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -57.9 -36.87 82.38 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.051 -1.071 . . . . 0.17000000000000001 111.485 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.57 HG23 ' SD ' ' A' ' 33' ' ' MET . 83.3 mt -62.13 -45.57 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 115.589 -0.305 . . . . 0.17999999999999999 111.215 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -63.73 -37.0 85.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.133 0.492 . . . . 1.1000000000000001 109.734 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 15.3 mm100 -63.08 -30.55 71.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.451 -0.795 . . . . 1.8200000000000001 110.395 175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.606 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 70.2 t80 -73.07 -47.99 39.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.688 -0.687 . . . . 0.20000000000000001 110.587 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.811 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -66.5 -25.01 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.059 0.457 . . . . 0.28000000000000003 109.791 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 20.7 ttmm -56.93 -34.78 68.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.65 -0.704 . . . . 1.8500000000000001 110.888 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.49 ' HG3' HD13 ' A' ' 21' ' ' ILE . 8.6 mm-40 -69.28 -37.89 78.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.333 0.587 . . . . 1.3100000000000001 109.815 176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -66.17 -37.63 86.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 0.23999999999999999 111.789 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' HG22 ' A' ' 119' ' ' VAL . 3.0 mtmm -71.24 -21.86 62.06 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.827 -0.349 . . . . 1.8799999999999999 110.455 177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.81 -47.14 26.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 1.77 110.836 -176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.82 -7.41 10.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.866 0.841 . . . . 0.33000000000000002 109.918 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.75 54.49 0.64 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.525 -1.67 . . . . 1.47 110.899 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -107.82 -147.19 13.08 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.149 -0.932 . . . . 0.26000000000000001 113.185 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 1.3 mptt -122.69 158.95 28.96 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.278 -1.008 . . . . 1.0600000000000001 108.278 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.6 tm? -114.62 130.69 56.82 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.516 -0.474 . . . . 0.17000000000000001 110.388 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 87.1 m -116.7 125.05 51.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.114 -0.494 . . . . 0.20999999999999999 110.38 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.5 tp -96.54 106.28 18.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.415 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' H ' ' HA ' ' A' ' 33' ' ' MET . 75.3 mt -74.84 152.19 38.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.909 0.385 . . . . 0.26000000000000001 110.596 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 49.2 tt0 -121.01 135.14 55.28 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.842 -0.799 . . . . 1.9299999999999999 108.842 172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.1 t-160 166.93 -63.96 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.938 0.774 . . . . 1.79 109.038 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.636 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 66.1 t80 -69.14 -36.31 77.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.899 -0.592 . . . . 3.9500000000000002 110.466 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -67.27 -17.28 64.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.007 -0.542 . . . . 2.2200000000000002 110.548 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.6 m -80.07 -16.63 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.022 -0.536 . . . . 1.78 110.483 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.5 t -112.68 -31.53 6.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 1.6299999999999999 110.514 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.512 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.0 t80 -95.23 141.88 23.83 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 109.308 -0.627 . . . . 2.8500000000000001 109.308 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 48.7 Cg_endo -68.86 -4.9 14.3 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.591 2.194 . . . . 0.68999999999999995 114.539 -173.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.531 HG12 ' HD2' ' A' ' 63' ' ' LYS . 7.9 mt -92.16 108.08 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 119.756 -0.777 . . . . 0.35999999999999999 110.213 176.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -124.69 118.71 27.08 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.996 -1.002 . . . . 1.3799999999999999 108.519 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 128' ' ' LEU . 24.3 m -138.97 168.2 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.43 0.53 . . . . 0.33000000000000002 112.43 -168.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -126.74 131.7 51.27 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.318 -0.855 . . . . 1.1100000000000001 110.547 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.567 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.7 mp -88.76 138.07 31.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.62 -0.718 . . . . 0.34999999999999998 110.212 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.7 m-85 -126.37 137.54 53.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.873 0.368 . . . . 0.33000000000000002 111.035 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.846 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.0 m-30 -109.44 154.66 22.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.652 -0.703 . . . . 0.34000000000000002 110.461 176.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.637 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -114.94 119.74 37.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.431 -0.952 . . . . 0.25 108.431 177.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.08 101.34 7.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.633 -0.136 . . . . 1.22 110.633 177.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.38 -97.83 0.55 Allowed Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.541 -1.024 . . . . 0.41999999999999998 110.541 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 m -121.32 -3.26 9.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.168 0.509 . . . . 1.3100000000000001 109.918 171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -90.59 120.71 31.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.843 -0.617 . . . . 2.27 111.272 -174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 32.0 t -87.04 131.09 35.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.79000000000000004 110.122 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 12.2 mmt -134.4 116.07 12.9 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.05 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -72.21 157.05 54.57 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.546 2.164 . . . . 0.28999999999999998 112.286 176.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.5 141.03 31.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.764 -0.653 . . . . 0.31 109.66 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -96.03 133.0 40.79 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.743 -0.466 . . . . 1.8500000000000001 109.743 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.3 m -56.61 119.27 5.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.46999999999999997 111.947 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.86 86.46 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.825 -0.625 . . . . 0.38 113.512 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -106.71 124.43 35.57 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.743 -0.466 . . . . 1.9299999999999999 109.743 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.44 112.05 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.077 1.852 . . . . 0.68000000000000005 110.169 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.521 ' HD1' HD22 ' A' ' 111' ' ' LEU . 4.9 t80 -117.09 137.69 52.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.494 -0.776 . . . . 0.40999999999999998 109.958 -173.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 120' ' ' GLN . 4.4 p -56.34 117.86 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.592 -0.731 . . . . 0.70999999999999996 112.333 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.3 p -118.81 -15.86 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.522 -0.763 . . . . 0.23000000000000001 110.706 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.5 pt20 -57.38 -44.22 84.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.984 0.735 . . . . 1.3500000000000001 112.984 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -118.68 42.31 2.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.098 0.475 . . . . 2.3500000000000001 111.698 -172.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.5 pt -88.33 167.53 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.102 0.477 . . . . 0.37 110.402 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.558 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -87.89 -46.44 9.4 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.306 -0.628 . . . . 0.5 109.306 173.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.32 160.65 39.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.237 -0.892 . . . . 0.22 110.863 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.846 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.7 ttt -129.53 154.48 46.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.317 -0.624 . . . . 1.1599999999999999 109.317 171.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.46 ' N ' ' HG3' ' A' ' 125' ' ' MET . 72.5 p -142.68 160.02 41.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.332 -0.618 . . . . 1.22 109.332 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.4 t -118.78 106.92 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 109.072 -0.714 . . . . 0.27000000000000002 109.072 174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 0.9 OUTLIER -104.44 149.98 37.97 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.333 -0.849 . . . . 0.42999999999999999 109.114 -179.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 98' ' ' VAL . 61.1 Cg_endo -74.47 167.19 27.71 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.362 2.041 . . . . 0.91000000000000003 110.93 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -30.65 -43.8 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.96 0.788 . . . . 3.29 112.97 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.65 62.17 1.2 Allowed Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 0.44 111.497 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 69.2 p -77.21 -3.16 38.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.475 0.71 . . . . 1.23 112.311 -171.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 2.9 p -56.74 -6.31 0.31 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.74 0.644 . . . . 1.3 112.74 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.0 m -55.19 -48.77 73.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.834 0.35 . . . . 0.44 111.019 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 148' ' ' ARG . 95.0 mt -118.1 5.77 12.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.315 -0.402 . . . . 0.37 111.56 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.0 ttpt -80.53 78.39 7.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.969 0.414 . . . . 1.6599999999999999 110.767 -176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.743 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.7 p -138.87 161.97 29.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.056 -0.52 . . . . 0.51000000000000001 109.864 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' N ' HG22 ' A' ' 137' ' ' VAL . 14.9 mttt -52.67 -49.63 64.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.119 0.485 . . . . 2.0600000000000001 111.254 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.15 151.11 40.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.76 -0.654 . . . . 0.39000000000000001 110.662 -176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.743 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 3.4 mtp -151.8 163.67 38.67 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.015 0.746 . . . . 0.78000000000000003 113.015 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.66 133.7 34.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.623 -1.171 . . . . 0.44 110.121 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 146' ' ' VAL . 81.2 tttt -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.898 -0.592 . . . . 1.1100000000000001 110.973 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.21 -41.37 70.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.662 -0.699 . . . . 0.66000000000000003 109.944 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.8 ttt -69.43 -41.62 76.08 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.951 -1.022 . . . . 0.47999999999999998 110.564 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.637 ' CD2' HD23 ' A' ' 103' ' ' LEU . 27.7 t80 -51.37 -51.75 51.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.787 -0.642 . . . . 0.29999999999999999 111.05 -175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.659 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 0.9 OUTLIER -67.58 -46.46 82.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.616 . . . . 0.19 111.745 179.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 t -64.18 -33.03 74.86 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 122.092 -0.38 . . . . 0.84999999999999998 110.798 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.691 ' HB2' HD21 ' A' ' 135' ' ' LEU . 5.2 mmp_? -69.78 -55.97 8.42 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.463 -0.335 . . . . 2.48 110.952 174.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -56.62 -34.47 64.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.852 -0.69 . . . . 0.17000000000000001 111.703 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.94 -40.28 84.18 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.74 0.274 . . . . 1.4199999999999999 111.74 177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.1 t -80.1 -21.79 42.9 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.979 0.419 . . . . 0.40000000000000002 110.042 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -11.62 60.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.774 0.797 . . . . 1.3100000000000001 109.402 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.76 -14.43 38.16 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.419 -1.264 . . . . 0.25 114.169 171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.88 125.58 14.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 1.022 . . . . 0.19 113.234 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.476 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 12.8 p -144.44 158.01 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 111.138 166.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.4 tt -155.94 117.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.802 -0.635 . . . . 0.28000000000000003 109.712 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.659 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 69.0 m -122.31 145.56 48.13 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.807 -0.558 . . . . 1.4399999999999999 112.069 -174.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 4.6 m-85 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.745 -0.645 . . . . 1.8100000000000001 110.266 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 121.039 0.447 . . . . 3.6800000000000002 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 1.2 mp0 -67.94 -45.24 74.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.517 -0.765 . . . . 2.3799999999999999 111.076 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -66.64 136.78 56.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.227 0.537 . . . . 1.6100000000000001 111.153 -175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.32 -167.4 30.19 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.566 -1.014 . . . . 0.26000000000000001 110.566 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.683 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.04 148.11 39.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.431 0.616 . . . . 0.17999999999999999 110.71 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.653 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.4 m-85 -127.45 130.48 49.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.452 -0.34 . . . . 0.56999999999999995 110.563 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.7 tm? -86.47 119.46 26.76 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.546 -0.909 . . . . 0.16 108.546 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.57 149.78 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.477 -0.329 . . . . 0.19 110.404 -175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 66.2 t80 -101.31 132.04 47.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 0.90000000000000002 110.039 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.38 152.44 39.01 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.404 -0.591 . . . . 0.60999999999999999 109.404 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -87.81 5.5 39.88 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.777 0.288 . . . . 2.3700000000000001 111.777 -174.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.43 129.38 41.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.899 -0.408 . . . . 1.3100000000000001 109.899 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t 58.97 27.44 16.31 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 1.23 110.044 -176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.4 m120 59.55 22.47 11.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.105 -0.952 . . . . 1.3 111.956 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 159.31 104.47 0.2 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.453 -0.879 . . . . 0.39000000000000001 112.52 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 98.4 m -136.58 150.49 48.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 110.23 -0.285 . . . . 0.40000000000000002 110.23 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.607 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.6 mt -103.59 149.67 24.68 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.102 0.477 . . . . 0.57999999999999996 110.198 174.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.28 128.66 21.17 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.329 -0.85 . . . . 0.19 109.867 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 tt -109.26 116.15 51.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.652 0.739 . . . . 0.28000000000000003 109.883 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.653 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 11.0 p -92.32 126.54 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.216 -0.902 . . . . 0.23999999999999999 110.741 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 47.7 m95 -103.47 106.96 17.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.56 . . . . 0.31 109.586 173.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CE ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -148.74 174.61 12.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 1.3600000000000001 110.374 -172.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -115.37 7.5 15.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.252 -0.886 . . . . 1.9399999999999999 109.049 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -119.81 174.4 6.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.817 -1.083 . . . . 1.45 109.596 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -85.52 134.65 34.02 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.262 0.553 . . . . 2.3500000000000001 110.643 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.6 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.9 t -117.55 122.42 69.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 109.254 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.74 178.81 5.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.576 -0.284 . . . . 1.98 110.731 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 63.55 24.98 14.23 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.733 -0.667 . . . . 2.0600000000000001 110.606 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.01 155.49 17.4 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.497 -0.774 . . . . 0.20999999999999999 111.261 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HB2' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -98.41 -30.22 12.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.812 -1.085 . . . . 0.38 109.909 -176.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.645 ' SD ' HG23 ' A' ' 70' ' ' ILE . 84.6 mtp -146.31 170.25 17.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.246 -0.434 . . . . 0.20000000000000001 111.131 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -147.75 152.43 37.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 110.981 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.683 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.76 131.06 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.528 . . . . 0.16 109.755 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -110.2 111.21 58.11 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 110.186 -0.301 . . . . 2.3799999999999999 110.186 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -75.65 135.62 18.13 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 121.916 1.744 . . . . 0.34999999999999998 112.005 175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 75.5 p -88.78 -42.69 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.582 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -95.24 174.23 7.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.832 -1.077 . . . . 2.1600000000000001 109.755 175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -54.77 137.13 45.35 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.53 . . . . 2.4199999999999999 110.048 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.46 132.12 56.4 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.503 -0.772 . . . . 0.72999999999999998 109.549 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 91.8 Cg_exo -44.83 119.28 2.27 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.565 2.843 . . . . 0.68000000000000005 112.722 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.54 -38.81 84.74 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.022 -0.99 . . . . 2.2799999999999998 112.195 -171.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.536 ' HA ' HG12 ' A' ' 47' ' ' VAL . 40.0 m-85 -77.56 -24.51 49.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.282 -0.417 . . . . 3.3399999999999999 111.05 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.8 mptt -65.21 -29.16 69.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.93 0.395 . . . . 1.9399999999999999 110.497 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 60.7 m-85 -69.5 -56.01 8.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.451 . . . . 0.93000000000000005 110.632 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.8 p -70.06 -37.72 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 1.0700000000000001 111.907 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.91 -38.91 69.85 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.928 -0.309 . . . . 1.6599999999999999 111.323 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -88.49 -11.48 45.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.495 -0.32 . . . . 2.0 111.123 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 67.55 16.06 9.86 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.582 0.706 . . . . 2.2599999999999998 110.051 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.25 -15.03 47.17 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.888 -1.051 . . . . 0.46000000000000002 112.641 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -107.36 129.44 54.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.522 0.201 . . . . 2.4300000000000002 111.014 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.0 119.95 9.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.872 0.368 . . . . 2.0499999999999998 110.964 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -86.8 121.76 29.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.374 0.607 . . . . 1.47 109.938 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -81.2 -53.31 6.48 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.977 -1.01 . . . . 0.54000000000000004 111.969 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 59' ' ' LEU . 20.1 tt -154.57 148.47 13.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.971 -0.381 . . . . 0.25 109.971 -175.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.3 ppt_? -131.81 172.21 12.58 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.995 -0.282 . . . . 2.23 111.555 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.411 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 64.3 t30 70.71 42.42 0.82 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.827 0.851 . . . . 1.3999999999999999 110.748 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 56' ' ' ILE . 43.6 mt -75.1 -19.61 59.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.858 -0.61 . . . . 0.33000000000000002 111.464 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -58.04 -47.39 83.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.124 -0.489 . . . . 1.76 112.27 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 p -84.42 -6.92 59.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.837 0.351 . . . . 1.5900000000000001 111.532 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 64' ' ' LYS . 21.2 t70 -158.11 108.11 2.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.024 0.44 . . . . 1.9199999999999999 110.414 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 1.6 ptpp? -64.09 -31.63 72.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.745 -0.661 . . . . 1.6799999999999999 111.363 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 34.6 mmtp -60.57 -22.78 64.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.555 -0.748 . . . . 1.0700000000000001 111.706 -176.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 55.4 mt -64.05 -34.68 78.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.614 -0.266 . . . . 0.34000000000000002 111.138 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.585 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.6 t80 -62.86 -35.02 78.62 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 109.555 -0.535 . . . . 0.23999999999999999 109.555 175.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -61.44 -54.91 37.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.299 -0.63 . . . . 0.40000000000000002 109.299 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -63.76 -34.71 78.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.349 -0.841 . . . . 1.22 111.042 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.607 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -61.06 -35.76 91.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.871 -0.68 . . . . 0.17000000000000001 111.582 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' SD ' ' A' ' 33' ' ' MET . 82.1 mt -59.42 -48.63 86.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.907 0.384 . . . . 0.17999999999999999 110.334 172.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 93.2 m -56.47 -38.38 71.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.044 -0.526 . . . . 1.1000000000000001 110.598 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 68' ' ' SER . 77.4 mm-40 -69.64 -28.61 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.044 -0.525 . . . . 1.8200000000000001 110.579 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.604 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.2 t80 -72.76 -49.12 32.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.72 -0.673 . . . . 0.20000000000000001 110.58 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.5 m -67.7 -23.62 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.199 0.524 . . . . 0.28000000000000003 110.0 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 25.6 tttm -57.86 -39.97 79.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.377 -0.829 . . . . 1.8500000000000001 110.494 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 80' ' ' ILE . 15.1 mm-40 -64.83 -33.28 75.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.2 0.524 . . . . 1.3100000000000001 109.6 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -72.48 -37.25 68.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 111.137 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.719 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -72.76 -20.66 61.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.521 0.677 . . . . 1.8799999999999999 109.208 176.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.3 -50.32 19.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.586 -1.188 . . . . 1.77 111.811 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -87.86 -11.46 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.596 0.713 . . . . 0.33000000000000002 110.461 -176.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 73.9 56.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 113.726 -1.579 . . . . 1.47 111.451 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -115.08 -142.58 7.82 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.323 -0.942 . . . . 0.26000000000000001 113.383 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -121.83 156.44 33.23 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.352 0.661 . . . . 1.0600000000000001 109.329 -179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.1 tm? -113.06 131.48 55.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 110.124 -0.325 . . . . 0.17000000000000001 110.124 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 80.1 m -119.64 120.03 35.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.148 -0.478 . . . . 0.20999999999999999 110.746 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.448 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -89.26 109.38 20.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 175.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 54.3 mt -79.87 150.51 30.6 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.315 -0.624 . . . . 0.26000000000000001 109.315 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 27.2 tt0 -120.98 135.72 55.14 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.706 -0.85 . . . . 1.9299999999999999 108.706 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 20.9 t60 164.43 -70.16 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.962 0.789 . . . . 1.79 109.094 -171.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' HB3' ' HG ' ' A' ' 32' ' ' LEU . 74.7 t80 -65.27 -32.52 74.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.629 -0.714 . . . . 3.9500000000000002 111.159 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -65.13 -27.5 68.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.621 . . . . 2.2200000000000002 111.442 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -89.5 -18.81 25.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 1.78 110.619 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t -92.35 -34.71 14.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.964 0.411 . . . . 1.6299999999999999 110.295 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.2 t80 -95.59 150.04 36.92 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.915 -0.772 . . . . 2.8500000000000001 108.915 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 56.9 Cg_endo -70.38 21.44 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.794 2.329 . . . . 0.68999999999999995 114.286 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 63' ' ' LYS . 71.5 mt -114.64 111.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.018 0.437 . . . . 0.35999999999999999 110.531 174.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 52.4 mtmt -121.46 119.13 31.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.661 -0.699 . . . . 1.3799999999999999 109.216 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 35.8 m -139.75 169.9 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.474 0.546 . . . . 0.33000000000000002 112.474 -171.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -134.6 131.85 38.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.346 -0.843 . . . . 1.1100000000000001 109.829 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -93.19 139.92 30.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.003 -0.544 . . . . 0.34999999999999998 110.916 -177.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -130.63 145.41 51.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.631 -0.258 . . . . 0.33000000000000002 110.418 177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 19.2 m-85 -114.17 146.52 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.144 0.497 . . . . 0.34000000000000002 110.26 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.8 OUTLIER -103.11 122.3 44.4 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.838 -1.171 . . . . 0.25 107.838 172.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -124.97 101.67 7.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 118.269 0.486 . . . . 1.22 110.771 175.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.01 -98.65 0.57 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.439 -0.664 . . . . 0.41999999999999998 111.439 -176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.2 p -118.45 -10.13 10.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.067 0.46 . . . . 1.3100000000000001 110.356 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.37 114.83 26.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.307 -0.406 . . . . 2.27 110.786 -174.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.6 p -91.71 137.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.256 -0.429 . . . . 0.79000000000000004 110.308 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 59.4 mtt -139.17 132.16 15.66 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 1.8500000000000001 110.954 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 84.9 Cg_endo -76.35 161.17 35.08 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.808 2.339 . . . . 0.28999999999999998 112.354 176.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -83.48 143.83 29.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.95 -0.568 . . . . 0.31 109.636 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 91.6 m-20 -96.39 135.98 37.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.0 m -60.52 122.01 13.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.201 -0.454 . . . . 0.46999999999999997 111.597 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.6 37.48 92.3 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.789 -0.641 . . . . 0.38 112.261 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 10.9 tp10 -131.03 127.61 22.07 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.411 -0.589 . . . . 1.9299999999999999 109.411 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.04 112.52 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.014 1.81 . . . . 0.68000000000000005 110.803 173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -116.71 143.16 45.98 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.607 -0.724 . . . . 0.40999999999999998 109.781 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.431 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.9 p -59.56 113.5 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.491 0.662 . . . . 0.70999999999999996 112.378 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.5 p -115.87 -18.17 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 110.294 177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.53 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 13.3 pt20 -63.47 -32.76 74.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.381 -0.827 . . . . 1.3500000000000001 112.497 -174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -120.79 37.96 4.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.363 0.602 . . . . 2.3500000000000001 110.739 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 104' ' ' LYS . 39.2 pt -90.28 169.0 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.242 0.544 . . . . 0.37 110.71 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.8 OUTLIER -101.69 -40.31 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.5 109.76 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.76 37.76 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.255 -0.884 . . . . 0.22 110.149 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.494 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -138.0 149.68 46.3 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.602 -0.518 . . . . 1.1599999999999999 109.602 177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.414 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 54.3 m -154.66 161.34 41.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 1.22 111.15 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG23 ' SG ' ' A' ' 71' ' ' CYS . 6.8 t -124.33 110.09 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.708 -0.678 . . . . 0.27000000000000002 110.181 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.95 138.16 19.57 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 108.815 -0.809 . . . . 0.42999999999999999 108.815 176.082 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 72.7 Cg_endo -81.4 120.36 3.6 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.609 1.54 . . . . 0.91000000000000003 112.48 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.609 ' HE3' ' C ' ' A' ' 97' ' ' LYS . 10.3 mmpt? 47.46 -71.88 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.074 1.349 . . . . 3.29 114.351 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.6 75.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.284 -0.726 . . . . 0.44 111.284 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 42.5 p -86.17 -3.57 58.99 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 123.147 0.579 . . . . 1.23 111.548 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 p -56.69 -8.18 0.54 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.63 0.604 . . . . 1.3 112.63 -178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.5 m -54.75 -47.31 74.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.262 0.553 . . . . 0.44 110.153 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.744 HD21 ' HB2' ' A' ' 148' ' ' ARG . 98.7 mt -117.65 21.84 12.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 0.37 111.788 -176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttpt -107.09 81.42 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.079 -0.388 . . . . 1.6599999999999999 110.933 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.687 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 2.8 p -140.23 162.22 24.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.936 -0.394 . . . . 0.51000000000000001 109.936 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -51.3 -46.75 62.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.909 0.337 . . . . 2.0600000000000001 111.909 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.24 151.7 46.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.667 -0.242 . . . . 0.39000000000000001 110.55 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.687 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -147.01 156.29 42.91 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.666 0.617 . . . . 0.78000000000000003 112.666 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.38 139.73 30.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.101 -0.954 . . . . 0.44 110.778 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.1 tttm -65.1 -32.42 74.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 1.1100000000000001 110.625 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.47 -36.78 68.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.458 -0.792 . . . . 0.66000000000000003 110.167 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.0 ttt -74.36 -40.72 61.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.968 -1.015 . . . . 0.47999999999999998 110.689 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.574 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.1 t80 -51.66 -53.97 33.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.836 -0.62 . . . . 0.29999999999999999 111.276 -174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.98 -43.39 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.875 -0.602 . . . . 0.19 111.743 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.7 t -64.29 -41.84 96.68 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.078 0.466 . . . . 0.84999999999999998 110.705 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.744 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.8 mmp_? -61.92 -44.84 95.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 2.48 111.142 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -69.56 -40.32 78.17 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.556 -0.83 . . . . 0.17000000000000001 112.027 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.4 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 3.5 t-20 -58.2 -40.56 81.9 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.226 0.21 . . . . 1.4199999999999999 111.376 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.9 t -73.22 -20.34 60.88 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.8 0.333 . . . . 0.40000000000000002 110.518 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.528 ' HG3' HD12 ' A' ' 128' ' ' LEU . 6.1 mm-40 -88.77 -5.76 57.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 1.3100000000000001 109.635 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.15 -13.38 37.19 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.51 -1.223 . . . . 0.25 114.585 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -143.56 125.16 14.9 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 119.096 1.448 . . . . 0.19 113.424 173.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.462 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 18.7 p -148.71 161.48 41.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.889 -0.596 . . . . 1.4199999999999999 111.077 164.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.5 tt -156.45 118.86 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.172 -0.677 . . . . 0.28000000000000003 109.172 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.8 p -121.12 145.52 47.72 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.105 0.409 . . . . 1.4399999999999999 112.105 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.719 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 3.1 m-85 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.565 -0.731 . . . . 1.8100000000000001 110.384 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.572 0.225 . . . . 3.6800000000000002 110.785 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 27' ' ' LYS . 37.2 mt-10 72.83 -52.9 0.71 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.42 0.688 . . . . 2.3799999999999999 112.823 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -55.6 129.47 39.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.857 0.36 . . . . 1.6100000000000001 111.208 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.681 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 150.42 -153.12 24.86 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.036 -1.078 . . . . 0.26000000000000001 112.181 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -127.74 153.37 46.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.592 -0.151 . . . . 0.17999999999999999 110.592 177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.725 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 13.9 m-85 -129.13 131.27 47.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.648 0.261 . . . . 0.56999999999999995 110.833 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD12 ' HB2' ' A' ' 32' ' ' LEU . 3.2 tm? -87.47 120.25 28.58 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.019 -1.104 . . . . 0.16 108.019 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -121.29 142.17 38.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 121.016 -0.274 . . . . 0.19 111.052 -174.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.48 126.07 42.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.15 -0.685 . . . . 0.90000000000000002 109.15 171.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -121.08 153.66 37.14 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.889 -0.412 . . . . 0.60999999999999999 109.889 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -84.47 -0.9 54.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.233 -0.44 . . . . 2.3700000000000001 111.447 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.08 134.45 57.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.484 -0.561 . . . . 1.3100000000000001 109.484 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.8 m 60.57 21.21 11.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.967 0.413 . . . . 1.23 110.546 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 60.4 22.52 12.09 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.55 -0.75 . . . . 1.3 111.577 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 154.66 100.34 0.18 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 111.661 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 96.8 m -129.0 144.01 51.05 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 110.193 -0.299 . . . . 0.40000000000000002 110.193 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD13 HD11 ' A' ' 59' ' ' LEU . 1.3 tp -104.18 134.01 48.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.241 0.544 . . . . 0.57999999999999996 110.418 175.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -129.93 129.47 43.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.059 -0.973 . . . . 0.19 110.26 -171.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASN . 11.1 tt -108.56 107.54 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.826 0.822 . . . . 0.28000000000000003 109.528 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.725 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.8 p -90.97 126.46 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.253 -0.885 . . . . 0.23999999999999999 110.858 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 7' ' ' ALA . 71.9 m95 -106.46 107.21 18.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.642 0.734 . . . . 0.31 109.647 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -141.01 174.62 10.34 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.659 -1.155 . . . . 1.3600000000000001 109.907 -170.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -118.9 18.1 13.3 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.3 -1.0 . . . . 1.9399999999999999 108.3 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -136.88 175.48 9.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.692 -1.14 . . . . 1.45 110.324 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB3' ' HG2' ' A' ' 4' ' ' GLU . 11.0 ptmm? -79.93 138.0 37.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.174 0.512 . . . . 2.3500000000000001 111.614 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.694 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 59.9 t -121.49 134.8 63.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.306 -0.861 . . . . 1.1599999999999999 108.825 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.14 178.28 4.33 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.868 -0.333 . . . . 1.98 110.508 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.2 m120 65.72 22.22 11.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.523 0.678 . . . . 2.0600000000000001 110.172 -175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.86 154.43 18.36 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 110.816 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.646 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.8 mp -97.96 -28.45 13.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.176 -0.92 . . . . 0.38 110.22 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.549 ' SD ' HG23 ' A' ' 70' ' ' ILE . 77.8 mtp -148.51 169.8 19.47 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.634 -0.712 . . . . 0.20000000000000001 110.865 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 84.9 t80 -149.45 153.91 38.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 110.394 -174.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 86.5 mt -126.11 125.61 68.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.229 -0.656 . . . . 0.16 109.229 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.46 109.39 56.15 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 108.733 -0.839 . . . . 2.3799999999999999 108.733 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 11.9 Cg_exo -73.64 129.63 13.85 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.369 2.046 . . . . 0.34999999999999998 112.904 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.526 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -82.23 -43.45 17.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.008 0.909 . . . . 0.85999999999999999 108.957 169.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.84 143.15 28.42 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.118 -1.401 . . . . 2.1600000000000001 108.448 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.8 139.97 49.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 2.4199999999999999 110.09 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -80.77 136.01 51.76 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.6 -0.727 . . . . 0.72999999999999998 111.175 -171.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 72.6 Cg_exo -49.82 120.75 6.35 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.479 2.786 . . . . 0.68000000000000005 112.256 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.2 -38.84 75.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.542 -0.753 . . . . 2.2799999999999998 111.65 -173.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 66.9 m-85 -69.43 -25.65 64.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.034 -0.53 . . . . 3.3399999999999999 110.893 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 13.7 mptt -68.24 -25.5 65.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.43 -0.35 . . . . 1.9399999999999999 111.105 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -74.23 -51.57 14.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.024 0.44 . . . . 0.93000000000000005 110.391 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.1 p -73.15 -39.02 56.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.614 -0.721 . . . . 1.0700000000000001 111.759 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -69.21 -39.84 78.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.921 0.391 . . . . 1.6599999999999999 110.881 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -86.11 -10.41 54.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.001 -0.545 . . . . 2.0 111.633 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.25 14.17 9.53 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.785 0.802 . . . . 2.2599999999999998 109.889 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.04 -13.52 66.75 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.309 -0.86 . . . . 0.46000000000000002 112.155 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 52' ' ' LYS . 24.3 mtpp -106.06 137.27 44.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.07 0.462 . . . . 2.4300000000000002 111.968 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' HB3' HG23 ' A' ' 21' ' ' ILE . 57.1 t30 -149.89 118.33 6.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.743 -0.662 . . . . 2.0499999999999998 109.687 170.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -90.09 121.5 32.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.316 0.579 . . . . 1.47 110.226 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 21' ' ' ILE . 55.2 mt -81.95 -60.66 2.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.228 -0.896 . . . . 0.54000000000000004 112.102 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.555 HG23 HD21 ' A' ' 59' ' ' LEU . 20.4 tt -144.12 154.84 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.074 -0.512 . . . . 0.25 110.646 -174.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -117.8 171.94 7.71 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.28 0.562 . . . . 2.23 111.89 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 66.17 37.81 4.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.02 -1.445 . . . . 1.3999999999999999 112.016 158.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 19' ' ' LEU . 48.5 mt -66.12 -23.86 66.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.646 -0.707 . . . . 0.33000000000000002 112.233 -175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 60' ' ' GLN . 3.6 tt0 -60.3 -46.63 89.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.941 0.4 . . . . 1.76 111.568 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.3 t -75.94 -10.77 59.69 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.851 -0.613 . . . . 1.5900000000000001 110.867 -172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 14.0 t70 -161.72 110.67 1.52 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.127 -0.488 . . . . 1.9199999999999999 110.669 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD2' HG12 ' A' ' 96' ' ' ILE . 1.4 mmmm -59.99 -36.49 77.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 1.6799999999999999 112.071 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 46.5 mmtm -65.57 -21.84 66.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.352 -0.84 . . . . 1.0700000000000001 111.657 -173.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 82.7 mt -57.92 -39.66 78.51 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.489 -0.323 . . . . 0.34000000000000002 111.266 175.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.9 t80 -61.38 -36.14 79.42 Favored 'General case' 0 C--O 1.227 -0.082 0 C-N-CA 120.695 -0.402 . . . . 0.23999999999999999 110.023 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' N ' ' HD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER -61.58 -57.12 13.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.466 0.651 . . . . 0.40000000000000002 109.329 -177.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 38.8 t -60.33 -37.53 80.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.054 -0.975 . . . . 1.22 111.173 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.6 -33.84 63.27 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.199 -1.001 . . . . 0.17000000000000001 111.737 175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 66' ' ' PHE . 88.1 mt -65.23 -46.8 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 122.094 0.158 . . . . 0.17999999999999999 111.179 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.1 p -62.51 -36.51 82.8 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.48 -0.563 . . . . 1.1000000000000001 109.48 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 17.2 mm-40 -63.62 -33.96 76.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.288 -0.869 . . . . 1.8200000000000001 110.814 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.7 t80 -71.69 -50.9 26.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.609 . . . . 0.20000000000000001 110.786 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.3 m -68.16 -22.06 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 109.832 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 39.1 tttp -53.42 -45.94 69.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.413 -0.812 . . . . 1.8500000000000001 110.613 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 6.8 tp10 -64.3 -38.05 89.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.918 -0.583 . . . . 1.3100000000000001 109.507 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.67 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -59.9 -33.31 71.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.037 -0.528 . . . . 0.23999999999999999 111.5 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 18.2 mtpt -73.08 -34.53 66.27 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.183 -0.673 . . . . 1.8799999999999999 109.183 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.06 -40.36 65.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.699 -0.682 . . . . 1.77 111.823 -172.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.73 -9.71 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.696 0.76 . . . . 0.33000000000000002 109.849 179.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 68.81 64.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 113.666 -1.606 . . . . 1.47 110.906 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 38' ' ' THR . . . -118.96 -151.15 8.91 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.342 -0.844 . . . . 0.26000000000000001 113.116 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -121.08 152.61 38.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.807 -0.812 . . . . 1.0600000000000001 108.807 176.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.473 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.3 tm? -107.74 137.56 45.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.743 0.306 . . . . 0.17000000000000001 110.254 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 88.7 m -124.83 126.34 45.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 0.20999999999999999 110.755 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -96.47 109.53 22.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.381 -0.599 . . . . 1.51 109.381 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 mt -80.88 151.86 28.42 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.753 -0.462 . . . . 0.26000000000000001 109.753 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 91' ' ' ASP . 3.7 tp60 -120.54 136.38 54.8 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.918 -0.713 . . . . 1.9299999999999999 110.732 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 33.3 t-80 162.46 -53.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 113.825 -1.534 . . . . 1.79 107.832 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.646 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 71.4 t80 -62.05 -52.75 62.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.54 -0.755 . . . . 3.9500000000000002 111.443 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.664 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . 0.8 OUTLIER -55.11 -32.86 62.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.864 0.364 . . . . 2.2200000000000002 111.744 -178.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.3 t -84.18 -10.16 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.625 0.25 . . . . 1.78 111.494 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 t -118.09 -34.27 4.18 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.192 -0.317 . . . . 1.6299999999999999 111.74 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.564 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 12.0 t80 -95.63 146.88 32.1 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.98 -0.378 . . . . 2.8500000000000001 109.98 -175.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 17.8 Cg_endo -60.89 -3.5 2.87 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.536 2.824 . . . . 0.68999999999999995 114.368 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG12 ' HD2' ' A' ' 63' ' ' LYS . 13.8 mt -101.96 108.83 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.35999999999999999 109.956 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 47.1 mttm -122.67 124.41 43.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.317 -0.856 . . . . 1.3799999999999999 108.718 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 33.3 m -145.3 174.39 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 111.848 0.314 . . . . 0.33000000000000002 111.848 -168.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 5.7 m-20 -141.17 137.35 32.63 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.801 -0.636 . . . . 1.1100000000000001 110.377 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -95.93 139.16 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 111.214 -176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.3 m-85 -131.13 141.93 50.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.232 -0.44 . . . . 0.33000000000000002 110.642 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.36 153.74 25.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.138 0.494 . . . . 0.34000000000000002 110.401 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.6 OUTLIER -113.23 115.74 28.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.293 -1.003 . . . . 0.25 108.293 174.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.575 ' HE2' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -124.69 109.2 12.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 1.22 110.626 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.8 -101.05 0.97 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.091 -0.804 . . . . 0.41999999999999998 111.091 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.7 p -121.73 -4.92 9.18 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.307 0.575 . . . . 1.3100000000000001 109.487 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -96.0 116.37 28.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 2.27 111.176 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.87 131.88 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 109.831 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 90.5 mmm -136.53 130.64 18.06 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.106 -0.497 . . . . 1.8500000000000001 111.072 -175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 87.8 Cg_endo -75.39 161.54 37.46 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.069 2.513 . . . . 0.28999999999999998 112.34 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 141.42 31.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.077 -0.511 . . . . 0.31 109.868 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 15.7 m120 -92.21 132.59 36.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 1.8500000000000001 109.353 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.9 m -59.12 118.99 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.951 -0.568 . . . . 0.46999999999999997 111.49 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.82 34.99 90.28 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.699 -0.682 . . . . 0.38 113.018 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 35.8 tt0 -130.2 133.75 25.3 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.976 -0.379 . . . . 1.9299999999999999 109.976 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 24.0 Cg_exo -65.47 112.61 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.305 2.003 . . . . 0.68000000000000005 110.624 170.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -118.24 138.3 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 109.827 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.575 HG13 ' HE2' ' A' ' 104' ' ' LYS . 2.1 p -55.85 114.49 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 113.017 0.747 . . . . 0.70999999999999996 113.017 -172.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.67 HG11 ' HB1' ' A' ' 77' ' ' ALA . 9.8 p -117.45 -13.78 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 109.95 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -71.15 124.13 23.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 1.3500000000000001 110.676 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.81 38.73 8.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.561 -0.745 . . . . 2.3500000000000001 110.804 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.408 HG22 ' HD2' ' A' ' 104' ' ' LYS . 38.2 pt -80.2 172.65 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.009 -0.541 . . . . 0.37 109.721 173.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.538 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -85.14 -51.4 6.66 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.121 -0.696 . . . . 0.5 109.121 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.7 165.39 35.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.555 -0.748 . . . . 0.22 111.053 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.461 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.8 tmt? -141.12 148.3 39.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.368 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 71.0 m -152.95 157.66 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.804 0.335 . . . . 1.22 110.923 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -121.15 113.24 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.942 -0.572 . . . . 0.27000000000000002 110.387 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.721 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.22 139.0 19.86 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.875 -0.787 . . . . 0.42999999999999999 108.875 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 131' ' ' GLY . 88.1 Cg_endo -81.4 118.26 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.39 1.393 . . . . 0.91000000000000003 112.289 177.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 4.2 mmpt? 48.73 -66.65 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.245 1.202 . . . . 3.29 114.245 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -69.93 73.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 112.07 -0.412 . . . . 0.44 112.07 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . 13.9 m -75.2 -5.11 42.74 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.093 0.557 . . . . 1.23 111.313 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 6.7 m -56.82 -14.0 3.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.978 -0.555 . . . . 1.3 112.101 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.9 m -52.37 -45.12 65.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.149 0.5 . . . . 0.44 110.652 172.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.7 mt -117.5 7.85 12.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.779 -0.646 . . . . 0.37 111.568 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.7 ttmt -88.46 81.99 7.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.851 0.358 . . . . 1.6599999999999999 110.913 -177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.3 p -139.75 161.14 27.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.5 -0.555 . . . . 0.51000000000000001 109.5 176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.405 ' H ' ' HG3' ' A' ' 138' ' ' LYS . 26.5 mtmt -44.95 -53.22 7.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.276 0.56 . . . . 2.0600000000000001 111.171 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.61 150.03 44.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.945 -1.025 . . . . 0.39000000000000001 110.53 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.1 mtp -146.11 155.9 43.08 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.116 0.784 . . . . 0.78000000000000003 113.116 -171.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.5 140.63 29.27 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.178 -0.919 . . . . 0.44 110.795 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.434 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 47.5 tttm -64.3 -31.92 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.558 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.7 -41.15 68.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.593 0.711 . . . . 0.66000000000000003 110.088 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 ttt -70.95 -38.02 72.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.136 -0.938 . . . . 0.47999999999999998 110.47 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.693 ' CD2' HD23 ' A' ' 103' ' ' LEU . 25.5 t80 -55.1 -50.03 70.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.29999999999999999 111.227 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.716 ' HB ' ' OG ' ' A' ' 157' ' ' SER . 1.1 p -67.16 -45.28 86.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.796 -0.638 . . . . 0.19 111.746 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.5 t -62.77 -41.88 99.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.922 0.392 . . . . 0.84999999999999998 110.711 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.782 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -63.56 -41.45 98.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.519 . . . . 2.48 111.313 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.65 -41.19 44.04 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.444 -0.884 . . . . 0.17000000000000001 111.91 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.475 ' HB2' ' HG ' ' A' ' 155' ' ' SER . 19.3 t-20 -56.16 -39.59 72.57 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.625 0.37 . . . . 1.4199999999999999 111.612 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.6 t -72.47 -25.24 61.35 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.913 -0.315 . . . . 0.40000000000000002 110.67 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -86.47 -3.85 59.08 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.64 0.733 . . . . 1.3100000000000001 109.886 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.31 35.93 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.854 -1.066 . . . . 0.25 114.927 171.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.6 125.01 14.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.293 1.546 . . . . 0.19 113.401 173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.475 ' HG ' ' HB2' ' A' ' 150' ' ' ASN . 24.7 p -150.63 158.8 44.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.638 -0.71 . . . . 1.4199999999999999 110.997 166.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.665 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 19.0 tt -156.59 117.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.791 -0.64 . . . . 0.28000000000000003 109.785 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.716 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 68.8 m -123.26 147.03 47.37 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 121.884 -0.51 . . . . 1.4399999999999999 112.008 -174.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.567 -0.742 . . . . 1.8100000000000001 110.57 175.004 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.305 0.574 . . . . 3.6800000000000002 109.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.4 -44.88 8.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.727 -0.67 . . . . 2.3799999999999999 111.214 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -77.21 129.88 36.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.958 0.408 . . . . 1.6100000000000001 110.726 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.54 ' O ' ' HE3' ' A' ' 24' ' ' LYS . . . 153.89 -154.08 25.26 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.284 -0.727 . . . . 0.26000000000000001 111.284 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -130.06 152.95 48.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.399 0.599 . . . . 0.17999999999999999 110.862 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.794 ' CD2' ' HB ' ' A' ' 28' ' ' VAL . 14.2 m-85 -132.2 134.25 45.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.523 0.202 . . . . 0.56999999999999995 110.928 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' A' ' 73' ' ' PHE . 2.2 tm? -89.79 119.45 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.125 -1.065 . . . . 0.16 108.125 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -118.55 149.51 20.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.723 0.297 . . . . 0.19 110.878 -174.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 42.1 t80 -96.97 138.44 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.90000000000000002 110.088 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 10.1 t70 -131.45 153.61 49.56 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.128 -0.487 . . . . 0.60999999999999999 109.716 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.4 -0.94 57.73 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.847 0.314 . . . . 2.3700000000000001 111.847 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 131.46 50.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.584 -0.28 . . . . 1.3100000000000001 111.13 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 8.6 t 58.62 25.97 13.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.016 -0.538 . . . . 1.23 110.249 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 60.31 54.61 3.88 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 1.3 111.067 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 118.56 106.09 2.26 Favored Glycine 0 C--O 1.22 -0.755 0 CA-C-N 115.777 -0.647 . . . . 0.39000000000000001 112.517 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.9 m -135.33 149.99 49.87 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.713 -0.477 . . . . 0.40000000000000002 109.713 176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.644 HD12 ' HA3' ' A' ' 69' ' ' GLY . 31.6 mt -103.3 158.77 16.1 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.115 0.483 . . . . 0.57999999999999996 109.846 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -150.13 130.17 13.49 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.415 -0.811 . . . . 0.19 109.811 -174.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.482 HD13 ' HG3' ' A' ' 76' ' ' GLU . 9.5 tt -109.44 113.43 44.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.552 0.692 . . . . 0.28000000000000003 109.694 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.6 p -93.32 122.64 44.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.436 -0.802 . . . . 0.23999999999999999 110.972 -177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 84.3 m95 -101.08 106.73 18.03 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.31 109.199 174.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' HE3' ' O ' ' A' ' 6' ' ' GLY . 0.0 OUTLIER -143.15 174.96 10.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.297 -0.865 . . . . 1.3600000000000001 110.555 -169.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.01 17.97 10.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.19 -1.041 . . . . 1.9399999999999999 108.19 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 24' ' ' LYS . 13.0 pt-20 -129.22 168.65 15.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.577 -1.192 . . . . 1.45 109.566 -175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -79.56 135.76 36.69 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.624 -0.431 . . . . 2.3500000000000001 110.768 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 57.7 t -121.67 129.14 75.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.913 -0.585 . . . . 1.1599999999999999 109.656 177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -111.39 178.51 4.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.164 -0.31 . . . . 1.98 110.164 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 67.31 18.37 10.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.581 0.55 . . . . 2.0600000000000001 110.567 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.53 150.71 20.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.751 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.708 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -94.36 -30.38 14.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.534 -0.757 . . . . 0.38 109.859 -177.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.626 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -144.01 170.17 16.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.20000000000000001 110.93 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 73.3 t80 -148.27 153.55 38.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 110.764 -174.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 74.5 mt -126.86 133.74 67.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.024 -0.534 . . . . 0.16 109.664 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -113.59 108.78 51.44 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.989 -0.374 . . . . 2.3799999999999999 109.989 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -75.1 125.98 9.61 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.745 1.63 . . . . 0.34999999999999998 111.42 174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.7 t -90.54 -22.16 21.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.92 -0.77 . . . . 0.85999999999999999 108.92 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -102.76 154.18 19.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.11 -0.95 . . . . 2.1600000000000001 108.528 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.04 131.29 50.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.238 0.542 . . . . 2.4199999999999999 110.306 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.36 139.68 48.4 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.091 -0.958 . . . . 0.72999999999999998 111.748 -170.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' LYS . 70.8 Cg_exo -43.96 122.0 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.098 3.199 . . . . 0.68000000000000005 112.886 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -69.03 -43.8 73.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.347 -0.842 . . . . 2.2799999999999998 112.388 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.423 ' HA ' HG12 ' A' ' 47' ' ' VAL . 90.3 m-85 -74.76 -24.35 58.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.429 -0.35 . . . . 3.3399999999999999 110.932 -173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.6 OUTLIER -64.64 -29.0 70.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.358 -0.383 . . . . 1.9399999999999999 110.792 177.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -67.01 -49.86 63.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.331 -0.395 . . . . 0.93000000000000005 110.877 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.35 -37.38 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.174 -0.466 . . . . 1.0700000000000001 111.566 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.59 -41.57 83.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.031 0.443 . . . . 1.6599999999999999 110.946 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.3 -11.94 44.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.138 -0.483 . . . . 2.0 111.155 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.97 3.8 3.74 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.909 0.861 . . . . 2.2599999999999998 110.234 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 -14.16 61.82 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.243 -0.889 . . . . 0.46000000000000002 111.921 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -107.82 123.83 49.16 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.958 -0.142 . . . . 2.4300000000000002 110.653 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -145.17 119.22 9.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.63 -0.428 . . . . 2.0499999999999998 111.569 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.78 124.76 31.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.728 -0.669 . . . . 1.47 109.753 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 19' ' ' LEU . 1.7 mp -83.82 -64.42 1.17 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.691 -0.686 . . . . 0.54000000000000004 112.424 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.56 HG23 HD21 ' A' ' 59' ' ' LEU . 18.7 tt -147.41 150.43 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.003 -0.999 . . . . 0.25 109.114 -166.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -135.04 172.3 13.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.995 0.739 . . . . 2.23 112.995 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' SER . 4.1 t-20 61.2 48.49 6.21 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.531 -1.213 . . . . 1.3999999999999999 111.319 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 56' ' ' ILE . 49.5 mt -74.96 -22.48 58.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 0.33000000000000002 112.048 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.33 -45.54 90.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.512 0.672 . . . . 1.76 111.05 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.3 m -81.05 -11.75 59.46 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.705 -1.134 . . . . 1.5900000000000001 111.392 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.99 107.52 2.74 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.766 -0.652 . . . . 1.9199999999999999 109.63 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' CE ' HG12 ' A' ' 96' ' ' ILE . 8.2 ptmt -71.18 -25.48 62.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.256 -0.429 . . . . 1.6799999999999999 110.723 -174.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -66.04 -24.79 66.81 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.278 -0.419 . . . . 1.0700000000000001 111.325 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 56' ' ' ILE . 73.5 mt -60.55 -37.32 80.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.24 -0.436 . . . . 0.34000000000000002 111.312 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.59 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.1 t80 -61.27 -34.37 75.06 Favored 'General case' 0 C--O 1.227 -0.084 0 N-CA-C 110.187 -0.301 . . . . 0.23999999999999999 110.187 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.6 OUTLIER -61.21 -57.07 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.374 0.607 . . . . 0.40000000000000002 109.641 -178.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -64.38 -33.15 75.19 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.393 -0.821 . . . . 1.22 110.641 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.18 -32.35 67.29 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.206 -0.997 . . . . 0.17000000000000001 111.508 175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.626 HG23 ' SD ' ' A' ' 33' ' ' MET . 87.8 mt -68.26 -46.87 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 122.487 0.315 . . . . 0.17999999999999999 111.462 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 p -63.08 -37.71 88.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.253 0.549 . . . . 1.1000000000000001 109.855 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 68' ' ' SER . 85.6 mm-40 -66.12 -27.62 68.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.274 -0.876 . . . . 1.8200000000000001 110.711 176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.56 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.7 t80 -73.47 -51.67 16.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.214 -0.448 . . . . 0.20000000000000001 110.435 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.1 m -65.57 -25.01 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.246 0.546 . . . . 0.28000000000000003 110.028 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 79.4 tttt -53.02 -38.98 62.84 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.102 -0.953 . . . . 1.8500000000000001 110.752 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 80' ' ' ILE . 21.1 mm-40 -65.48 -43.52 89.97 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.845 0.355 . . . . 1.3100000000000001 110.117 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HA ' ' CD1' ' A' ' 80' ' ' ILE . . . -65.25 -38.64 90.96 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 120.632 -0.427 . . . . 0.23999999999999999 111.226 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 12.3 pttp -72.25 -20.28 61.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.777 0.799 . . . . 1.8799999999999999 109.929 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.79 -38.61 18.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.639 -1.164 . . . . 1.77 112.864 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.707 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -97.15 -8.89 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.772 0.796 . . . . 0.33000000000000002 110.252 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 76.55 58.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.521 -1.672 . . . . 1.47 110.797 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -105.13 -163.22 23.82 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 113.98 -1.464 . . . . 0.26000000000000001 112.849 174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -119.64 154.9 33.31 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.961 -1.125 . . . . 1.0600000000000001 107.961 173.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.0 tm? -110.83 131.53 54.97 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.548 -0.461 . . . . 0.17000000000000001 110.831 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 94.6 m -120.21 123.13 42.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.838 -0.619 . . . . 0.20999999999999999 110.596 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 33' ' ' MET . 12.3 tp -94.69 101.99 13.86 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.224 -0.444 . . . . 1.51 110.197 175.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.6 mt -74.07 149.35 41.18 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.515 -0.55 . . . . 0.26000000000000001 109.515 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 51.8 tt0 -123.54 136.87 54.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.074 -0.65 . . . . 1.9299999999999999 109.855 173.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 49.7 t60 163.67 -40.94 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.938 -1.134 . . . . 1.79 107.938 -173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.708 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 15.7 p90 -57.45 -20.08 28.16 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 114.876 -1.056 . . . . 3.9500000000000002 111.986 175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.35 -19.13 64.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 2.2200000000000002 111.572 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -23.49 58.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.15 0.5 . . . . 1.78 110.545 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -108.73 -34.31 6.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.634 . . . . 1.6299999999999999 110.486 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' HD21 ' A' ' 32' ' ' LEU . 15.4 m-85 -89.58 135.39 30.89 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.764 -0.653 . . . . 2.8500000000000001 111.839 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -83.73 14.95 2.25 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.65 2.234 . . . . 0.68999999999999995 110.743 168.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.48 HG12 ' CE ' ' A' ' 63' ' ' LYS . 4.7 mt -115.58 113.67 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.716 -0.675 . . . . 0.35999999999999999 110.831 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' HB3' ' HE3' ' A' ' 130' ' ' LYS . 88.4 mttt -123.76 128.45 49.59 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.49 -0.93 . . . . 1.3799999999999999 108.49 176.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 129' ' ' PRO . 22.6 m -145.05 167.22 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.175 0.435 . . . . 0.33000000000000002 112.175 -166.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 4.1 m-20 -128.71 130.88 47.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.705 . . . . 1.1100000000000001 110.156 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -97.28 136.94 37.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.806 -0.634 . . . . 0.34999999999999998 111.048 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.1 m-85 -130.4 142.61 50.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.533 -0.303 . . . . 0.33000000000000002 110.903 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 m-85 -109.91 153.97 23.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.34000000000000002 110.072 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.672 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -112.48 121.49 44.98 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.381 -0.97 . . . . 0.25 108.381 174.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HE3' HG22 ' A' ' 122' ' ' ILE . 7.1 mptt -120.57 102.16 8.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.418 -0.216 . . . . 1.22 110.418 174.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.3 -97.68 0.69 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.056 -0.818 . . . . 0.41999999999999998 111.056 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -124.81 -0.62 7.96 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.275 0.56 . . . . 1.3100000000000001 109.675 169.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 138' ' ' LYS . 58.6 tptt -92.09 119.97 32.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.714 -0.676 . . . . 2.27 110.672 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 140' ' ' MET . 20.7 t -85.81 139.14 17.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.393 -0.367 . . . . 0.79000000000000004 110.522 177.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 mmt -136.32 112.78 10.22 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.362 -0.381 . . . . 1.8500000000000001 111.233 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 91.9 Cg_endo -78.63 153.52 26.6 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.998 2.465 . . . . 0.28999999999999998 113.065 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.86 144.44 29.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.499 -0.773 . . . . 0.31 110.285 -176.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.443 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 44.9 m-80 -101.81 131.67 48.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.219 -0.66 . . . . 1.8500000000000001 109.219 174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.6 m -57.88 125.45 23.1 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.935 0.398 . . . . 0.46999999999999997 111.478 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.12 20.79 73.28 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.641 -0.708 . . . . 0.38 113.415 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.2 tt0 -120.03 120.87 29.95 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.848 -0.427 . . . . 1.9299999999999999 109.848 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.44 111.94 1.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.157 1.905 . . . . 0.68000000000000005 110.362 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -118.25 141.3 48.65 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.437 -0.801 . . . . 0.40999999999999998 110.367 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.408 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.2 p -60.16 116.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.70999999999999996 112.324 -173.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 78' ' ' LYS . 7.7 p -121.83 -15.54 6.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.971 -1.013 . . . . 0.23000000000000001 110.349 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.4 ' HG2' HG23 ' A' ' 118' ' ' VAL . 9.5 pt20 -55.28 -40.69 71.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.532 -0.758 . . . . 1.3500000000000001 112.155 -175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -117.44 75.29 0.97 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.37 0.605 . . . . 2.3500000000000001 110.263 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.459 HG22 ' HE3' ' A' ' 104' ' ' LYS . 34.1 pt -123.11 157.93 28.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.462 -0.79 . . . . 0.37 110.69 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.1 m-20 -88.77 -36.63 15.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.084 -0.962 . . . . 0.5 109.535 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -161.4 170.92 19.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.18 -0.918 . . . . 0.22 110.5 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.438 ' CA ' ' HE1' ' A' ' 145' ' ' PHE . 1.9 tmt? -147.12 151.96 37.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.866 -0.79 . . . . 1.1599999999999999 108.866 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.431 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.6 m -149.85 159.21 44.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 1.22 111.69 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.9 t -123.51 109.49 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.469 -0.787 . . . . 0.27000000000000002 110.046 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.624 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -106.02 138.43 19.66 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.733 -0.84 . . . . 0.42999999999999999 108.733 175.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 98' ' ' VAL . 90.7 Cg_endo -82.29 117.19 2.77 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.27 1.314 . . . . 0.91000000000000003 112.683 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' HE3' ' HB3' ' A' ' 97' ' ' LYS . 1.7 mmpt? 51.05 -60.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.458 1.281 . . . . 3.29 114.458 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -71.91 78.66 0.63 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.558 -0.617 . . . . 0.44 111.558 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 3.7 p -78.26 -5.75 52.91 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.505 0.322 . . . . 1.23 111.277 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.581 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 19.9 m -57.45 -17.25 12.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.991 -178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.446 ' HB2' ' HG ' ' A' ' 128' ' ' LEU . 10.0 m -52.39 -46.78 66.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.094 0.474 . . . . 0.44 110.544 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD12 HD21 ' A' ' 128' ' ' LEU . 91.7 mt -118.0 20.13 13.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.683 -0.69 . . . . 0.37 111.371 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 39.6 ttmt -91.6 68.81 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.225 0.535 . . . . 1.6599999999999999 111.373 -175.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 1.8 p -140.99 143.96 27.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.924 -0.769 . . . . 0.51000000000000001 108.924 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' LYS . 34.8 mtmt -47.23 -46.43 24.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.434 0.635 . . . . 2.0600000000000001 111.021 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -129.05 147.78 50.94 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.933 -1.031 . . . . 0.39000000000000001 111.224 -175.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.671 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.2 mtp -161.07 162.77 31.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 112.12 -173.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -87.94 137.33 32.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.539 -0.755 . . . . 0.44 110.748 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 51.1 tttm -62.41 -30.09 70.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.826 -0.625 . . . . 1.1100000000000001 111.083 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -69.34 -41.34 76.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.809 0.814 . . . . 0.66000000000000003 109.535 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.3 ttt -71.14 -39.8 71.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.577 -1.192 . . . . 0.47999999999999998 110.564 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.672 ' CD2' HD23 ' A' ' 103' ' ' LEU . 33.4 t80 -53.7 -55.38 26.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.009 -0.542 . . . . 0.29999999999999999 111.247 -174.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.762 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.3 p -64.87 -45.61 94.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.296 -0.411 . . . . 0.19 111.63 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.1 m -61.55 -35.26 77.28 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 0.84999999999999998 110.892 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.622 ' HB2' HD21 ' A' ' 135' ' ' LEU . 2.7 mmp_? -68.83 -46.55 68.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 2.48 111.208 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -73.21 -42.82 41.6 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.498 -0.858 . . . . 0.17000000000000001 112.389 -177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.38 -26.98 67.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.293 0.108 . . . . 1.4199999999999999 111.293 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 148' ' ' ARG . 10.2 t -78.52 -22.83 46.75 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.584 -0.447 . . . . 0.40000000000000002 109.881 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -83.82 -3.26 57.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.677 0.751 . . . . 1.3100000000000001 109.217 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.53 -13.8 39.13 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.514 -1.221 . . . . 0.25 114.23 171.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.83 125.51 15.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.03 1.415 . . . . 0.19 113.402 173.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.762 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 10.4 t -153.91 165.24 36.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.439 -0.8 . . . . 1.4199999999999999 109.885 166.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.616 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 13.9 tt -157.12 117.35 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 114.954 -1.021 . . . . 0.28000000000000003 109.262 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.637 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 70.6 m -122.32 127.15 49.47 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 121.972 -0.455 . . . . 1.4399999999999999 111.025 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.2 0 CA-C-O 118.016 -0.992 . . . . 1.8100000000000001 110.922 -172.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 111.464 0.172 . . . . 3.6800000000000002 111.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.82 -28.32 19.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.863 0.363 . . . . 2.3799999999999999 111.453 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -95.57 117.99 31.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.387 -0.37 . . . . 1.6100000000000001 110.754 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 35' ' ' ILE . . . 155.87 -154.23 25.36 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.527 -0.844 . . . . 0.26000000000000001 112.78 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -109.17 143.46 38.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.565 0.221 . . . . 0.17999999999999999 110.619 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.745 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 69.3 m-85 -120.95 126.77 50.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.506 -0.316 . . . . 0.56999999999999995 111.567 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.4 tm? -86.36 120.09 27.33 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.587 -0.894 . . . . 0.16 108.587 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.62 142.79 36.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.434 -0.348 . . . . 0.19 110.496 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.409 ' CE2' ' HA2' ' A' ' 17' ' ' GLY . 5.1 t80 -96.91 129.44 44.36 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.336 -0.987 . . . . 0.90000000000000002 108.336 173.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -121.82 152.05 39.95 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.567 -0.453 . . . . 0.60999999999999999 110.675 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -82.8 -2.17 53.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.589 -0.732 . . . . 2.3700000000000001 111.565 -175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 130.95 49.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 110.068 -0.345 . . . . 1.3100000000000001 110.068 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.2 t 60.14 21.81 11.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.157 0.503 . . . . 1.23 110.096 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.492 HD22 ' NE2' ' A' ' 60' ' ' GLN . 93.0 m-20 59.82 28.26 17.71 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.27 -0.877 . . . . 1.3 111.394 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 151.73 103.5 0.25 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.788 -0.72 . . . . 0.39000000000000001 112.065 177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 93.4 m -138.39 148.88 44.98 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.208 -0.293 . . . . 0.40000000000000002 110.208 175.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.671 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.7 mt -104.0 143.42 32.9 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.54 0.685 . . . . 0.57999999999999996 110.164 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -137.2 127.85 26.97 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.465 -1.243 . . . . 0.19 109.337 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 53' ' ' ASN . 7.1 tt -112.43 111.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 122.021 0.915 . . . . 0.28000000000000003 109.708 175.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.745 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 13.3 p -96.17 135.43 30.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.901 -1.045 . . . . 0.23999999999999999 110.366 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 79.3 m95 -105.39 107.58 18.64 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.125 -0.695 . . . . 0.31 109.125 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.805 ' HD3' ' CG2' ' A' ' 28' ' ' VAL . 1.4 ptmm? -157.82 173.09 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.436 0.636 . . . . 1.3600000000000001 110.496 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -109.65 11.4 24.66 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.235 -0.893 . . . . 1.9399999999999999 109.234 -173.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 14.8 tt0 -120.56 136.24 54.85 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.874 -1.057 . . . . 1.45 110.301 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HA ' ' OH ' ' A' ' 8' ' ' TYR . 35.0 ttpt -65.19 117.59 8.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.357 0.599 . . . . 2.3500000000000001 111.498 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.805 ' CG2' ' HD3' ' A' ' 24' ' ' LYS . 41.9 t -93.37 119.7 41.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 109.912 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -89.55 166.72 13.48 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.579 -0.526 . . . . 1.98 109.579 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 69.75 15.56 8.0 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.586 0.554 . . . . 2.0600000000000001 110.364 -172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.58 146.17 25.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.20999999999999999 110.003 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.749 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.1 mp -93.34 -28.87 15.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.821 -0.627 . . . . 0.38 109.826 -176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.675 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.2 mtp -146.61 169.06 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 0.20000000000000001 111.082 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 82.1 t80 -149.39 154.64 39.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.23000000000000001 110.738 -175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 78.8 mt -127.24 123.28 61.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.887 -0.783 . . . . 0.16 108.887 177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.61 110.23 62.69 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.66 -0.496 . . . . 2.3799999999999999 109.66 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.05 133.08 10.84 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.789 2.326 . . . . 0.34999999999999998 111.674 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.5 p -79.83 -37.07 35.85 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.519 0.676 . . . . 0.85999999999999999 110.153 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -100.01 173.77 6.49 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.988 -1.005 . . . . 2.1600000000000001 110.267 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.52 134.61 57.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.833 -0.621 . . . . 2.4199999999999999 110.19 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.532 HG12 ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -82.21 149.38 62.04 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.722 . . . . 0.72999999999999998 110.913 -175.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' HG12 ' A' ' 41' ' ' VAL . 84.8 Cg_exo -47.48 121.15 5.16 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.301 2.668 . . . . 0.68000000000000005 112.043 177.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.47 -35.13 47.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.658 -0.701 . . . . 2.2799999999999998 111.961 -171.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.547 ' HA ' HG12 ' A' ' 47' ' ' VAL . 93.3 m-85 -76.69 -23.47 53.16 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.454 -0.498 . . . . 3.3399999999999999 110.95 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 14.1 mptt -61.24 -31.45 71.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.232 -0.44 . . . . 1.9399999999999999 110.456 173.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.19 -43.06 74.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.801 -0.636 . . . . 0.93000000000000005 111.153 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 44' ' ' PHE . 8.0 p -87.56 -45.14 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.545 0.572 . . . . 1.0700000000000001 112.545 -173.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -71.03 -50.63 32.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.388 . . . . 1.6599999999999999 111.137 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 10.4 mmt180 -77.05 -5.18 47.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.277 -0.42 . . . . 2.0 110.73 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 68.28 11.09 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.184 -174.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.31 -12.99 63.01 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.083 -0.962 . . . . 0.46000000000000002 112.374 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -105.59 126.89 52.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 2.4300000000000002 111.778 -175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 49' ' ' ARG . 8.5 m-80 -134.19 120.37 19.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.167 -0.47 . . . . 2.0499999999999998 110.473 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.13 132.89 34.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.223 0.535 . . . . 1.47 109.935 174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 21' ' ' ILE . 26.5 mt -91.66 -64.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.536 -0.756 . . . . 0.54000000000000004 111.539 -177.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 59' ' ' LEU . 20.0 tt -146.77 145.86 19.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.494 -0.775 . . . . 0.25 109.432 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.7 ppt_? -135.91 171.62 14.2 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.182 -0.607 . . . . 2.23 111.813 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.3 t30 65.21 47.02 2.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.949 -1.023 . . . . 1.3999999999999999 110.494 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 56' ' ' ILE . 44.6 mt -71.17 -16.55 62.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.327 -0.851 . . . . 0.33000000000000002 110.309 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.492 ' NE2' HD22 ' A' ' 16' ' ' ASN . 6.6 tt0 -59.44 -47.46 85.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.712 -0.676 . . . . 1.76 111.873 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.4 t -75.66 -28.31 58.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.382 0.611 . . . . 1.5900000000000001 110.272 -174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -145.87 101.45 3.54 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.243 -0.89 . . . . 1.9199999999999999 110.248 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -62.85 -30.71 71.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.092 -0.504 . . . . 1.6799999999999999 110.985 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 35.8 mmtm -57.72 -23.22 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.689 -0.687 . . . . 1.0700000000000001 111.771 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 mt -64.84 -28.39 69.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.523 -0.308 . . . . 0.34000000000000002 111.289 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.5 t80 -67.22 -33.27 75.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.484 -0.561 . . . . 0.23999999999999999 109.484 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -64.82 -58.24 6.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.567 0.699 . . . . 0.40000000000000002 109.203 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 32.2 t -61.95 -35.97 80.01 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.093 -0.958 . . . . 1.22 110.814 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.671 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.14 -36.36 67.92 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.619 176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.675 HG23 ' SD ' ' A' ' 33' ' ' MET . 95.2 mt -60.94 -45.94 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 122.411 0.285 . . . . 0.17999999999999999 111.189 174.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.3 p -63.48 -37.18 86.32 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.585 -0.524 . . . . 1.1000000000000001 109.585 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.615 ' HG3' ' O ' ' A' ' 68' ' ' SER . 76.8 mt-30 -62.37 -34.01 75.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.438 -0.801 . . . . 1.8200000000000001 110.19 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 89.9 t80 -69.76 -53.13 19.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.20000000000000001 110.769 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 70' ' ' ILE . 1.4 m -66.35 -24.5 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.28000000000000003 110.389 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.615 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 28.7 tttm -53.46 -40.81 65.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 1.8500000000000001 110.709 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 80' ' ' ILE . 10.1 mm-40 -66.69 -33.31 75.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.666 -0.697 . . . . 1.3100000000000001 110.234 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.04 -30.78 70.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.668 -0.696 . . . . 0.23999999999999999 111.234 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -74.46 -21.53 59.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.297 -0.631 . . . . 1.8799999999999999 109.297 176.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.4 -45.17 15.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.751 -0.658 . . . . 1.77 111.017 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.53 -9.45 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 122.103 0.954 . . . . 0.33000000000000002 109.383 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 68.65 57.29 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.254 -1.794 . . . . 1.47 111.041 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.514 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -114.17 -145.56 9.03 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.728 -0.749 . . . . 0.26000000000000001 113.11 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' HD2' ' C ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -121.97 159.77 26.26 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 123.225 0.61 . . . . 1.0600000000000001 109.762 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.1 tm? -113.9 135.4 54.02 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 110.111 -0.329 . . . . 0.17000000000000001 110.111 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -124.06 121.19 34.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.016 -0.538 . . . . 0.20999999999999999 110.614 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.7 tm? -90.6 108.08 19.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.944 -0.761 . . . . 1.51 108.944 174.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.6 mt -78.46 149.86 33.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.556 -0.535 . . . . 0.26000000000000001 109.556 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 63.6 tt0 -121.59 135.91 54.97 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.352 -0.539 . . . . 1.9299999999999999 110.006 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 40.5 t-80 159.03 -48.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.057 -1.09 . . . . 1.79 108.057 -171.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.749 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 19.6 p90 -58.8 -32.56 69.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.858 -1.065 . . . . 3.9500000000000002 111.31 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.633 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 17.8 p-10 -68.36 -18.05 64.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.313 -0.403 . . . . 2.2200000000000002 111.246 -175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 t -91.01 -9.43 45.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 1.78 110.566 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.6 t -117.87 -36.56 3.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 1.6299999999999999 111.057 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -97.39 147.81 33.51 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.129 -0.487 . . . . 2.8500000000000001 110.49 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.91 -6.06 16.43 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.953 2.435 . . . . 0.68999999999999995 113.401 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.419 HD11 ' HB2' ' A' ' 63' ' ' LYS . 56.9 mt -96.3 113.33 30.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.934 0.397 . . . . 0.35999999999999999 110.686 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.633 ' HE2' ' O ' ' A' ' 91' ' ' ASP . 93.7 mttt -120.0 124.65 46.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.193 -0.669 . . . . 1.3799999999999999 109.193 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.6 168.54 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.202 0.445 . . . . 0.33000000000000002 112.202 -171.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 29.1 m-20 -130.53 130.82 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 109.796 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -96.72 138.6 34.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.142 -0.481 . . . . 0.34999999999999998 111.131 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.7 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 7.0 m-85 -131.7 144.56 51.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.479 -0.328 . . . . 0.33000000000000002 110.781 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -112.04 147.37 36.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.195 0.521 . . . . 0.34000000000000002 110.61 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.686 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.8 OUTLIER -106.08 121.61 44.5 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.973 -1.121 . . . . 0.25 107.973 173.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.668 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -122.52 101.73 7.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.589 0.233 . . . . 1.22 110.581 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.48 -97.45 0.61 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.074 -0.811 . . . . 0.41999999999999998 111.074 -176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 139' ' ' THR . 5.8 p -123.9 -0.15 8.51 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.352 0.596 . . . . 1.3100000000000001 109.711 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 138' ' ' LYS . 3.4 tppp? -99.37 114.71 27.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.85 -0.614 . . . . 2.27 110.761 -175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.2 p -94.82 133.41 35.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.985 0.422 . . . . 0.79000000000000004 110.475 176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 96.0 mmm -135.72 132.46 19.59 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 110.945 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 73.2 Cg_endo -71.98 158.88 51.66 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.28999999999999998 112.816 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.421 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.05 135.76 34.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.404 -0.591 . . . . 0.31 109.404 177.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 92.9 m-20 -89.94 127.1 35.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.337 -0.616 . . . . 1.8500000000000001 109.337 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 55.9 m -57.17 120.1 7.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.75 -0.659 . . . . 0.46999999999999997 112.009 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.29 13.62 81.31 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.405 -0.816 . . . . 0.38 113.229 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 33.8 tt0 -113.28 129.66 24.37 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.272 -0.27 . . . . 1.9299999999999999 110.272 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 25.6 Cg_exo -64.75 113.07 2.18 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.33 2.02 . . . . 0.68000000000000005 110.608 170.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.421 ' HD1' HD22 ' A' ' 111' ' ' LEU . 5.4 t80 -117.25 144.82 44.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.675 -0.693 . . . . 0.40999999999999998 109.951 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -59.57 113.0 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.46 0.648 . . . . 0.70999999999999996 112.747 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 77' ' ' ALA . 11.5 p -117.99 -19.49 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.23000000000000001 110.243 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -56.58 -36.96 69.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.311 -0.858 . . . . 1.3500000000000001 111.977 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -126.22 65.23 1.23 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.263 0.554 . . . . 2.3500000000000001 110.233 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.668 HG22 ' HD2' ' A' ' 104' ' ' LYS . 46.9 pt -108.62 171.1 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.802 -0.635 . . . . 0.37 110.156 175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.624 ' HB2' HD12 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -99.01 -40.62 7.95 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.726 -0.67 . . . . 0.5 109.312 173.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.45 163.43 37.18 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.285 -0.871 . . . . 0.22 110.53 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.439 ' HG3' HG21 ' A' ' 74' ' ' VAL . 1.9 tmt? -139.64 149.75 44.12 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.286 -0.635 . . . . 1.1599999999999999 109.286 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 23.9 m -148.78 157.34 43.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.977 0.418 . . . . 1.22 111.666 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.1 t -121.47 109.77 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.525 -0.762 . . . . 0.27000000000000002 109.835 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -103.68 132.3 21.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.617 -0.512 . . . . 0.42999999999999999 109.617 177.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 91.5 Cg_endo -82.57 120.22 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.163 1.909 . . . . 0.91000000000000003 112.107 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 11.2 mmpt? 25.99 54.36 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.755 1.284 . . . . 3.29 112.435 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.45 52.32 0.11 Allowed Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.119 -1.855 . . . . 0.44 109.635 -178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -74.32 -7.16 51.88 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.98 -0.61 . . . . 1.23 111.738 -173.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.528 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 3.1 m -65.06 -12.38 49.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 1.3 111.345 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 29.1 m -53.97 -44.66 70.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.271 0.557 . . . . 0.44 110.522 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.673 HD21 ' HB2' ' A' ' 148' ' ' ARG . 83.2 mt -117.18 9.06 13.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.394 -0.821 . . . . 0.37 111.108 -175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 23.4 ttpp -88.6 78.4 7.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.377 -0.374 . . . . 1.6599999999999999 111.139 -174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.783 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 3.2 p -139.86 165.67 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.054 -0.721 . . . . 0.51000000000000001 109.054 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 107' ' ' LYS . 33.5 mtmt -53.9 -53.94 45.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.379 0.609 . . . . 2.0600000000000001 110.454 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -134.47 148.38 50.57 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.26 -0.882 . . . . 0.39000000000000001 111.461 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.783 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 2.1 mtp -150.14 157.56 43.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.78000000000000003 112.389 -173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.02 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.372 -0.831 . . . . 0.44 110.64 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' VAL . 83.5 tttt -64.97 -30.4 71.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 1.1100000000000001 110.48 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.56 -44.02 65.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.492 0.663 . . . . 0.66000000000000003 109.991 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -67.88 -38.71 83.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.069 -0.968 . . . . 0.47999999999999998 109.986 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.686 ' CD2' HD23 ' A' ' 103' ' ' LEU . 24.9 t80 -55.21 -54.54 42.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.898 -0.592 . . . . 0.29999999999999999 110.919 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.783 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -64.32 -46.41 93.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.241 -0.436 . . . . 0.19 111.652 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.7 t -61.06 -38.83 87.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.041 0.448 . . . . 0.84999999999999998 110.658 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HB2' HD21 ' A' ' 135' ' ' LEU . 22.1 mmt-85 -64.6 -51.3 63.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 2.48 111.143 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -66.22 -39.55 94.51 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.481 -0.866 . . . . 0.17000000000000001 111.502 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -57.63 -40.86 80.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.649 0.38 . . . . 1.4199999999999999 111.436 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 148' ' ' ARG . 12.1 t -75.63 -26.57 57.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.879 -0.329 . . . . 0.40000000000000002 110.551 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -76.56 -9.38 58.62 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.42 0.629 . . . . 1.3100000000000001 110.261 170.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.57 -13.16 35.85 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.157 -0.929 . . . . 0.25 114.75 171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -144.46 125.32 14.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 119.081 1.441 . . . . 0.19 113.164 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.783 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 9.0 t -150.41 164.51 35.7 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.94 -0.573 . . . . 1.4199999999999999 110.587 165.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 14.9 tt -157.97 118.5 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.741 -1.118 . . . . 0.28000000000000003 109.394 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.653 ' OG ' ' HB ' ' A' ' 146' ' ' VAL . 74.3 m -122.36 145.16 48.52 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.835 -0.541 . . . . 1.4399999999999999 111.907 -175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.508 -0.769 . . . . 1.8100000000000001 111.016 177.411 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 120.462 0.173 . . . . 3.6800000000000002 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.86 -57.37 12.07 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.628 0.252 . . . . 2.3799999999999999 110.711 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -83.3 126.52 32.77 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.12 -0.632 . . . . 1.6100000000000001 109.707 177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.28 -162.7 29.33 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.226 -0.988 . . . . 0.26000000000000001 112.515 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -122.6 152.06 40.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.567 0.222 . . . . 0.17999999999999999 111.096 -176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.724 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 11.7 m-85 -128.91 132.25 47.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.399 -0.364 . . . . 0.56999999999999995 110.509 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' A' ' 32' ' ' LEU . 2.8 tm? -87.12 119.88 27.82 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.243 -1.021 . . . . 0.16 108.243 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -121.5 141.28 42.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.749 0.309 . . . . 0.19 110.937 -174.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 56.5 t80 -98.07 128.8 44.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.026 -0.534 . . . . 0.90000000000000002 109.896 174.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -121.05 152.06 39.08 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.051 -0.722 . . . . 0.60999999999999999 109.051 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -86.08 3.43 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 2.3700000000000001 111.055 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.32 134.89 56.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.354 -0.385 . . . . 1.3100000000000001 110.14 173.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 22.5 m 57.24 26.45 12.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.122 0.487 . . . . 1.23 110.297 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 60' ' ' GLN . 16.8 m120 63.96 27.63 14.35 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.162 -0.926 . . . . 1.3 111.251 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 139.36 108.42 0.79 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.727 -0.749 . . . . 0.39000000000000001 112.341 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 90.9 m -135.63 150.47 49.65 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.113 -0.328 . . . . 0.40000000000000002 110.113 177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' HA3' ' A' ' 69' ' ' GLY . 16.2 mt -103.68 149.94 24.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.273 0.558 . . . . 0.57999999999999996 110.409 174.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 0.5 OUTLIER -144.23 128.14 17.41 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.895 -1.048 . . . . 0.19 109.479 -173.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.682 HG23 ' HB2' ' A' ' 53' ' ' ASN . 6.7 tt -111.24 110.85 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.746 0.784 . . . . 0.28000000000000003 109.637 174.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.724 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 7.1 p -90.91 126.41 43.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.139 -0.937 . . . . 0.23999999999999999 111.452 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 44.5 m95 -101.76 110.05 21.95 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.513 0.673 . . . . 0.31 110.057 173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' HG2' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -148.27 174.25 12.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.233 -0.894 . . . . 1.3600000000000001 110.208 -173.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -118.29 17.48 13.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.062 -0.972 . . . . 1.9399999999999999 108.644 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 11.4 pt-20 -129.84 177.85 6.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.303 -1.317 . . . . 1.45 109.737 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -96.19 120.0 35.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.251 0.548 . . . . 2.3500000000000001 110.71 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.723 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 80.2 t -97.06 131.8 43.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 1.1599999999999999 110.131 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -101.05 171.21 7.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.625 0.25 . . . . 1.98 111.029 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 63.51 34.82 12.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.708 -0.678 . . . . 2.0600000000000001 110.899 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.14 18.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.862 -0.608 . . . . 0.20999999999999999 111.133 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 1.2 mp -97.97 -32.94 11.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.989 -1.005 . . . . 0.38 110.357 -177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.643 ' SD ' HG23 ' A' ' 70' ' ' ILE . 83.6 mtp -144.41 170.18 16.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.20000000000000001 110.761 -177.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 88.0 t80 -148.61 153.07 37.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 0.23000000000000001 110.943 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 73.7 mt -128.14 134.32 65.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.945 -0.761 . . . . 0.16 108.945 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -122.03 110.59 32.89 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.614 -0.513 . . . . 2.3799999999999999 109.614 179.164 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 36' ' ' LYS . 4.2 Cg_exo -77.07 132.09 12.48 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.615 2.21 . . . . 0.34999999999999998 112.501 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 83' ' ' LYS . 9.7 p -93.17 -33.49 13.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.629 0.728 . . . . 0.85999999999999999 109.34 172.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -86.92 172.69 9.85 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.395 -1.275 . . . . 2.1600000000000001 108.783 170.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -81.31 138.57 35.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.254 0.55 . . . . 2.4199999999999999 110.544 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.17 134.42 49.15 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.342 -0.844 . . . . 0.72999999999999998 111.663 -172.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.438 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 97.4 Cg_exo -46.84 123.15 6.88 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.339 3.359 . . . . 0.68000000000000005 113.434 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.97 -42.8 80.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.203 -0.908 . . . . 2.2799999999999998 112.609 -173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.523 ' HA ' HG12 ' A' ' 47' ' ' VAL . 72.4 m-85 -71.36 -25.15 62.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.96 0.409 . . . . 3.3399999999999999 110.976 -173.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 5.0 mptp? -66.07 -23.77 66.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 1.9399999999999999 111.012 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' ' HB3' ' A' ' 23' ' ' TRP . 73.9 m-85 -77.44 -48.94 15.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 0.93000000000000005 110.723 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.4 p -75.53 -42.8 42.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.085 -0.507 . . . . 1.0700000000000001 112.188 -173.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -74.0 -34.71 64.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.057 0.456 . . . . 1.6599999999999999 111.022 -173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' CG ' ' A' ' 53' ' ' ASN . 95.3 mtt180 -88.6 -8.48 54.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.096 -0.502 . . . . 2.0 111.662 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 66.67 14.78 9.92 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.28 0.562 . . . . 2.2599999999999998 110.607 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.45 -14.04 52.67 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.46000000000000002 112.853 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -106.69 123.46 48.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 2.4300000000000002 111.034 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.682 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.2 m-20 -119.48 117.18 27.73 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.232 -0.44 . . . . 2.0499999999999998 110.095 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.93 115.19 27.85 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.326 0.584 . . . . 1.47 110.03 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.2 mt -82.72 -53.49 5.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 112.299 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -156.73 147.73 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.745 -0.465 . . . . 0.25 109.745 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -132.05 171.17 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.39 0.515 . . . . 2.23 112.39 -175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 15' ' ' SER . 3.8 t-20 67.81 46.03 1.33 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.817 -1.083 . . . . 1.3999999999999999 111.001 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 56' ' ' ILE . 54.2 mt -74.66 -25.09 58.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.8 -0.636 . . . . 0.33000000000000002 112.069 -176.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 16' ' ' ASN . 22.5 tt0 -56.98 -46.57 82.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.68 0.753 . . . . 1.76 111.17 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.9 m -82.9 -2.8 55.87 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.787 -1.097 . . . . 1.5900000000000001 111.578 -171.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 37.5 t70 -163.74 103.11 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.162 -0.472 . . . . 1.9199999999999999 109.974 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -61.68 -32.98 73.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.761 -0.654 . . . . 1.6799999999999999 111.323 -176.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.8 mmtp -62.89 -23.52 67.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.674 -0.693 . . . . 1.0700000000000001 112.037 -176.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 66.2 mt -58.42 -39.32 79.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.728 -0.215 . . . . 0.34000000000000002 111.15 174.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -60.33 -35.47 75.71 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.252 -0.277 . . . . 0.23999999999999999 110.252 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -60.97 -57.18 13.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.353 0.596 . . . . 0.40000000000000002 109.887 -177.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 43.3 t -66.51 -30.38 70.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.662 -0.699 . . . . 1.22 110.979 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.678 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.25 -35.03 76.26 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 119.847 -1.168 . . . . 0.17000000000000001 111.187 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.643 HG23 ' SD ' ' A' ' 33' ' ' MET . 90.5 mt -63.85 -44.54 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 115.496 -0.352 . . . . 0.17999999999999999 111.002 174.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 156' ' ' ILE . 8.8 p -63.46 -37.57 87.81 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.063 0.458 . . . . 1.1000000000000001 110.031 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 68' ' ' SER . 11.4 mm-40 -65.4 -29.21 69.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.594 -0.73 . . . . 1.8200000000000001 110.489 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.564 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 80.8 t80 -71.33 -51.46 24.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.598 -0.728 . . . . 0.20000000000000001 110.445 176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.76 HG21 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -64.05 -28.05 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 109.814 -0.439 . . . . 0.28000000000000003 109.814 179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 82.2 tttt -50.81 -47.2 60.03 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.315 -0.857 . . . . 1.8500000000000001 110.84 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 80' ' ' ILE . 25.7 tp10 -63.38 -37.2 86.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.285 -0.871 . . . . 1.3100000000000001 110.078 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.43 -33.87 74.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.354 -0.384 . . . . 0.23999999999999999 111.599 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE2' ' CE1' ' A' ' 158' ' ' PHE . 0.8 OUTLIER -76.29 -20.83 56.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.346 -0.613 . . . . 1.8799999999999999 109.346 177.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -39.5 16.44 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.487 -0.779 . . . . 1.77 111.906 -174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.91 -10.62 9.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.684 0.754 . . . . 0.33000000000000002 109.711 178.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 71.12 60.65 0.17 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.706 -1.588 . . . . 1.47 110.807 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -116.63 -150.58 9.39 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.089 -0.959 . . . . 0.26000000000000001 112.827 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.48 153.33 38.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.975 -0.75 . . . . 1.0600000000000001 108.975 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -107.13 133.68 51.37 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.858 -0.337 . . . . 0.17000000000000001 110.162 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.5 m -124.35 126.42 45.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 110.357 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' A' ' 33' ' ' MET . 9.8 tp -95.44 110.95 22.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.416 -0.356 . . . . 1.51 110.267 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 44.6 mt -78.0 152.43 33.07 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.471 -0.566 . . . . 0.26000000000000001 109.471 175.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 28.2 tt0 -119.63 135.49 54.79 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.275 -0.57 . . . . 1.9299999999999999 109.905 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 12.8 t60 165.98 -53.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.837 -1.074 . . . . 1.79 108.481 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.588 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 43.1 t80 -62.13 -48.04 81.89 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.033 -0.985 . . . . 3.9500000000000002 111.452 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.453 ' OD1' ' HA ' ' A' ' 97' ' ' LYS . 1.8 m-20 -57.18 -23.18 45.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.896 0.379 . . . . 2.2200000000000002 111.718 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.7 m -87.03 -15.55 38.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.304 -0.407 . . . . 1.78 111.337 -176.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.5 m -118.66 -35.31 3.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.755 0.312 . . . . 1.6299999999999999 111.779 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 11.5 t80 -96.14 145.26 29.26 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.642 -0.503 . . . . 2.8500000000000001 109.642 -177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.566 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 18.9 Cg_endo -60.94 -5.95 5.46 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.197 2.598 . . . . 0.68999999999999995 114.032 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 66' ' ' PHE . 61.0 mt -97.81 109.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.229 0.538 . . . . 0.35999999999999999 110.504 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HA ' ' OD1' ' A' ' 91' ' ' ASP . 13.8 ptpt -124.57 126.58 46.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.128 -0.942 . . . . 1.3799999999999999 108.918 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.72 175.4 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.156 0.799 . . . . 0.33000000000000002 113.156 -167.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.86 134.1 42.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.297 -0.865 . . . . 1.1100000000000001 110.235 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.511 ' HB3' ' CE ' ' A' ' 125' ' ' MET . 5.3 mp -104.97 135.91 45.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.34999999999999998 111.134 -175.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -132.14 147.77 52.45 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.749 0.309 . . . . 0.33000000000000002 111.379 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.708 ' CE1' ' SD ' ' A' ' 125' ' ' MET . 7.5 m-85 -111.86 155.26 23.9 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.974 -0.557 . . . . 0.34000000000000002 111.04 174.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -113.13 115.7 28.69 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.148 -1.056 . . . . 0.25 108.148 171.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.566 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -121.03 103.66 9.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.772 0.32 . . . . 1.22 110.671 176.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.15 -99.06 0.84 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.971 -0.852 . . . . 0.41999999999999998 110.971 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 139' ' ' THR . 16.7 p -122.15 -3.45 9.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.343 0.592 . . . . 1.3100000000000001 109.483 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -94.47 113.89 25.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 2.27 110.866 -174.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.5 p -93.23 132.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.158 0.504 . . . . 0.79000000000000004 110.302 175.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtt -138.25 133.98 17.48 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.687 -0.688 . . . . 1.8500000000000001 110.669 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 71.7 Cg_endo -73.98 158.24 46.22 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.631 2.22 . . . . 0.28999999999999998 112.227 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.7 138.58 33.23 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -90.88 135.16 33.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.415 -0.587 . . . . 1.8500000000000001 109.415 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.9 m -60.0 118.98 6.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.773 -0.649 . . . . 0.46999999999999997 111.078 -175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.64 38.5 95.74 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.839 -0.619 . . . . 0.38 112.863 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.457 ' OE1' ' HD2' ' A' ' 116' ' ' PRO . 10.0 tp10 -131.76 128.41 21.66 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.775 -0.454 . . . . 1.9299999999999999 109.775 177.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 115' ' ' GLU . 30.4 Cg_endo -64.16 112.12 1.79 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.052 1.835 . . . . 0.68000000000000005 110.793 172.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.472 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.0 t80 -113.16 138.33 50.12 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 109.446 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 9.7 p -62.72 116.47 2.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.511 0.672 . . . . 0.70999999999999996 111.774 -173.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.671 HG11 ' HB1' ' A' ' 77' ' ' ALA . 7.8 p -119.9 -8.57 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.437 -0.801 . . . . 0.23000000000000001 110.638 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.63 -14.35 62.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.8 -0.637 . . . . 1.3500000000000001 112.437 -172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -140.16 37.85 1.92 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.621 0.725 . . . . 2.3500000000000001 110.491 -173.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.566 HG22 ' HD2' ' A' ' 104' ' ' LYS . 28.6 pt -90.61 169.94 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.343 0.592 . . . . 0.37 110.626 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.603 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.0 m-20 -100.86 -39.57 7.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.973 -1.012 . . . . 0.5 109.877 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.48 158.71 32.45 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.441 -0.8 . . . . 0.22 110.532 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.76 ' SD ' HG21 ' A' ' 74' ' ' VAL . 9.9 ttt -134.94 153.45 52.07 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.465 -0.569 . . . . 1.1599999999999999 109.465 172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.2 m -151.99 159.79 43.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.654 0.264 . . . . 1.22 110.638 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 3.6 t -126.39 109.71 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.024 -0.534 . . . . 0.27000000000000002 110.097 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.628 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -102.88 141.67 22.98 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 108.802 -0.814 . . . . 0.42999999999999999 108.802 177.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 131' ' ' GLY . 65.9 Cg_endo -80.24 118.14 3.59 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.037 1.158 . . . . 0.91000000000000003 111.933 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 47.31 -71.53 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.589 1.181 . . . . 3.29 114.104 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -65.04 83.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 N-CA-C 112.023 -0.431 . . . . 0.44 112.023 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 19.9 p -86.65 -3.94 59.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.912 0.485 . . . . 1.23 111.149 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 14.3 p -56.61 -9.56 0.78 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.778 -0.647 . . . . 1.3 112.691 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.9 m -59.53 -40.3 86.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.236 0.541 . . . . 0.44 110.072 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.629 HD21 ' HB2' ' A' ' 148' ' ' ARG . 96.3 mt -117.47 -6.48 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.569 -0.741 . . . . 0.37 111.766 -176.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 22.6 ttpp -81.6 83.16 7.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 1.6599999999999999 111.019 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.759 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.65 171.69 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.354 -0.61 . . . . 0.51000000000000001 109.354 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.478 ' N ' HG22 ' A' ' 137' ' ' VAL . 24.6 mttt -62.35 -46.67 87.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.105 0.479 . . . . 2.0600000000000001 111.041 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -141.74 149.19 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.579 -0.737 . . . . 0.39000000000000001 110.282 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.759 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -148.32 157.35 43.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.701 0.63 . . . . 0.78000000000000003 112.701 -172.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.8 139.92 29.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.155 -0.929 . . . . 0.44 110.573 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HD2' ' HB3' ' A' ' 123' ' ' ASP . 54.7 tttm -62.56 -31.18 71.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.789 -0.641 . . . . 1.1100000000000001 110.669 177.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -35.98 67.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.436 -0.802 . . . . 0.66000000000000003 110.172 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.4 ttt -76.04 -39.29 55.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.988 -1.005 . . . . 0.47999999999999998 110.709 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 103' ' ' LEU . 16.3 t80 -53.06 -54.41 35.83 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.566 0.541 . . . . 0.29999999999999999 110.933 -174.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.507 ' HA ' ' HB2' ' A' ' 155' ' ' SER . 0.8 OUTLIER -63.84 -44.37 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.752 -0.658 . . . . 0.19 111.693 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.2 t -65.76 -34.6 78.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.954 0.407 . . . . 0.84999999999999998 110.966 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.629 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.1 OUTLIER -66.61 -49.07 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 2.48 111.261 175.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -67.28 -38.8 91.89 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.359 -0.924 . . . . 0.17000000000000001 111.917 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -57.79 -44.72 86.48 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.186 0.194 . . . . 1.4199999999999999 111.237 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.7 t -71.61 -28.56 63.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.816 0.341 . . . . 0.40000000000000002 110.526 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -76.07 -9.67 58.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.548 0.689 . . . . 1.3100000000000001 110.275 172.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.62 -12.86 32.79 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.106 -0.952 . . . . 0.25 115.071 171.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 67' ' ' TYR . . . -144.0 124.44 13.92 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.058 1.429 . . . . 0.19 113.078 171.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.507 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 31.8 p -148.5 159.89 43.61 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.323 0.582 . . . . 1.4199999999999999 111.481 166.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.658 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.9 tt -155.78 118.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 109.757 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.5 p -121.43 145.5 47.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.563 -0.29 . . . . 1.4399999999999999 111.566 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.506 ' CE1' ' HE2' ' A' ' 78' ' ' LYS . 6.2 m-85 . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.867 -0.587 . . . . 1.8100000000000001 110.277 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.851 0.357 . . . . 3.6800000000000002 110.584 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.52 ' HB3' ' C ' ' A' ' 26' ' ' GLU . 37.4 mt-10 -84.38 -26.87 28.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.35 -0.386 . . . . 2.3799999999999999 111.509 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -60.89 133.59 56.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 1.6100000000000001 111.339 -175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.73 -157.72 27.33 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.408 -0.815 . . . . 0.26000000000000001 111.76 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -126.81 153.62 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.908 0.354 . . . . 0.17999999999999999 111.088 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.72 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 20.7 m-85 -130.98 137.76 49.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.318 -0.401 . . . . 0.56999999999999995 110.734 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 33' ' ' MET . 2.6 tm? -91.31 120.82 32.51 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.418 -0.956 . . . . 0.16 108.418 176.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -119.08 144.84 26.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 120.737 0.303 . . . . 0.19 110.621 -175.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 67.8 t80 -97.97 128.89 44.81 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.12 -0.696 . . . . 0.90000000000000002 109.12 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -121.11 156.01 33.22 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.515 -0.311 . . . . 0.60999999999999999 110.236 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -84.77 -2.82 58.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.602 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.84 132.17 53.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.971 -0.381 . . . . 1.3100000000000001 109.971 175.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.5 m 58.73 23.27 10.94 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.253 0.346 . . . . 1.23 110.892 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 58.16 30.47 19.43 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.762 -0.654 . . . . 1.3 111.395 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 151.67 100.65 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.795 -0.717 . . . . 0.39000000000000001 112.065 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 99.7 m -137.37 149.32 46.9 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 110.432 -0.21 . . . . 0.40000000000000002 110.432 176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 69' ' ' GLY . 14.5 mt -104.13 145.2 30.53 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.966 0.412 . . . . 0.57999999999999996 110.101 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -138.69 128.42 24.94 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.442 -0.799 . . . . 0.19 109.735 -174.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 9.8 tt -105.92 113.29 42.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.72 0.771 . . . . 0.28000000000000003 109.744 174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 8.0 p -91.11 119.24 37.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.223 -0.899 . . . . 0.23999999999999999 110.685 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 63.3 m95 -98.34 106.51 18.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.023 -0.732 . . . . 0.31 109.023 173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -144.72 173.77 11.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.321 -0.854 . . . . 1.3600000000000001 110.26 -171.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 9.55 18.2 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.082 0.944 . . . . 1.9399999999999999 108.776 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' C ' ' HB3' ' A' ' 4' ' ' GLU . 9.6 pt-20 -129.07 177.85 6.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.946 -1.479 . . . . 1.45 109.722 -175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -89.68 143.39 26.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.552 -0.459 . . . . 2.3500000000000001 110.675 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 96.6 t -121.28 131.66 72.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.897 -0.592 . . . . 1.1599999999999999 110.271 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -100.3 177.19 5.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.44 -0.345 . . . . 1.98 110.647 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 66.37 20.21 10.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.531 0.682 . . . . 2.0600000000000001 109.798 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -99.36 149.43 23.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.607 -0.724 . . . . 0.20999999999999999 111.24 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.626 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -98.19 -31.13 12.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.02 -0.991 . . . . 0.38 109.896 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.725 ' SD ' HG23 ' A' ' 70' ' ' ILE . 92.7 mtp -142.04 169.78 16.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.906 -0.588 . . . . 0.20000000000000001 110.958 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 75.0 t80 -149.03 152.56 36.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 110.948 -174.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.6 mt -129.21 132.94 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.16 109.579 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -113.56 110.93 49.53 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 110.13 -0.322 . . . . 2.3799999999999999 110.13 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' HB3' HG13 ' A' ' 80' ' ' ILE . 6.4 Cg_exo -78.23 126.37 7.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.954 1.769 . . . . 0.34999999999999998 111.992 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.0 p -94.04 -32.4 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.877 0.846 . . . . 0.85999999999999999 108.883 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.46 151.87 22.69 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.428 -1.323 . . . . 2.1600000000000001 107.428 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.84 134.57 56.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.189 0.519 . . . . 2.4199999999999999 110.234 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.15 135.52 50.92 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.322 -0.854 . . . . 0.72999999999999998 111.104 -173.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' VAL . 80.6 Cg_exo -48.31 120.6 5.19 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.893 3.062 . . . . 0.68000000000000005 112.684 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -71.25 -38.49 71.93 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.926 -0.579 . . . . 2.2799999999999998 112.408 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.503 ' HA ' HG12 ' A' ' 47' ' ' VAL . 63.4 m-85 -71.81 -22.33 61.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.015 0.436 . . . . 3.3399999999999999 110.513 -175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -68.22 -39.25 82.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.974 -0.557 . . . . 1.9399999999999999 111.066 176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -61.41 -47.25 86.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 0.93000000000000005 110.918 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 44' ' ' PHE . 9.5 p -75.7 -32.63 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.612 -0.722 . . . . 1.0700000000000001 111.513 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -74.85 -43.38 54.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.319 . . . . 1.6599999999999999 111.043 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -80.63 -15.04 57.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 2.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 67.59 12.63 8.97 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.214 1.007 . . . . 2.2599999999999998 109.942 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.74 -15.33 52.64 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 114.766 -1.107 . . . . 0.46000000000000002 112.19 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -107.15 124.8 50.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.23 -0.285 . . . . 2.4300000000000002 110.23 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -148.05 119.89 8.14 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.24 -0.584 . . . . 2.0499999999999998 111.36 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.61 122.9 31.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.791 -0.64 . . . . 1.47 109.779 176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.54000000000000004 111.438 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 59' ' ' LEU . 19.4 tt -145.26 151.87 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 108.861 -0.792 . . . . 0.25 108.861 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 0.5 OUTLIER -139.25 173.66 11.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.657 0.614 . . . . 2.23 112.657 -175.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.3 t30 64.67 47.43 2.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 114.695 -1.139 . . . . 1.3999999999999999 110.242 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 56' ' ' ILE . 50.8 mt -75.93 -15.1 60.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.541 -0.754 . . . . 0.33000000000000002 111.312 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.76 -47.23 74.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.947 0.721 . . . . 1.76 112.947 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.9 p -79.94 -19.57 47.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.236 0.541 . . . . 1.5900000000000001 111.278 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.482 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 19.5 t70 -147.59 111.5 5.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.735 -0.666 . . . . 1.9199999999999999 110.456 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE3' HG12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -70.07 -29.19 66.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.691 -176.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 63' ' ' LYS . 32.4 mmtp -64.93 -22.43 67.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 111.603 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 79.3 mt -58.87 -37.8 77.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.803 -0.18 . . . . 0.34000000000000002 111.236 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' HD1' HD11 ' A' ' 19' ' ' LEU . 12.3 t80 -60.53 -36.68 78.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 109.713 -0.476 . . . . 0.23999999999999999 109.713 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.684 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -61.35 -55.36 32.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 0.40000000000000002 110.152 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 33.3 m -71.21 -27.42 63.48 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.049 -0.523 . . . . 1.22 111.431 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.52 -37.24 88.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.803 -1.189 . . . . 0.17000000000000001 110.381 171.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.725 HG23 ' SD ' ' A' ' 33' ' ' MET . 73.7 mt -59.91 -49.29 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.701 -0.749 . . . . 0.17999999999999999 111.77 173.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 p -60.12 -35.78 76.01 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.215 0.531 . . . . 1.1000000000000001 110.113 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' SER . 14.6 mm-40 -62.78 -39.91 95.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.404 -0.816 . . . . 1.8200000000000001 110.11 175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 92.8 t80 -62.49 -45.17 94.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.584 -0.734 . . . . 0.20000000000000001 110.84 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.781 HG21 ' SD ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -69.02 -27.18 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.124 0.488 . . . . 0.28000000000000003 110.243 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 83.6 tttt -63.76 -32.09 73.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 1.8500000000000001 110.439 176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.9 mm-40 -63.35 -37.73 88.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.106 -0.702 . . . . 1.3100000000000001 109.106 176.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -73.67 -31.55 63.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.53 -0.759 . . . . 0.23999999999999999 111.31 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.722 ' HG2' HG22 ' A' ' 119' ' ' VAL . 13.1 mtpp -69.11 -21.04 64.07 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 120.777 -0.369 . . . . 1.8799999999999999 110.442 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.67 -49.29 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.004 0.431 . . . . 1.77 110.953 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -84.4 -13.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.731 0.777 . . . . 0.33000000000000002 109.609 -177.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 71.91 54.41 0.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.647 -1.615 . . . . 1.47 111.826 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.84 -136.72 7.52 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.141 -1.028 . . . . 0.26000000000000001 113.386 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.54 156.58 33.88 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.473 0.709 . . . . 1.0600000000000001 109.492 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 85' ' ' THR . 1.9 tm? -115.49 142.41 46.75 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.382 -0.229 . . . . 0.17000000000000001 110.382 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 84' ' ' LEU . 94.5 m -135.23 136.93 42.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.617 0.367 . . . . 0.20999999999999999 111.123 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.79 ' HG ' HD13 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -104.73 111.02 23.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 109.949 -0.389 . . . . 1.51 109.949 176.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -78.45 150.94 32.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.213 -0.662 . . . . 0.26000000000000001 109.213 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -119.65 134.28 55.29 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.029 -0.669 . . . . 1.9299999999999999 109.562 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 42.5 t-80 165.72 -49.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.21 -0.905 . . . . 1.79 109.012 -174.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.626 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 59.4 t80 -64.77 -43.31 93.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.3 -0.864 . . . . 3.9500000000000002 111.534 -178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.75 -33.52 35.3 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 2.2200000000000002 111.356 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.5 m -71.22 -31.25 67.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 1.78 111.583 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.0 m -100.75 -36.63 9.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.851 0.358 . . . . 1.6299999999999999 111.804 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.544 ' CG ' ' HD2' ' A' ' 95' ' ' PRO . 4.0 t80 -97.36 146.92 32.2 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.383 -0.371 . . . . 2.8500000000000001 110.157 -175.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' HD2' ' CG ' ' A' ' 94' ' ' PHE . 58.7 Cg_endo -70.37 23.35 0.19 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.121 2.547 . . . . 0.68999999999999995 113.972 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.533 HG12 ' HE3' ' A' ' 63' ' ' LYS . 76.2 mt -117.69 111.71 35.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.074 0.464 . . . . 0.35999999999999999 110.578 174.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.551 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 92.7 mttt -124.21 125.59 44.68 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.659 -0.867 . . . . 1.3799999999999999 108.659 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.81 163.89 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.738 0.644 . . . . 0.33000000000000002 112.738 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -125.15 140.59 52.74 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.637 -0.875 . . . . 1.1100000000000001 108.637 171.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD13 ' HG ' ' A' ' 86' ' ' LEU . 6.3 mp -105.97 136.29 45.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.598 0.237 . . . . 0.34999999999999998 111.192 -176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 4.1 m-85 -124.97 154.43 41.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.105 0.409 . . . . 0.33000000000000002 112.105 -175.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.916 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 2.5 m-30 -120.5 149.85 41.76 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.824 -0.626 . . . . 0.34000000000000002 111.816 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.7 OUTLIER -110.19 124.3 51.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.25 108.85 173.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE2' HG22 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -121.72 105.47 10.43 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.386 -0.227 . . . . 1.22 110.386 174.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.62 -98.42 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.501 -0.857 . . . . 0.41999999999999998 111.457 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.8 m -125.18 5.69 7.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.912 0.387 . . . . 1.3100000000000001 110.804 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 138' ' ' LYS . 3.2 ttmp? -108.47 136.64 47.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.986 0.422 . . . . 2.27 110.389 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.9 p -104.59 132.52 51.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 121.229 0.538 . . . . 0.79000000000000004 110.462 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.4 mmm -133.42 123.19 17.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.582 -0.736 . . . . 1.8500000000000001 109.965 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 56.7 Cg_endo -70.45 152.16 65.58 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.511 2.14 . . . . 0.28999999999999998 112.658 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.572 ' HG ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -83.73 139.69 32.58 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.605 -0.887 . . . . 0.31 108.605 178.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 115' ' ' GLU . 48.7 t30 -90.59 130.82 36.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.849 -0.426 . . . . 1.8500000000000001 109.849 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.3 m -60.39 121.93 13.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.922 -0.581 . . . . 0.46999999999999997 111.328 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.1 20.37 79.3 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.534 -0.757 . . . . 0.38 113.093 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 112' ' ' ASN . 19.5 tp10 -123.39 124.66 26.28 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.091 -0.337 . . . . 1.9299999999999999 110.091 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 115' ' ' GLU . 37.4 Cg_endo -65.42 112.73 2.21 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.253 1.969 . . . . 0.68000000000000005 110.818 173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.532 ' HD1' HD22 ' A' ' 111' ' ' LEU . 7.6 t80 -122.76 142.27 50.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.3 -175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.499 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.8 p -53.7 107.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.426 -0.806 . . . . 0.70999999999999996 113.034 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.722 HG22 ' HG2' ' A' ' 78' ' ' LYS . 7.6 p -102.75 -20.73 5.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.392 -0.822 . . . . 0.23000000000000001 110.241 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.414 ' CG ' HG23 ' A' ' 118' ' ' VAL . 3.3 pt20 -56.53 -49.02 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.465 -0.789 . . . . 1.3500000000000001 110.598 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 120' ' ' GLN . 36.5 t70 -104.48 72.01 1.03 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.9 -0.591 . . . . 2.3500000000000001 110.74 -175.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' HE2' ' A' ' 104' ' ' LYS . 10.9 pt -139.27 156.4 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.806 -0.634 . . . . 0.37 109.619 174.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.526 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.2 m-20 -89.29 -38.26 14.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.574 -0.739 . . . . 0.5 111.001 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.9 158.08 37.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.013 -0.539 . . . . 0.22 110.827 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.916 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.3 ttt -137.24 150.08 47.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.09 -0.504 . . . . 1.1599999999999999 109.906 175.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 58.2 p -140.34 164.51 29.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.959 0.409 . . . . 1.22 111.76 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 4.7 t -127.64 107.47 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.42 -0.809 . . . . 0.27000000000000002 109.33 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.463 HD21 ' HG ' ' A' ' 135' ' ' LEU . 1.5 mp -106.47 136.99 19.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 120.835 0.35 . . . . 0.42999999999999999 110.261 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -85.47 117.89 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.408 2.072 . . . . 0.91000000000000003 112.852 175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.576 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.5 mmpt? 51.76 -61.01 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.557 1.318 . . . . 3.29 114.557 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -73.39 54.74 1.96 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.291 -0.724 . . . . 0.44 111.291 174.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 128' ' ' LEU . 5.3 m -78.07 -7.51 57.03 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.114 0.566 . . . . 1.23 110.395 -177.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 49.1 m -65.81 -13.04 58.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.632 -0.713 . . . . 1.3 110.879 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.2 m -53.69 -42.29 67.83 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.799 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 148' ' ' ARG . 67.6 mt -109.25 21.95 16.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.132 -0.486 . . . . 0.37 110.965 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 25.6 ttpp -107.35 80.7 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.886 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.705 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.3 p -140.45 167.88 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.526 -0.546 . . . . 0.51000000000000001 109.526 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.458 ' N ' HG22 ' A' ' 137' ' ' VAL . 36.5 mttt -60.16 -44.82 94.71 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 111.084 -176.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.35 149.85 44.65 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.987 -0.551 . . . . 0.39000000000000001 110.269 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.705 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.9 mtp -145.95 160.92 41.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.291 0.567 . . . . 0.78000000000000003 112.35 -173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.51 130.51 35.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.171 -0.922 . . . . 0.44 109.943 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 146' ' ' VAL . 87.8 tttt -60.15 -26.81 66.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 110.806 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.68 -44.53 56.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.665 0.745 . . . . 0.66000000000000003 110.011 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.2 ttt -68.73 -36.55 78.55 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.921 -1.036 . . . . 0.47999999999999998 110.086 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.13 -57.64 10.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.928 -0.578 . . . . 0.29999999999999999 110.803 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.704 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -65.69 -43.17 93.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.06 -0.518 . . . . 0.19 111.68 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 44.9 t -62.5 -42.93 99.84 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.916 -0.314 . . . . 0.84999999999999998 110.9 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.667 ' HB2' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -61.96 -44.71 96.19 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.358 -0.383 . . . . 2.48 110.798 176.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -68.93 -40.51 84.39 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.413 -0.899 . . . . 0.17000000000000001 111.525 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -60.53 -41.31 94.17 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.236 0.214 . . . . 1.4199999999999999 111.441 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.2 t -76.11 -23.33 54.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.145 0.498 . . . . 0.40000000000000002 110.218 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -12.56 60.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 109.702 169.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.67 -13.9 35.31 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.853 -1.067 . . . . 0.25 114.395 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -145.94 126.81 14.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.634 1.217 . . . . 0.19 113.62 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.704 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 5.9 t -153.01 166.92 30.9 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 109.775 163.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 12.2 tt -155.28 119.05 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.063 -0.971 . . . . 0.28000000000000003 109.196 -177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.9 p -120.56 131.77 54.83 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.178 0.513 . . . . 1.4399999999999999 111.137 -171.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.582 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 73.9 m-85 . . . . . 0 N--CA 1.439 -1.009 0 CA-C-O 118.481 -0.771 . . . . 1.8100000000000001 109.882 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.536 0.208 . . . . 3.6800000000000002 111.374 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.22 -63.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.611 0.243 . . . . 2.3799999999999999 110.796 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -88.77 115.44 26.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.433 0.635 . . . . 1.6100000000000001 110.479 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 159.51 -165.6 34.52 Favored Glycine 0 C--N 1.315 -0.616 0 CA-C-N 115.117 -0.947 . . . . 0.26000000000000001 111.616 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -119.86 154.64 34.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.906 0.353 . . . . 0.17999999999999999 111.238 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 7.5 m-85 -129.14 133.57 47.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.208 -0.451 . . . . 0.56999999999999995 110.294 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.595 HD11 HD22 ' A' ' 19' ' ' LEU . 3.1 tm? -87.19 114.35 23.73 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.621 -1.252 . . . . 0.16 107.621 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -111.45 141.46 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.34 -0.391 . . . . 0.19 110.632 -172.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -96.44 125.05 40.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 109.416 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -119.68 144.89 46.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.301 -0.629 . . . . 0.60999999999999999 109.301 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.21 7.12 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.275 -0.42 . . . . 2.3700000000000001 111.368 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 127.4 31.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.655 -0.498 . . . . 1.3100000000000001 109.655 172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.5 t 58.91 23.64 11.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.36 0.6 . . . . 1.23 109.817 -176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 m120 58.71 25.89 13.94 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 114.985 -1.007 . . . . 1.3 111.495 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 59' ' ' LEU . . . 160.36 102.12 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.467 -0.873 . . . . 0.39000000000000001 112.212 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 91.5 m -137.43 147.85 45.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.964 -0.384 . . . . 0.40000000000000002 109.964 174.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.623 HD11 ' HD1' ' A' ' 66' ' ' PHE . 16.8 mt -103.7 143.43 32.8 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.175 0.512 . . . . 0.57999999999999996 110.205 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -138.34 128.51 25.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.149 -0.932 . . . . 0.19 109.309 -175.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.26 109.6 28.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.666 0.746 . . . . 0.28000000000000003 109.868 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.711 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 9.0 p -91.43 123.98 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.37 -0.832 . . . . 0.23999999999999999 111.02 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 37.1 m95 -100.51 107.12 18.74 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.101 -0.703 . . . . 0.31 109.101 171.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.6 157.46 43.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.163 -0.926 . . . . 1.3600000000000001 110.341 -172.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 25' ' ' LYS . 1.0 OUTLIER -105.19 25.83 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.583 0.706 . . . . 1.9399999999999999 109.586 177.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 10.3 pt-20 -131.0 174.21 10.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.686 -1.143 . . . . 1.45 109.148 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.92 100.48 10.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.681 0.276 . . . . 2.3500000000000001 110.593 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.535 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -87.09 135.88 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 110.237 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -92.92 -175.1 3.79 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.766 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.444 HD22 HG12 ' A' ' 10' ' ' VAL . 15.3 t30 69.75 22.92 5.88 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.848 0.832 . . . . 2.0600000000000001 110.326 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.62 147.44 28.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.856 -0.611 . . . . 0.20999999999999999 111.236 -176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.715 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -98.06 -22.73 16.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.735 -0.666 . . . . 0.38 109.83 -178.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.609 ' SD ' HG23 ' A' ' 70' ' ' ILE . 73.7 mtp -147.77 170.13 18.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.89 -0.595 . . . . 0.20000000000000001 110.913 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 83.5 t80 -149.14 155.54 40.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.623 -174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 87.0 mt -130.27 131.28 65.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.301 -0.629 . . . . 0.16 109.301 176.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.19 109.07 41.17 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.347 -0.541 . . . . 2.3799999999999999 109.605 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.84 127.56 7.11 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.009 2.473 . . . . 0.34999999999999998 112.45 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.9 p -86.33 -28.0 23.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.933 0.873 . . . . 0.85999999999999999 108.938 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -85.97 159.54 19.6 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.086 -1.415 . . . . 2.1600000000000001 108.784 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -68.89 131.21 44.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.591 -0.522 . . . . 2.4199999999999999 109.591 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.48 142.14 49.76 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.72999999999999998 111.435 -172.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 80.2 Cg_exo -49.6 121.41 7.15 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.718 2.945 . . . . 0.68000000000000005 112.722 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.98 -34.23 59.77 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.849 -0.614 . . . . 2.2799999999999998 111.469 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 47' ' ' VAL . 32.3 m-85 -65.51 -25.04 67.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.049 0.452 . . . . 3.3399999999999999 110.455 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 4.7 mptp? -71.86 -21.03 61.72 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.014 -0.539 . . . . 1.9399999999999999 110.95 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.78 -38.72 25.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.414 . . . . 0.93000000000000005 110.546 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 44' ' ' PHE . 3.7 p -85.94 -52.31 12.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.337 0.495 . . . . 1.0700000000000001 112.337 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -72.05 -35.14 69.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 1.6599999999999999 111.251 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 96.7 mtt180 -88.2 -14.84 37.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.34 -0.391 . . . . 2.0 111.058 177.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 69.31 -5.71 1.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.686 0.755 . . . . 2.2599999999999998 110.235 -172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 49' ' ' ARG . . . 109.83 -13.12 32.21 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.613 -0.721 . . . . 0.46000000000000002 111.824 -176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' HA ' ' HE1' ' A' ' 20' ' ' PHE . 12.8 ptmt -104.6 134.11 48.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.973 0.416 . . . . 2.4300000000000002 111.203 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -148.75 120.18 7.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.056 -0.52 . . . . 2.0499999999999998 110.021 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -87.85 120.09 28.83 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.413 0.625 . . . . 1.47 109.853 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.9 mt -80.75 -63.11 1.48 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 0.54000000000000004 111.697 -172.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 59' ' ' LEU . 20.9 tt -147.8 151.14 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.813 -0.63 . . . . 0.25 109.338 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 5.6 ppt_? -136.95 172.07 13.56 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.597 -0.441 . . . . 2.23 111.891 -174.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.5 t-20 69.98 45.98 0.68 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.27 -0.877 . . . . 1.3999999999999999 110.61 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 17' ' ' GLY . 37.1 mt -76.91 -19.86 56.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.471 -0.786 . . . . 0.33000000000000002 111.599 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -59.51 -47.5 85.28 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.343 0.497 . . . . 1.76 112.343 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.6 p -84.36 -23.58 30.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.346 0.593 . . . . 1.5900000000000001 110.647 -175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -133.83 96.33 3.64 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.37 -0.832 . . . . 1.9199999999999999 110.312 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE3' HG12 ' A' ' 96' ' ' ILE . 30.1 mttp -59.17 -40.9 87.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.495 -0.775 . . . . 1.6799999999999999 111.845 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 34.4 mmtp -61.22 -20.46 62.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 1.0700000000000001 112.044 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 56' ' ' ILE . 57.5 mt -62.45 -36.66 83.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.79 175.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.623 ' HD1' HD11 ' A' ' 19' ' ' LEU . 10.1 t80 -64.15 -37.2 86.62 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.791 -0.448 . . . . 0.23999999999999999 109.791 175.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.72 -56.21 22.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.449 0.642 . . . . 0.40000000000000002 109.913 -176.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.5 p -70.69 -29.5 65.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.47 -0.786 . . . . 1.22 111.33 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -59.28 -38.21 92.96 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.52 -0.848 . . . . 0.17000000000000001 111.107 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.609 HG23 ' SD ' ' A' ' 33' ' ' MET . 92.9 mt -57.85 -45.51 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.863 0.363 . . . . 0.17999999999999999 110.246 171.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.787 ' SG ' ' HB1' ' A' ' 154' ' ' ALA . 64.4 m -61.34 -38.81 88.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.972 -0.558 . . . . 1.1000000000000001 110.692 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 12.6 mm-40 -65.56 -28.84 69.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.303 0.573 . . . . 1.8200000000000001 110.398 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.563 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 81.8 t80 -73.26 -46.87 47.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.58 -0.736 . . . . 0.20000000000000001 110.43 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -67.87 -26.62 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.587 -0.523 . . . . 0.28000000000000003 109.587 177.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HB2' ' CD1' ' A' ' 156' ' ' ILE . 37.3 tttp -53.5 -46.37 70.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.407 -0.815 . . . . 1.8500000000000001 110.47 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.1 tp10 -64.06 -45.62 87.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.031 -0.531 . . . . 1.3100000000000001 109.695 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.496 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -55.53 -39.74 70.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.23999999999999999 111.511 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 5.4 pttm -80.8 -20.14 43.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.397 0.618 . . . . 1.8799999999999999 110.293 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -76.49 -46.24 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.544 -0.753 . . . . 1.77 111.696 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -86.62 -12.21 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.532 0.682 . . . . 0.33000000000000002 110.037 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 75.46 56.65 0.06 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 113.916 -1.493 . . . . 1.47 111.508 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.34 -153.1 13.65 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.284 -0.871 . . . . 0.26000000000000001 112.161 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -120.88 149.9 41.89 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.94 -0.763 . . . . 1.0600000000000001 108.94 177.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.2 tm? -106.92 136.77 46.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.17000000000000001 110.299 -176.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 82.8 m -126.31 130.39 50.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.20999999999999999 110.796 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.6 tm? -101.47 111.83 24.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.955 -0.566 . . . . 1.51 109.489 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.91 148.87 26.02 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.883 -0.784 . . . . 0.26000000000000001 108.883 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 3.6 pt20 -123.15 138.58 54.62 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.528 -0.869 . . . . 1.9299999999999999 110.672 175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 13.7 t60 163.14 -38.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 1.79 107.16 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.715 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 22.4 p90 -57.42 -32.04 66.47 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.516 -1.22 . . . . 3.9500000000000002 111.647 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -66.07 -12.98 59.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.346 -0.388 . . . . 2.2200000000000002 111.765 -173.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 t -93.96 -15.07 25.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.625 0.25 . . . . 1.78 111.064 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -116.5 -36.03 4.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.081 0.467 . . . . 1.6299999999999999 110.852 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.629 ' CD2' ' HD2' ' A' ' 95' ' ' PRO . 5.8 t80 -95.98 129.42 34.13 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.951 -0.759 . . . . 2.8500000000000001 108.951 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.629 ' HD2' ' CD2' ' A' ' 94' ' ' PHE . 72.8 Cg_endo -73.01 20.13 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.029 2.486 . . . . 0.68999999999999995 114.27 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 63' ' ' LYS . 17.0 mt -117.06 116.97 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.133 0.492 . . . . 0.35999999999999999 110.71 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 86.7 mttt -116.84 128.79 55.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.452 -0.795 . . . . 1.3799999999999999 109.252 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 29.4 m -150.68 168.3 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.257 -171.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.03 138.26 40.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.627 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.3 mp -94.96 133.48 38.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.56 -0.745 . . . . 0.34999999999999998 111.306 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.2 m-85 -128.17 143.49 51.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.004 -0.544 . . . . 0.33000000000000002 109.98 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.853 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 9.7 m-30 -112.82 155.0 25.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.238 0.542 . . . . 0.34000000000000002 110.372 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.9 OUTLIER -110.86 126.2 54.42 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.122 -1.066 . . . . 0.25 108.122 174.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 1.011 ' HD2' HG22 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -133.42 109.13 9.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.869 0.366 . . . . 1.22 110.959 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.54 -102.88 0.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.637 -0.71 . . . . 0.41999999999999998 111.336 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 139' ' ' THR . 5.1 p -118.64 -4.52 10.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.156 0.503 . . . . 1.3100000000000001 110.217 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -100.08 116.37 31.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.204 -0.453 . . . . 2.27 111.185 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 135' ' ' LEU . 1.6 p -82.21 135.91 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.934 -0.576 . . . . 0.79000000000000004 109.723 172.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 89.6 mmm -134.65 119.59 14.03 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.8500000000000001 111.007 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.6 Cg_endo -74.42 155.96 45.71 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.522 2.148 . . . . 0.28999999999999998 112.445 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.507 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.19 142.62 30.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.31 109.767 -179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 115' ' ' GLU . 18.9 m120 -94.57 142.18 27.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.94 -0.393 . . . . 1.8500000000000001 109.94 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 26.0 m -64.81 122.1 16.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.46999999999999997 111.44 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 67.11 22.23 72.36 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.883 -0.599 . . . . 0.38 113.055 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 112' ' ' ASN . 36.2 tt0 -119.1 127.22 26.62 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.174 -0.306 . . . . 1.9299999999999999 110.174 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 115' ' ' GLU . 27.6 Cg_exo -65.23 113.02 2.25 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.527 2.151 . . . . 0.68000000000000005 111.098 172.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.507 ' HD1' HD22 ' A' ' 111' ' ' LEU . 3.9 t80 -114.85 137.88 51.43 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.613 -0.722 . . . . 0.40999999999999998 109.791 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 120' ' ' GLN . 5.4 p -59.88 110.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.535 0.683 . . . . 0.70999999999999996 112.167 -174.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.496 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.1 p -111.36 -15.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.325 -0.852 . . . . 0.23000000000000001 110.708 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.47 ' HG2' HG23 ' A' ' 118' ' ' VAL . 11.4 pt20 -55.23 -40.91 71.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 1.3500000000000001 112.042 -175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -122.76 61.87 1.0 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.466 0.651 . . . . 2.3500000000000001 110.026 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.011 HG22 ' HD2' ' A' ' 104' ' ' LYS . 47.7 pt -99.61 167.55 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.73 -0.668 . . . . 0.37 109.548 173.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.611 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.0 OUTLIER -93.01 -43.42 8.92 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.124 -0.695 . . . . 0.5 109.124 173.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.4 159.82 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.266 -0.879 . . . . 0.22 110.602 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.857 ' SD ' HG11 ' A' ' 74' ' ' VAL . 11.0 ttt -130.48 153.95 48.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.228 -0.656 . . . . 1.1599999999999999 109.228 170.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.49 ' HB3' ' HA3' ' A' ' 149' ' ' GLY . 69.6 m -152.41 155.91 38.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.482 HG23 ' SG ' ' A' ' 71' ' ' CYS . 4.1 t -121.88 109.97 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.385 -0.371 . . . . 0.27000000000000002 110.197 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD21 HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -104.45 136.69 19.14 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.426 -0.51 . . . . 0.42999999999999999 109.797 179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 71.5 Cg_endo -79.89 122.33 4.82 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.507 2.138 . . . . 0.91000000000000003 112.352 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.592 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 53.58 -78.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.009 0.818 . . . . 3.29 112.993 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -69.39 90.58 0.29 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.404 -0.427 . . . . 0.44 112.129 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.2 m -80.53 -4.34 53.57 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.611 0.364 . . . . 1.23 110.49 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 1.6 m -55.85 -19.97 13.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.5 -0.773 . . . . 1.3 112.473 -172.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.1 m -51.06 -44.51 61.17 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.245 0.545 . . . . 0.44 110.742 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.696 HD21 ' HB2' ' A' ' 148' ' ' ARG . 97.7 mt -117.97 17.53 14.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.434 -0.803 . . . . 0.37 111.714 -176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.538 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 40.2 ttmt -100.65 81.75 2.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.689 0.28 . . . . 1.6599999999999999 110.596 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.7 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 6.1 p -140.57 169.4 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.293 -0.632 . . . . 0.51000000000000001 109.293 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 137' ' ' VAL . 45.5 mmtt -55.25 -54.29 45.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.889 0.852 . . . . 2.0600000000000001 110.414 -177.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER -136.52 149.74 48.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.154 -1.385 . . . . 0.39000000000000001 110.074 -177.136 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.7 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.3 mtp -145.7 154.49 42.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.652 0.612 . . . . 0.78000000000000003 112.652 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.2 144.89 25.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.564 -0.743 . . . . 0.44 110.993 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' ' HG ' ' A' ' 103' ' ' LEU . 48.2 tttm -67.41 -31.67 72.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.922 -0.581 . . . . 1.1100000000000001 110.595 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -72.9 -38.72 66.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.525 -0.761 . . . . 0.66000000000000003 110.104 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.9 ttt -72.57 -39.59 67.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.09 -0.959 . . . . 0.47999999999999998 110.846 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.65 ' CD2' HD23 ' A' ' 103' ' ' LEU . 17.7 t80 -52.71 -55.76 20.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.29999999999999999 110.942 -174.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 146' ' ' VAL . 0.7 OUTLIER -63.06 -44.58 99.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 0.19 111.431 178.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.2 t -61.9 -37.73 85.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.064 0.459 . . . . 0.84999999999999998 110.839 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HB2' HD21 ' A' ' 135' ' ' LEU . 3.2 mmp_? -67.66 -50.1 59.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.867 -0.606 . . . . 2.48 111.042 176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 126' ' ' SER . . . -64.66 -41.3 97.79 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.776 -0.726 . . . . 0.17000000000000001 112.187 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.414 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 10.3 t30 -56.86 -37.19 70.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.784 0.29 . . . . 1.4199999999999999 111.784 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 148' ' ' ARG . 11.8 t -79.5 -25.84 41.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.93 0.395 . . . . 0.40000000000000002 110.37 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.32 -12.02 60.42 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 121.606 0.717 . . . . 1.3100000000000001 109.43 168.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.03 33.46 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 114.902 -1.044 . . . . 0.25 114.834 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.787 ' HB1' ' SG ' ' A' ' 71' ' ' CYS . . . -142.69 125.48 16.02 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 119.114 1.457 . . . . 0.19 113.249 173.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 146' ' ' VAL . 15.7 p -147.56 159.85 43.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.749 -0.659 . . . . 1.4199999999999999 111.35 167.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.611 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 8.8 tt -154.85 118.64 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.612 -0.722 . . . . 0.28000000000000003 109.351 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.0 p -120.63 145.53 47.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.587 -0.279 . . . . 1.4399999999999999 111.667 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.343 -0.836 . . . . 1.8100000000000001 110.139 171.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.669 0.271 . . . . 3.6800000000000002 110.949 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.2 -54.18 7.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.681 0.277 . . . . 2.3799999999999999 110.713 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -84.42 125.81 32.68 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.585 -0.446 . . . . 1.6100000000000001 110.042 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.16 -164.43 29.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.582 -0.818 . . . . 0.26000000000000001 111.341 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -115.86 147.5 40.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.868 0.334 . . . . 0.17999999999999999 110.99 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.68 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 4.3 m-85 -124.63 134.69 52.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.447 -0.342 . . . . 0.56999999999999995 110.424 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 19' ' ' LEU . 2.9 tm? -88.3 115.76 26.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.47 -0.937 . . . . 0.16 108.47 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -120.51 145.63 26.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 116.048 -0.524 . . . . 0.19 110.563 -174.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.654 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 78.5 t80 -97.56 134.38 40.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.652 -0.499 . . . . 0.90000000000000002 109.652 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.45 153.57 37.71 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.463 -0.569 . . . . 0.60999999999999999 109.463 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.81 3.01 46.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.54 -0.3 . . . . 2.3700000000000001 111.693 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 132.51 54.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.652 -0.499 . . . . 1.3100000000000001 109.652 172.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 57' ' ' ARG . 49.5 m 59.13 23.12 11.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.992 0.425 . . . . 1.23 110.359 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.29 29.04 17.51 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.247 -0.888 . . . . 1.3 111.123 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.654 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 153.48 102.13 0.21 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.6 -0.809 . . . . 0.39000000000000001 112.386 177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 86.2 m -136.51 150.51 48.7 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 110.024 -0.361 . . . . 0.40000000000000002 110.024 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.5 mt -103.66 145.91 29.37 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.227 0.536 . . . . 0.57999999999999996 110.15 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -137.67 128.44 27.01 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.021 -0.991 . . . . 0.19 109.523 -173.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.5 tt -109.21 109.99 30.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.672 0.749 . . . . 0.28000000000000003 109.541 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.68 ' CG1' ' HB2' ' A' ' 8' ' ' TYR . 10.5 p -91.16 124.04 43.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.446 -0.797 . . . . 0.23999999999999999 111.029 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 33.9 m95 -101.71 107.11 18.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.276 0.56 . . . . 0.31 109.579 173.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.674 ' HE2' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -149.37 175.28 11.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 110.597 -170.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -118.14 18.0 13.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.694 -1.139 . . . . 1.9399999999999999 108.162 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 26.2 tt0 -127.06 157.63 39.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.24 -1.345 . . . . 1.45 109.602 -176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -88.65 94.67 9.97 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 122.145 -0.347 . . . . 2.3500000000000001 110.382 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG13 ' HE2' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -77.34 143.75 12.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 108.971 -0.751 . . . . 1.1599999999999999 108.971 176.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -106.59 174.85 5.71 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.192 -0.458 . . . . 1.98 110.825 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.7 t30 65.35 39.16 5.4 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.687 0.756 . . . . 2.0600000000000001 110.406 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.13 150.37 27.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.319 -0.855 . . . . 0.20999999999999999 110.617 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.641 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -98.13 -23.96 15.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.419 -177.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.644 ' SD ' HG23 ' A' ' 70' ' ' ILE . 78.6 mtp -145.64 169.7 17.92 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.168 -0.469 . . . . 0.20000000000000001 111.41 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 86.0 t80 -149.51 154.48 38.83 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.769 -175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 85.5 mt -127.17 126.52 68.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.148 -0.686 . . . . 0.16 109.148 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.21 109.93 53.95 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.966 -0.753 . . . . 2.3799999999999999 108.966 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.05 130.27 15.23 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 112.403 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.425 ' H ' ' HA2' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -81.37 -45.63 15.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.679 0.752 . . . . 0.85999999999999999 109.785 172.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -87.62 162.86 16.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.46 -1.245 . . . . 2.1600000000000001 109.987 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -57.01 136.72 56.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 2.4199999999999999 110.742 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.86 135.89 48.25 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.616 -0.72 . . . . 0.72999999999999998 110.874 -175.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 89.1 Cg_exo -49.34 120.84 6.14 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.46 2.773 . . . . 0.68000000000000005 112.332 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.24 -34.78 61.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.972 -0.558 . . . . 2.2799999999999998 111.735 -173.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 47' ' ' VAL . 71.7 m-85 -69.6 -27.22 64.91 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.718 -0.393 . . . . 3.3399999999999999 110.652 -176.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD3' ' CB ' ' A' ' 42' ' ' PRO . 4.8 mptp? -67.45 -24.33 65.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.117 -0.492 . . . . 1.9399999999999999 110.977 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -77.36 -45.82 24.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.971 0.415 . . . . 0.93000000000000005 110.502 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -78.6 -40.03 23.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.405 0.52 . . . . 1.0700000000000001 112.405 -173.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -76.05 -39.28 55.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.0 0.428 . . . . 1.6599999999999999 110.896 -176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' LYS . 99.5 mtt180 -87.39 -13.97 41.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.387 -0.37 . . . . 2.0 111.274 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 64.54 12.15 7.21 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.831 -0.622 . . . . 2.2599999999999998 110.693 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.31 -13.1 66.15 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 112.324 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -104.87 127.12 52.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 2.4300000000000002 111.611 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -148.64 119.39 7.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 110.164 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' OE2' HG21 ' A' ' 18' ' ' THR . 45.2 mt-10 -87.67 131.96 34.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.658 0.742 . . . . 1.47 110.292 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.89 -60.17 2.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.958 -1.019 . . . . 0.54000000000000004 111.539 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG23 HD21 ' A' ' 59' ' ' LEU . 21.1 tt -150.77 145.69 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.021 -0.536 . . . . 0.25 109.603 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' HD3' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -130.1 171.88 12.36 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.669 -0.412 . . . . 2.23 112.043 -175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.9 t30 68.25 45.27 1.25 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.186 -0.916 . . . . 1.3999999999999999 110.431 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 56' ' ' ILE . 47.0 mt -73.75 -19.23 60.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.479 -0.782 . . . . 0.33000000000000002 110.903 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -54.56 -46.49 73.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.609 0.719 . . . . 1.76 111.202 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -87.86 -0.43 56.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.738 -1.119 . . . . 1.5900000000000001 111.861 -168.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 24.2 t70 -169.81 121.58 0.69 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.088 0.471 . . . . 1.9199999999999999 110.733 175.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HD3' HG12 ' A' ' 96' ' ' ILE . 56.3 mttp -70.43 -37.82 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.553 -0.749 . . . . 1.6799999999999999 111.907 -177.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 47.4 mmtm -59.78 -23.69 63.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.957 -0.565 . . . . 1.0700000000000001 111.119 -175.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 62' ' ' ASP . 74.9 mt -59.68 -38.06 80.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.291 -0.413 . . . . 0.34000000000000002 111.045 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.599 ' HD1' HD11 ' A' ' 19' ' ' LEU . 13.0 t80 -65.04 -35.92 82.7 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 109.719 -0.474 . . . . 0.23999999999999999 109.719 175.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -61.95 -56.04 23.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.66 0.743 . . . . 0.40000000000000002 109.281 -178.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 t -66.7 -31.5 72.21 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.104 -0.953 . . . . 1.22 110.985 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.653 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -58.81 -37.11 89.81 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.058 -1.068 . . . . 0.17000000000000001 111.003 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.644 HG23 ' SD ' ' A' ' 33' ' ' MET . 89.5 mt -60.06 -45.41 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.487 -0.357 . . . . 0.17999999999999999 110.934 172.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.9 p -63.27 -37.78 88.61 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.057 0.456 . . . . 1.1000000000000001 109.783 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 84.0 mm-40 -63.23 -31.84 73.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.565 -0.743 . . . . 1.8200000000000001 110.548 175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.544 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 91.9 t80 -70.29 -50.19 41.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.751 -0.658 . . . . 0.20000000000000001 110.328 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' SD ' ' A' ' 125' ' ' MET . 0.9 OUTLIER -67.31 -25.32 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.107 0.48 . . . . 0.28000000000000003 109.995 178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.0 ttpp -52.42 -45.07 65.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.416 -0.811 . . . . 1.8500000000000001 110.35 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 80' ' ' ILE . 13.4 tp10 -67.28 -35.94 80.54 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.228 -0.897 . . . . 1.3100000000000001 110.338 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -61.35 -34.61 75.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 0.23999999999999999 111.449 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 8.5 mtpt -74.08 -23.99 59.42 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.634 -0.506 . . . . 1.8799999999999999 109.634 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.27 -44.82 28.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.714 -0.675 . . . . 1.77 111.391 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -90.41 -10.15 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.667 0.746 . . . . 0.33000000000000002 109.918 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 70.5 63.88 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.77 -1.559 . . . . 1.47 110.946 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 83' ' ' LYS . . . -117.96 -153.24 9.56 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.188 -0.915 . . . . 0.26000000000000001 112.961 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -121.07 152.01 39.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.851 -0.796 . . . . 1.0600000000000001 108.851 176.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD11 ' HE3' ' A' ' 33' ' ' MET . 2.5 tm? -106.69 134.99 48.99 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.199 -0.297 . . . . 0.17000000000000001 110.199 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 98.7 m -123.31 127.78 49.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.20999999999999999 110.787 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 100' ' ' LEU . 2.8 tm? -98.48 110.68 23.23 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.496 -0.557 . . . . 1.51 109.496 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.55 138.41 35.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.728 -0.842 . . . . 0.26000000000000001 108.728 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' HIS . 51.6 tt0 -121.83 135.07 54.9 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.751 -0.78 . . . . 1.9299999999999999 110.4 -178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 22.1 p-80 155.85 -29.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 O-C-N 124.653 1.22 . . . . 1.79 108.311 -174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.641 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 14.2 p90 -63.99 -22.87 67.11 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.421 -0.809 . . . . 3.9500000000000002 111.121 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 8.0 p-10 -68.16 -16.74 64.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.964 -0.562 . . . . 2.2200000000000002 112.315 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.9 p -93.74 -24.01 17.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.802 -0.359 . . . . 1.78 111.439 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.6 t -98.86 -35.16 10.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 1.6299999999999999 110.634 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.21 139.87 21.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.202 -0.454 . . . . 2.8500000000000001 110.087 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.52 19.38 0.64 Allowed 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.764 2.31 . . . . 0.68999999999999995 112.901 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG12 ' HD3' ' A' ' 63' ' ' LYS . 70.5 mt -122.24 119.14 57.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.88 0.371 . . . . 0.35999999999999999 110.246 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' ' HE3' ' A' ' 130' ' ' LYS . 90.8 mttt -123.89 120.17 31.76 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.338 -0.615 . . . . 1.3799999999999999 109.338 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.1 m -142.96 168.47 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.736 0.643 . . . . 0.33000000000000002 112.736 -170.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.462 ' HB2' ' OG ' ' A' ' 132' ' ' SER . 9.6 m-20 -132.79 134.84 45.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 1.1100000000000001 109.897 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 125' ' ' MET . 4.9 mp -91.34 135.03 34.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.736 -0.665 . . . . 0.34999999999999998 110.653 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 110' ' ' PRO . 6.1 m-85 -125.33 141.25 52.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.688 0.28 . . . . 0.33000000000000002 110.549 175.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.848 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 4.3 m-30 -111.5 153.85 25.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.919 -0.582 . . . . 0.34000000000000002 110.914 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 145' ' ' PHE . 0.7 OUTLIER -117.25 120.78 39.29 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.311 -0.996 . . . . 0.25 108.311 176.051 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.641 ' HD2' HG22 ' A' ' 122' ' ' ILE . 3.4 mppt? -131.05 110.13 11.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 1.22 111.282 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.4 -101.02 1.11 Allowed Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.85 -0.9 . . . . 0.41999999999999998 110.85 -177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.5 p -125.31 -1.97 7.56 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.138 0.494 . . . . 1.3100000000000001 109.979 173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -98.22 118.61 35.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.221 0.534 . . . . 2.27 110.983 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.545 HG21 ' O ' ' A' ' 135' ' ' LEU . 2.1 p -87.79 132.23 33.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.543 -0.753 . . . . 0.79000000000000004 109.769 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 63.2 mtt -131.76 125.55 20.45 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.987 -0.552 . . . . 1.8500000000000001 110.308 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 72.5 Cg_endo -74.09 154.24 47.06 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.426 2.084 . . . . 0.28999999999999998 112.149 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.594 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -83.86 139.24 32.77 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.58 142.19 31.38 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.12 -0.491 . . . . 1.8500000000000001 110.34 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.2 m -57.81 120.38 8.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.513 -0.767 . . . . 0.46999999999999997 112.259 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.17 34.18 89.25 Favored Glycine 0 N--CA 1.452 -0.3 0 CA-C-N 115.724 -0.671 . . . . 0.38 113.503 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -125.0 128.25 24.89 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.99 111.33 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.118 1.878 . . . . 0.68000000000000005 110.553 171.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' HD1' HD22 ' A' ' 111' ' ' LEU . 2.8 t80 -115.65 136.65 52.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.267 -0.879 . . . . 0.40999999999999998 109.521 -174.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' HA ' ' HG3' ' A' ' 83' ' ' LYS . 3.4 p -57.13 117.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.539 . . . . 0.70999999999999996 112.42 -173.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.632 HG11 ' HB1' ' A' ' 77' ' ' ALA . 8.0 p -121.03 -17.59 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.314 -0.857 . . . . 0.23000000000000001 110.584 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -56.47 -44.56 80.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.473 -0.785 . . . . 1.3500000000000001 112.979 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -118.51 40.85 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.084 0.469 . . . . 2.3500000000000001 111.69 -174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 104' ' ' LYS . 29.7 pt -86.98 178.97 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.058 0.456 . . . . 0.37 111.094 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.563 ' HB2' HD12 ' A' ' 103' ' ' LEU . 2.6 m-20 -102.73 -43.54 5.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.5 109.99 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.19 35.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.781 -0.645 . . . . 0.22 110.882 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.848 ' SD ' ' HE1' ' A' ' 102' ' ' PHE . 10.0 ttt -132.38 153.13 51.09 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 1.1599999999999999 109.874 171.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' SER . 81.7 p -140.52 165.94 26.07 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.998 0.428 . . . . 1.22 110.709 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.7 t -127.08 107.7 17.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.949 -0.76 . . . . 0.27000000000000002 108.949 172.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.522 HD12 ' CB ' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -105.4 137.72 19.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.093 -0.706 . . . . 0.42999999999999999 109.093 178.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 87.6 Cg_endo -84.7 119.93 2.31 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.98 1.787 . . . . 0.91000000000000003 112.974 175.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 130' ' ' LYS . 10.6 mmpt? 50.63 -66.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.712 1.375 . . . . 3.29 114.712 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -72.36 54.6 1.54 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.048 -0.821 . . . . 0.44 111.048 173.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 99' ' ' ASP . 8.0 m -71.44 -5.72 34.98 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.68 0.792 . . . . 1.23 111.031 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 12.9 m -62.58 -4.47 1.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.602 -0.726 . . . . 1.3 111.801 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 m -49.79 -46.53 50.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.328 0.585 . . . . 0.44 110.053 169.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.654 HD21 ' CB ' ' A' ' 148' ' ' ARG . 80.8 mt -116.48 22.12 13.02 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.047 -0.979 . . . . 0.37 111.568 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 38.2 ttpt -102.43 81.88 2.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.875 0.369 . . . . 1.6599999999999999 110.559 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' CG1' ' HG3' ' A' ' 140' ' ' MET . 7.5 p -139.82 169.35 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.702 -0.481 . . . . 0.51000000000000001 109.702 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 137' ' ' VAL . 19.3 mttt -59.35 -46.76 87.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.945 0.402 . . . . 2.0600000000000001 111.246 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.41 146.34 33.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.39000000000000001 110.891 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.733 ' HG3' ' CG1' ' A' ' 137' ' ' VAL . 1.8 mtp -145.12 154.4 42.43 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.699 0.629 . . . . 0.78000000000000003 112.699 -172.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.46 141.57 28.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.302 -0.863 . . . . 0.44 110.826 175.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.534 ' O ' HG12 ' A' ' 146' ' ' VAL . 77.1 tttt -62.59 -32.64 73.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 1.1100000000000001 110.4 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.87 -41.14 75.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.423 -0.808 . . . . 0.66000000000000003 109.89 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 ttt -70.75 -42.86 69.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.178 -0.919 . . . . 0.47999999999999998 110.311 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.639 ' CD2' HD23 ' A' ' 103' ' ' LEU . 28.2 t80 -52.23 -55.93 18.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.734 -0.667 . . . . 0.29999999999999999 111.523 -173.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.737 ' HA ' ' OG ' ' A' ' 155' ' ' SER . 1.1 p -62.37 -47.48 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.131 -0.486 . . . . 0.19 111.606 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 42.1 t -61.59 -36.86 81.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.094 0.473 . . . . 0.84999999999999998 110.706 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.654 ' CB ' HD21 ' A' ' 135' ' ' LEU . 16.1 mmt180 -66.59 -52.89 40.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.762 -0.654 . . . . 2.48 111.334 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.22 -35.35 91.43 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.401 -0.904 . . . . 0.17000000000000001 111.428 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -61.89 -34.96 76.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.651 0.241 . . . . 1.4199999999999999 111.651 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 148' ' ' ARG . 13.3 t -80.35 -24.71 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.452 -0.499 . . . . 0.40000000000000002 110.256 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.522 ' CB ' HD12 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -74.66 -10.89 59.96 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.643 0.735 . . . . 1.3100000000000001 109.637 168.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 107.56 -13.83 39.03 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 114.649 -1.16 . . . . 0.25 114.086 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.59 124.89 14.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.414 1.107 . . . . 0.19 113.021 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.737 ' OG ' ' HA ' ' A' ' 146' ' ' VAL . 4.6 t -150.91 166.34 30.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.659 -0.7 . . . . 1.4199999999999999 109.838 163.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 16.1 tt -155.85 118.12 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.208 -0.905 . . . . 0.28000000000000003 109.296 -177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 p -112.44 145.71 39.69 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.346 -0.388 . . . . 1.4399999999999999 111.305 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.456 -0.783 . . . . 1.8100000000000001 110.64 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.523 0.202 . . . . 3.6800000000000002 111.363 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.34 -58.97 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.372 0.508 . . . . 2.3799999999999999 112.372 -173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -57.09 131.76 50.86 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.332 0.587 . . . . 1.6100000000000001 111.612 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 149.99 -161.48 28.89 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.523 -0.762 . . . . 0.26000000000000001 111.348 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 35' ' ' ILE . . . -121.32 150.85 40.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.974 0.387 . . . . 0.17999999999999999 110.343 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.697 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 6.6 m-85 -129.74 131.74 46.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.466 -0.333 . . . . 0.56999999999999995 110.807 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 19' ' ' LEU . 2.7 tm? -87.03 119.23 27.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.677 -0.86 . . . . 0.16 108.677 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -122.53 152.19 26.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.379 -0.373 . . . . 0.19 110.511 -175.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.605 ' CE1' ' HA2' ' A' ' 17' ' ' GLY . 59.8 t80 -97.52 132.82 42.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.589 -0.523 . . . . 0.90000000000000002 109.589 172.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -121.22 147.06 46.14 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.78 -0.822 . . . . 0.60999999999999999 108.78 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.4 29.36 2.91 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.955 0.407 . . . . 2.3700000000000001 110.303 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.98 -77.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.964 -0.562 . . . . 1.3100000000000001 111.599 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 58' ' ' ASN . 23.8 t -86.09 47.24 1.43 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.856 -0.794 . . . . 1.23 108.856 176.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 57.35 24.62 10.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.913 -1.04 . . . . 1.3 110.72 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.605 ' HA2' ' CE1' ' A' ' 11' ' ' PHE . . . 145.97 104.56 0.42 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.67 -0.776 . . . . 0.39000000000000001 111.431 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.5 m -142.99 153.63 43.19 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.708 -0.479 . . . . 0.40000000000000002 109.708 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 ' HA3' ' A' ' 69' ' ' GLY . 17.8 mt -103.55 149.55 24.77 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.57999999999999996 110.198 175.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -138.77 128.18 24.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.177 -0.92 . . . . 0.19 109.57 -175.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tt -108.43 115.11 48.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.28000000000000003 109.616 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 28' ' ' VAL . 9.1 p -90.81 128.09 42.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.302 -0.863 . . . . 0.23999999999999999 110.523 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 7' ' ' ALA . 48.8 m95 -105.57 107.97 19.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.315 -0.624 . . . . 0.31 109.315 172.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -148.71 173.81 12.84 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.32 -0.855 . . . . 1.3600000000000001 110.266 -174.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -112.02 6.94 19.62 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.403 -0.817 . . . . 1.9399999999999999 109.109 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' H ' ' HG2' ' A' ' 24' ' ' LYS . 43.7 mt-10 -121.24 179.02 4.54 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.804 -1.089 . . . . 1.45 110.738 -176.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -78.45 135.9 37.5 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.093 -0.503 . . . . 2.3500000000000001 111.207 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.722 HG21 HG11 ' A' ' 22' ' ' VAL . 66.2 t -120.64 109.8 26.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.019 -0.734 . . . . 1.1599999999999999 109.019 171.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -86.18 177.11 7.63 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.258 -0.428 . . . . 1.98 110.791 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 68.3 20.38 8.74 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.633 0.583 . . . . 2.0600000000000001 111.023 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 154.45 17.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.275 0.56 . . . . 0.20999999999999999 111.449 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.701 ' HG ' ' CB ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -97.98 -27.35 14.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.216 -0.902 . . . . 0.38 109.895 -177.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 70' ' ' ILE . 80.0 mtp -147.36 170.05 18.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.922 -0.581 . . . . 0.20000000000000001 110.737 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 82.9 t80 -149.48 153.69 37.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.813 0.339 . . . . 0.23000000000000001 111.059 -174.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 80.8 mt -124.34 130.82 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.893 -0.594 . . . . 0.16 109.554 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 9.8 tppt? -109.49 108.73 60.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.883 -0.414 . . . . 2.3799999999999999 109.883 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 80' ' ' ILE . 13.8 Cg_exo -73.53 127.69 11.99 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 C-N-CA 122.184 1.923 . . . . 0.34999999999999998 112.217 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 82' ' ' GLY . 80.7 p -77.89 -38.41 45.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.508 0.67 . . . . 0.85999999999999999 109.757 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -96.24 172.54 7.9 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.967 -1.015 . . . . 2.1600000000000001 109.168 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -69.95 133.37 47.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.25 0.548 . . . . 2.4199999999999999 110.071 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.26 137.59 48.97 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.105 -0.952 . . . . 0.72999999999999998 111.203 -173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.4 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . 74.1 Cg_exo -48.41 119.32 3.99 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.533 2.822 . . . . 0.68000000000000005 111.934 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -69.23 -37.5 78.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.907 -0.588 . . . . 2.2799999999999998 111.563 -171.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.498 ' HA ' HG12 ' A' ' 47' ' ' VAL . 89.8 m-85 -71.49 -24.71 62.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.848 0.356 . . . . 3.3399999999999999 111.299 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 13.8 mptt -67.81 -18.01 64.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.782 0.325 . . . . 1.9399999999999999 111.295 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.47 -51.97 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.962 0.41 . . . . 0.93000000000000005 110.411 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 44' ' ' PHE . 7.1 p -70.11 -39.9 77.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.757 -0.656 . . . . 1.0700000000000001 111.556 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -72.9 -28.18 62.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.28 0.562 . . . . 1.6599999999999999 110.389 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 1.0 OUTLIER -84.17 -19.61 33.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.813 -0.631 . . . . 2.0 109.87 178.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 28.7 t-20 69.77 7.66 6.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.979 0.895 . . . . 2.2599999999999998 109.526 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.65 -13.54 28.94 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.154 -0.93 . . . . 0.46000000000000002 111.775 -174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 29.0 mtpp -107.5 124.72 50.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.454 0.302 . . . . 2.4300000000000002 110.798 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 3.3 t-20 -147.52 119.16 7.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.248 -0.581 . . . . 2.0499999999999998 111.301 175.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -84.64 118.54 24.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.577 -0.738 . . . . 1.47 109.449 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.3 mt -79.56 -63.53 1.39 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.842 -1.072 . . . . 0.54000000000000004 111.356 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 59' ' ' LEU . 18.1 tt -140.98 146.4 23.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.244 -0.889 . . . . 0.25 108.747 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 58' ' ' ASN . 4.9 ppt_? -133.61 171.45 14.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.183 -0.607 . . . . 2.23 112.543 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 57' ' ' ARG . 3.8 t-20 66.33 40.76 3.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.658 -1.155 . . . . 1.3999999999999999 110.612 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 HD21 HG23 ' A' ' 56' ' ' ILE . 38.7 mt -65.35 -18.91 65.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.278 -0.873 . . . . 0.33000000000000002 110.497 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.48 -46.49 80.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.76 111.432 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 75.2 m -86.48 -11.39 51.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.976 -1.011 . . . . 1.5900000000000001 111.372 -171.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG ' ' A' ' 65' ' ' LEU . 21.4 t70 -160.77 118.29 2.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.935 -0.575 . . . . 1.9199999999999999 110.266 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.88 -30.94 59.03 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.6799999999999999 110.892 -177.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 67' ' ' TYR . 33.5 mmtp -59.91 -25.35 65.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.281 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 56' ' ' ILE . 80.6 mt -58.58 -38.29 77.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.145 -0.479 . . . . 0.34000000000000002 111.252 173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.651 ' HD1' HD11 ' A' ' 19' ' ' LEU . 11.4 t80 -63.19 -33.45 75.5 Favored 'General case' 0 C--O 1.228 -0.067 0 N-CA-C 109.776 -0.453 . . . . 0.23999999999999999 109.776 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.523 ' O ' ' HB ' ' A' ' 70' ' ' ILE . 0.5 OUTLIER -62.3 -56.41 18.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.315 0.579 . . . . 0.40000000000000002 109.46 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -64.96 -34.71 79.07 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.22 111.058 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -56.87 -31.78 61.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.297 -0.954 . . . . 0.17000000000000001 111.341 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.612 ' O ' HG13 ' A' ' 74' ' ' VAL . 90.4 mt -64.39 -48.28 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.438 -0.381 . . . . 0.17999999999999999 111.042 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' HG22 ' A' ' 74' ' ' VAL . 13.9 p -64.48 -37.4 87.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.157 0.503 . . . . 1.1000000000000001 109.775 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 68' ' ' SER . 82.5 mm-40 -63.69 -29.93 71.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.435 -0.802 . . . . 1.8200000000000001 110.478 175.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.556 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 66.8 t80 -72.81 -49.48 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.844 -0.617 . . . . 0.20000000000000001 110.603 176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG11 ' SD ' ' A' ' 125' ' ' MET . 1.0 OUTLIER -63.73 -24.42 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.303 0.573 . . . . 0.28000000000000003 109.843 179.42 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 87.7 tttt -57.17 -41.16 78.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.114 -0.948 . . . . 1.8500000000000001 111.286 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 80' ' ' ILE . 20.1 mm-40 -65.24 -33.83 76.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.314 0.578 . . . . 1.3100000000000001 110.069 177.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -68.74 -32.38 72.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.23999999999999999 110.951 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HD2' ' CD1' ' A' ' 158' ' ' PHE . 3.2 mtmp? -73.01 -22.79 60.6 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.087 -0.708 . . . . 1.8799999999999999 109.087 174.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -44.43 26.22 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.582 -0.735 . . . . 1.77 111.614 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -92.37 -9.01 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.816 0.817 . . . . 0.33000000000000002 109.899 -178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 70.04 55.91 0.31 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.652 -1.613 . . . . 1.47 111.369 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' A' ' 38' ' ' THR . . . -110.22 -142.99 9.57 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.317 -0.944 . . . . 0.26000000000000001 113.588 178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -122.09 156.31 33.86 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.884 -0.784 . . . . 1.0600000000000001 108.884 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.476 HD11 ' CE ' ' A' ' 33' ' ' MET . 2.5 tm? -113.2 132.49 55.47 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.609 -0.436 . . . . 0.17000000000000001 109.914 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 34' ' ' PHE . 95.6 m -120.66 123.5 42.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.002 -0.544 . . . . 0.20999999999999999 110.748 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 33' ' ' MET . 17.1 tp -93.44 106.66 18.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.085 -0.507 . . . . 1.51 110.106 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.27 149.61 35.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.611 -0.515 . . . . 0.26000000000000001 109.611 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.464 ' HG3' ' OD2' ' A' ' 91' ' ' ASP . 51.1 tt0 -122.21 135.97 54.84 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.321 -0.552 . . . . 1.9299999999999999 110.15 175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 83.9 t60 161.71 -50.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.992 -1.003 . . . . 1.79 108.501 -171.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.701 ' CB ' ' HG ' ' A' ' 32' ' ' LEU . 17.4 p90 -56.24 -33.36 65.33 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.207 -0.906 . . . . 3.9500000000000002 111.845 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 88' ' ' GLN . 13.0 p-10 -66.97 -15.05 63.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.113 0.412 . . . . 2.2200000000000002 112.113 -172.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 m -87.32 -19.17 28.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.865 0.364 . . . . 1.78 111.052 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -110.97 -34.55 6.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.158 0.504 . . . . 1.6299999999999999 110.485 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.9 143.48 26.19 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.0 -0.545 . . . . 2.8500000000000001 110.063 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.01 -9.23 17.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.758 2.306 . . . . 0.68999999999999995 113.33 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.93 112.28 25.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.215 0.531 . . . . 0.35999999999999999 111.448 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.568 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 15.3 ptpt -124.14 138.37 54.43 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.26 -0.882 . . . . 1.3799999999999999 109.787 174.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 17.3 m -152.34 174.68 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.621 -0.718 . . . . 0.33000000000000002 110.88 -167.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 7.9 m-20 -133.25 136.44 45.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.742 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.528 HD23 ' HE1' ' A' ' 125' ' ' MET . 5.2 mp -98.06 134.5 41.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 111.057 -177.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 132' ' ' SER . 6.2 m-85 -129.29 140.81 51.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.581 -0.282 . . . . 0.33000000000000002 110.781 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.856 ' HE1' ' SD ' ' A' ' 125' ' ' MET . 7.7 m-30 -110.95 147.74 34.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.215 0.531 . . . . 0.34000000000000002 111.214 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 123' ' ' ASP . 0.6 OUTLIER -107.88 117.85 35.19 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.222 -1.029 . . . . 0.25 108.222 174.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 108.54 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.956 0.408 . . . . 1.22 110.376 172.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.35 -99.95 0.84 Allowed Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.359 -0.696 . . . . 0.41999999999999998 111.359 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 139' ' ' THR . 38.0 m -127.5 -3.42 6.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.16 0.505 . . . . 1.3100000000000001 109.796 173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -98.92 114.7 27.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 2.27 110.757 -177.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 140' ' ' MET . 7.2 p -83.91 141.26 15.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.79000000000000004 110.492 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.6 mtt -139.04 124.24 11.85 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.057 -0.519 . . . . 1.8500000000000001 110.703 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 101' ' ' TYR . 64.9 Cg_endo -71.58 156.78 57.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.711 2.274 . . . . 0.28999999999999998 112.331 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 HD22 ' HD1' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -84.47 134.42 34.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.081 -0.509 . . . . 0.31 109.714 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -89.91 131.23 35.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.448 -0.575 . . . . 1.8500000000000001 109.448 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 13.6 m -56.34 121.13 8.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.46999999999999997 112.01 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.41 16.54 75.62 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.792 -0.64 . . . . 0.38 113.41 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -112.8 122.67 35.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.524 -0.547 . . . . 1.9299999999999999 109.524 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.06 110.76 1.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.841 1.694 . . . . 0.68000000000000005 110.061 172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.408 ' HD1' HD22 ' A' ' 111' ' ' LEU . 6.5 t80 -115.39 144.78 43.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.566 -0.743 . . . . 0.40999999999999998 109.955 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 2.7 p -57.35 108.35 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.617 0.722 . . . . 0.70999999999999996 112.667 -173.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.669 HG11 ' HB1' ' A' ' 77' ' ' ALA . 13.0 p -111.28 -11.16 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 109.479 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -69.36 121.05 16.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.699 -0.682 . . . . 1.3500000000000001 110.515 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 62.22 39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 2.3500000000000001 111.104 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.6 pt -76.29 176.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.578 -0.897 . . . . 0.37 108.578 168.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 103' ' ' LEU . 1.2 m-20 -94.57 -46.96 6.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.365 -0.605 . . . . 0.5 109.365 174.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -158.13 164.37 36.69 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.977 -0.556 . . . . 0.22 110.603 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.864 ' SD ' HG11 ' A' ' 74' ' ' VAL . 9.9 ttt -135.42 151.83 50.81 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.341 -0.614 . . . . 1.1599999999999999 109.341 170.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' MET . 69.7 m -147.06 155.79 42.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.991 -0.374 . . . . 1.22 109.991 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 154' ' ' ALA . 2.3 t -124.93 110.23 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.387 -0.37 . . . . 0.27000000000000002 110.276 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -105.2 140.42 21.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.15 -0.685 . . . . 0.42999999999999999 109.15 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 95.1 Cg_endo -82.48 121.71 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 121.924 1.749 . . . . 0.91000000000000003 112.599 176.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.568 ' HE2' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 56.1 -72.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.608 0.966 . . . . 3.29 113.608 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.95 74.39 0.8 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.496 -0.383 . . . . 0.44 112.466 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . 63.5 p -77.93 -6.0 52.96 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 122.669 0.388 . . . . 1.23 110.791 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 136' ' ' LYS . 18.0 p -56.02 -18.71 10.16 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.767 -0.651 . . . . 1.3 111.455 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.0 m -48.63 -46.83 40.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.914 -0.585 . . . . 0.44 110.852 173.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 148' ' ' ARG . 81.8 mt -116.31 8.23 14.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 0.37 111.554 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HE2' ' OH ' ' A' ' 101' ' ' TYR . 32.5 ttmt -92.05 81.82 5.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.902 0.382 . . . . 1.6599999999999999 109.98 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.8 153.13 29.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.973 -0.558 . . . . 0.51000000000000001 109.751 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -44.97 -45.16 10.38 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.804 0.335 . . . . 2.0600000000000001 111.884 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -139.28 149.62 44.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 175.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -132.89 139.9 47.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.805 0.335 . . . . 0.78000000000000003 111.081 -166.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' MET . . . -88.3 126.1 35.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.326 -0.62 . . . . 0.44 109.326 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.481 ' O ' HG12 ' A' ' 146' ' ' VAL . 82.8 tttt -61.03 -28.97 69.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.011 0.434 . . . . 1.1100000000000001 110.967 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.53 -41.17 66.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.643 -0.708 . . . . 0.66000000000000003 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' ALA . 14.4 ttt -76.92 -33.45 57.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.47999999999999998 110.286 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.548 ' HD2' ' SD ' ' A' ' 140' ' ' MET . 55.6 t80 -52.86 -55.77 20.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 111.347 -177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -65.73 -43.43 93.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.794 -0.639 . . . . 0.19 111.175 178.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.8 t -62.51 -41.09 98.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.777 0.322 . . . . 0.84999999999999998 110.99 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.721 ' HB2' HD21 ' A' ' 135' ' ' LEU . 4.2 mmp_? -67.33 -33.32 75.01 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.976 0.417 . . . . 2.48 111.244 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -76.63 -46.87 10.82 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.506 -0.854 . . . . 0.17000000000000001 111.902 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 155' ' ' SER . 6.7 t30 -61.47 -32.18 72.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.59 0.234 . . . . 1.4199999999999999 111.29 -178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 148' ' ' ARG . 14.4 t -72.77 -23.66 60.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.806 0.336 . . . . 0.40000000000000002 110.357 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -92.31 -1.29 57.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 1.3100000000000001 110.134 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.29 -13.67 36.64 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 114.804 -1.089 . . . . 0.25 115.071 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 127' ' ' VAL . . . -143.54 125.32 15.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.34 1.57 . . . . 0.19 113.437 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 150' ' ' ASN . 17.5 p -147.22 162.71 38.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.416 -0.811 . . . . 1.4199999999999999 110.412 166.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 75' ' ' LYS . 11.5 tt -155.74 117.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.868 -0.606 . . . . 0.28000000000000003 109.614 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 77.4 p -120.14 125.71 48.89 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.738 -0.467 . . . . 1.4399999999999999 109.738 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.614 ' CD1' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.044 0 CA-C-O 118.725 -0.655 . . . . 1.8100000000000001 111.524 -172.812 . . . . . . . . 2 2 . 1 stop_ save_